data_2kbs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kbs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.81 0.338 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -105.16 147.79 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -109.43 138.17 46.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.0 128.86 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.456 ' CD2' ' CG2' ' A' ' 86' ' ' THR . 3.9 m-85 -114.58 116.64 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mm -104.3 124.68 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.678 0.275 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.507 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 102.62 20.39 11.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.304 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 48' ' ' SER . 0.5 OUTLIER -132.62 158.57 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.213 0.506 . . . . 0.0 111.581 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 m -114.82 173.73 6.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.649 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 pt -143.53 145.54 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.103 0.478 . . . . 0.0 111.71 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -129.03 162.46 27.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.38 143.83 32.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.781 0.324 . . . . 0.0 110.443 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.67 175.14 43.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.073 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD2' ' CD1' ' A' ' 97' ' ' LEU . 55.8 Cg_endo -69.55 -160.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.843 2.362 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -85.87 -27.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.301 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -66.43 -32.65 74.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -151.08 70.48 8.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.35 137.51 28.44 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.624 2.216 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.05 -175.44 46.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.389 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 67' ' ' PHE . 22.4 mm -92.93 116.58 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.424 ' CE2' ' HA2' ' A' ' 94' ' ' GLY . 2.6 m-85 -105.12 170.37 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.82 134.06 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.024 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.1 -169.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.438 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -51.59 149.24 4.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 25' ' ' CYS . 6.0 m -130.17 155.43 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -95.89 147.11 32.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.46 144.62 22.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.39 -24.23 26.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.507 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -74.06 -179.08 3.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -70.48 -35.9 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 45.1 t -52.83 -51.25 61.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -33.73 75.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -31.13 71.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.14 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 m -88.54 -20.82 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.392 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.03 39.0 3.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.074 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.404 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 8.0 mt -90.38 159.31 16.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.088 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 179.49 171.24 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 2.3 mt -60.35 147.71 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.66 -41.93 2.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.9 m-20 -55.15 169.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.657 0.265 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.8 113.03 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.094 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -69.22 121.96 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.9 m -111.55 8.54 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.775 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.37 147.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.986 0.422 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 47.5 t -153.68 100.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.856 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 63.47 30.42 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.83 -29.62 12.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.429 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.4 118.48 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.72 123.26 20.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 3.1 m-85 -98.86 19.83 14.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -41.15 96.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -139.13 28.54 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.675 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.29 140.99 50.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.74 154.69 36.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -58.29 -54.61 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.001 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -57.2 -40.0 76.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.49 -40.76 88.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.27 83.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.68 -36.13 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.44 -58.96 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.67 -40.46 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.207 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.03 -31.95 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -34.77 38.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.4 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.068 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -97.8 119.29 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -67.17 -39.76 86.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.709 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 p -113.39 107.17 15.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.548 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.31 146.34 32.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.954 0.407 . . . . 0.0 111.303 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.456 ' CG2' ' CD2' ' A' ' 14' ' ' PHE . 31.3 m -85.22 123.03 30.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.064 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 pt -118.25 126.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.534 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -95.46 112.37 24.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.465 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.419 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -112.74 149.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.039 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.4 t -122.09 115.45 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -56.71 137.76 53.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.524 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.12 -17.49 0.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.176 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.73 -22.19 45.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 110.991 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.424 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -117.11 -30.69 1.87 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.551 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -56.16 -34.54 66.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 0.0 111.027 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -42.05 78.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.426 ' CD1' ' HD2' ' A' ' 31' ' ' PRO . 3.2 mm? -71.24 -48.59 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 2.1 m-85 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 34.5 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.778 0.323 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 27.0 m -134.89 148.13 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.12 127.83 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.888 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.835 0.35 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -99.2 145.54 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.222 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 139.07 39.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.778 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.4 t -145.99 145.51 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -131.93 121.92 24.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mm -108.27 129.69 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.934 0.397 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 113.11 27.26 3.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.205 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.18 156.05 36.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.94 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.9 t -114.87 136.09 53.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.026 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.9 pt -101.64 146.95 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 111.443 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 p -129.0 161.84 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.723 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 144.78 31.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.77 173.73 42.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.606 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.21 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.537 2.158 . . . . 0.0 112.365 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 mt -68.22 -28.12 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -66.76 -26.84 67.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.216 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.51 76.78 5.47 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.22 133.28 12.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.514 2.142 . . . . 0.0 112.263 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.15 -179.95 38.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.0 mm -88.71 114.6 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 20.2 m-85 -109.03 173.55 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.3 mm -107.83 131.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.269 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.22 -168.98 1.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.528 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -45.87 140.3 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.3 t -108.66 157.44 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -108.15 121.44 43.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.53 151.17 39.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.4 2.067 . . . . 0.0 112.135 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 53.51 24.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.41 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -151.61 -169.28 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.08 -46.56 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.394 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 53' ' ' LEU . 23.0 t -56.26 -42.01 76.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -38.77 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.98 -35.61 81.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.91 -27.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.47 30.32 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.589 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.424 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 11.7 mt -75.73 166.36 23.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -179.31 155.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.783 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mt -53.16 131.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.008 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.12 -25.72 8.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.284 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -69.11 166.52 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' HG3' ' CE2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -148.05 115.18 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.084 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 59' ' ' ILE . 46.8 mt -69.27 117.26 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.6 m -98.71 -15.36 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.73 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -158.34 155.05 28.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 HG22 ' CG ' ' A' ' 67' ' ' PHE . 47.8 t -152.12 103.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 60.01 31.3 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.9 -28.38 13.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.06 126.39 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.126 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.18 112.91 3.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CG ' HG22 ' A' ' 62' ' ' VAL . 1.2 m-85 -98.75 11.68 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -72.3 -44.29 62.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.712 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -123.43 30.5 6.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.414 HD21 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.0 146.96 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.914 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.42 167.59 20.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -66.3 -55.16 17.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -39.11 80.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.63 -37.82 82.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.752 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -66.15 -46.07 78.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.962 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.8 t -68.71 -42.46 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.044 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -56.07 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -58.84 -43.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.79 -31.42 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -69.67 -67.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.11 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.27 136.1 38.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -51.19 7.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.622 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.0 p -106.14 83.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.02 139.81 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.0 m -90.49 116.85 28.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.24 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.4 pt -111.91 129.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.71 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.27 108.9 21.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.449 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.82 146.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.15 112.59 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 110.977 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -56.6 143.37 36.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.347 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 82.75 -19.48 0.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.779 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.62 -20.68 49.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.88 -30.85 2.05 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.533 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -56.62 -34.28 67.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.52 0.2 . . . . 0.0 111.398 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.23 -49.8 31.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.463 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 9.3 mt -71.15 -43.28 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.831 0.348 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 33.5 m -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.31 143.43 27.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.944 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -97.91 135.51 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -94.39 140.44 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.6 t -145.52 137.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -124.76 115.99 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.8 mm -101.15 127.64 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.232 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.616 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 48' ' ' SER . 13.5 tp . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 106.75 23.82 6.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.27 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 2.8 t -145.09 164.85 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 111.016 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 m -114.94 173.75 6.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -142.81 145.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 111.377 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.24 161.95 28.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.789 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.95 141.9 35.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.745 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.03 172.95 34.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.917 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.65 -165.71 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.34 -25.54 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.26 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.15 -5.48 49.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.283 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -171.01 59.31 0.29 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.773 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.27 144.54 56.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.606 2.204 . . . . 0.0 112.315 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.13 174.87 33.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.278 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 75' ' ' ALA . 11.8 mm -89.58 113.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.898 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 3.6 m-85 -101.96 172.51 6.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.3 mm -109.21 136.26 45.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.234 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.05 -169.35 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.375 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -45.02 145.72 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.73 151.32 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -105.43 124.02 37.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 159.79 8.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.045 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.01 50.24 67.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.422 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 2.5 m -141.05 -173.62 3.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.733 0.301 . . . . 0.0 110.912 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.9 mt -78.15 -42.32 32.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -52.87 -40.11 63.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.939 0.4 . . . . 0.0 110.572 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.33 68.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.611 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -37.15 79.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.817 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.2 m -83.05 -30.22 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.72 52.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.0 mt -97.63 164.89 12.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.12 162.42 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 4.1 mt -58.02 140.9 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 -37.16 3.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.257 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.51 156.14 13.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.756 0.312 . . . . 0.0 110.637 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -140.4 119.09 12.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -69.42 117.13 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.614 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.64 -16.01 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.714 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -155.52 148.36 24.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.402 . . . . 0.0 111.044 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 41.8 t -147.66 105.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 55.92 32.66 20.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.8 23.41 38.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.659 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.21 120.16 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.326 . . . . 0.0 111.063 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -65.14 111.92 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.433 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 2.3 m-85 -95.78 19.84 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.86 -41.07 45.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -123.61 28.04 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.694 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.52 148.98 26.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.45 164.33 17.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -59.37 -48.95 79.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -60.63 -41.85 95.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.0 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -45.73 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . . . -59.07 -47.71 84.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.0 t -66.87 -43.47 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -58.13 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.28 -44.58 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 0.0 111.094 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.43 -31.51 72.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 t -66.56 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.56 131.76 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -77.66 -55.69 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.8 m -100.03 83.03 2.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.84 141.87 46.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -89.85 116.94 28.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.02 126.51 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 0.0 111.542 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -96.04 122.9 39.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 145.94 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.409 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.415 ' CG1' ' HB1' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -111.18 126.17 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.298 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -65.91 132.11 47.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.525 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 85.54 -19.42 0.32 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.627 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.415 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -53.6 -24.18 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.52 -30.77 2.97 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -34.56 66.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.624 0.25 . . . . 0.0 111.282 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.65 -50.01 44.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.463 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 18.9 mt -71.52 -41.03 69.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.005 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.193 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 30.6 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 32.5 m -111.68 145.09 39.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -98.06 111.78 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.842 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.99 0.424 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -102.01 116.85 33.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HE3' ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -86.23 131.88 34.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.763 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 40.1 t -140.75 149.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.286 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 86' ' ' THR . 5.1 m-85 -128.32 131.59 48.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.705 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.8 131.29 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.38 2.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.063 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.419 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 1.3 t -160.23 160.71 33.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.0 110.486 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -114.36 173.45 6.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.53 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 27' ' ' ILE . 10.0 pt -135.29 153.5 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.41 . . . . 0.0 111.354 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 p -131.29 162.68 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.8 p -104.61 140.79 37.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 175.31 43.58 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.716 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.06 -167.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.646 2.231 . . . . 0.0 112.586 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.9 mt -78.2 -21.42 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.257 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -71.92 -30.31 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.1 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 35' ' ' PRO . 11.2 mttm -147.53 64.77 8.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 21.8 Cg_exo -64.7 114.45 2.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.629 2.22 . . . . 0.0 112.014 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 -157.38 8.99 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 HG13 ' CD2' ' A' ' 67' ' ' PHE . 19.7 mm -111.67 118.0 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.053 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CZ ' ' HA2' ' A' ' 94' ' ' GLY . 2.1 m-85 -100.36 172.28 7.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -118.74 121.62 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.553 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.33 -169.5 2.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.611 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -54.34 141.99 28.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 25' ' ' CYS . 1.7 m -119.71 153.48 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 147.07 32.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.38 172.74 15.75 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.29 33.89 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.603 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.7 p -119.11 -171.76 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.788 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.4 mt -78.0 -44.03 27.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 25' ' ' CYS . 1.5 t -53.05 -46.13 68.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.533 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -36.28 75.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.564 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.06 -38.5 83.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' HB ' ' CG1' ' A' ' 13' ' ' VAL . 21.0 m -80.36 -29.69 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 36.18 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.377 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 mt -85.06 161.05 19.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.0 166.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.674 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.86 144.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.94 -13.3 45.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.646 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.5 m-20 -86.32 162.32 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -142.85 114.93 8.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.07 117.19 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.851 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.7 m -106.86 6.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.764 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -177.15 149.89 0.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.843 0.354 . . . . 0.0 111.136 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.422 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 58.1 t -153.84 112.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 56.95 29.47 16.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.73 -26.18 19.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.45 124.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.899 0.38 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.22 114.88 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 37' ' ' ILE . 1.9 m-85 -95.75 22.31 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -53.8 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.642 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -111.78 28.49 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.17 147.69 27.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.61 163.09 20.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -59.5 -50.34 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -59.56 -37.5 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -43.15 99.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.2 90.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.16 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.95 -43.85 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.4 -57.21 12.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 m -58.02 -45.34 88.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.84 -29.66 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.645 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.58 -34.65 27.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -69.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.383 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.77 131.18 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.288 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.33 -50.61 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.551 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -102.4 86.92 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.507 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.42 143.16 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.289 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.42 HG23 ' CE2' ' A' ' 14' ' ' PHE . 62.9 m -92.19 116.92 29.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.051 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 pt -109.37 130.44 62.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.928 0.394 . . . . 0.0 111.546 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.18 103.56 13.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.785 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.444 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -110.85 147.61 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.44 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -55.38 138.41 45.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.268 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 85.68 -22.45 0.18 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.773 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.68 55.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.922 0.392 . . . . 0.0 111.023 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.514 ' HA2' ' CZ ' ' A' ' 38' ' ' PHE . . . -110.86 -30.21 3.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.67 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -55.75 -34.49 65.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.549 0.214 . . . . 0.0 111.482 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.22 -50.05 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 19.3 mt -71.53 -50.03 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.022 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.371 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.1 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 83.1 m -129.76 149.48 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.37 144.02 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.921 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.756 0.312 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -118.59 158.41 25.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -121.08 141.2 51.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.37 150.06 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.339 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CE1' ' OG ' ' A' ' 16' ' ' SER . 1.8 t80 -128.13 120.36 27.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.699 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.5 mm -110.14 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.084 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.401 ' OG ' ' CE1' ' A' ' 14' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.961 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 100.03 27.92 7.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.455 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t -154.28 159.29 41.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.2 m -114.42 173.68 6.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.93 138.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 111.221 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.1 p -116.28 161.71 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.829 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 t -105.17 144.91 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.46 171.89 35.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.37 -166.44 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.66 2.24 . . . . 0.0 112.393 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.43 -25.28 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -68.22 -28.14 66.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 tttp -157.25 65.63 3.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.226 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.78 144.68 84.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.62 2.213 . . . . 0.0 112.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 38' ' ' PHE . . . 163.61 168.64 25.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.551 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.7 mm -82.89 114.58 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.051 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 70.2 m-85 -108.25 176.15 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.205 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.69 137.85 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.623 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -169.45 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.23 150.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.9 t -126.97 157.59 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -121.94 141.69 34.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 160.6 43.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.534 2.156 . . . . 0.0 112.399 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.52 82.63 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.933 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.525 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.4 m -103.87 -166.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.35 -43.47 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.769 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.421 ' OG ' ' CD1' ' A' ' 53' ' ' LEU . 11.7 t -56.15 -40.58 74.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.53 79.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.22 -35.09 79.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -78.9 -17.44 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.467 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.52 5.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.289 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CD1' ' OG ' ' A' ' 48' ' ' SER . 9.1 mt -88.97 155.06 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -167.04 161.03 14.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.94 149.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.1 -23.39 35.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.291 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 46.6 m-20 -71.99 166.73 21.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 2.6 tt0 -152.66 119.03 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 111.348 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.39 117.47 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.92 -19.81 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.869 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -159.95 157.28 28.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.105 0.478 . . . . 0.0 111.416 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 46.3 t -150.21 117.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.499 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.416 ' ND2' ' CB ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER 45.36 47.78 10.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 111.168 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.73 22.29 73.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.311 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.31 127.38 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.94 114.66 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.117 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -99.33 -21.42 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.072 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 m -53.12 -45.82 68.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -106.85 35.45 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -105.54 149.68 26.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.765 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.11 166.07 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -60.17 -53.92 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.17 -39.63 79.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -61.32 -43.57 98.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -58.8 -45.54 89.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.73 -39.95 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.79 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.356 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.9 m -59.06 -44.82 92.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 3.5 mm? -63.45 -31.53 72.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.733 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.66 -31.63 28.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 t -64.66 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.4 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.15 135.3 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.089 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -78.53 -52.07 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.617 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.2 p -102.29 85.17 2.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.416 ' CB ' ' ND2' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -116.65 146.32 42.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 111.422 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -90.85 117.35 29.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.395 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.407 HG21 ' CG2' ' A' ' 62' ' ' VAL . 12.3 pt -115.17 121.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.547 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.33 120.76 33.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -122.38 144.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.25 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.24 112.45 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.728 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -56.58 139.38 50.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.479 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.26 -17.32 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.131 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.75 -19.27 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 111.23 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 -30.82 2.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.623 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -56.47 -34.61 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.314 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.56 -49.91 69.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 21.8 mt -71.56 -42.92 67.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.249 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 21.6 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.804 0.335 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 39.1 m -133.35 143.1 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.23 141.19 28.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -105.96 146.73 29.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 111.047 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -97.95 149.87 21.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.725 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -152.99 141.1 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.04 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -129.23 123.72 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mm -110.77 127.64 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.806 179.905 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.04 30.89 8.45 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.3 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 42.2 t -151.43 158.65 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 111.009 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.31 173.9 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -136.01 175.8 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.966 0.412 . . . . 0.0 111.359 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 t -146.76 162.16 39.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.639 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -104.83 148.26 26.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.607 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -88.72 154.49 24.85 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.02 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' CD ' ' CD1' ' A' ' 97' ' ' LEU . 57.8 Cg_endo -70.78 -159.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.882 2.388 . . . . 0.0 112.032 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -80.69 -27.05 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.348 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -85.67 0.59 52.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.548 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 35' ' ' PRO . 7.4 tttp -175.98 65.43 0.23 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.203 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 13.8 Cg_exo -69.3 119.1 6.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 111.921 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.41 -175.41 38.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.781 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 37' ' ' ILE . 15.4 mm -106.11 111.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.309 . . . . 0.0 110.937 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 1.8 m-30 -100.99 174.5 5.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 mm -107.85 138.37 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.13 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -169.44 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.402 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -45.25 137.52 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.58 157.79 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -107.6 154.52 40.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.79 154.03 15.21 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.743 2.296 . . . . 0.0 112.407 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.1 26.98 64.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.585 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.452 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -111.94 -177.8 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.696 0.284 . . . . 0.0 110.848 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.8 mt -73.09 -46.19 52.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.756 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -52.93 -38.8 62.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.74 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.437 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.89 -40.19 87.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.704 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.87 -27.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.86 48.96 1.12 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 mt -96.04 154.27 17.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -168.01 166.88 13.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.69 138.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.8 17.2 21.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.376 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 89' ' ' ILE . 48.2 m-20 -110.39 159.94 17.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.675 0.274 . . . . 0.0 110.677 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 14.4 tm0? -140.05 112.2 7.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 59' ' ' ILE . 33.9 mt -69.23 118.45 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.516 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.42 13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.945 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -176.99 146.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.934 0.397 . . . . 0.0 111.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 67' ' ' PHE . 39.0 t -149.53 98.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 58.04 30.27 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.18 -28.59 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.512 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.35 129.05 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.099 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.82 109.79 6.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.421 ' CG ' HG21 ' A' ' 62' ' ' VAL . 1.8 m-85 -96.79 -11.42 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.398 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -50.37 -27.84 7.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.763 0.316 . . . . 0.0 111.21 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -144.57 31.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.68 144.04 28.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.847 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.5 162.93 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -63.64 -54.93 28.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -58.17 -41.02 82.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.38 -34.3 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.688 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -69.13 -45.32 70.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.007 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.8 t -68.03 -38.73 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -56.5 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.29 -45.54 93.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.072 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.32 -31.17 71.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.606 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.63 -33.45 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 t -61.72 -61.24 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.9 m -97.4 127.22 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.974 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -74.22 -48.8 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 t -98.61 94.27 6.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.36 140.23 46.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.2 m -91.89 133.11 35.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.272 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.19 139.76 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.63 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.45 104.39 14.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.213 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -107.41 143.19 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.95 129.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.48 131.88 47.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.828 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HA ' ' CG ' ' A' ' 95' ' ' ARG . . . 82.06 -17.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.521 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.52 -22.43 32.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.782 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.26 -30.27 2.31 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.39 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.439 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -55.83 -34.62 65.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.78 -38.92 64.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.962 0.41 . . . . 0.0 110.322 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.458 ' HG ' ' CZ ' ' A' ' 38' ' ' PHE . 3.9 mm? -71.4 -54.09 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 12.3 mm . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 85.3 m -134.19 146.32 50.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.15 128.14 42.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.902 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.765 0.317 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -109.03 158.84 17.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.423 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -121.6 140.54 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.712 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.5 t -145.48 145.57 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.246 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 86' ' ' THR . 1.8 m-85 -123.53 129.07 50.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.657 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm -119.72 125.68 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.175 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 179.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.794 0.33 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.35 18.71 32.49 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.398 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -139.36 158.66 43.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.524 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 173.53 6.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 pt -143.55 152.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.7 p -136.15 160.28 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -105.48 155.09 19.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.71 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.02 -166.04 24.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.88 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.54 -164.17 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.03 -24.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.244 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.42 -29.4 62.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.07 63.31 8.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.34 140.87 31.08 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.517 2.145 . . . . 0.0 112.335 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.98 31.97 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.1 mm -85.84 110.32 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 111.023 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -100.69 171.94 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.038 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.2 mm -107.78 137.15 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.322 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -169.4 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.189 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 147.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.105 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.43 157.92 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -96.62 156.37 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.804 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -50.57 3.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.509 2.139 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.7 -123.4 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.947 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 25.0 p 47.63 -159.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 111.313 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt -102.48 -29.42 11.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 p -52.83 -52.4 57.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.013 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.38 78.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.075 0.464 . . . . 0.0 110.76 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.42 -41.65 90.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.993 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.2 m -81.43 -29.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.11 61.78 0.82 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.371 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.92 155.38 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.28 159.64 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.42 147.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.65 -28.55 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -63.35 146.92 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -132.05 117.82 18.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.237 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.24 119.42 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -99.47 -20.98 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.659 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.0 155.05 34.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.419 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 47.8 t -151.1 96.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 57.42 36.9 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.85 -28.56 13.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.448 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.91 114.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.18 115.41 5.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CZ ' HG22 ' A' ' 62' ' ' VAL . 2.4 m-85 -97.27 25.03 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.024 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -70.94 -53.81 13.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.59 28.67 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tp -74.2 149.4 40.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 173.02 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.6 -58.34 5.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -57.61 -34.86 69.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -44.49 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.24 -44.64 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.11 -43.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -54.81 -55.5 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.202 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.3 m -59.1 -45.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.078 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.08 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.58 -28.4 30.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -68.04 -64.34 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.401 ' CB ' ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -84.75 140.08 31.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.149 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -78.79 -59.61 2.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.65 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 t -102.41 101.36 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -131.7 142.5 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.998 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.425 HG21 ' CE1' ' A' ' 14' ' ' PHE . 17.5 m -87.88 116.96 26.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.283 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.0 pt -111.77 123.99 68.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.984 0.421 . . . . 0.0 111.717 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -93.23 113.5 25.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.249 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.34 147.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.29 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.9 t -116.31 134.05 60.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.539 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -71.19 129.69 39.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.943 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.69 -17.33 0.49 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.678 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.88 -21.95 13.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.296 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.59 -30.24 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.606 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 6.2 ptm180 -56.13 -38.27 70.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -51.42 -49.95 60.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.732 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.45 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 12.5 mt -71.61 -35.94 70.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.351 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 23.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.789 0.328 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 95.0 m -121.89 144.15 49.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -88.83 147.87 24.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 89' ' ' ILE . 36.0 ttpt -102.67 143.9 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 0.0 111.084 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 131.35 52.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -137.96 144.26 31.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -130.09 125.77 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.3 mm -113.79 119.73 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.748 0.308 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.89 -2.31 24.36 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.348 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.3 p -139.18 166.41 24.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.038 0.419 . . . . 0.0 111.162 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 t -114.81 173.92 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 pt -141.74 151.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.971 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.6 161.84 39.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.09 146.63 28.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.658 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.61 -168.55 36.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.109 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.55 -164.81 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.884 2.39 . . . . 0.0 112.536 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.11 -27.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.267 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.88 -28.99 70.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.92 75.81 6.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.721 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.81 128.2 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.481 2.121 . . . . 0.0 112.339 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.63 167.9 39.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.522 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -102.53 106.23 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -100.44 -176.62 3.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.409 HG21 HD11 ' A' ' 39' ' ' ILE . 22.8 mm -107.49 144.08 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 111.914 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -168.9 1.5 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.888 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -41.95 149.36 0.14 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 111.178 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.6 t -132.08 154.87 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 144.5 33.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 158.42 51.43 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.508 2.139 . . . . 0.0 112.422 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.43 69.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.4 m -142.96 -178.5 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.9 -50.83 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -59.14 -37.54 77.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.018 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.17 -41.21 67.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.31 -46.94 84.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.8 m -68.06 -28.81 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.196 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.27 55.09 0.87 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.438 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.0 mt -102.29 166.95 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.19 165.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.21 132.77 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.72 -30.42 6.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.32 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.435 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 2.1 m-20 -60.06 171.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.646 0.26 . . . . 0.0 110.736 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 4.9 tm0? -152.12 110.34 3.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.4 mt -69.45 117.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.502 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.49 4.14 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.998 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.37 148.44 1.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.423 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 41.3 t -151.85 104.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 60.33 30.78 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.03 13.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.3 133.04 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.17 116.67 21.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.423 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 2.7 m-85 -92.14 13.7 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -33.75 76.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.556 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -140.75 32.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.645 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.72 146.77 29.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.6 167.69 21.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -65.32 -57.32 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -39.13 72.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.47 -38.38 84.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -66.4 -45.79 78.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.1 t -68.55 -43.98 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.062 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -55.36 -57.15 13.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.55 -45.53 86.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.267 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.26 -30.2 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -82.56 -31.77 28.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -59.53 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.82 135.16 36.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.33 -39.64 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -108.2 87.27 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.05 145.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.0 m -90.44 121.36 32.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.117 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.67 126.36 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.725 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.58 109.52 21.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.258 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -111.54 149.58 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.306 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.66 118.47 54.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.62 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -58.96 138.42 57.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.674 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.48 -18.26 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.245 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.57 -18.88 61.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.44 -30.97 2.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.48 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -56.64 -34.22 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -48.14 -46.11 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.5 mt -71.32 -45.24 63.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.87 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.772 0.32 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 58.7 m -140.87 132.5 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.85 143.61 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.839 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.854 0.359 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 89' ' ' ILE . 14.3 ttpp -101.98 145.9 28.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -110.91 142.06 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.0 t -142.62 151.63 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.4 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 86' ' ' THR . 22.6 m-85 -130.08 131.78 45.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.2 mm -129.44 104.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.845 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 1.1 t . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.535 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 84.67 33.33 19.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.767 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 1.7 t -152.13 156.5 39.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.792 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -114.55 173.73 6.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 pt -136.94 137.37 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.248 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -120.07 161.88 20.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.771 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -105.16 154.33 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.28 179.69 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.723 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.17 -168.27 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.645 2.23 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -75.07 -26.9 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.134 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.48 -33.48 74.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -149.86 76.32 8.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.884 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.25 141.89 26.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.697 2.264 . . . . 0.0 112.312 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.66 171.54 25.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.8 mm -82.91 114.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.442 ' CE1' HD13 ' A' ' 97' ' ' LEU . 93.8 m-85 -103.01 174.05 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 mm -107.81 135.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.536 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.2 -169.68 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.243 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.43 141.39 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 25' ' ' CYS . 1.9 m -123.86 147.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.107 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.89 153.3 39.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.33 179.56 5.38 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.575 2.183 . . . . 0.0 112.328 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.1 34.67 47.36 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.535 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 18.5 p -132.13 -165.72 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 110.848 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.38 -42.61 12.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 p -53.05 -39.24 63.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.605 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.08 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.54 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.75 -42.43 95.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.5 m -78.66 -34.72 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.62 60.62 0.41 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.285 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 mt -110.91 164.47 12.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 111.039 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 175.94 165.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 4.1 mt -54.93 139.96 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.009 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.72 -30.41 8.14 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.183 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' HB3' HG13 ' A' ' 89' ' ' ILE . 85.7 m-20 -70.61 165.56 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.668 0.271 . . . . 0.0 110.491 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HG3' ' CD1' ' A' ' 38' ' ' PHE . 4.0 tt0 -151.35 117.07 5.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.17 117.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 m -98.08 5.06 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.828 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.84 156.77 1.12 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.911 0.386 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 94.2 t -154.19 100.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.45 29.98 17.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.18 -31.21 8.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.86 120.13 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.131 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.16 104.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 2.4 m-85 -91.32 9.21 32.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.64 70.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -141.28 30.55 1.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' A' ' 75' ' ' ALA . 1.2 tp -81.71 147.49 29.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.9 158.37 34.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -57.47 -51.96 67.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.019 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -39.5 84.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -41.86 95.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -62.89 -47.31 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.016 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.99 -35.7 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.52 -58.74 6.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 79' ' ' LEU . 34.6 m -57.49 -43.65 83.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.731 0.301 . . . . 0.0 110.952 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.42 HD21 HG23 ' A' ' 78' ' ' VAL . 2.3 mm? -61.67 -34.09 75.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.84 -27.74 30.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.6 t -93.23 140.54 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.117 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -79.06 -42.81 25.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.569 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.2 t -104.74 92.08 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.632 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.21 146.23 47.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.424 HG21 ' CE1' ' A' ' 14' ' ' PHE . 6.7 m -101.57 116.97 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.218 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.7 pt -106.84 125.79 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.599 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.0 m -96.91 103.5 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.133 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.426 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -109.26 147.52 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.4 t -120.92 114.95 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -55.4 137.88 47.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.49 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.87 -17.39 0.48 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.102 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.52 -21.97 29.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.798 0.333 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.69 -31.12 2.02 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.521 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -56.96 -34.64 68.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.498 0.19 . . . . 0.0 111.289 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -51.89 -49.96 61.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.442 HD13 ' CE1' ' A' ' 38' ' ' PHE . 13.6 mt -71.35 -40.09 70.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.997 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.428 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 1.9 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.809 0.338 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 69.2 m -128.81 123.71 33.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -88.28 121.99 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.853 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 6.1 ttpm? -98.01 148.07 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.977 0.418 . . . . 0.0 110.955 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.98 145.22 30.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 87' ' ' ILE . 60.4 t -147.99 146.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -137.1 120.67 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.1 mm -105.12 117.7 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 179.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.885 0.374 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 107.61 16.77 12.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.8 t -140.68 156.23 46.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.951 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -114.83 173.6 6.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 pt -138.9 141.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 111.092 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -131.02 161.66 31.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -105.15 145.2 30.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.16 178.47 44.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.659 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.38 -168.15 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.64 2.227 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mp -71.33 -26.84 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -69.76 -30.11 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -149.5 68.39 9.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.83 140.15 22.95 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.206 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.72 -179.67 36.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 mm -88.63 114.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.021 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 34.1 m-85 -111.07 176.85 4.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.316 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.8 mm -107.56 136.66 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.706 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.29 -169.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.396 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -44.41 140.66 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.401 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.6 157.97 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.31 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -99.76 129.81 27.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.98 -50.3 13.69 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.477 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.33 75.52 1.01 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -160.92 -179.81 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.968 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.86 -41.86 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -52.91 -43.78 66.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.9 77.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.638 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.39 -36.75 76.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.3 m -85.25 -26.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.52 39.9 1.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.399 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 mt -89.64 134.13 34.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -149.44 163.27 38.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.578 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 33.9 mt -58.86 148.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -22.7 39.58 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.32 161.9 28.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.665 0.269 . . . . 0.0 110.663 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.409 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -141.5 114.57 8.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.424 HG23 ' CD2' ' A' ' 67' ' ' PHE . 40.9 mt -69.26 117.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.544 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -103.49 3.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.984 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.03 152.0 1.14 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.366 . . . . 0.0 111.236 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.447 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 48.6 t -151.53 105.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.961 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.57 29.87 17.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.98 -28.31 16.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.9 t -59.4 122.86 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.11 111.7 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.447 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 1.8 m-85 -90.2 -2.39 58.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.346 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -59.76 -41.83 91.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.26 31.41 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.7 147.56 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.79 161.43 23.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -59.05 -50.53 73.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -59.49 -40.07 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -43.17 99.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . . . -60.21 -44.55 95.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -70.2 -43.63 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.088 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -54.88 -52.87 61.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.274 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -61.96 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.45 -31.52 72.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.6 -31.87 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.27 -67.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.75 133.43 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.047 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -76.02 -57.23 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 m -99.74 97.62 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.12 141.01 50.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.284 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.8 m -93.5 132.99 37.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.281 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.495 HD12 HG22 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -125.15 140.12 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.704 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -101.37 108.83 20.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -112.72 147.43 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.037 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.4 t -115.13 123.37 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.648 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -63.59 134.7 55.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.757 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.86 -17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.543 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.75 -20.26 21.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.373 . . . . 0.0 111.139 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 -30.38 2.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.733 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 3.1 ptt180 -56.03 -34.71 66.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.58 -50.01 34.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.757 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 11.0 mt -71.55 -47.4 55.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.993 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 7.9 m-85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.406 HD13 HG21 ' B' ' 115' ' ' ILE . 31.0 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 33.5 m -113.74 150.94 32.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.18 135.26 45.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 -179.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.768 0.318 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 14.3 ttpt -95.69 133.94 39.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -96.0 143.94 26.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 t -149.51 153.24 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.262 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.4 ' CD2' HG21 ' A' ' 86' ' ' THR . 0.6 OUTLIER -133.27 121.79 22.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mm -112.55 136.6 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.415 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 179.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 48' ' ' SER . 13.8 tp . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.34 24.24 7.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.377 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 41.8 t -149.44 159.05 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -114.44 173.57 6.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.191 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 pt -137.05 149.35 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.432 . . . . 0.0 111.407 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -128.57 162.23 27.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.696 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.7 139.48 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.7 179.67 45.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.047 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' A' ' 97' ' ' LEU . 56.8 Cg_endo -70.04 -160.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.959 2.44 . . . . 0.0 112.346 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -86.01 -28.25 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -64.57 -32.81 74.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -142.38 76.55 18.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 126.32 10.57 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.153 . . . . 0.0 112.423 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.01 173.98 41.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.51 115.97 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.425 ' CE1' ' HA3' ' A' ' 30' ' ' GLY . 5.3 m-85 -100.61 172.54 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mm -107.77 134.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.029 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.15 -169.27 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -46.22 141.41 3.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 t -111.15 157.13 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.072 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -108.41 112.53 60.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 155.32 9.47 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.405 2.07 . . . . 0.0 112.28 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.1 29.37 74.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.504 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.416 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 71.3 p -124.6 -170.72 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 mt -76.39 -45.42 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 11.6 p -52.9 -37.21 60.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.974 0.416 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.38 -37.99 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.563 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.43 -31.19 69.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.801 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.59 -30.56 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.74 58.81 0.59 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.374 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.28 167.82 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -179.75 162.24 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 98' ' ' PHE . 3.5 mt -56.8 142.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.24 -23.53 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.133 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.58 163.47 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -148.59 115.14 5.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.089 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.35 117.32 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.694 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.8 m -97.9 -4.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.892 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.82 150.73 8.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 61.4 t -149.5 98.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.72 35.39 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.44 -27.93 15.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.545 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.6 124.42 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 109.73 5.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 1.9 m-85 -87.5 -10.02 52.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.362 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.7 p -56.42 -31.92 64.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.852 0.358 . . . . 0.0 111.0 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -132.92 32.09 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.3 tp -92.09 147.59 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.24 162.14 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.17 -57.67 9.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -36.17 70.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -39.53 94.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.581 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -63.33 -46.68 85.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.816 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.28 -35.43 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.952 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -58.77 6.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -57.32 -41.23 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.324 . . . . 0.0 111.097 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.43 -31.97 73.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -82.57 -31.17 29.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.227 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -74.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.56 118.85 10.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.08 -56.97 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.92 105.54 15.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.31 144.51 51.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.966 0.413 . . . . 0.0 111.41 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.4 HG21 ' CD2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -93.21 116.93 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.146 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.2 pt -109.69 127.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.75 103.53 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.659 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -105.08 145.49 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.08 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -115.24 117.25 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.713 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -57.57 135.48 56.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.935 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.462 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . . . 82.95 -17.35 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.432 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.78 -19.99 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.15 -29.99 3.08 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.578 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 2.4 ptp180 -55.4 -34.67 64.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.569 0.223 . . . . 0.0 111.277 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -55.99 -43.62 77.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.042 0.448 . . . . 0.0 110.11 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.432 ' CD1' ' HD2' ' A' ' 31' ' ' PRO . 2.8 mm? -71.44 -50.11 34.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.794 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 4.1 m-85 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.388 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 80.3 m -133.25 136.37 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -88.71 112.33 23.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -115.36 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -91.73 135.27 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -137.47 142.22 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.998 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -125.87 130.0 50.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.02 106.48 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 -179.76 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.68 0.276 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.89 33.17 6.17 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.631 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 t -151.45 168.9 23.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 0.0 110.794 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -114.69 172.28 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.418 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.6 pt -142.34 140.34 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 111.203 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 t -122.49 161.72 23.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.995 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -105.25 138.7 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.13 38.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.514 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.64 -172.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.54 2.16 . . . . 0.0 112.28 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -70.12 -25.17 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -70.13 -27.49 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.166 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' N ' ' HD3' ' A' ' 35' ' ' PRO . 6.5 mtpt -147.7 64.07 8.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.249 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 17.3 Cg_exo -66.75 126.2 14.99 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.195 . . . . 0.0 112.1 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.72 42.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 HG13 ' CD2' ' A' ' 67' ' ' PHE . 11.2 mm -89.88 115.51 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.056 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 3.9 m-85 -103.61 171.72 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mm -107.55 134.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.366 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.12 -169.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.439 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -47.74 144.84 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.166 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -110.26 157.92 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -115.07 133.62 22.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.4 161.52 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.438 2.092 . . . . 0.0 112.293 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.46 70.36 0.97 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.432 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -161.75 -167.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 110.976 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 2.5 mm? -84.76 -44.67 13.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 p -55.71 -39.49 71.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.926 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.96 79.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.5 -44.49 96.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.75 -24.89 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 63.76 1.06 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 mt -105.67 164.94 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.26 162.25 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.65 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.8 mt -56.88 143.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.96 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.5 -34.87 5.23 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.201 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.92 162.37 19.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.6 117.52 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.156 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.22 117.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.467 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG1' HG11 ' A' ' 90' ' ' VAL . 33.9 m -100.45 -18.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.744 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.03 149.57 27.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 67' ' ' PHE . 46.8 t -143.83 95.05 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.086 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 59.9 36.86 21.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -29.8 9.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.542 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.08 116.62 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.14 119.66 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CD1' HG22 ' A' ' 62' ' ' VAL . 1.4 m-85 -96.78 22.66 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.7 t -79.92 -58.85 2.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -104.49 29.03 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.644 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -89.12 147.75 24.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -82.66 173.73 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -68.65 -54.25 17.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -56.61 -39.15 73.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -60.05 -42.81 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -61.37 -46.45 90.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.978 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.35 -38.82 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.9 -53.6 55.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.163 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -59.45 -43.59 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.32 -35.22 80.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.488 . . . . 0.0 110.65 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -82.92 -26.25 31.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.681 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -85.29 -67.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.588 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.93 -37.34 60.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.496 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 67.36 -72.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.282 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.7 p -90.19 86.0 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.023 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.73 146.22 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.589 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.2 m -94.51 116.73 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.9 pt -110.86 127.64 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 0.0 111.634 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.72 107.84 20.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.97 146.88 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.41 HG11 ' CG1' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -109.58 130.01 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -70.08 130.63 42.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.432 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.478 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . . . 87.13 -17.23 0.35 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.47 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.55 -21.31 9.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 111.262 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.92 -30.74 2.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.725 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 4.5 ptp180 -56.59 -34.67 67.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.462 0.172 . . . . 0.0 111.385 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.52 -50.13 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 17.1 mt -71.56 -41.8 68.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.774 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 27.2 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.854 0.359 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 31.6 m -119.31 151.01 39.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 124.63 49.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.802 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' CD ' ' CG2' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -101.34 120.35 40.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.23 143.47 27.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 t -151.36 151.92 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.221 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.51 131.08 39.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 mm -120.1 134.95 61.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.276 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.9 tp . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.923 0.392 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.33 17.19 14.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.469 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 4.8 t -142.88 166.95 23.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.7 m -114.49 169.44 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.6 pt -142.66 155.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.983 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 m -146.62 162.1 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.84 150.94 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.89 -172.93 45.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.907 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.09 -164.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.661 2.24 . . . . 0.0 112.418 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.3 -25.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.375 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.6 -29.86 70.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -156.41 66.06 4.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.77 116.6 3.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.493 2.129 . . . . 0.0 112.176 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.84 141.78 8.31 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.0 mm -82.76 106.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.574 0.226 . . . . 0.0 110.889 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 4.3 p90 -100.55 -176.35 3.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mm -107.06 140.53 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 111.625 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -169.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.109 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -46.34 143.52 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.087 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.3 150.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.982 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -106.33 108.84 62.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.78 145.3 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.332 2.022 . . . . 0.0 112.315 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.7 40.21 9.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.304 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.498 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.5 m -144.42 -173.52 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.93 -48.51 65.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.676 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.36 97.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 110.599 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.39 -53.1 62.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.54 -28.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.207 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.54 65.61 0.83 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.3 mt -106.24 156.5 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -167.0 162.59 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 98' ' ' PHE . 3.7 mt -56.26 146.71 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.009 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.33 -32.43 7.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.34 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' HB3' HG13 ' A' ' 89' ' ' ILE . 49.5 m-20 -58.9 164.99 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.578 0.228 . . . . 0.0 110.862 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -147.55 113.66 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 59' ' ' ILE . 40.7 mt -69.36 117.09 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.61 7.85 9.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.946 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.7 145.67 0.54 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.0 t -148.43 99.27 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.886 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.47 30.82 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.9 13.21 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.14 129.49 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.75 121.92 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -99.19 26.68 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.27 -66.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.49 30.69 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.618 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tp -79.51 145.52 33.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.977 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.06 162.89 24.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.792 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 28' ' ' SER . 3.3 t-160 -60.51 -54.13 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.11 -38.47 70.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.39 -47.23 86.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.72 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.71 -45.49 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.3 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -55.03 -53.57 54.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.256 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.22 -43.42 93.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.078 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.49 -31.17 71.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.711 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -82.53 -30.05 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -70.01 -66.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.223 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -81.45 118.79 22.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -68.8 -40.31 79.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.5 p -114.23 102.68 10.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.47 146.17 43.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -91.5 116.99 29.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.185 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 HG23 ' A' ' 87' ' ' ILE . 16.1 pt -111.36 130.99 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.642 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.99 103.61 13.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.322 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.485 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -104.62 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.22 115.94 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 110.774 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -57.06 140.39 49.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.636 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.41 -22.72 0.22 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.014 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.69 -20.79 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.906 0.384 . . . . 0.0 111.191 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.03 3.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -56.68 -34.61 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -50.26 -49.65 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.09 -39.83 71.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CE2' ' CD2' ' A' ' 38' ' ' PHE . 4.1 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.161 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 95.9 m -129.37 145.98 51.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.41 116.38 31.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.884 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -117.97 141.25 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 138.84 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.98 136.69 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -119.51 117.67 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.1 mm -106.81 126.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 tp . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.68 26.93 11.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.433 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 50.6 t -147.37 159.33 43.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -114.43 173.65 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 pt -139.4 157.47 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.399 . . . . 0.0 111.37 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.29 162.03 28.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -104.8 140.82 37.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.523 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 162.1 31.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' CD ' ' CD1' ' A' ' 97' ' ' LEU . 27.6 Cg_endo -62.11 -159.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.955 2.437 . . . . 0.0 112.216 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.67 -27.63 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.95 -29.89 55.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.05 60.77 13.11 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.88 135.04 20.75 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.29 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.25 -146.96 8.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.621 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG13 ' CD2' ' A' ' 67' ' ' PHE . 19.7 mm -127.13 111.14 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.999 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.462 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 20.0 m-85 -100.58 173.55 6.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -107.84 133.21 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.12 -169.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.724 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -44.71 133.93 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.645 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.01 148.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.961 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.55 145.21 30.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.02 172.12 15.33 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.503 2.135 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.14 33.87 61.67 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.492 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -131.73 -172.79 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.42 -47.43 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.556 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.4 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 2.5 p -59.44 -35.92 74.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.35 72.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.89 -39.99 91.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.785 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.6 m -75.11 -29.76 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.03 55.14 0.93 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.4 mt -97.0 144.98 26.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.42 162.83 40.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mt -56.96 138.54 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.085 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.82 -40.14 2.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.446 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -55.54 166.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.737 0.303 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -146.79 116.72 7.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.42 HG21 ' CD2' ' A' ' 67' ' ' PHE . 30.5 mt -69.47 120.08 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.455 ' CG1' HG13 ' A' ' 90' ' ' VAL . 29.7 m -100.09 -18.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.597 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -158.67 155.14 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.312 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -153.1 109.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 58.77 30.8 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.6 -31.09 8.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.489 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.54 131.88 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.29 116.4 17.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 75' ' ' ALA . 2.1 m-85 -89.79 -9.4 49.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.321 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.8 t -55.38 -30.73 60.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -130.41 32.52 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tp -96.46 147.63 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.99 174.22 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -68.97 -54.7 13.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.78 -38.32 78.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -60.62 -44.57 96.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -63.1 -40.88 98.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.6 t -70.26 -47.0 69.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -52.67 62.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.244 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 m -60.17 -44.78 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.84 -30.67 31.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -69.9 -67.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.254 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -83.39 138.82 33.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -89.99 -55.26 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -91.85 81.92 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.592 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.03 145.22 48.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.49 119.36 31.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.034 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.2 pt -116.55 122.44 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.792 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.84 122.7 38.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.32 144.74 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.455 HG13 ' CG1' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -111.69 131.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.451 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -68.58 132.51 47.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.249 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 86.26 -17.89 0.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HB3' HG11 ' A' ' 90' ' ' VAL . . . -55.09 -20.9 10.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.34 -29.99 2.18 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.751 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -55.56 -34.46 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.531 0.205 . . . . 0.0 111.188 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -49.3 -39.81 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.046 0.451 . . . . 0.0 110.358 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HG ' ' CZ ' ' A' ' 38' ' ' PHE . 3.2 mm? -71.29 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.851 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.387 -179.719 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.7 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 29.9 m -133.03 131.6 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.11 137.17 32.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.173 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.843 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.808 0.337 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -101.28 140.5 35.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.29 134.6 41.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.56 147.23 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -135.96 126.16 26.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.1 mm -114.49 115.06 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.266 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.85 0.357 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.73 25.23 12.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.347 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.406 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 32.5 t -148.98 159.02 44.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -114.32 173.8 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.5 pt -137.96 141.25 39.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.255 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -119.09 161.72 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.06 147.9 27.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.66 175.37 43.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.69 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.36 -165.6 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.662 2.241 . . . . 0.0 112.262 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.6 -28.93 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.253 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -78.54 -28.91 46.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -138.63 60.08 18.75 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.42 136.49 21.78 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.43 -172.03 44.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 mm -98.08 115.21 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 6.1 m-85 -110.89 175.9 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 mm -107.69 137.04 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.375 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.16 -169.41 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.436 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -48.83 141.42 7.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 t -110.93 154.14 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.947 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -109.81 146.27 33.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 161.4 45.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.52 2.146 . . . . 0.0 112.291 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.68 57.47 19.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.404 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.471 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -152.59 -173.42 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.98 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.22 -48.59 33.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.585 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -55.07 -42.11 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.97 82.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.62 -41.79 87.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.0 m -74.26 -30.04 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.063 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.91 61.84 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.9 mt -109.58 162.99 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 111.035 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.2 162.29 3.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.629 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.449 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 6.3 mt -54.86 145.68 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.44 -30.58 10.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.301 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.23 162.91 8.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.263 . . . . 0.0 110.601 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 3.6 tm0? -144.93 113.73 6.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.5 mt -69.22 117.14 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.774 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.95 -25.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.648 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -152.86 158.11 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 111.283 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 59.8 t -149.98 103.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.952 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 63.76 30.2 14.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 -26.82 19.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.623 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.37 130.54 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.72 125.3 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -99.35 -17.62 17.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.269 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -50.55 65.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.786 0.327 . . . . 0.0 111.092 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.07 30.77 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.53 146.69 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.24 170.93 15.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -70.89 -55.82 7.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -58.12 -34.07 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -40.31 91.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.66 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -62.86 -44.48 96.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.805 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.55 -35.76 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.015 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 -52.35 63.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.13 -43.38 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.19 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.94 -30.8 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.799 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -82.61 -34.19 27.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.61 -65.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.1 125.32 29.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -73.71 -43.97 57.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.604 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.2 p -115.08 98.89 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.53 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.3 146.16 51.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.98 0.419 . . . . 0.0 111.277 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 m -92.9 116.98 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.198 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.2 pt -114.02 129.2 70.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 111.673 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -101.84 110.32 22.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.354 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.5 147.04 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.209 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.1 t -117.06 113.34 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -57.24 141.09 47.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.8 -19.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.957 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.92 -20.17 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.47 -30.51 2.03 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.502 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -56.08 -34.13 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -48.14 -42.83 30.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.744 0.306 . . . . 0.0 110.616 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 56.6 mt -71.35 -49.31 43.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.717 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 17.1 m-85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.821 0.343 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 90.1 m -125.49 151.0 46.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.24 108.6 20.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.885 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.806 0.336 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 89' ' ' ILE . 12.8 ttpp -100.28 114.6 28.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -86.53 142.6 28.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -148.56 158.86 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' CD2' ' A' ' 14' ' ' PHE . 51.1 p90 -141.07 116.88 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.706 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mm -102.43 135.45 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.196 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 111.11 23.44 5.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.402 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.8 t -150.7 164.3 36.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.65 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -114.43 173.32 6.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.391 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 pt -137.15 146.67 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.389 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.5 p -125.17 161.87 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.734 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.93 144.52 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.83 38.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.882 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.28 -164.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.771 2.314 . . . . 0.0 112.32 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -81.96 -28.93 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.17 -29.56 54.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -141.83 60.54 11.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.85 147.82 35.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.41 175.88 32.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.4 mm -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.485 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 26.3 m-85 -108.5 174.53 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.9 mm -107.63 134.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.375 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -106.19 -169.42 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.392 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -45.28 153.06 0.23 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.36 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.48 157.98 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 138.75 27.9 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 155.44 69.45 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.41 2.073 . . . . 0.0 112.329 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.05 7.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.357 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.439 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -157.2 -170.29 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.726 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.94 -45.35 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.852 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 p -55.7 -45.3 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.62 88.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -60.56 -40.12 90.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 m -76.83 -27.11 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.49 57.66 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -98.75 156.96 16.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -163.44 159.6 22.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mt -55.23 153.51 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.1 -23.93 31.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.221 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.67 159.46 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.279 . . . . 0.0 110.58 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -146.85 120.22 9.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -69.31 117.18 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.6 m -97.32 -5.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.843 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.83 148.07 5.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.44 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 49.0 t -146.77 109.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 57.95 30.56 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.73 12.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.23 138.08 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.13 111.4 14.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 1.5 m-85 -91.09 11.08 24.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.317 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -75.27 -34.87 61.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -127.25 29.53 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 tp -87.35 148.92 24.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 163.87 21.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -56.62 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -57.81 -40.32 79.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -41.02 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . . . -63.23 -46.05 88.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.7 t -69.4 -35.56 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -50.81 69.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.18 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -62.73 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.26 -31.87 73.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.62 -34.37 27.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 -62.4 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.84 134.56 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.193 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -98.41 25.88 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.855 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -177.93 71.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.27 146.17 41.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.7 m -90.5 116.87 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.026 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 pt -110.79 128.27 67.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.919 0.39 . . . . 0.0 111.582 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.23 122.19 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -128.19 147.39 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.72 117.87 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.736 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -56.26 136.42 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.801 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.47 -17.5 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.276 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.73 35.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.11 -30.3 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.484 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -56.05 -34.4 65.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -48.38 -49.99 32.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.485 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 10.1 mt -71.76 -45.82 60.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.855 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.283 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.845 0.355 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 28.7 m -125.45 138.82 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.32 140.27 29.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 89' ' ' ILE . 5.9 ttpm? -96.78 136.93 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.093 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -100.6 136.08 41.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.4 t -141.92 143.96 26.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -128.34 124.92 37.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 15' ' ' ILE . 28.9 mm -116.93 124.16 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.213 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.916 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.4 tp . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.741 0.305 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 63.36 50.9 58.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.555 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -161.52 156.99 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.78 173.46 6.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -142.01 133.65 26.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.341 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.06 162.17 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.734 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.86 145.7 30.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 110.381 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.6 160.33 30.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.028 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 97' ' ' LEU . 59.0 Cg_endo -71.33 -160.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.827 2.351 . . . . 0.0 112.156 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.33 -29.57 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.67 -31.78 72.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -155.4 74.31 5.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.28 125.99 10.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.589 2.193 . . . . 0.0 112.32 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.23 -178.99 48.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.9 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 111.097 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.5 m-85 -107.54 170.39 8.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.7 mm -107.65 129.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 -169.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -46.72 141.2 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.36 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 t -109.27 157.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.7 mttp -120.91 145.28 41.12 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 17.3 Cg_exo -66.67 173.56 7.76 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.616 2.211 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.32 43.22 43.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.757 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -136.71 -174.16 3.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.369 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.9 mt -84.95 -35.24 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 p -56.28 -41.07 75.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.22 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.686 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -59.8 -39.66 85.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.45 -30.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.035 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.73 64.12 0.72 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 mt -108.25 164.56 12.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 111.005 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.05 162.62 5.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mt -59.83 140.44 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.811 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.413 ' HA2' ' CD2' ' A' ' 98' ' ' PHE . . . 109.08 -38.16 3.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.451 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -55.52 157.33 3.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.673 0.273 . . . . 0.0 110.767 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.44 114.99 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.161 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.06 121.09 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.869 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.0 m -109.47 9.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.885 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.62 146.5 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 111.336 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 61.9 t -151.0 106.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.68 30.94 20.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.016 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.41 13.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.29 129.67 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -71.45 107.35 4.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -82.54 0.02 44.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.376 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -60.53 -54.3 47.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -108.72 33.7 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.419 ' CD2' ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -92.94 148.28 22.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -89.52 170.57 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -62.76 -53.03 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -57.6 -38.0 74.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.89 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -67.56 -42.07 83.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.1 t -70.87 -46.58 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.04 -55.92 25.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.39 -45.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.02 -30.83 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.715 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -82.58 -30.49 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -66.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -84.9 144.81 28.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -92.65 -57.6 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -89.86 77.67 6.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 139.23 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -92.74 116.9 29.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.12 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 87' ' ' ILE . 10.1 pt -111.05 127.44 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.696 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.26 103.48 15.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.469 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -105.34 151.39 7.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.89 114.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.768 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -55.38 136.63 49.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.506 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 84.59 -20.56 0.29 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.194 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.18 46.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.87 -30.13 2.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.519 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -55.43 -34.52 64.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 111.01 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -54.03 -37.13 63.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.128 0.489 . . . . 0.0 110.108 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.422 ' HG ' ' CZ ' ' A' ' 38' ' ' PHE . 4.6 mm? -71.29 -55.27 8.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.413 ' CD2' ' HA2' ' A' ' 56' ' ' GLY . 23.6 m-85 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.847 0.356 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 25.5 m -115.13 151.04 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.94 125.95 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.968 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.817 0.341 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' CD ' ' CG2' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -120.17 117.37 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.602 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -86.24 143.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -148.16 150.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.298 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -130.3 122.24 27.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.777 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.33 129.4 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.1 tp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.826 0.345 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 93.88 29.16 10.08 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.383 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -155.93 157.55 36.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -114.7 173.8 6.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.12 153.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.041 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.3 p -137.22 161.71 35.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -105.45 154.96 19.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -108.86 -177.35 21.64 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.764 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.49 -166.44 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -85.63 -23.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.236 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -69.75 -30.99 68.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -146.47 69.54 12.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.92 143.12 32.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.93 163.78 20.11 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 HG13 ' CD2' ' A' ' 67' ' ' PHE . 12.7 mm -81.63 114.56 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 97' ' ' LEU . 2.8 m-30 -100.53 171.73 7.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.187 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.72 121.03 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.017 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -169.41 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.548 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.51 140.08 2.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 t -119.53 140.11 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.711 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -104.44 149.68 37.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.32 168.42 21.02 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.658 2.238 . . . . 0.0 112.321 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.02 60.8 8.17 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.308 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.494 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -158.9 -177.62 6.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.984 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.65 -49.67 37.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.819 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.72 -38.29 72.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.04 -38.43 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.79 -42.78 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.09 -27.26 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.273 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.97 52.58 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 mt -94.96 160.25 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -159.57 158.55 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mt -58.55 136.56 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 111.47 -37.81 3.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.402 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 55.2 m-20 -49.21 164.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.291 . . . . 0.0 110.908 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -146.94 113.7 6.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.115 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.47 122.87 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.441 ' CG1' HG13 ' A' ' 90' ' ' VAL . 34.5 m -110.63 5.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.846 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -168.5 146.16 4.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 111.13 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.417 HG23 ' CZ ' ' A' ' 67' ' ' PHE . 39.1 t -152.22 107.92 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 57.51 31.06 19.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.13 14.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.9 127.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.878 0.371 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.09 119.24 16.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 75' ' ' ALA . 1.6 m-85 -96.19 23.11 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 p -77.16 -57.14 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.585 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -108.41 29.37 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.675 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.65 148.48 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.32 164.69 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -59.69 -55.04 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -56.99 -37.6 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -61.94 -41.6 98.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -61.63 -47.32 85.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.59 -42.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.123 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -56.74 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.8 m -58.49 -45.94 89.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.849 0.357 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.42 -31.78 73.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.521 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -82.65 -29.51 29.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 t -65.97 -63.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.28 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.51 139.6 30.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -59.48 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.61 88.13 6.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.556 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.53 134.91 54.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -84.64 117.0 23.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.9 pt -112.38 133.61 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.636 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.0 114.67 29.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.572 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.421 ' CG2' ' CD ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -114.53 152.31 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.956 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 ' CG1' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -123.13 115.86 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.498 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -58.61 134.12 56.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 85.74 -20.37 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.249 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.68 -24.32 33.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.091 0.472 . . . . 0.0 110.816 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.44 -30.32 1.73 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.134 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 42.3 mtp180 -56.06 -34.25 65.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.293 0.237 . . . . 0.0 111.287 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -48.18 -49.4 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.449 HD13 ' CE2' ' A' ' 38' ' ' PHE . 19.7 mt -71.33 -43.76 66.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.766 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.875 0.369 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 23.7 m -127.26 129.48 47.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.99 133.17 34.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.94 179.84 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.807 0.337 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 21.2 ttpt -114.67 150.26 35.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.775 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 148.15 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.5 t -147.28 141.75 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -126.11 117.77 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.73 115.9 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.215 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.885 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 59.96 50.2 70.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.733 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.38 152.82 24.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -114.89 173.57 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.9 pt -135.54 141.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -117.22 161.53 19.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.798 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -105.45 142.91 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.769 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -91.4 167.8 31.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.624 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.67 -165.62 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.716 2.277 . . . . 0.0 112.276 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.79 -28.17 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.164 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.34 -26.76 65.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -156.48 66.9 4.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.243 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.59 111.69 3.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.013 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.45 -170.74 37.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.608 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.431 HG13 ' CD2' ' A' ' 67' ' ' PHE . 14.0 mm -94.97 118.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CE2' HD13 ' A' ' 97' ' ' LEU . 52.0 m-85 -111.24 174.67 5.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.318 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -107.69 136.46 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.194 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.12 -169.45 1.58 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.638 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -47.25 140.19 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.262 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.86 148.75 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -107.94 138.84 20.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.3 173.22 2.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.471 2.114 . . . . 0.0 112.111 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.22 27.77 24.7 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.448 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -121.8 166.24 14.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.86 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.32 -35.66 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -53.09 -40.95 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.03 -39.85 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.56 -35.06 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.803 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 m -82.44 -30.83 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.68 41.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.457 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.18 164.68 14.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.988 0.423 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.93 168.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.2 mt -65.07 133.78 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.721 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ARG . . . 112.77 -18.0 22.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.358 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' HB3' HG13 ' A' ' 89' ' ' ILE . 64.5 m-20 -71.97 169.13 16.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.456 ' HG3' ' CE2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -148.52 115.08 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.04 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mt -69.02 116.95 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.652 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.21 3.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.793 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -176.44 152.68 1.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 47.7 t -151.95 102.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 60.58 37.77 19.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.92 -31.94 7.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 t -70.51 114.65 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 111.029 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.13 124.16 21.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CD2' HG13 ' A' ' 37' ' ' ILE . 2.2 m-85 -96.11 21.9 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.102 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.7 t -73.76 -37.58 64.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -128.9 28.85 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.733 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.74 148.01 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.03 158.05 25.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -57.34 -53.51 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.47 -38.62 77.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -44.13 97.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -59.54 -45.66 91.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.31 -42.64 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -55.99 -58.9 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -58.58 -40.53 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.181 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.55 -29.52 68.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -82.59 -33.18 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -60.94 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -45.84 22.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.7 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -100.42 92.44 5.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.22 144.35 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.4 m -89.43 117.01 28.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.272 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.859 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.0 t -94.66 116.66 29.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.247 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.424 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -123.67 142.66 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.207 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.76 131.86 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.508 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -69.65 136.56 51.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.713 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.99 -17.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.396 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.95 -21.3 11.26 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.881 0.372 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -30.47 2.52 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HD3' ' CB ' ' A' ' 92' ' ' ALA . 1.7 ptt180 -56.04 -34.47 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.672 0.273 . . . . 0.0 111.321 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -49.97 38.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.458 HD13 ' CE2' ' A' ' 38' ' ' PHE . 14.9 mt -71.39 -58.43 3.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.411 -179.579 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.836 0.351 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 68.5 m -124.4 147.36 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.01 138.05 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.862 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.763 0.316 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' CD ' ' CG2' ' A' ' 89' ' ' ILE . 0.8 OUTLIER -112.4 141.2 46.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -109.3 143.55 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.409 ' CG2' ' HD3' ' A' ' 11' ' ' LYS . 18.5 t -149.96 153.15 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.389 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.37 114.54 9.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.636 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.3 mm -97.92 118.92 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.0 28.24 9.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.364 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -147.28 160.95 41.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.393 . . . . 0.0 111.152 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.94 173.64 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.971 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 27' ' ' ILE . 26.0 pt -143.45 135.57 23.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.2 t -119.78 161.78 20.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.657 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.11 147.67 27.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 -178.32 46.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.589 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.68 -165.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.62 2.213 . . . . 0.0 112.236 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.86 -30.06 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -68.05 -30.21 69.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.53 74.14 17.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.014 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.82 141.51 27.31 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.6 173.33 40.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 HG13 ' CE2' ' A' ' 67' ' ' PHE . 23.9 mm -90.32 115.09 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.054 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 3.4 m-85 -105.56 171.35 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.7 mm -107.73 137.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.1 -169.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.442 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 142.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.184 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.08 157.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.972 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -114.5 145.43 33.79 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 162.51 38.8 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.543 2.162 . . . . 0.0 112.197 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.9 86.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -135.56 -177.36 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.04 -49.52 43.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.628 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -53.46 -41.84 66.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.43 84.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -64.15 -37.57 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.89 -36.38 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.46 70.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.406 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.3 mt -116.38 150.91 36.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -154.58 162.45 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.455 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.9 mt -57.92 137.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.67 -29.18 9.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.564 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB3' HG13 ' A' ' 89' ' ' ILE . 21.6 m-20 -57.63 164.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.649 0.261 . . . . 0.0 110.593 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -146.39 114.4 6.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.239 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.27 117.15 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.06 0.58 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.808 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -175.62 159.49 2.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -155.22 103.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 63.78 17.23 10.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.278 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.12 -27.21 9.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.642 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.8 p -65.05 134.23 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.728 0.299 . . . . 0.0 111.215 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.57 121.81 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 1.4 m-85 -94.84 19.02 10.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.236 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -75.34 -56.74 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.98 26.65 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.415 HD23 ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -87.19 150.34 24.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.26 167.9 11.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.56 -53.57 56.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -54.67 -41.99 70.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -59.77 -42.64 93.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -63.4 -46.13 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.133 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.4 t -68.67 -36.96 76.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -58.98 6.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG22 HD23 ' A' ' 79' ' ' LEU . 34.3 m -57.86 -40.47 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.312 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.416 HD23 HG22 ' A' ' 78' ' ' VAL . 3.0 mm? -66.55 -32.14 73.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 110.656 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -35.97 37.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 t -61.0 -57.08 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.92 142.84 29.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.253 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.11 -49.03 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.509 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 t -98.21 81.99 2.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.51 137.83 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.278 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.5 m -85.97 116.92 24.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.2 pt -110.28 132.68 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -101.88 118.95 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.37 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.441 ' CG2' ' CD ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -123.4 151.84 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.1 t -125.71 110.45 24.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.442 . . . . 0.0 110.701 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -55.41 138.18 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.462 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 85.38 -22.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.927 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.46 -21.85 39.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.033 0.444 . . . . 0.0 110.854 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.27 -30.34 1.92 Allowed Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.428 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 31.6 mtt-85 -56.19 -34.73 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.558 0.218 . . . . 0.0 111.352 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -49.32 -50.03 41.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.679 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' A' ' 38' ' ' PHE . 11.3 mt -71.74 -43.51 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.455 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.358 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.791 0.329 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 78.5 m -150.93 148.94 29.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.67 136.57 34.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.855 -179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.72 115.21 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -105.16 147.79 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -109.43 138.17 46.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.0 128.86 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.456 ' CD2' ' CG2' ' A' ' 86' ' ' THR . 3.9 m-85 -114.58 116.64 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mm -104.3 124.68 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.8 m -138.25 124.99 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 78.12 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.954 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.02 -30.69 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.47 -120.93 4.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.584 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -143.81 43.15 1.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 151.26 44.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.82 -168.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.43 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -77.66 -40.97 39.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.678 0.275 . . . . 0.0 110.662 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.507 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 102.62 20.39 11.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.304 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 48' ' ' SER . 0.5 OUTLIER -132.62 158.57 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.213 0.506 . . . . 0.0 111.581 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 m -114.82 173.73 6.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.649 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.8 pt -143.53 145.54 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.103 0.478 . . . . 0.0 111.71 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -129.03 162.46 27.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.38 143.83 32.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.781 0.324 . . . . 0.0 110.443 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.67 175.14 43.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.073 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD2' ' CD1' ' A' ' 97' ' ' LEU . 55.8 Cg_endo -69.55 -160.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.843 2.362 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -85.87 -27.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.301 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -66.43 -32.65 74.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -151.08 70.48 8.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.35 137.51 28.44 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.624 2.216 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.05 -175.44 46.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.389 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 67' ' ' PHE . 22.4 mm -92.93 116.58 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.424 ' CE2' ' HA2' ' A' ' 94' ' ' GLY . 2.6 m-85 -105.12 170.37 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.82 134.06 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.024 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.1 -169.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.438 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -51.59 149.24 4.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 25' ' ' CYS . 6.0 m -130.17 155.43 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -95.89 147.11 32.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.46 144.62 22.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.39 -24.23 26.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.507 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -74.06 -179.08 3.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -70.48 -35.9 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 45.1 t -52.83 -51.25 61.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -33.73 75.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -31.13 71.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.14 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 m -88.54 -20.82 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.392 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.03 39.0 3.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.074 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.404 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 8.0 mt -90.38 159.31 16.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.088 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 179.49 171.24 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 2.3 mt -60.35 147.71 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.66 -41.93 2.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.9 m-20 -55.15 169.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.657 0.265 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.8 113.03 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.094 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -69.22 121.96 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.9 m -111.55 8.54 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.775 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.37 147.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.986 0.422 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 47.5 t -153.68 100.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.856 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 63.47 30.42 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.83 -29.62 12.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.429 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.4 118.48 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.72 123.26 20.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 3.1 m-85 -98.86 19.83 14.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -41.15 96.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -139.13 28.54 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.675 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.29 140.99 50.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.74 154.69 36.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -58.29 -54.61 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.001 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -57.2 -40.0 76.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.49 -40.76 88.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.27 83.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.68 -36.13 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.44 -58.96 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.3 m -57.67 -40.46 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.207 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.03 -31.95 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -34.77 38.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.4 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.068 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -97.8 119.29 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -67.17 -39.76 86.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.709 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 p -113.39 107.17 15.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.548 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.31 146.34 32.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.954 0.407 . . . . 0.0 111.303 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.456 ' CG2' ' CD2' ' A' ' 14' ' ' PHE . 31.3 m -85.22 123.03 30.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.064 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.3 pt -118.25 126.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.534 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -95.46 112.37 24.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.465 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.419 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -112.74 149.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.039 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.4 t -122.09 115.45 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -56.71 137.76 53.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.524 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.12 -17.49 0.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.176 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.73 -22.19 45.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 110.991 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -117.11 -30.69 1.87 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.551 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -56.16 -34.54 66.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 0.0 111.027 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -42.05 78.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.426 ' CD1' ' HD2' ' A' ' 31' ' ' PRO . 3.2 mm? -71.24 -48.59 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 2.1 m-85 -50.26 -34.08 22.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.5 mmt -69.34 72.51 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.728 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.0 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.421 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.31 151.06 30.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.641 2.228 . . . . 0.0 112.281 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 4.7 mt -83.29 154.35 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.76 149.22 40.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.02 152.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 27.0 m -134.89 148.13 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.12 127.83 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.888 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 61.67 116.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -99.2 145.54 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.222 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 139.07 39.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.778 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.4 t -145.99 145.51 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -131.93 121.92 24.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mm -108.27 129.69 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.36 144.38 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.57 52.5 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.794 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.4 m -130.03 111.02 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.0 -26.43 20.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.478 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.408 ' CB ' HD21 ' A' ' 47' ' ' LEU . 73.3 m -122.65 -173.7 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.727 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 112.29 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.4 -104.24 0.16 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.924 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.9 tp -125.06 -66.75 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.608 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 113.11 27.26 3.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.205 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.0 t -154.18 156.05 36.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.94 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.9 t -114.87 136.09 53.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.026 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.9 pt -101.64 146.95 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 111.443 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 p -129.0 161.84 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.723 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 144.78 31.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.77 173.73 42.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.606 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.21 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.537 2.158 . . . . 0.0 112.365 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 mt -68.22 -28.12 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -66.76 -26.84 67.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.216 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.51 76.78 5.47 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.112 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.22 133.28 12.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.514 2.142 . . . . 0.0 112.263 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.15 -179.95 38.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.0 mm -88.71 114.6 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 20.2 m-85 -109.03 173.55 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.3 mm -107.83 131.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.269 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.22 -168.98 1.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.528 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -45.87 140.3 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.3 t -108.66 157.44 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -108.15 121.44 43.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.53 151.17 39.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.4 2.067 . . . . 0.0 112.135 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 53.51 24.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.41 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -151.61 -169.28 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD21 ' CB ' ' A' ' 20' ' ' SER . 2.3 mm? -76.08 -46.56 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.394 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 53' ' ' LEU . 23.0 t -56.26 -42.01 76.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -38.77 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.98 -35.61 81.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.91 -27.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.47 30.32 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.589 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.424 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 11.7 mt -75.73 166.36 23.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -179.31 155.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.783 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mt -53.16 131.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.008 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.12 -25.72 8.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.284 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -69.11 166.52 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' HG3' ' CE2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -148.05 115.18 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.084 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 59' ' ' ILE . 46.8 mt -69.27 117.26 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.6 m -98.71 -15.36 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.73 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -158.34 155.05 28.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG22 ' CG ' ' A' ' 67' ' ' PHE . 47.8 t -152.12 103.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 60.01 31.3 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.9 -28.38 13.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.06 126.39 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.126 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.18 112.91 3.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CG ' HG22 ' A' ' 62' ' ' VAL . 1.2 m-85 -98.75 11.68 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -72.3 -44.29 62.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.712 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -123.43 30.5 6.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.414 HD21 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.0 146.96 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.914 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.42 167.59 20.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -66.3 -55.16 17.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -39.11 80.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.63 -37.82 82.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.752 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -66.15 -46.07 78.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.962 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.8 t -68.71 -42.46 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.044 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -56.07 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -58.84 -43.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.79 -31.42 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -69.67 -67.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.11 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.27 136.1 38.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -51.19 7.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.622 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.0 p -106.14 83.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.02 139.81 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.0 m -90.49 116.85 28.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.24 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.4 pt -111.91 129.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.71 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.27 108.9 21.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.449 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.82 146.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.15 112.59 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 110.977 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -56.6 143.37 36.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.347 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 82.75 -19.48 0.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.779 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.62 -20.68 49.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.88 -30.85 2.05 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.533 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -56.62 -34.28 67.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.52 0.2 . . . . 0.0 111.398 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.23 -49.8 31.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.463 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 9.3 mt -71.15 -43.28 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -58.74 -66.26 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 142.5 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.72 0.295 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.29 159.55 22.44 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.629 2.219 . . . . 0.0 112.292 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.72 166.53 12.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -78.65 138.71 38.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.79 136.21 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.189 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 33.5 m -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.31 143.43 27.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.944 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 63.45 124.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.042 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -97.91 135.51 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -94.39 140.44 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.6 t -145.52 137.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -124.76 115.99 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.8 mm -101.15 127.64 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.232 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 131.21 34.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.616 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.72 -70.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.934 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 m 40.98 89.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.867 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.99 26.37 6.73 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.59 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m 56.19 25.62 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 111.22 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.87 109.46 21.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.11 -96.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.013 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 48' ' ' SER . 13.5 tp -140.79 -56.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 106.75 23.82 6.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.27 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 2.8 t -145.09 164.85 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 111.016 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 m -114.94 173.75 6.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -142.81 145.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 111.377 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.24 161.95 28.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.789 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.95 141.9 35.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.745 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.03 172.95 34.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.917 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.65 -165.71 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.34 -25.54 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.26 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.15 -5.48 49.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.283 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -171.01 59.31 0.29 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.773 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.27 144.54 56.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.606 2.204 . . . . 0.0 112.315 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.13 174.87 33.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.278 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 75' ' ' ALA . 11.8 mm -89.58 113.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.898 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 3.6 m-85 -101.96 172.51 6.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.3 mm -109.21 136.26 45.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.234 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.05 -169.35 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.375 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -45.02 145.72 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.73 151.32 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -105.43 124.02 37.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 159.79 8.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.045 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.01 50.24 67.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.422 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 2.5 m -141.05 -173.62 3.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.733 0.301 . . . . 0.0 110.912 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.9 mt -78.15 -42.32 32.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -52.87 -40.11 63.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.939 0.4 . . . . 0.0 110.572 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.33 68.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.611 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -37.15 79.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.817 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.2 m -83.05 -30.22 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.72 52.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.0 mt -97.63 164.89 12.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.934 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.12 162.42 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 4.1 mt -58.02 140.9 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 -37.16 3.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.257 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.51 156.14 13.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.756 0.312 . . . . 0.0 110.637 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -140.4 119.09 12.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mt -69.42 117.13 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.614 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.64 -16.01 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.714 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -155.52 148.36 24.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.402 . . . . 0.0 111.044 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 41.8 t -147.66 105.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 55.92 32.66 20.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.8 23.41 38.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.659 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.21 120.16 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.326 . . . . 0.0 111.063 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -65.14 111.92 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.433 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 2.3 m-85 -95.78 19.84 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.86 -41.07 45.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -123.61 28.04 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.694 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.52 148.98 26.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.45 164.33 17.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -59.37 -48.95 79.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -60.63 -41.85 95.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.0 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -45.73 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 37' ' ' ILE . . . -59.07 -47.71 84.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.0 t -66.87 -43.47 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -58.13 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.28 -44.58 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 0.0 111.094 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.43 -31.51 72.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 t -66.56 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.56 131.76 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -77.66 -55.69 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.8 m -100.03 83.03 2.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.84 141.87 46.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -89.85 116.94 28.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 pt -115.02 126.51 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 0.0 111.542 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -96.04 122.9 39.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 145.94 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.409 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' CG1' ' HB1' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -111.18 126.17 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.298 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.424 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -65.91 132.11 47.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.525 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 85.54 -19.42 0.32 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.627 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.415 ' HB1' ' CG1' ' A' ' 90' ' ' VAL . . . -53.6 -24.18 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.52 -30.77 2.97 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -34.56 66.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.624 0.25 . . . . 0.0 111.282 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.65 -50.01 44.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.463 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 18.9 mt -71.52 -41.03 69.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.005 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -55.3 -50.77 68.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.193 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ptm -56.16 153.47 9.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.64 -179.48 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.61 2.207 . . . . 0.0 112.27 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 160.44 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.2 164.02 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 30.6 mt -144.49 134.29 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.202 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 32.5 m -111.68 145.09 39.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -98.06 111.78 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.842 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.793 0.33 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.99 131.38 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' CB ' ' NZ ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -102.01 116.85 33.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HE3' ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -86.23 131.88 34.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.763 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 40.1 t -140.75 149.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.286 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 86' ' ' THR . 5.1 m-85 -128.32 131.59 48.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.705 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.8 131.29 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.21 156.68 48.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.51 46.78 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.03 80.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.63 -110.36 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.591 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.1 t -149.53 30.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 145.67 26.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.05 -55.36 5.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.435 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.7 tp -148.13 -64.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.38 2.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.063 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.419 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 1.3 t -160.23 160.71 33.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.0 110.486 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -114.36 173.45 6.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.53 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 27' ' ' ILE . 10.0 pt -135.29 153.5 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.41 . . . . 0.0 111.354 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 p -131.29 162.68 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.8 p -104.61 140.79 37.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 175.31 43.58 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.716 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.06 -167.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.646 2.231 . . . . 0.0 112.586 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.9 mt -78.2 -21.42 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.257 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -71.92 -30.31 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.1 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 35' ' ' PRO . 11.2 mttm -147.53 64.77 8.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 21.8 Cg_exo -64.7 114.45 2.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.629 2.22 . . . . 0.0 112.014 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 -157.38 8.99 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 HG13 ' CD2' ' A' ' 67' ' ' PHE . 19.7 mm -111.67 118.0 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.053 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' CZ ' ' HA2' ' A' ' 94' ' ' GLY . 2.1 m-85 -100.36 172.28 7.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -118.74 121.62 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.553 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.33 -169.5 2.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.611 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -54.34 141.99 28.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 25' ' ' CYS . 1.7 m -119.71 153.48 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 147.07 32.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.38 172.74 15.75 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.29 33.89 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.603 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.7 p -119.11 -171.76 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.788 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.4 mt -78.0 -44.03 27.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 25' ' ' CYS . 1.5 t -53.05 -46.13 68.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.533 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -36.28 75.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.564 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.06 -38.5 83.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' HB ' ' CG1' ' A' ' 13' ' ' VAL . 21.0 m -80.36 -29.69 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 36.18 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.377 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 mt -85.06 161.05 19.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.0 166.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.674 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.86 144.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.94 -13.3 45.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.646 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.5 m-20 -86.32 162.32 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -142.85 114.93 8.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.07 117.19 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.851 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.7 m -106.86 6.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.764 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -177.15 149.89 0.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.843 0.354 . . . . 0.0 111.136 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.422 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 58.1 t -153.84 112.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 56.95 29.47 16.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.73 -26.18 19.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.45 124.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.899 0.38 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.22 114.88 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 37' ' ' ILE . 1.9 m-85 -95.75 22.31 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -53.8 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.642 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -111.78 28.49 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.17 147.69 27.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.61 163.09 20.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -59.5 -50.34 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -59.56 -37.5 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -43.15 99.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.2 90.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.16 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.5 t -67.95 -43.85 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.4 -57.21 12.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 m -58.02 -45.34 88.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.84 -29.66 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.645 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.58 -34.65 27.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -69.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.383 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.77 131.18 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.288 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.33 -50.61 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.551 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -102.4 86.92 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.507 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.42 143.16 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.289 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.42 HG23 ' CE2' ' A' ' 14' ' ' PHE . 62.9 m -92.19 116.92 29.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.051 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 pt -109.37 130.44 62.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.928 0.394 . . . . 0.0 111.546 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.18 103.56 13.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.785 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.444 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -110.85 147.61 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.44 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -55.38 138.41 45.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.268 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 85.68 -22.45 0.18 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.773 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.68 55.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.922 0.392 . . . . 0.0 111.023 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.514 ' HA2' ' CZ ' ' A' ' 38' ' ' PHE . . . -110.86 -30.21 3.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.67 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -55.75 -34.49 65.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.549 0.214 . . . . 0.0 111.482 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.22 -50.05 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 19.3 mt -71.53 -50.03 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.022 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -54.14 11.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.371 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.0 mmt -73.35 119.28 17.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.967 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 52.5 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 -167.97 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.581 2.187 . . . . 0.0 112.302 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mt -77.47 170.28 16.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.62 150.19 44.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.1 mt -139.57 139.2 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 83.1 m -129.76 149.48 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.37 144.02 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.921 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.707 0.289 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.51 125.54 24.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -118.59 158.41 25.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -121.08 141.2 51.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.37 150.06 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.339 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CE1' ' OG ' ' A' ' 16' ' ' SER . 1.8 t80 -128.13 120.36 27.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.699 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.5 mm -110.14 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.084 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.401 ' OG ' ' CE1' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -134.61 138.48 44.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.961 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -73.44 122.07 21.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.768 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.82 -44.28 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.31 -72.36 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -145.32 32.03 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.844 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -119.69 122.67 41.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.62 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.6 tp -133.2 -56.29 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 100.03 27.92 7.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.455 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t -154.28 159.29 41.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.2 m -114.42 173.68 6.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.93 138.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 111.221 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.1 p -116.28 161.71 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.829 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 t -105.17 144.91 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.46 171.89 35.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.37 -166.44 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.66 2.24 . . . . 0.0 112.393 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.43 -25.28 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -68.22 -28.14 66.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 tttp -157.25 65.63 3.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.226 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.78 144.68 84.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.62 2.213 . . . . 0.0 112.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 38' ' ' PHE . . . 163.61 168.64 25.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.551 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.7 mm -82.89 114.58 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.051 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 70.2 m-85 -108.25 176.15 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.205 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.69 137.85 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.623 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -169.45 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.23 150.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.9 t -126.97 157.59 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -121.94 141.69 34.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 160.6 43.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.534 2.156 . . . . 0.0 112.399 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.52 82.63 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.933 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.525 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.4 m -103.87 -166.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.35 -43.47 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.769 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.421 ' OG ' ' CD1' ' A' ' 53' ' ' LEU . 11.7 t -56.15 -40.58 74.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.53 79.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.22 -35.09 79.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -78.9 -17.44 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.467 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.52 5.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.289 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CD1' ' OG ' ' A' ' 48' ' ' SER . 9.1 mt -88.97 155.06 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -167.04 161.03 14.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.94 149.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.1 -23.39 35.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.291 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 46.6 m-20 -71.99 166.73 21.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 2.6 tt0 -152.66 119.03 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 111.348 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.39 117.47 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.92 -19.81 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.869 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -159.95 157.28 28.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.105 0.478 . . . . 0.0 111.416 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 46.3 t -150.21 117.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.499 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.416 ' ND2' ' CB ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER 45.36 47.78 10.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 111.168 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.73 22.29 73.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.311 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.31 127.38 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.94 114.66 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.117 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -99.33 -21.42 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.072 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 m -53.12 -45.82 68.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -106.85 35.45 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -105.54 149.68 26.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.765 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.11 166.07 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -60.17 -53.92 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.17 -39.63 79.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -61.32 -43.57 98.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -58.8 -45.54 89.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.73 -39.95 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.79 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.356 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.9 m -59.06 -44.82 92.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 3.5 mm? -63.45 -31.53 72.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.733 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.66 -31.63 28.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 t -64.66 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.4 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.15 135.3 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.089 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -78.53 -52.07 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.617 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.2 p -102.29 85.17 2.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.416 ' CB ' ' ND2' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -116.65 146.32 42.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 111.422 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -90.85 117.35 29.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.395 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.407 HG21 ' CG2' ' A' ' 62' ' ' VAL . 12.3 pt -115.17 121.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.547 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.33 120.76 33.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -122.38 144.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.25 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.24 112.45 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.728 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -56.58 139.38 50.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.479 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.26 -17.32 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.131 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.75 -19.27 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 111.23 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 -30.82 2.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.623 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -56.47 -34.61 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.314 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.56 -49.91 69.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.476 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 21.8 mt -71.56 -42.92 67.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -50.17 -42.38 50.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.249 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.9 ptm -85.46 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.642 0.258 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.83 152.38 52.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.548 2.165 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mt -60.28 164.76 3.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.48 144.68 41.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 21.6 mt -135.92 138.61 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.157 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 39.1 m -133.35 143.1 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.23 141.19 28.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.784 0.326 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -70.67 121.82 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.789 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -105.96 146.73 29.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 111.047 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -97.95 149.87 21.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.725 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.8 t -152.99 141.1 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.04 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -129.23 123.72 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.0 mm -110.77 127.64 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -141.49 124.15 15.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.806 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.62 109.29 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 p -111.3 -32.31 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.94 5.59 46.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.52 31.27 20.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.997 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -29.52 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.3 -156.2 19.06 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 tp -88.47 -48.72 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.04 30.89 8.45 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.3 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 42.2 t -151.43 158.65 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 111.009 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.31 173.9 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -136.01 175.8 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.966 0.412 . . . . 0.0 111.359 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 t -146.76 162.16 39.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.639 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -104.83 148.26 26.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.607 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -88.72 154.49 24.85 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.02 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' CD ' ' CD1' ' A' ' 97' ' ' LEU . 57.8 Cg_endo -70.78 -159.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.882 2.388 . . . . 0.0 112.032 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -80.69 -27.05 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.348 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -85.67 0.59 52.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.548 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 35' ' ' PRO . 7.4 tttp -175.98 65.43 0.23 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.203 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 13.8 Cg_exo -69.3 119.1 6.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 111.921 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.41 -175.41 38.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.781 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 37' ' ' ILE . 15.4 mm -106.11 111.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.309 . . . . 0.0 110.937 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 1.8 m-30 -100.99 174.5 5.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.4 mm -107.85 138.37 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.13 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -169.44 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.402 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -45.25 137.52 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.58 157.79 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -107.6 154.52 40.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.79 154.03 15.21 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.743 2.296 . . . . 0.0 112.407 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.1 26.98 64.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.585 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.452 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -111.94 -177.8 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.696 0.284 . . . . 0.0 110.848 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.8 mt -73.09 -46.19 52.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.756 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -52.93 -38.8 62.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.74 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.437 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.89 -40.19 87.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.704 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.87 -27.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.86 48.96 1.12 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 mt -96.04 154.27 17.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -168.01 166.88 13.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.69 138.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.8 17.2 21.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.376 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 89' ' ' ILE . 48.2 m-20 -110.39 159.94 17.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.675 0.274 . . . . 0.0 110.677 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 14.4 tm0? -140.05 112.2 7.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 59' ' ' ILE . 33.9 mt -69.23 118.45 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.516 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.42 13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.945 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -176.99 146.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.934 0.397 . . . . 0.0 111.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 67' ' ' PHE . 39.0 t -149.53 98.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 58.04 30.27 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.18 -28.59 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.512 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.35 129.05 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.099 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.82 109.79 6.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.421 ' CG ' HG21 ' A' ' 62' ' ' VAL . 1.8 m-85 -96.79 -11.42 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.398 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -50.37 -27.84 7.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.763 0.316 . . . . 0.0 111.21 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -144.57 31.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.68 144.04 28.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.847 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.5 162.93 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -63.64 -54.93 28.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -58.17 -41.02 82.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.38 -34.3 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.688 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -69.13 -45.32 70.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.007 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.8 t -68.03 -38.73 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -56.5 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.29 -45.54 93.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.072 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.32 -31.17 71.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.606 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.63 -33.45 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 t -61.72 -61.24 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.9 m -97.4 127.22 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.974 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -74.22 -48.8 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 t -98.61 94.27 6.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.36 140.23 46.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.2 m -91.89 133.11 35.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.272 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.19 139.76 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.63 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.45 104.39 14.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.213 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -107.41 143.19 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.95 129.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.48 131.88 47.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.828 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HA ' ' CG ' ' A' ' 95' ' ' ARG . . . 82.06 -17.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.521 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.52 -22.43 32.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.782 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.26 -30.27 2.31 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.39 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.439 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -55.83 -34.62 65.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.78 -38.92 64.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.962 0.41 . . . . 0.0 110.322 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.458 ' HG ' ' CZ ' ' A' ' 38' ' ' PHE . 3.9 mm? -71.4 -54.09 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -51.29 -30.5 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.51 -48.89 79.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.656 0.265 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.35 153.99 70.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.495 2.13 . . . . 0.0 112.253 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.35 151.18 45.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -59.07 137.48 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 12.3 mm -120.54 148.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 85.3 m -134.19 146.32 50.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.15 128.14 42.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.902 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tttm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.0 124.11 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -109.03 158.84 17.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.423 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -121.6 140.54 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.712 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.5 t -145.48 145.57 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.246 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 86' ' ' THR . 1.8 m-85 -123.53 129.07 50.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.657 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm -119.72 125.68 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.175 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 p -130.54 123.18 29.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -169.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t 64.6 136.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.62 -39.15 2.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -66.41 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.738 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.73 -172.85 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.98 -76.57 0.14 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.016 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.5 tp -141.06 -43.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.852 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.35 18.71 32.49 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.398 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -139.36 158.66 43.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.524 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 173.53 6.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 pt -143.55 152.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.7 p -136.15 160.28 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -105.48 155.09 19.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.71 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.02 -166.04 24.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.88 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.54 -164.17 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.03 -24.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.244 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.42 -29.4 62.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.07 63.31 8.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.34 140.87 31.08 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.517 2.145 . . . . 0.0 112.335 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.98 31.97 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.1 mm -85.84 110.32 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 111.023 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -100.69 171.94 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.038 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.2 mm -107.78 137.15 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.322 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -169.4 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.189 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 147.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.105 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.5 t -121.43 157.92 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -96.62 156.37 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.804 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -50.57 3.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.509 2.139 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.7 -123.4 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.947 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 25.0 p 47.63 -159.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 111.313 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt -102.48 -29.42 11.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 p -52.83 -52.4 57.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.013 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.38 78.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.075 0.464 . . . . 0.0 110.76 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.42 -41.65 90.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.993 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.2 m -81.43 -29.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.11 61.78 0.82 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.371 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.92 155.38 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.28 159.64 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.42 147.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.65 -28.55 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -63.35 146.92 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -132.05 117.82 18.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.237 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.24 119.42 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -99.47 -20.98 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.659 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.0 155.05 34.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.419 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 47.8 t -151.1 96.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 57.42 36.9 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.85 -28.56 13.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.448 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.91 114.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.18 115.41 5.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.419 ' CZ ' HG22 ' A' ' 62' ' ' VAL . 2.4 m-85 -97.27 25.03 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.024 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -70.94 -53.81 13.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.59 28.67 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tp -74.2 149.4 40.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 173.02 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.6 -58.34 5.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -57.61 -34.86 69.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -44.49 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.24 -44.64 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.11 -43.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.032 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -54.81 -55.5 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.202 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.3 m -59.1 -45.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.078 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.08 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.58 -28.4 30.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -68.04 -64.34 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.401 ' CB ' ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -84.75 140.08 31.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.149 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -78.79 -59.61 2.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.65 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 t -102.41 101.36 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -131.7 142.5 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.998 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.425 HG21 ' CE1' ' A' ' 14' ' ' PHE . 17.5 m -87.88 116.96 26.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.283 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.0 pt -111.77 123.99 68.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.984 0.421 . . . . 0.0 111.717 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -93.23 113.5 25.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.249 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.34 147.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.29 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.9 t -116.31 134.05 60.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.539 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -71.19 129.69 39.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.943 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.69 -17.33 0.49 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.678 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.88 -21.95 13.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.296 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.59 -30.24 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.606 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 6.2 ptm180 -56.13 -38.27 70.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -51.42 -49.95 60.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.732 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.45 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 12.5 mt -71.61 -35.94 70.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -40.73 66.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.4 mmt -57.48 115.19 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.122 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.22 174.7 10.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.698 2.265 . . . . 0.0 112.404 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 11.5 mt -109.3 130.12 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.755 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -72.1 166.89 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 23.3 mt -149.23 133.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 95.0 m -121.89 144.15 49.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -88.83 147.87 24.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.825 0.345 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.44 115.07 5.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.748 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 89' ' ' ILE . 36.0 ttpt -102.67 143.9 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 0.0 111.084 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 131.35 52.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -137.96 144.26 31.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -130.09 125.77 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.3 mm -113.79 119.73 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.7 p -140.22 135.34 32.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 105.59 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.07 -33.08 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.7 -89.28 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -122.67 39.67 3.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -133.57 118.95 18.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.17 -100.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.517 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 tp -121.3 -56.08 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.308 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.89 -2.31 24.36 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.348 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 20.3 p -139.18 166.41 24.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.038 0.419 . . . . 0.0 111.162 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 t -114.81 173.92 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 pt -141.74 151.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.971 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.6 161.84 39.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.09 146.63 28.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.658 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.61 -168.55 36.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.109 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.55 -164.81 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.884 2.39 . . . . 0.0 112.536 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mp -83.11 -27.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.267 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.88 -28.99 70.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.92 75.81 6.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.721 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.81 128.2 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.481 2.121 . . . . 0.0 112.339 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.63 167.9 39.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.522 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -102.53 106.23 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -100.44 -176.62 3.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.409 HG21 HD11 ' A' ' 39' ' ' ILE . 22.8 mm -107.49 144.08 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 111.914 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -168.9 1.5 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.888 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -41.95 149.36 0.14 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 111.178 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.6 t -132.08 154.87 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 144.5 33.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 158.42 51.43 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.508 2.139 . . . . 0.0 112.422 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.43 69.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.4 m -142.96 -178.5 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.9 -50.83 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.9 p -59.14 -37.54 77.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.018 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.17 -41.21 67.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.31 -46.94 84.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.8 m -68.06 -28.81 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.196 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.27 55.09 0.87 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.438 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.0 mt -102.29 166.95 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.19 165.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.21 132.77 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.72 -30.42 6.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.32 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 2.1 m-20 -60.06 171.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.646 0.26 . . . . 0.0 110.736 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 4.9 tm0? -152.12 110.34 3.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.4 mt -69.45 117.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.502 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.49 4.14 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.998 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.37 148.44 1.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.423 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 41.3 t -151.85 104.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 60.33 30.78 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.03 13.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.3 133.04 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.17 116.67 21.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.423 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 2.7 m-85 -92.14 13.7 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -33.75 76.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.556 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -140.75 32.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.645 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.72 146.77 29.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.6 167.69 21.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -65.32 -57.32 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -39.13 72.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.47 -38.38 84.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -66.4 -45.79 78.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.1 t -68.55 -43.98 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.062 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -55.36 -57.15 13.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.7 m -57.55 -45.53 86.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.267 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.26 -30.2 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -82.56 -31.77 28.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -59.53 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.82 135.16 36.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.33 -39.64 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -108.2 87.27 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.05 145.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.0 m -90.44 121.36 32.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.117 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.67 126.36 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.725 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.58 109.52 21.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.258 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -111.54 149.58 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.306 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.66 118.47 54.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.62 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -58.96 138.42 57.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.674 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.48 -18.26 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.245 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.57 -18.88 61.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.44 -30.97 2.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.48 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -56.64 -34.22 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -48.14 -46.11 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.5 mt -71.32 -45.24 63.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.87 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -58.57 -28.36 65.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.51 118.75 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 111.052 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.632 0.253 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.73 158.0 35.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.585 2.19 . . . . 0.0 112.398 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.05 127.57 54.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.83 149.02 49.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 9.8 mt -136.98 146.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.024 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 58.7 m -140.87 132.5 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.85 143.61 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.839 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.9 tptp . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.54 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 89' ' ' ILE . 14.3 ttpp -101.98 145.9 28.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -110.91 142.06 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.0 t -142.62 151.63 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.4 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 86' ' ' THR . 22.6 m-85 -130.08 131.78 45.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.2 mm -129.44 104.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.845 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 1.1 t -116.45 26.05 10.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.5 mp 48.04 63.2 2.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.441 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.19 111.37 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.15 86.05 1.78 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.294 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.47 2.78 3.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.526 0.203 . . . . 0.0 111.411 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.11 101.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.817 0.342 . . . . 0.0 111.284 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.01 145.16 4.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.568 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -77.45 -48.44 17.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.363 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.535 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 84.67 33.33 19.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.767 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 1.7 t -152.13 156.5 39.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.792 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -114.55 173.73 6.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 pt -136.94 137.37 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.248 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -120.07 161.88 20.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.771 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -105.16 154.33 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.28 179.69 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.723 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.17 -168.27 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.645 2.23 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -75.07 -26.9 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.134 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.48 -33.48 74.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -149.86 76.32 8.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.884 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.25 141.89 26.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.697 2.264 . . . . 0.0 112.312 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.66 171.54 25.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.8 mm -82.91 114.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.442 ' CE1' HD13 ' A' ' 97' ' ' LEU . 93.8 m-85 -103.01 174.05 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.2 mm -107.81 135.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.536 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.2 -169.68 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.243 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.43 141.39 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 25' ' ' CYS . 1.9 m -123.86 147.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.107 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.89 153.3 39.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.33 179.56 5.38 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.575 2.183 . . . . 0.0 112.328 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.1 34.67 47.36 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.535 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 18.5 p -132.13 -165.72 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 110.848 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.38 -42.61 12.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 p -53.05 -39.24 63.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.605 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.08 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.54 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.75 -42.43 95.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.5 m -78.66 -34.72 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.62 60.62 0.41 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.285 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 mt -110.91 164.47 12.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 111.039 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 175.94 165.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 4.1 mt -54.93 139.96 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.009 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.72 -30.41 8.14 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.183 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' HB3' HG13 ' A' ' 89' ' ' ILE . 85.7 m-20 -70.61 165.56 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.668 0.271 . . . . 0.0 110.491 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HG3' ' CD1' ' A' ' 38' ' ' PHE . 4.0 tt0 -151.35 117.07 5.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.17 117.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.3 m -98.08 5.06 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.828 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.84 156.77 1.12 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.911 0.386 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 94.2 t -154.19 100.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.45 29.98 17.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.18 -31.21 8.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.86 120.13 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.131 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.16 104.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 2.4 m-85 -91.32 9.21 32.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.64 70.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -141.28 30.55 1.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' A' ' 75' ' ' ALA . 1.2 tp -81.71 147.49 29.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.9 158.37 34.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -57.47 -51.96 67.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.019 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -39.5 84.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -41.86 95.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -62.89 -47.31 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.016 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.99 -35.7 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.52 -58.74 6.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 79' ' ' LEU . 34.6 m -57.49 -43.65 83.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.731 0.301 . . . . 0.0 110.952 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.42 HD21 HG23 ' A' ' 78' ' ' VAL . 2.3 mm? -61.67 -34.09 75.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.84 -27.74 30.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.6 t -93.23 140.54 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.117 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -79.06 -42.81 25.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.569 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.2 t -104.74 92.08 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.632 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.21 146.23 47.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.424 HG21 ' CE1' ' A' ' 14' ' ' PHE . 6.7 m -101.57 116.97 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.218 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.7 pt -106.84 125.79 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.599 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.0 m -96.91 103.5 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.133 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.426 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -109.26 147.52 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.4 t -120.92 114.95 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -55.4 137.88 47.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.49 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.87 -17.39 0.48 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.102 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.52 -21.97 29.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.798 0.333 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.69 -31.12 2.02 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.521 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -56.96 -34.64 68.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.498 0.19 . . . . 0.0 111.289 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -51.89 -49.96 61.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.442 HD13 ' CE1' ' A' ' 38' ' ' PHE . 13.6 mt -71.35 -40.09 70.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.997 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.428 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 1.9 m-85 -53.88 -37.86 64.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -105.79 86.83 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.924 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.715 0.293 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 -170.72 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.524 2.149 . . . . 0.0 112.286 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -129.43 147.84 51.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.25 154.86 30.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.8 mt -144.9 127.7 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 69.2 m -128.81 123.71 33.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -88.28 121.99 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.853 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.749 0.309 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 60.51 108.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 6.1 ttpm? -98.01 148.07 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.977 0.418 . . . . 0.0 110.955 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.98 145.22 30.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 87' ' ' ILE . 60.4 t -147.99 146.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -137.1 120.67 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.1 mm -105.12 117.7 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.6 t -124.52 126.62 46.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.03 146.03 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -133.76 31.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.009 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.48 -114.04 0.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 31.86 5.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 107.51 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.731 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.36 -83.93 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.482 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.8 tp -148.52 -54.3 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.453 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 107.61 16.77 12.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.8 t -140.68 156.23 46.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.951 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -114.83 173.6 6.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 pt -138.9 141.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 111.092 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -131.02 161.66 31.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -105.15 145.2 30.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.16 178.47 44.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.659 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.38 -168.15 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.64 2.227 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mp -71.33 -26.84 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -69.76 -30.11 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -149.5 68.39 9.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.83 140.15 22.95 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.206 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.72 -179.67 36.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 mm -88.63 114.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.021 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 34.1 m-85 -111.07 176.85 4.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.316 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.8 mm -107.56 136.66 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.706 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.29 -169.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.396 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -44.41 140.66 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.401 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.6 157.97 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.31 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -99.76 129.81 27.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.98 -50.3 13.69 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.477 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.33 75.52 1.01 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -160.92 -179.81 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.968 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.86 -41.86 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -52.91 -43.78 66.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.9 77.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.638 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.39 -36.75 76.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.3 m -85.25 -26.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.52 39.9 1.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.399 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 mt -89.64 134.13 34.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -149.44 163.27 38.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.578 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 33.9 mt -58.86 148.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -22.7 39.58 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.32 161.9 28.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.665 0.269 . . . . 0.0 110.663 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.409 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -141.5 114.57 8.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.424 HG23 ' CD2' ' A' ' 67' ' ' PHE . 40.9 mt -69.26 117.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.544 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -103.49 3.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.984 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.03 152.0 1.14 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.366 . . . . 0.0 111.236 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.447 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 48.6 t -151.53 105.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.961 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.57 29.87 17.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.98 -28.31 16.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.9 t -59.4 122.86 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.11 111.7 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.447 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 1.8 m-85 -90.2 -2.39 58.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.346 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -59.76 -41.83 91.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.26 31.41 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.7 147.56 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.79 161.43 23.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -59.05 -50.53 73.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -59.49 -40.07 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -43.17 99.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . . . -60.21 -44.55 95.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -70.2 -43.63 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.088 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -54.88 -52.87 61.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.274 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -61.96 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.45 -31.52 72.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.6 -31.87 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.27 -67.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.75 133.43 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.047 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -76.02 -57.23 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 m -99.74 97.62 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.12 141.01 50.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.284 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.8 m -93.5 132.99 37.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.281 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.495 HD12 HG22 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -125.15 140.12 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.704 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -101.37 108.83 20.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -112.72 147.43 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.037 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.4 t -115.13 123.37 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.648 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -63.59 134.7 55.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.757 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.86 -17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.543 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.75 -20.26 21.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.373 . . . . 0.0 111.139 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 -30.38 2.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.733 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 3.1 ptt180 -56.03 -34.71 66.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.58 -50.01 34.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.757 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 11.0 mt -71.55 -47.4 55.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.993 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 7.9 m-85 -49.65 -27.58 4.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 85.5 mmm -57.79 145.49 34.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.951 -179.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.669 0.271 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.06 144.75 53.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.595 2.196 . . . . 0.0 112.389 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 12.0 mt -96.38 158.98 15.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -102.94 163.9 11.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.406 HD13 HG21 ' B' ' 115' ' ' ILE . 31.0 mt -144.65 125.09 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 33.5 m -113.74 150.94 32.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.18 135.26 45.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 -179.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -58.77 131.84 52.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 14.3 ttpt -95.69 133.94 39.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -96.0 143.94 26.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 t -149.51 153.24 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.262 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.4 ' CD2' HG21 ' A' ' 86' ' ' THR . 0.6 OUTLIER -133.27 121.79 22.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mm -112.55 136.6 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.415 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 p -141.5 173.35 11.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.402 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -77.65 -57.22 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 17' ' ' LEU . 14.6 p 43.69 40.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.584 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.98 -115.11 0.9 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -122.1 -41.38 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -57.42 138.78 54.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.78 -62.5 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.464 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 48' ' ' SER . 13.8 tp -146.05 -57.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.847 0.356 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.34 24.24 7.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.377 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 41.8 t -149.44 159.05 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -114.44 173.57 6.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.191 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 pt -137.05 149.35 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.432 . . . . 0.0 111.407 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -128.57 162.23 27.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.696 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.7 139.48 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.7 179.67 45.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.047 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' A' ' 97' ' ' LEU . 56.8 Cg_endo -70.04 -160.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.959 2.44 . . . . 0.0 112.346 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -86.01 -28.25 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -64.57 -32.81 74.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -142.38 76.55 18.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 126.32 10.57 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.153 . . . . 0.0 112.423 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.01 173.98 41.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.5 mm -87.51 115.97 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.425 ' CE1' ' HA3' ' A' ' 30' ' ' GLY . 5.3 m-85 -100.61 172.54 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mm -107.77 134.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.029 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.15 -169.27 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -46.22 141.41 3.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 t -111.15 157.13 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.072 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -108.41 112.53 60.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 155.32 9.47 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.405 2.07 . . . . 0.0 112.28 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.1 29.37 74.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.504 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.416 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 71.3 p -124.6 -170.72 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 mt -76.39 -45.42 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 11.6 p -52.9 -37.21 60.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.974 0.416 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.38 -37.99 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.563 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.43 -31.19 69.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.801 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.59 -30.56 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.74 58.81 0.59 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.374 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.28 167.82 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -179.75 162.24 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 98' ' ' PHE . 3.5 mt -56.8 142.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.24 -23.53 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.133 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.58 163.47 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -148.59 115.14 5.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.089 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.35 117.32 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.694 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.8 m -97.9 -4.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.892 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.82 150.73 8.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 61.4 t -149.5 98.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.72 35.39 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.44 -27.93 15.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.545 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.6 124.42 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 109.73 5.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 1.9 m-85 -87.5 -10.02 52.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.362 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.7 p -56.42 -31.92 64.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.852 0.358 . . . . 0.0 111.0 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -132.92 32.09 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.3 tp -92.09 147.59 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.24 162.14 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.17 -57.67 9.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -36.17 70.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -39.53 94.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.581 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -63.33 -46.68 85.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.816 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.7 t -68.28 -35.43 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.952 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -58.77 6.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -57.32 -41.23 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.324 . . . . 0.0 111.097 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.43 -31.97 73.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -82.57 -31.17 29.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.227 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -74.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.56 118.85 10.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.08 -56.97 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.92 105.54 15.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.31 144.51 51.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.966 0.413 . . . . 0.0 111.41 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.4 HG21 ' CD2' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -93.21 116.93 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.146 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.2 pt -109.69 127.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.75 103.53 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.659 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -105.08 145.49 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.08 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -115.24 117.25 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.713 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -57.57 135.48 56.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.935 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.462 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . . . 82.95 -17.35 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.432 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.78 -19.99 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.15 -29.99 3.08 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.578 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 2.4 ptp180 -55.4 -34.67 64.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.569 0.223 . . . . 0.0 111.277 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -55.99 -43.62 77.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.042 0.448 . . . . 0.0 110.11 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.432 ' CD1' ' HD2' ' A' ' 31' ' ' PRO . 2.8 mm? -71.44 -50.11 34.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.794 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 4.1 m-85 -49.79 -32.37 13.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.388 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.6 mmt -77.37 -53.88 7.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.984 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.672 0.272 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 -176.1 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.492 2.128 . . . . 0.0 112.324 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.85 158.95 32.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -88.87 149.19 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.98 143.54 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 80.3 m -133.25 136.37 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -88.71 112.33 23.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 61.24 153.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.983 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -115.36 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -91.73 135.27 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -137.47 142.22 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.998 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -125.87 130.0 50.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.3 mm -122.02 106.48 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.4 t -106.32 -22.56 12.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 68.0 160.45 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.862 0.363 . . . . 0.0 110.906 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -99.4 -65.33 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.18 -76.77 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.581 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.0 p -157.98 30.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.42 -29.51 21.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.001 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.96 174.96 26.65 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.36 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -40.75 87.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.446 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.89 33.17 6.17 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.631 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.9 t -151.45 168.9 23.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 0.0 110.794 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -114.69 172.28 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.418 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.6 pt -142.34 140.34 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 111.203 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 t -122.49 161.72 23.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.995 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -105.25 138.7 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.13 38.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.514 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.64 -172.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.54 2.16 . . . . 0.0 112.28 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -70.12 -25.17 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -70.13 -27.49 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.166 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' N ' ' HD3' ' A' ' 35' ' ' PRO . 6.5 mtpt -147.7 64.07 8.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.249 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 17.3 Cg_exo -66.75 126.2 14.99 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.195 . . . . 0.0 112.1 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.72 42.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 HG13 ' CD2' ' A' ' 67' ' ' PHE . 11.2 mm -89.88 115.51 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.056 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 3.9 m-85 -103.61 171.72 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mm -107.55 134.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.366 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.12 -169.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.439 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -47.74 144.84 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.166 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 t -110.26 157.92 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -115.07 133.62 22.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.4 161.52 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.438 2.092 . . . . 0.0 112.293 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.46 70.36 0.97 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.432 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -161.75 -167.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 110.976 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 2.5 mm? -84.76 -44.67 13.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 p -55.71 -39.49 71.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.926 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.96 79.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.5 -44.49 96.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.75 -24.89 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 63.76 1.06 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 mt -105.67 164.94 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.26 162.25 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.65 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.8 mt -56.88 143.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.96 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.5 -34.87 5.23 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.201 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.92 162.37 19.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.6 117.52 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.156 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.22 117.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.467 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG1' HG11 ' A' ' 90' ' ' VAL . 33.9 m -100.45 -18.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.744 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.03 149.57 27.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 67' ' ' PHE . 46.8 t -143.83 95.05 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.086 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 59.9 36.86 21.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -29.8 9.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.542 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.08 116.62 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.14 119.66 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CD1' HG22 ' A' ' 62' ' ' VAL . 1.4 m-85 -96.78 22.66 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.7 t -79.92 -58.85 2.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -104.49 29.03 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.644 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -89.12 147.75 24.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -82.66 173.73 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -68.65 -54.25 17.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -56.61 -39.15 73.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -60.05 -42.81 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -61.37 -46.45 90.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.978 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.35 -38.82 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.9 -53.6 55.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.163 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -59.45 -43.59 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -64.32 -35.22 80.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.488 . . . . 0.0 110.65 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -82.92 -26.25 31.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.681 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -85.29 -67.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.588 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.93 -37.34 60.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.496 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 67.36 -72.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.282 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.7 p -90.19 86.0 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.023 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.73 146.22 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.589 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.2 m -94.51 116.73 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.9 pt -110.86 127.64 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 0.0 111.634 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.72 107.84 20.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.97 146.88 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.41 HG11 ' CG1' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -109.58 130.01 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -70.08 130.63 42.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.432 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.478 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . . . 87.13 -17.23 0.35 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.47 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.55 -21.31 9.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 111.262 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.92 -30.74 2.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.725 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.478 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 4.5 ptp180 -56.59 -34.67 67.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.462 0.172 . . . . 0.0 111.385 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.52 -50.13 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 17.1 mt -71.56 -41.8 68.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.774 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -56.25 -22.74 31.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 33.7 mtt -59.11 86.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.713 0.292 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 -169.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.528 2.152 . . . . 0.0 112.39 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 18.5 mt -112.89 140.8 47.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -77.22 142.15 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.22 141.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 31.6 m -119.31 151.01 39.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 124.63 49.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.802 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 tptt . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -104.92 144.95 31.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.963 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' CD ' ' CG2' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -101.34 120.35 40.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.23 143.47 27.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 t -151.36 151.92 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.221 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.51 131.08 39.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 mm -120.1 134.95 61.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.276 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -141.5 128.6 20.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -75.21 104.3 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.897 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -88.43 60.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.034 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.81 -62.46 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.496 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -113.68 146.92 39.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.768 0.318 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 62.29 128.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.99 -50.24 4.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.9 tp -136.01 -56.23 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.688 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.498 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.33 17.19 14.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.469 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 4.8 t -142.88 166.95 23.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.7 m -114.49 169.44 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.6 pt -142.66 155.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.983 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 m -146.62 162.1 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.84 150.94 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.89 -172.93 45.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.907 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.09 -164.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.661 2.24 . . . . 0.0 112.418 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.3 -25.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.375 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.6 -29.86 70.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -156.41 66.06 4.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.77 116.6 3.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.493 2.129 . . . . 0.0 112.176 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.84 141.78 8.31 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.0 mm -82.76 106.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.574 0.226 . . . . 0.0 110.889 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 4.3 p90 -100.55 -176.35 3.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.6 mm -107.06 140.53 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 111.625 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -169.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.109 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -46.34 143.52 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.087 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.3 150.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.982 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -106.33 108.84 62.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.78 145.3 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.332 2.022 . . . . 0.0 112.315 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.7 40.21 9.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.304 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.498 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.5 m -144.42 -173.52 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -67.93 -48.51 65.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.676 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.36 97.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 110.599 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.39 -53.1 62.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.54 -28.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.207 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.54 65.61 0.83 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.3 mt -106.24 156.5 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -167.0 162.59 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 98' ' ' PHE . 3.7 mt -56.26 146.71 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.009 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.33 -32.43 7.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.34 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' HB3' HG13 ' A' ' 89' ' ' ILE . 49.5 m-20 -58.9 164.99 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.578 0.228 . . . . 0.0 110.862 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -147.55 113.66 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 59' ' ' ILE . 40.7 mt -69.36 117.09 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.61 7.85 9.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.946 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.7 145.67 0.54 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.0 t -148.43 99.27 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.886 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.47 30.82 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.9 13.21 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.14 129.49 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.75 121.92 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -99.19 26.68 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.27 -66.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.49 30.69 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.618 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tp -79.51 145.52 33.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.977 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.06 162.89 24.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.792 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 28' ' ' SER . 3.3 t-160 -60.51 -54.13 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.11 -38.47 70.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.39 -47.23 86.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.72 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.71 -45.49 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.3 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -55.03 -53.57 54.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.256 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.22 -43.42 93.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.078 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.49 -31.17 71.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.711 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -82.53 -30.05 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -70.01 -66.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.223 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -81.45 118.79 22.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -68.8 -40.31 79.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.5 p -114.23 102.68 10.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.47 146.17 43.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -91.5 116.99 29.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.185 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 HG23 ' A' ' 87' ' ' ILE . 16.1 pt -111.36 130.99 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.642 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.99 103.61 13.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.322 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.485 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -104.62 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.22 115.94 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 110.774 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -57.06 140.39 49.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.636 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.41 -22.72 0.22 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.014 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.69 -20.79 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.906 0.384 . . . . 0.0 111.191 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.03 3.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -56.68 -34.61 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -50.26 -49.65 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.09 -39.83 71.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CE2' ' CD2' ' A' ' 38' ' ' PHE . 4.1 m-85 -54.66 -47.96 72.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.161 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.78 130.88 34.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.931 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.771 0.319 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.88 157.39 62.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.168 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.65 140.45 49.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.43 159.36 34.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.676 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -141.17 141.98 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 95.9 m -129.37 145.98 51.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.41 116.38 31.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.884 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttm . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.733 0.301 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 145.6 40.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -117.97 141.25 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 138.84 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.98 136.69 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -119.51 117.67 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.1 mm -106.81 126.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 p -139.79 112.87 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.22 112.06 1.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 m -136.11 94.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.25 70.67 1.31 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.564 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m 60.18 173.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 60.7 110.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.15 -69.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.435 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 tp -126.73 -53.51 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.863 0.364 . . . . 0.0 110.572 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.68 26.93 11.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.433 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 50.6 t -147.37 159.33 43.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m -114.43 173.65 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 pt -139.4 157.47 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.399 . . . . 0.0 111.37 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.29 162.03 28.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -104.8 140.82 37.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.523 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 162.1 31.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' CD ' ' CD1' ' A' ' 97' ' ' LEU . 27.6 Cg_endo -62.11 -159.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.955 2.437 . . . . 0.0 112.216 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.67 -27.63 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.95 -29.89 55.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.05 60.77 13.11 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.88 135.04 20.75 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.29 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.25 -146.96 8.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.621 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG13 ' CD2' ' A' ' 67' ' ' PHE . 19.7 mm -127.13 111.14 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.999 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 20.0 m-85 -100.58 173.55 6.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.5 mm -107.84 133.21 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.12 -169.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.724 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -44.71 133.93 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.645 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.2 t -111.01 148.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.961 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.55 145.21 30.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.02 172.12 15.33 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.503 2.135 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.14 33.87 61.67 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.492 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -131.73 -172.79 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.42 -47.43 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.556 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.4 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 2.5 p -59.44 -35.92 74.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.35 72.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.89 -39.99 91.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.785 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.6 m -75.11 -29.76 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.03 55.14 0.93 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.4 mt -97.0 144.98 26.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.42 162.83 40.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mt -56.96 138.54 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.085 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.82 -40.14 2.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.446 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -55.54 166.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.737 0.303 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -146.79 116.72 7.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.42 HG21 ' CD2' ' A' ' 67' ' ' PHE . 30.5 mt -69.47 120.08 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.455 ' CG1' HG13 ' A' ' 90' ' ' VAL . 29.7 m -100.09 -18.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.597 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -158.67 155.14 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.312 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 56.2 t -153.1 109.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 58.77 30.8 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.6 -31.09 8.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.489 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.54 131.88 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.29 116.4 17.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 75' ' ' ALA . 2.1 m-85 -89.79 -9.4 49.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.321 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.8 t -55.38 -30.73 60.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -130.41 32.52 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.5 tp -96.46 147.63 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.99 174.22 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -68.97 -54.7 13.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.78 -38.32 78.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -60.62 -44.57 96.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -63.1 -40.88 98.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.6 t -70.26 -47.0 69.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -52.67 62.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.244 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 m -60.17 -44.78 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.84 -30.67 31.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -69.9 -67.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.254 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -83.39 138.82 33.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -89.99 -55.26 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -91.85 81.92 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.592 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.03 145.22 48.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.49 119.36 31.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.034 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.2 pt -116.55 122.44 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.792 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.84 122.7 38.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.32 144.74 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.455 HG13 ' CG1' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -111.69 131.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.451 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -68.58 132.51 47.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.249 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 86.26 -17.89 0.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.404 ' HB3' HG11 ' A' ' 90' ' ' VAL . . . -55.09 -20.9 10.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.34 -29.99 2.18 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.751 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -55.56 -34.46 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.531 0.205 . . . . 0.0 111.188 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -49.3 -39.81 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.046 0.451 . . . . 0.0 110.358 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HG ' ' CZ ' ' A' ' 38' ' ' PHE . 3.2 mm? -71.29 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.851 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -48.73 -28.54 3.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.387 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.5 mmm -58.84 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.945 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.814 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.81 153.68 77.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.62 2.213 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 4.4 mt -72.75 174.07 8.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -81.79 168.64 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.7 mt -148.32 139.88 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 29.9 m -133.03 131.6 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.11 137.17 32.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.173 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.843 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.007 0.432 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.38 140.62 53.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -101.28 140.5 35.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.29 134.6 41.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -139.56 147.23 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -135.96 126.16 26.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.1 mm -114.49 115.06 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -106.53 -22.85 12.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.266 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 16' ' ' SER . 3.0 tt 86.86 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t 69.61 -67.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 111.201 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.66 -55.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.55 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 m -83.97 157.41 21.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.58 -165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.467 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -114.75 -77.46 0.73 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.566 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.19 -48.34 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.688 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.73 25.23 12.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.347 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.406 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 32.5 t -148.98 159.02 44.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -114.32 173.8 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.5 pt -137.96 141.25 39.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.255 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -119.09 161.72 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.06 147.9 27.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.66 175.37 43.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.69 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.36 -165.6 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.662 2.241 . . . . 0.0 112.262 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.6 -28.93 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.253 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -78.54 -28.91 46.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -138.63 60.08 18.75 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.42 136.49 21.78 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.43 -172.03 44.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 mm -98.08 115.21 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 6.1 m-85 -110.89 175.9 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.1 mm -107.69 137.04 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.375 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.16 -169.41 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.436 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -48.83 141.42 7.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 t -110.93 154.14 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.947 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -109.81 146.27 33.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 161.4 45.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.52 2.146 . . . . 0.0 112.291 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.68 57.47 19.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.404 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.471 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -152.59 -173.42 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.98 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.22 -48.59 33.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.585 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -55.07 -42.11 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.97 82.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.62 -41.79 87.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.0 m -74.26 -30.04 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.063 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.91 61.84 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.9 mt -109.58 162.99 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 111.035 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.2 162.29 3.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.629 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.449 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 6.3 mt -54.86 145.68 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.44 -30.58 10.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.301 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.23 162.91 8.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.263 . . . . 0.0 110.601 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 3.6 tm0? -144.93 113.73 6.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.5 mt -69.22 117.14 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.774 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.9 m -92.95 -25.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.648 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -152.86 158.11 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 111.283 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 59.8 t -149.98 103.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.952 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 63.76 30.2 14.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 -26.82 19.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.623 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.37 130.54 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.72 125.3 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -99.35 -17.62 17.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.269 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -50.55 65.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.786 0.327 . . . . 0.0 111.092 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.07 30.77 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.53 146.69 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.24 170.93 15.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -70.89 -55.82 7.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -58.12 -34.07 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -40.31 91.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.66 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -62.86 -44.48 96.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.805 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.55 -35.76 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.015 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 -52.35 63.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.13 -43.38 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.19 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.94 -30.8 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.799 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -82.61 -34.19 27.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.61 -65.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.1 125.32 29.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -73.71 -43.97 57.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.604 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.2 p -115.08 98.89 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.53 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.3 146.16 51.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.98 0.419 . . . . 0.0 111.277 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 m -92.9 116.98 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.198 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.2 pt -114.02 129.2 70.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 111.673 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -101.84 110.32 22.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.354 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.5 147.04 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.209 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.1 t -117.06 113.34 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -57.24 141.09 47.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.8 -19.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.957 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.92 -20.17 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.47 -30.51 2.03 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.502 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -56.08 -34.13 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -48.14 -42.83 30.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.744 0.306 . . . . 0.0 110.616 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 38' ' ' PHE . 56.6 mt -71.35 -49.31 43.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.717 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 17.1 m-85 -54.3 -28.85 44.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.37 124.86 19.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.074 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.4 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 154.45 65.91 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.577 2.184 . . . . 0.0 112.276 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 10.0 mt -138.33 149.06 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -88.32 158.68 18.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.2 mt -137.19 147.24 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 90.1 m -125.49 151.0 46.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.24 108.6 20.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.885 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -161.19 118.79 2.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 89' ' ' ILE . 12.8 ttpp -100.28 114.6 28.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -86.53 142.6 28.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -148.56 158.86 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' CD2' ' A' ' 14' ' ' PHE . 51.1 p90 -141.07 116.88 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.706 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mm -102.43 135.45 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.196 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.16 131.18 27.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.95 134.08 41.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 21' ' ' ARG . 7.5 m -106.99 -156.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.58 -45.14 12.24 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.059 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -164.49 64.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.381 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.403 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -156.11 109.9 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -76.75 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.602 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -138.57 -63.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 111.11 23.44 5.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.402 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.8 t -150.7 164.3 36.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.65 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -114.43 173.32 6.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.391 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 pt -137.15 146.67 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.389 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.5 p -125.17 161.87 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.734 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.93 144.52 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.83 38.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.882 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.28 -164.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.771 2.314 . . . . 0.0 112.32 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -81.96 -28.93 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.17 -29.56 54.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -141.83 60.54 11.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.85 147.82 35.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.41 175.88 32.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.4 mm -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.485 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 26.3 m-85 -108.5 174.53 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.9 mm -107.63 134.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.375 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -106.19 -169.42 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.392 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -45.28 153.06 0.23 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.36 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.48 157.98 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 138.75 27.9 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 155.44 69.45 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.41 2.073 . . . . 0.0 112.329 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.05 7.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.357 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.439 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -157.2 -170.29 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.726 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.94 -45.35 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.852 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 p -55.7 -45.3 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.62 88.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -60.56 -40.12 90.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.5 m -76.83 -27.11 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.49 57.66 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -98.75 156.96 16.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -163.44 159.6 22.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mt -55.23 153.51 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.1 -23.93 31.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.221 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.67 159.46 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.279 . . . . 0.0 110.58 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -146.85 120.22 9.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -69.31 117.18 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.6 m -97.32 -5.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.843 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.83 148.07 5.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.44 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 49.0 t -146.77 109.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 57.95 30.56 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.73 12.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.23 138.08 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.13 111.4 14.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.44 ' CZ ' ' CG2' ' A' ' 62' ' ' VAL . 1.5 m-85 -91.09 11.08 24.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.317 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -75.27 -34.87 61.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -127.25 29.53 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 tp -87.35 148.92 24.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 163.87 21.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -56.62 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -57.81 -40.32 79.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -41.02 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . . . -63.23 -46.05 88.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.7 t -69.4 -35.56 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -50.81 69.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.18 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -62.73 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.26 -31.87 73.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.62 -34.37 27.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 -62.4 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.84 134.56 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.193 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -98.41 25.88 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.855 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -177.93 71.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.27 146.17 41.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.7 m -90.5 116.87 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.026 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 pt -110.79 128.27 67.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.919 0.39 . . . . 0.0 111.582 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.23 122.19 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -128.19 147.39 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.72 117.87 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.736 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -56.26 136.42 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.801 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.47 -17.5 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.276 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.73 35.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.11 -30.3 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.484 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -56.05 -34.4 65.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -48.38 -49.99 32.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.485 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 10.1 mt -71.76 -45.82 60.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.855 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -28.64 53.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.283 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.41 126.09 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.766 0.317 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.81 143.61 56.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.602 2.201 . . . . 0.0 112.407 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mt -65.64 160.65 22.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.75 153.82 19.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.12 134.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 28.7 m -125.45 138.82 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.32 140.27 29.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -157.86 129.39 6.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.761 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 89' ' ' ILE . 5.9 ttpm? -96.78 136.93 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.093 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -100.6 136.08 41.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.4 t -141.92 143.96 26.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -128.34 124.92 37.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 15' ' ' ILE . 28.9 mm -116.93 124.16 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.213 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -120.57 109.39 15.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.41 58.52 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -160.4 37.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.251 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.52 -59.25 0.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -158.86 -46.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.806 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.48 166.41 23.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.45 -164.18 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.439 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.4 tp -72.69 -29.71 63.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.741 0.305 . . . . 0.0 110.433 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 63.36 50.9 58.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.555 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -161.52 156.99 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.78 173.46 6.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -142.01 133.65 26.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.341 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.06 162.17 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.734 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.86 145.7 30.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 110.381 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.6 160.33 30.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.028 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 97' ' ' LEU . 59.0 Cg_endo -71.33 -160.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.827 2.351 . . . . 0.0 112.156 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.33 -29.57 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.67 -31.78 72.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -155.4 74.31 5.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.28 125.99 10.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.589 2.193 . . . . 0.0 112.32 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.23 -178.99 48.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.9 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 111.097 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.5 m-85 -107.54 170.39 8.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.7 mm -107.65 129.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 -169.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -46.72 141.2 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.36 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 t -109.27 157.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.7 mttp -120.91 145.28 41.12 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 17.3 Cg_exo -66.67 173.56 7.76 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.616 2.211 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.32 43.22 43.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.757 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -136.71 -174.16 3.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.369 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.9 mt -84.95 -35.24 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 p -56.28 -41.07 75.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.22 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.686 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -59.8 -39.66 85.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.45 -30.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.035 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.73 64.12 0.72 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 mt -108.25 164.56 12.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 111.005 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.05 162.62 5.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mt -59.83 140.44 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.811 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.413 ' HA2' ' CD2' ' A' ' 98' ' ' PHE . . . 109.08 -38.16 3.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.451 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -55.52 157.33 3.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.673 0.273 . . . . 0.0 110.767 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.44 114.99 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.161 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.06 121.09 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.869 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.0 m -109.47 9.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.885 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.62 146.5 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 111.336 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 61.9 t -151.0 106.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.68 30.94 20.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.016 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.41 13.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.29 129.67 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -71.45 107.35 4.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -82.54 0.02 44.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.376 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -60.53 -54.3 47.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -108.72 33.7 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.419 ' CD2' ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -92.94 148.28 22.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -89.52 170.57 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -62.76 -53.03 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -57.6 -38.0 74.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.89 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -67.56 -42.07 83.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.1 t -70.87 -46.58 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.04 -55.92 25.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.39 -45.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.02 -30.83 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.715 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -82.58 -30.49 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -66.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -84.9 144.81 28.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -92.65 -57.6 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -89.86 77.67 6.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 139.23 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -92.74 116.9 29.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.12 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 87' ' ' ILE . 10.1 pt -111.05 127.44 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.696 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.26 103.48 15.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.469 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -105.34 151.39 7.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.89 114.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.768 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -55.38 136.63 49.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.506 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 84.59 -20.56 0.29 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.194 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.18 46.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.87 -30.13 2.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.519 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -55.43 -34.52 64.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 111.01 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -54.03 -37.13 63.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.128 0.489 . . . . 0.0 110.108 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.422 ' HG ' ' CZ ' ' A' ' 38' ' ' PHE . 4.6 mm? -71.29 -55.27 8.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.413 ' CD2' ' HA2' ' A' ' 56' ' ' GLY . 23.6 m-85 -50.83 -30.92 15.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 21.0 mmt -70.2 121.84 18.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.942 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.701 0.286 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.3 170.35 2.39 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.534 2.156 . . . . 0.0 112.255 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 28.2 mt -119.36 149.0 42.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.792 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -93.15 158.01 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.1 mt -147.51 130.02 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 25.5 m -115.13 151.04 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.94 125.95 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.968 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.643 0.259 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.08 140.62 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' CD ' ' CG2' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -120.17 117.37 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.602 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -86.24 143.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -148.16 150.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.298 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -130.3 122.24 27.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.777 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.33 129.4 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.28 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.4 144.98 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.49 -44.54 94.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.5 t 68.57 -67.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.286 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.43 -84.73 0.62 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.541 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -140.03 31.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 116.88 23.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.7 -87.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.614 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.1 tp -132.94 -48.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.345 . . . . 0.0 110.651 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 93.88 29.16 10.08 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.383 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -155.93 157.55 36.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -114.7 173.8 6.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.12 153.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.041 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.3 p -137.22 161.71 35.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -105.45 154.96 19.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -108.86 -177.35 21.64 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.764 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.49 -166.44 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -85.63 -23.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.236 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -69.75 -30.99 68.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -146.47 69.54 12.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.92 143.12 32.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.93 163.78 20.11 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 HG13 ' CD2' ' A' ' 67' ' ' PHE . 12.7 mm -81.63 114.56 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 97' ' ' LEU . 2.8 m-30 -100.53 171.73 7.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.187 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.72 121.03 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.017 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -169.41 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.548 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.51 140.08 2.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.6 t -119.53 140.11 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.711 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -104.44 149.68 37.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.32 168.42 21.02 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.658 2.238 . . . . 0.0 112.321 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.02 60.8 8.17 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.308 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.494 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -158.9 -177.62 6.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.984 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.65 -49.67 37.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.819 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.72 -38.29 72.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.04 -38.43 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.79 -42.78 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.09 -27.26 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.273 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.97 52.58 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 mt -94.96 160.25 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -159.57 158.55 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mt -58.55 136.56 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 111.47 -37.81 3.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' HB3' ' CD1' ' A' ' 89' ' ' ILE . 55.2 m-20 -49.21 164.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.291 . . . . 0.0 110.908 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -146.94 113.7 6.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.115 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.47 122.87 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.441 ' CG1' HG13 ' A' ' 90' ' ' VAL . 34.5 m -110.63 5.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.846 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -168.5 146.16 4.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 111.13 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.417 HG23 ' CZ ' ' A' ' 67' ' ' PHE . 39.1 t -152.22 107.92 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 57.51 31.06 19.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.13 14.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.9 127.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.878 0.371 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.09 119.24 16.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 75' ' ' ALA . 1.6 m-85 -96.19 23.11 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 p -77.16 -57.14 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.585 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -108.41 29.37 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.675 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.65 148.48 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.944 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.32 164.69 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -59.69 -55.04 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -56.99 -37.6 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -61.94 -41.6 98.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -61.63 -47.32 85.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.59 -42.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.123 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -56.74 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.8 m -58.49 -45.94 89.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.849 0.357 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.42 -31.78 73.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.521 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -82.65 -29.51 29.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 t -65.97 -63.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.28 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.51 139.6 30.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -59.48 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.61 88.13 6.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.556 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.53 134.91 54.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -84.64 117.0 23.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.9 pt -112.38 133.61 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.636 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.0 114.67 29.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.572 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.421 ' CG2' ' CD ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -114.53 152.31 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.956 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 ' CG1' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -123.13 115.86 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.498 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -58.61 134.12 56.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 85.74 -20.37 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.249 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.68 -24.32 33.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.091 0.472 . . . . 0.0 110.816 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.44 -30.32 1.73 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.134 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 42.3 mtp180 -56.06 -34.25 65.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.293 0.237 . . . . 0.0 111.287 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -48.18 -49.4 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.449 HD13 ' CE2' ' A' ' 38' ' ' PHE . 19.7 mt -71.33 -43.76 66.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.766 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -30.45 59.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -59.48 -34.28 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.589 0.233 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.25 103.25 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.652 2.235 . . . . 0.0 112.457 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.63 179.77 6.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -96.09 150.51 20.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt -138.67 127.2 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.219 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 23.7 m -127.26 129.48 47.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.99 133.17 34.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.94 179.84 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.863 0.363 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -61.63 127.16 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 21.2 ttpt -114.67 150.26 35.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.775 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 148.15 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.5 t -147.28 141.75 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -126.11 117.77 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.73 115.9 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.215 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.9 p -134.69 131.49 37.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.04 153.79 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.27 54.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 -91.0 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.562 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -117.89 67.88 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -153.64 -177.46 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.783 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.75 -157.14 7.09 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.465 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.9 tp -93.34 -29.44 15.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.555 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 59.96 50.2 70.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.733 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.38 152.82 24.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -114.89 173.57 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.9 pt -135.54 141.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -117.22 161.53 19.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.798 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -105.45 142.91 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.769 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -91.4 167.8 31.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.624 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.67 -165.62 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.716 2.277 . . . . 0.0 112.276 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.79 -28.17 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.164 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.34 -26.76 65.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -156.48 66.9 4.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.243 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.59 111.69 3.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.013 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.45 -170.74 37.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.608 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.431 HG13 ' CD2' ' A' ' 67' ' ' PHE . 14.0 mm -94.97 118.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' CE2' HD13 ' A' ' 97' ' ' LEU . 52.0 m-85 -111.24 174.67 5.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.318 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -107.69 136.46 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.194 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.12 -169.45 1.58 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.638 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -47.25 140.19 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.262 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.86 148.75 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -107.94 138.84 20.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.3 173.22 2.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.471 2.114 . . . . 0.0 112.111 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.22 27.77 24.7 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.448 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -121.8 166.24 14.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.86 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.32 -35.66 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -53.09 -40.95 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.03 -39.85 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.56 -35.06 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.803 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 m -82.44 -30.83 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.68 41.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.457 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.18 164.68 14.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.988 0.423 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.93 168.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.2 mt -65.07 133.78 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.721 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ARG . . . 112.77 -18.0 22.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.358 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' HB3' HG13 ' A' ' 89' ' ' ILE . 64.5 m-20 -71.97 169.13 16.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.456 ' HG3' ' CE2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -148.52 115.08 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.04 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mt -69.02 116.95 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.652 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.21 3.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.793 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -176.44 152.68 1.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 47.7 t -151.95 102.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 60.58 37.77 19.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.92 -31.94 7.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 t -70.51 114.65 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 111.029 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.13 124.16 21.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CD2' HG13 ' A' ' 37' ' ' ILE . 2.2 m-85 -96.11 21.9 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.102 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.7 t -73.76 -37.58 64.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -128.9 28.85 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.733 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.74 148.01 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.03 158.05 25.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -57.34 -53.51 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.47 -38.62 77.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -44.13 97.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 67' ' ' PHE . . . -59.54 -45.66 91.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.1 t -69.31 -42.64 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -55.99 -58.9 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -58.58 -40.53 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.181 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.55 -29.52 68.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -82.59 -33.18 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -60.94 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -45.84 22.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.7 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -100.42 92.44 5.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.22 144.35 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.4 m -89.43 117.01 28.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.272 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.859 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.0 t -94.66 116.66 29.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.247 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.424 HG13 ' HB3' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -123.67 142.66 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.207 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.76 131.86 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.508 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -69.65 136.56 51.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.713 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 83.99 -17.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.396 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.95 -21.3 11.26 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.881 0.372 . . . . 0.0 111.102 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -30.47 2.52 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HD3' ' CB ' ' A' ' 92' ' ' ALA . 1.7 ptt180 -56.04 -34.47 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.672 0.273 . . . . 0.0 111.321 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -49.97 38.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.458 HD13 ' CE2' ' A' ' 38' ' ' PHE . 14.9 mt -71.39 -58.43 3.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -46.05 -40.5 10.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.411 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 38.0 mmt -73.17 64.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.901 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.729 0.299 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.13 160.93 2.81 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.624 2.216 . . . . 0.0 112.303 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.57 128.56 52.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.73 145.24 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt -141.71 138.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 68.5 m -124.4 147.36 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.01 138.05 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.862 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -59.88 131.93 52.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' CD ' ' CG2' ' A' ' 89' ' ' ILE . 0.8 OUTLIER -112.4 141.2 46.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -109.3 143.55 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.409 ' CG2' ' HD3' ' A' ' 11' ' ' LYS . 18.5 t -149.96 153.15 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.389 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.37 114.54 9.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.636 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.3 mm -97.92 118.92 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 p -129.25 109.97 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.16 121.84 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 t -71.03 -47.26 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.07 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.84 -58.58 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 t -164.34 49.11 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.935 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -110.75 -30.78 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.023 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.5 -122.53 6.92 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.5 tp -124.41 -50.24 1.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.0 28.24 9.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.364 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' HB2' ' CB ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -147.28 160.95 41.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.393 . . . . 0.0 111.152 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.94 173.64 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.971 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 27' ' ' ILE . 26.0 pt -143.45 135.57 23.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.2 t -119.78 161.78 20.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.657 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.11 147.67 27.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 -178.32 46.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.589 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.68 -165.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.62 2.213 . . . . 0.0 112.236 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.86 -30.06 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -68.05 -30.21 69.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.53 74.14 17.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.014 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.82 141.51 27.31 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.6 173.33 40.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 HG13 ' CE2' ' A' ' 67' ' ' PHE . 23.9 mm -90.32 115.09 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.054 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 3.4 m-85 -105.56 171.35 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.7 mm -107.73 137.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.1 -169.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.442 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 142.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.184 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.08 157.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.972 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -114.5 145.43 33.79 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 162.51 38.8 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.543 2.162 . . . . 0.0 112.197 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.9 86.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.472 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -135.56 -177.36 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.04 -49.52 43.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.628 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -53.46 -41.84 66.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.43 84.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -64.15 -37.57 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.89 -36.38 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.46 70.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.406 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.3 mt -116.38 150.91 36.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -154.58 162.45 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.455 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.9 mt -57.92 137.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.67 -29.18 9.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.564 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' HB3' HG13 ' A' ' 89' ' ' ILE . 21.6 m-20 -57.63 164.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.649 0.261 . . . . 0.0 110.593 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -146.39 114.4 6.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.239 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.27 117.15 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.06 0.58 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.808 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -175.62 159.49 2.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -155.22 103.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 63.78 17.23 10.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.278 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.12 -27.21 9.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.642 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.8 p -65.05 134.23 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.728 0.299 . . . . 0.0 111.215 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.57 121.81 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 75' ' ' ALA . 1.4 m-85 -94.84 19.02 10.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.236 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -75.34 -56.74 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.98 26.65 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.415 HD23 ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -87.19 150.34 24.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.26 167.9 11.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.56 -53.57 56.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -54.67 -41.99 70.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -59.77 -42.64 93.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -63.4 -46.13 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.133 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.4 t -68.67 -36.96 76.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -58.98 6.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG22 HD23 ' A' ' 79' ' ' LEU . 34.3 m -57.86 -40.47 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.312 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.416 HD23 HG22 ' A' ' 78' ' ' VAL . 3.0 mm? -66.55 -32.14 73.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 110.656 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -35.97 37.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 t -61.0 -57.08 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.92 142.84 29.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.253 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.11 -49.03 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.509 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 t -98.21 81.99 2.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.51 137.83 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.278 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.5 m -85.97 116.92 24.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.2 pt -110.28 132.68 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -101.88 118.95 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.37 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.441 ' CG2' ' CD ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -123.4 151.84 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.1 t -125.71 110.45 24.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.442 . . . . 0.0 110.701 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . -55.41 138.18 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.462 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 91' ' ' ALA . . . 85.38 -22.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.927 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.46 -21.85 39.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.033 0.444 . . . . 0.0 110.854 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.27 -30.34 1.92 Allowed Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.428 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 31.6 mtt-85 -56.19 -34.73 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.558 0.218 . . . . 0.0 111.352 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -49.32 -50.03 41.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.679 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' A' ' 38' ' ' PHE . 11.3 mt -71.74 -43.51 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.455 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -53.01 -24.76 10.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.358 -179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.6 mmm -53.13 122.49 9.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.43 179.22 6.73 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.607 2.205 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 16.8 mt -123.25 149.8 44.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.78 107.21 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 21.2 mt -100.62 158.44 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' THR . . . . . . . . . . . . . 78.5 m -150.93 148.94 29.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.67 136.57 34.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.855 -179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 90' ' ' VAL . 5.2 mt-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.81 0.338 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -105.16 147.79 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -109.43 138.17 46.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.784 HG13 ' HB ' ' A' ' 51' ' ' VAL . 40.5 t -143.0 128.86 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.786 ' CD2' HG23 ' A' ' 86' ' ' THR . 3.9 m-85 -114.58 116.64 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 51' ' ' VAL . 42.3 mm -104.3 124.68 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.87 HD21 ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.678 0.275 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 102.62 20.39 11.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.304 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -132.62 158.57 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.213 0.506 . . . . 0.0 111.581 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 m -114.82 173.73 6.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.649 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.983 HD11 HG22 ' A' ' 76' ' ' VAL . 4.8 pt -143.53 145.54 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.103 0.478 . . . . 0.0 111.71 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -129.03 162.46 27.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.38 143.83 32.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.781 0.324 . . . . 0.0 110.443 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.67 175.14 43.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.073 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.788 ' CD ' HD12 ' A' ' 97' ' ' LEU . 55.8 Cg_endo -69.55 -160.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.843 2.362 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -85.87 -27.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.301 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -66.43 -32.65 74.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' HD11 ' A' ' 97' ' ' LEU . 16.9 mttp -151.08 70.48 8.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.35 137.51 28.44 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.624 2.216 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.05 -175.44 46.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.389 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.442 HG13 ' CD2' ' A' ' 67' ' ' PHE . 22.4 mm -92.93 116.58 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 27' ' ' ILE . 2.6 m-85 -105.12 170.37 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.82 134.06 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.024 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.1 -169.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.438 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.425 ' ND1' HD11 ' A' ' 55' ' ' ILE . 1.8 t60 -51.59 149.24 4.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.014 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' A' ' 25' ' ' CYS . 6.0 m -130.17 155.43 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -95.89 147.11 32.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.46 144.62 22.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.39 -24.23 26.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.524 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -74.06 -179.08 3.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -70.48 -35.9 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.522 ' HA ' HD12 ' A' ' 53' ' ' LEU . 45.1 t -52.83 -51.25 61.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -33.73 75.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -31.13 71.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.14 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.784 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.3 m -88.54 -20.82 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.03 39.0 3.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.074 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 48' ' ' SER . 8.0 mt -90.38 159.31 16.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.088 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 179.49 171.24 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 2.3 mt -60.35 147.71 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 103.66 -41.93 2.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.431 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.9 m-20 -55.15 169.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.657 0.265 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.523 ' CB ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -150.8 113.03 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.094 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -69.22 121.96 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.453 ' CG2' HG23 ' A' ' 90' ' ' VAL . 27.9 m -111.55 8.54 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.775 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.37 147.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.986 0.422 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.874 HG22 HG22 ' A' ' 87' ' ' ILE . 47.5 t -153.68 100.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.856 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 63.47 30.42 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.83 -29.62 12.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.429 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.4 118.48 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.72 123.26 20.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 3.1 m-85 -98.86 19.83 14.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -41.15 96.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -139.13 28.54 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.675 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.556 HD21 ' N ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -71.29 140.99 50.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.74 154.69 36.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -58.29 -54.61 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.001 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -57.2 -40.0 76.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.5 mm-40 -59.49 -40.76 88.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.556 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -63.1 -47.27 83.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.983 HG22 HD11 ' A' ' 27' ' ' ILE . 40.3 t -68.68 -36.13 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.44 -58.96 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 74' ' ' GLU . 29.3 m -57.67 -40.46 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.207 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.467 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.7 mm? -67.03 -31.95 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -34.77 38.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.4 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.068 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.563 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.1 m -97.8 119.29 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -67.17 -39.76 86.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.709 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 p -113.39 107.17 15.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.548 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.599 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -144.31 146.34 32.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.954 0.407 . . . . 0.0 111.303 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.786 HG23 ' CD2' ' A' ' 14' ' ' PHE . 31.3 m -85.22 123.03 30.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.064 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 62' ' ' VAL . 6.3 pt -118.25 126.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.534 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -95.46 112.37 24.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.465 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -112.74 149.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.039 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 10' ' ' GLU . 32.4 t -122.09 115.45 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.71 137.76 53.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.524 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.12 -17.49 0.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.176 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -57.73 -22.19 45.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 110.991 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -117.11 -30.69 1.87 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.551 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 58.0 mtp180 -56.16 -34.54 66.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 0.0 111.027 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -42.05 78.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.788 HD12 ' CD ' ' A' ' 31' ' ' PRO . 3.2 mm? -71.24 -48.59 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 2.1 m-85 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 34.5 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.778 0.323 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 76' ' ' VAL . 27.0 m -134.89 148.13 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.12 127.83 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 27' ' ' ILE . 14.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.5 mm-40 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.835 0.35 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 5.8 ttpm? -99.2 145.54 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.222 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 139.07 39.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.778 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.794 HG13 ' HB ' ' A' ' 51' ' ' VAL . 39.4 t -145.99 145.51 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -131.93 121.92 24.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mm -108.27 129.69 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.9 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.934 0.397 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 113.11 27.26 3.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.205 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 42' ' ' VAL . 54.0 t -154.18 156.05 36.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.94 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.9 t -114.87 136.09 53.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.026 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.678 HD11 HG22 ' A' ' 76' ' ' VAL . 20.9 pt -101.64 146.95 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 111.443 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 p -129.0 161.84 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.723 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 144.78 31.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.77 173.73 42.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.606 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.21 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.537 2.158 . . . . 0.0 112.365 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 mt -68.22 -28.12 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -66.76 -26.84 67.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.216 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HB3' HD11 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -154.51 76.78 5.47 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.112 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.22 133.28 12.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.514 2.142 . . . . 0.0 112.263 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.15 -179.95 38.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 75' ' ' ALA . 20.0 mm -88.71 114.6 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE2' HD12 ' A' ' 97' ' ' LEU . 20.2 m-85 -109.03 173.55 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.528 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.3 mm -107.83 131.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.269 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.22 -168.98 1.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.528 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.429 ' HA ' HD11 ' A' ' 55' ' ' ILE . 44.8 t-80 -45.87 140.3 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' SG ' ' A' ' 25' ' ' CYS . 25.3 t -108.66 157.44 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.458 ' N ' HG12 ' A' ' 42' ' ' VAL . 12.2 mttt -108.15 121.44 43.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.53 151.17 39.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.4 2.067 . . . . 0.0 112.135 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 53.51 24.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.41 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.456 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -151.61 -169.28 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 47' ' ' LEU . 2.3 mm? -76.08 -46.56 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.394 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 51' ' ' VAL . 23.0 t -56.26 -42.01 76.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -38.77 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.98 -35.61 81.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.794 ' HB ' HG13 ' A' ' 13' ' ' VAL . 31.0 m -77.91 -27.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.47 30.32 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.589 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.444 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 11.7 mt -75.73 166.36 23.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -179.31 155.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.783 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 41' ' ' HIS . 4.6 mt -53.16 131.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.008 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 117.12 -25.72 8.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.284 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' CB ' HD11 ' A' ' 89' ' ' ILE . 52.5 m-20 -69.11 166.52 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -148.05 115.18 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.084 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.27 117.26 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 88' ' ' SER . 35.6 m -98.71 -15.36 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.73 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -158.34 155.05 28.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.931 HG13 HG22 ' A' ' 87' ' ' ILE . 47.8 t -152.12 103.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.01 31.3 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.9 -28.38 13.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.06 126.39 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.126 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.18 112.91 3.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.2 m-85 -98.75 11.68 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -72.3 -44.29 62.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.712 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -123.43 30.5 6.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.604 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.0 146.96 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.914 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.499 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -73.42 167.59 20.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -66.3 -55.16 17.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -39.11 80.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.63 -37.82 82.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.752 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.646 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -66.15 -46.07 78.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.962 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.692 HG11 HG21 ' B' ' 116' ' ' THR . 24.8 t -68.71 -42.46 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.044 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -56.07 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 79' ' ' LEU . 32.7 m -58.84 -43.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.452 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -65.79 -31.42 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -69.67 -67.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.11 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.679 ' CB ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -77.27 136.1 38.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -51.19 7.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.622 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.0 p -106.14 83.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.679 HD23 ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -116.02 139.81 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.0 m -90.49 116.85 28.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.24 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.931 HG22 HG13 ' A' ' 62' ' ' VAL . 17.4 pt -111.91 129.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.71 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.579 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -97.27 108.9 21.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.449 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.466 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -109.82 146.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 10' ' ' GLU . 11.4 t -117.15 112.59 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 110.977 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.6 143.37 36.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.347 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.75 -19.48 0.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.779 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -58.62 -20.68 49.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.88 -30.85 2.05 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.533 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 59.3 mtt180 -56.62 -34.28 67.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.52 0.2 . . . . 0.0 111.398 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.23 -49.8 31.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' A' ' 34' ' ' LYS . 9.3 mt -71.15 -43.28 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.831 0.348 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.692 HG21 HG11 ' A' ' 76' ' ' VAL . 33.5 m -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.31 143.43 27.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 27' ' ' ILE . 3.6 mp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -97.91 135.51 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -94.39 140.44 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.875 HG13 ' HB ' ' A' ' 51' ' ' VAL . 44.6 t -145.52 137.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -124.76 115.99 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.493 HD12 HD13 ' A' ' 23' ' ' LEU . 42.8 mm -101.15 127.64 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.232 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.616 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 HD12 ' A' ' 15' ' ' ILE . 13.5 tp . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 106.75 23.82 6.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.27 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.776 ' SG ' HG22 ' A' ' 42' ' ' VAL . 2.8 t -145.09 164.85 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 111.016 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 m -114.94 173.75 6.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.758 HD13 HD11 ' B' ' 118' ' ' LEU . 16.0 pt -142.81 145.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 111.377 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.24 161.95 28.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.789 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.95 141.9 35.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.745 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.03 172.95 34.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.917 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' HD13 ' A' ' 97' ' ' LEU . 42.2 Cg_endo -67.65 -165.71 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.34 -25.54 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.26 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.15 -5.48 49.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.283 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HB3' HD11 ' A' ' 97' ' ' LEU . 6.9 tttt -171.01 59.31 0.29 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.773 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.27 144.54 56.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.606 2.204 . . . . 0.0 112.315 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.13 174.87 33.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.278 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 75' ' ' ALA . 11.8 mm -89.58 113.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.898 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.937 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.6 m-85 -101.96 172.51 6.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.503 HG23 ' SG ' ' A' ' 25' ' ' CYS . 23.3 mm -109.21 136.26 45.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.234 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.05 -169.35 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.375 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -45.02 145.72 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.776 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.2 t -113.73 151.32 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -105.43 124.02 37.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 159.79 8.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.045 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.01 50.24 67.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 2.5 m -141.05 -173.62 3.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.733 0.301 . . . . 0.0 110.912 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.9 mt -78.15 -42.32 32.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -52.87 -40.11 63.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.939 0.4 . . . . 0.0 110.572 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.33 68.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.611 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -37.15 79.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.817 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.875 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.2 m -83.05 -30.22 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.08 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.72 52.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 48' ' ' SER . 14.0 mt -97.63 164.89 12.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.12 162.42 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 4.1 mt -58.02 140.9 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 -37.16 3.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.257 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.51 156.14 13.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.756 0.312 . . . . 0.0 110.637 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.4 119.09 12.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 62' ' ' VAL . 15.5 mt -69.42 117.13 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.614 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.64 -16.01 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.714 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -155.52 148.36 24.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.402 . . . . 0.0 111.044 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.859 HG13 HG22 ' A' ' 87' ' ' ILE . 41.8 t -147.66 105.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 55.92 32.66 20.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.8 23.41 38.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.659 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 62' ' ' VAL . 23.6 t -112.21 120.16 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.326 . . . . 0.0 111.063 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -65.14 111.92 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.676 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.3 m-85 -95.78 19.84 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.86 -41.07 45.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -123.61 28.04 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.694 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -83.52 148.98 26.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.45 164.33 17.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.2 t-160 -59.37 -48.95 79.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -60.63 -41.85 95.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.0 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -59.04 -45.73 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.608 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -59.07 -47.71 84.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.745 HG22 HD11 ' A' ' 27' ' ' ILE . 28.0 t -66.87 -43.47 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -58.13 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.7 m -57.28 -44.58 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.528 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.4 mm? -64.43 -31.51 72.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.693 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.1 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 t -66.56 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -87.56 131.76 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -77.66 -55.69 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.8 m -100.03 83.03 2.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -113.84 141.87 46.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -89.85 116.94 28.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.859 HG22 HG13 ' A' ' 62' ' ' VAL . 12.3 pt -115.02 126.51 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 0.0 111.542 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -96.04 122.9 39.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 145.94 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.409 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.77 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -111.18 126.17 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.298 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -65.91 132.11 47.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.525 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.54 -19.42 0.32 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.627 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.77 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -53.6 -24.18 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.52 -30.77 2.97 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -34.56 66.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.624 0.25 . . . . 0.0 111.282 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.65 -50.01 44.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.937 HD12 ' CE2' ' A' ' 38' ' ' PHE . 18.9 mt -71.52 -41.03 69.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.005 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.193 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 30.6 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.452 HG21 HG21 ' A' ' 76' ' ' VAL . 32.5 m -111.68 145.09 39.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -98.06 111.78 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.758 HD11 HD13 ' A' ' 27' ' ' ILE . 6.1 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.546 ' HA ' HG22 ' A' ' 90' ' ' VAL . 4.9 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.99 0.424 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.741 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -102.01 116.85 33.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -86.23 131.88 34.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.763 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.759 HG13 ' HB ' ' A' ' 51' ' ' VAL . 40.1 t -140.75 149.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.286 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 5.1 m-85 -128.32 131.59 48.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.705 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.8 131.29 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 48' ' ' SER . 12.7 tp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 108.67 36.38 2.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.063 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.718 ' SG ' HG12 ' A' ' 42' ' ' VAL . 1.3 t -160.23 160.71 33.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.0 110.486 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 4.2 m -114.36 173.45 6.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.53 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.12 HD11 HG22 ' A' ' 76' ' ' VAL . 10.0 pt -135.29 153.5 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.41 . . . . 0.0 111.354 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 29.5 p -131.29 162.68 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.8 p -104.61 140.79 37.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 175.31 43.58 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.716 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.72 ' HD2' HD13 ' A' ' 97' ' ' LEU . 57.5 Cg_endo -71.06 -167.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.646 2.231 . . . . 0.0 112.586 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.9 mt -78.2 -21.42 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.257 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -71.92 -30.31 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.1 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB3' HD11 ' A' ' 97' ' ' LEU . 11.2 mttm -147.53 64.77 8.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 21.8 Cg_exo -64.7 114.45 2.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.629 2.22 . . . . 0.0 112.014 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 -157.38 8.99 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 75' ' ' ALA . 19.7 mm -111.67 118.0 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.053 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.868 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 2.1 m-85 -100.36 172.28 7.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.716 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.4 mm -118.74 121.62 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.33 -169.5 2.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.611 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -54.34 141.99 28.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.718 HG12 ' SG ' ' A' ' 25' ' ' CYS . 1.7 m -119.71 153.48 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 147.07 32.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.38 172.74 15.75 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.29 33.89 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.603 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 73.7 p -119.11 -171.76 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.788 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 4.4 mt -78.0 -44.03 27.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -53.05 -46.13 68.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.533 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -36.28 75.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.564 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.06 -38.5 83.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.759 ' HB ' HG13 ' A' ' 13' ' ' VAL . 21.0 m -80.36 -29.69 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 36.18 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.377 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 48' ' ' SER . 13.1 mt -85.06 161.05 19.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.0 166.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.674 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.86 144.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 105.94 -13.3 45.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.646 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.457 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.5 m-20 -86.32 162.32 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.446 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -142.85 114.93 8.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.07 117.19 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.851 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 88' ' ' SER . 30.7 m -106.86 6.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.764 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -177.15 149.89 0.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.843 0.354 . . . . 0.0 111.136 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.85 HG22 HG22 ' A' ' 87' ' ' ILE . 58.1 t -153.84 112.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 56.95 29.47 16.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.73 -26.18 19.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.45 124.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.899 0.38 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.22 114.88 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.9 m-85 -95.75 22.31 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -53.8 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.642 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -111.78 28.49 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.554 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.1 tp -83.17 147.69 27.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.61 163.09 20.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -59.5 -50.34 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -59.56 -37.5 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HB3' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -61.64 -43.15 99.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.554 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.66 -46.2 90.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.16 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.12 HG22 HD11 ' A' ' 27' ' ' ILE . 40.5 t -67.95 -43.85 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.4 -57.21 12.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 79' ' ' LEU . 33.3 m -58.02 -45.34 88.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.512 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.4 mm? -63.84 -29.66 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.645 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.814 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.3 mptp? -82.58 -34.65 27.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -69.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.383 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -75.77 131.18 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.288 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.33 -50.61 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.551 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -102.4 86.92 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.507 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -121.42 143.16 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.289 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 m -92.19 116.92 29.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.051 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 62' ' ' VAL . 5.9 pt -109.37 130.44 62.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.928 0.394 . . . . 0.0 111.546 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -105.18 103.56 13.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.785 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.741 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.85 147.61 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.9 t -114.44 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 0.0 110.964 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.655 ' HB2' ' NZ ' ' A' ' 11' ' ' LYS . . . -55.38 138.41 45.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.268 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.68 -22.45 0.18 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.773 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.68 55.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.922 0.392 . . . . 0.0 111.023 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA2' ' CZ ' ' A' ' 38' ' ' PHE . . . -110.86 -30.21 3.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.67 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 27.4 mtp85 -55.75 -34.49 65.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.549 0.214 . . . . 0.0 111.482 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.22 -50.05 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.868 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 19.3 mt -71.53 -50.03 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.022 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.371 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.1 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.566 HG21 HG21 ' A' ' 76' ' ' VAL . 83.1 m -129.76 149.48 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.37 144.02 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.814 HD23 ' HE2' ' A' ' 80' ' ' LYS . 15.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.3 mt-10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.756 0.312 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -118.59 158.41 25.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -121.08 141.2 51.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.704 HG13 ' HB ' ' A' ' 51' ' ' VAL . 21.7 t -141.37 150.06 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.339 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' HE1' ' HG ' ' A' ' 16' ' ' SER . 1.8 t80 -128.13 120.36 27.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.699 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 23' ' ' LEU . 36.5 mm -110.14 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.435 ' HG ' ' HE1' ' A' ' 14' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.961 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.622 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.6 tp . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 100.03 27.92 7.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.455 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.658 ' SG ' HG22 ' A' ' 42' ' ' VAL . 35.9 t -154.28 159.29 41.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.2 m -114.42 173.68 6.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.764 HD11 HG22 ' A' ' 76' ' ' VAL . 19.1 pt -135.93 138.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.1 p -116.28 161.71 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.829 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 t -105.17 144.91 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.46 171.89 35.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.575 ' HD2' HD13 ' A' ' 97' ' ' LEU . 57.6 Cg_endo -71.37 -166.44 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.66 2.24 . . . . 0.0 112.393 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.43 -25.28 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -68.22 -28.14 66.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' HB3' HD11 ' A' ' 97' ' ' LEU . 11.8 tttp -157.25 65.63 3.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.226 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.78 144.68 84.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.62 2.213 . . . . 0.0 112.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 38' ' ' PHE . . . 163.61 168.64 25.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.551 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 75' ' ' ALA . 24.7 mm -82.89 114.58 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.051 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.591 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 70.2 m-85 -108.25 176.15 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.205 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.648 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.8 mm -107.69 137.85 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.623 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -169.45 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.23 150.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.658 HG22 ' SG ' ' A' ' 25' ' ' CYS . 29.9 t -126.97 157.59 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' N ' HG12 ' A' ' 42' ' ' VAL . 14.3 pttt -121.94 141.69 34.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 160.6 43.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.534 2.156 . . . . 0.0 112.399 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.52 82.63 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.933 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.541 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.4 m -103.87 -166.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.5 mm? -80.35 -43.47 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.769 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 53' ' ' LEU . 11.7 t -56.15 -40.58 74.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.53 79.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.22 -35.09 79.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.704 ' HB ' HG13 ' A' ' 13' ' ' VAL . 25.4 m -78.9 -17.44 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.467 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.52 5.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.289 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 9.1 mt -88.97 155.06 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -167.04 161.03 14.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.94 149.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 101.1 -23.39 35.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.291 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.418 ' HB3' HG13 ' A' ' 89' ' ' ILE . 46.6 m-20 -71.99 166.73 21.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 2.6 tt0 -152.66 119.03 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 111.348 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.39 117.47 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.92 -19.81 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.869 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -159.95 157.28 28.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.105 0.478 . . . . 0.0 111.416 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.727 HG12 ' ND2' ' A' ' 63' ' ' ASN . 46.3 t -150.21 117.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.499 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.727 ' ND2' HG12 ' A' ' 62' ' ' VAL . 0.1 OUTLIER 45.36 47.78 10.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 111.168 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.73 22.29 73.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.311 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 62' ' ' VAL . 21.8 t -109.31 127.38 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.91 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.94 114.66 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.117 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.69 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -99.33 -21.42 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.072 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 m -53.12 -45.82 68.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -106.85 35.45 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.2 tp -105.54 149.68 26.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.765 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.42 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -84.11 166.07 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -60.17 -53.92 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.17 -39.63 79.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.405 ' C ' HD21 ' A' ' 70' ' ' LEU . 2.9 mt-10 -61.32 -43.57 98.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.756 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -58.8 -45.54 89.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.764 HG22 HD11 ' A' ' 27' ' ' ILE . 39.1 t -68.73 -39.95 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.79 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.356 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 79' ' ' LEU . 29.9 m -59.06 -44.82 92.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 110.939 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -63.45 -31.53 72.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.733 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HE3' HD23 ' B' ' 118' ' ' LEU . 1.1 mptm? -82.66 -31.63 28.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 t -64.66 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.4 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.421 ' CB ' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -88.15 135.3 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.089 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -78.53 -52.07 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.617 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.2 p -102.29 85.17 2.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.427 ' CD2' ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -116.65 146.32 42.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 111.422 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -90.85 117.35 29.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.395 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.645 HG22 HG13 ' A' ' 62' ' ' VAL . 12.3 pt -115.17 121.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.547 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.33 120.76 33.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.534 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -122.38 144.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.25 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 89' ' ' ILE . 41.0 t -115.24 112.45 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.728 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.58 139.38 50.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.479 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.26 -17.32 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.131 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -59.75 -19.27 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 111.23 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 -30.82 2.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.623 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 51.0 mtp180 -56.47 -34.61 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.314 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.56 -49.91 69.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 34' ' ' LYS . 21.8 mt -71.56 -42.92 67.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.249 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 21.6 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.804 0.335 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.61 HG21 HG21 ' A' ' 76' ' ' VAL . 39.1 m -133.35 143.1 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.23 141.19 28.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.742 ' HA ' HG22 ' A' ' 90' ' ' VAL . 13.5 tt0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -105.96 146.73 29.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 111.047 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -97.95 149.87 21.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.725 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.798 HG13 ' HB ' ' A' ' 51' ' ' VAL . 57.8 t -152.99 141.1 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.04 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -129.23 123.72 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.653 HD12 ' CD1' ' A' ' 23' ' ' LEU . 22.0 mm -110.77 127.64 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.806 179.905 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.653 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.0 tp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.04 30.89 8.45 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.3 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 39' ' ' ILE . 42.2 t -151.43 158.65 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 111.009 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.31 173.9 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.796 HD13 HD11 ' B' ' 118' ' ' LEU . 11.7 pt -136.01 175.8 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.966 0.412 . . . . 0.0 111.359 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 t -146.76 162.16 39.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.639 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -104.83 148.26 26.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.607 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -88.72 154.49 24.85 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.02 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.484 ' CD ' HD12 ' A' ' 97' ' ' LEU . 57.8 Cg_endo -70.78 -159.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.882 2.388 . . . . 0.0 112.032 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -80.69 -27.05 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.348 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -85.67 0.59 52.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.548 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HD3' HD21 ' A' ' 97' ' ' LEU . 7.4 tttp -175.98 65.43 0.23 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.203 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 13.8 Cg_exo -69.3 119.1 6.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 111.921 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.41 -175.41 38.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.781 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.404 HG13 ' CD2' ' A' ' 67' ' ' PHE . 15.4 mm -106.11 111.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.309 . . . . 0.0 110.937 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 1.8 m-30 -100.99 174.5 5.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.655 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.4 mm -107.85 138.37 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.13 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -169.44 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.402 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -45.25 137.52 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 43' ' ' LYS . 18.7 t -108.58 157.79 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.461 ' N ' HG12 ' A' ' 42' ' ' VAL . 13.4 mttt -107.6 154.52 40.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.79 154.03 15.21 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.743 2.296 . . . . 0.0 112.407 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.1 26.98 64.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.585 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.465 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -111.94 -177.8 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.696 0.284 . . . . 0.0 110.848 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 24.8 mt -73.09 -46.19 52.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.756 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -52.93 -38.8 62.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.74 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.437 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.89 -40.19 87.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.704 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.798 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.6 m -78.87 -27.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.056 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.86 48.96 1.12 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 48' ' ' SER . 15.2 mt -96.04 154.27 17.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HA ' HG21 ' A' ' 42' ' ' VAL . 12.5 tt0 -168.01 166.88 13.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.69 138.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.8 17.2 21.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.376 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' CB ' HD11 ' A' ' 89' ' ' ILE . 48.2 m-20 -110.39 159.94 17.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.675 0.274 . . . . 0.0 110.677 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 14.4 tm0? -140.05 112.2 7.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -69.23 118.45 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 88' ' ' SER . 33.2 m -106.42 13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.945 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -176.99 146.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.934 0.397 . . . . 0.0 111.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.803 HG13 HG22 ' A' ' 87' ' ' ILE . 39.0 t -149.53 98.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.04 30.27 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.18 -28.59 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.512 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.35 129.05 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.099 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.82 109.79 6.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.772 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.8 m-85 -96.79 -11.42 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.398 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -50.37 -27.84 7.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.763 0.316 . . . . 0.0 111.21 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -144.57 31.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.772 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -84.68 144.04 28.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.847 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.5 162.93 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -63.64 -54.93 28.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -58.17 -41.02 82.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' HD21 ' A' ' 70' ' ' LEU . 2.0 mp0 -60.38 -34.3 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.688 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -69.13 -45.32 70.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.007 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.82 HG21 HG21 ' B' ' 116' ' ' THR . 42.8 t -68.03 -38.73 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -56.5 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.1 m -59.29 -45.54 93.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.072 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.512 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.5 mm? -62.32 -31.17 71.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.606 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.445 ' HE2' HD23 ' B' ' 118' ' ' LEU . 0.1 OUTLIER -82.63 -33.45 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 t -61.72 -61.24 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.442 ' HB2' HD23 ' A' ' 85' ' ' LEU . 3.9 m -97.4 127.22 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.974 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -74.22 -48.8 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 t -98.61 94.27 6.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -134.36 140.23 46.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.2 m -91.89 133.11 35.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.272 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.803 HG22 HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -125.19 139.76 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.63 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -102.45 104.39 14.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.213 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.444 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -107.41 143.19 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 10' ' ' GLU . 21.8 t -110.95 129.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -65.48 131.88 47.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.828 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.06 -17.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.521 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.52 -22.43 32.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.782 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.26 -30.27 2.31 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.39 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.442 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -55.83 -34.62 65.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.78 -38.92 64.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.962 0.41 . . . . 0.0 110.322 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.53 HD21 ' HD3' ' A' ' 34' ' ' LYS . 3.9 mm? -71.4 -54.09 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.3 mm . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.82 HG21 HG21 ' A' ' 76' ' ' VAL . 85.3 m -134.19 146.32 50.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.15 128.14 42.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.796 HD11 HD13 ' A' ' 27' ' ' ILE . 40.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.496 ' HA ' HG13 ' A' ' 90' ' ' VAL . 1.2 mp0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.765 0.317 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -109.03 158.84 17.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.423 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -121.6 140.54 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.712 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 51' ' ' VAL . 58.5 t -145.48 145.57 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.246 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.871 ' CD1' HG23 ' A' ' 86' ' ' THR . 1.8 m-85 -123.53 129.07 50.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.657 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 23' ' ' LEU . 36.4 mm -119.72 125.68 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.607 HD13 HD12 ' A' ' 15' ' ' ILE . 12.5 tp . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.794 0.33 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.35 18.71 32.49 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.398 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.683 ' SG ' HG23 ' A' ' 39' ' ' ILE . 49.1 t -139.36 158.66 43.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.524 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 173.53 6.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 76' ' ' VAL . 15.3 pt -143.55 152.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.7 p -136.15 160.28 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -105.48 155.09 19.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.71 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.02 -166.04 24.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.88 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.54 -164.17 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.03 -24.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.244 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.42 -29.4 62.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' CB ' HD21 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -147.07 63.31 8.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.34 140.87 31.08 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.517 2.145 . . . . 0.0 112.335 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.98 31.97 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.416 HG13 ' HB2' ' A' ' 75' ' ' ALA . 12.1 mm -85.84 110.32 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -100.69 171.94 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.038 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.683 HG23 ' SG ' ' A' ' 25' ' ' CYS . 20.2 mm -107.78 137.15 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.322 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -169.4 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.189 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 147.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.105 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.616 HG22 ' SG ' ' A' ' 25' ' ' CYS . 35.5 t -121.43 157.92 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 3.1 mtpm? -96.62 156.37 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.804 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -50.57 3.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.509 2.139 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.7 -123.4 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.947 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.459 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 25.0 p 47.63 -159.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 111.313 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt -102.48 -29.42 11.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 51' ' ' VAL . 3.7 p -52.83 -52.4 57.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 43' ' ' LYS . . . -62.01 -35.38 78.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.075 0.464 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.42 -41.65 90.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.993 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.787 ' HB ' HG13 ' A' ' 13' ' ' VAL . 18.2 m -81.43 -29.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.11 61.78 0.82 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.371 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.92 155.38 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.28 159.64 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.42 147.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.65 -28.55 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' CB ' HD11 ' A' ' 89' ' ' ILE . 36.2 m-20 -63.35 146.92 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.689 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 1.5 tm0? -132.05 117.82 18.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.24 119.42 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 88' ' ' SER . 35.3 m -99.47 -20.98 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.0 155.05 34.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.748 HG13 HG22 ' A' ' 87' ' ' ILE . 47.8 t -151.1 96.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 57.42 36.9 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.85 -28.56 13.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.448 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.91 114.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.18 115.41 5.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.651 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.4 m-85 -97.27 25.03 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.024 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -70.94 -53.81 13.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.59 28.67 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.537 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.1 tp -74.2 149.4 40.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 173.02 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.438 ' CE1' ' HG1' ' B' ' 116' ' ' THR . 3.1 t60 -66.6 -58.34 5.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -57.61 -34.86 69.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -44.49 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.537 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.24 -44.64 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.768 HG11 HG21 ' B' ' 116' ' ' THR . 39.1 t -69.11 -43.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.032 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -54.81 -55.5 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.202 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 79' ' ' LEU . 28.3 m -59.1 -45.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.475 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -65.08 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.78 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.1 mptp? -82.58 -28.4 30.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -68.04 -64.34 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.716 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -84.75 140.08 31.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.149 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -78.79 -59.61 2.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.65 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 t -102.41 101.36 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -131.7 142.5 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.998 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.871 HG23 ' CD1' ' A' ' 14' ' ' PHE . 17.5 m -87.88 116.96 26.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.283 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.748 HG22 HG13 ' A' ' 62' ' ' VAL . 15.0 pt -111.77 123.99 68.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.984 0.421 . . . . 0.0 111.717 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 60' ' ' VAL . 6.2 t -93.23 113.5 25.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.249 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.51 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -118.34 147.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.29 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 10' ' ' GLU . 11.9 t -116.31 134.05 60.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.539 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -71.19 129.69 39.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.943 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.69 -17.33 0.49 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.678 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -54.88 -21.95 13.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.296 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.59 -30.24 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.606 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.407 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 6.2 ptm180 -56.13 -38.27 70.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -51.42 -49.95 60.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.732 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.62 HD21 ' CB ' ' A' ' 34' ' ' LYS . 12.5 mt -71.61 -35.94 70.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.351 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 23.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.789 0.328 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.768 HG21 HG11 ' A' ' 76' ' ' VAL . 95.0 m -121.89 144.15 49.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -88.83 147.87 24.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.78 HD23 ' HE2' ' A' ' 80' ' ' LYS . 1.7 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.0 ttpt -102.67 143.9 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 0.0 111.084 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 131.35 52.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.746 HG13 ' HB ' ' A' ' 51' ' ' VAL . 44.1 t -137.96 144.26 31.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 86' ' ' THR . 2.7 m-85 -130.09 125.77 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.477 HD12 ' CD1' ' A' ' 23' ' ' LEU . 35.3 mm -113.79 119.73 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' B' ' 118' ' ' LEU . 6.7 tp . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.748 0.308 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.89 -2.31 24.36 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.348 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' HD21 ' A' ' 23' ' ' LEU . 20.3 p -139.18 166.41 24.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.038 0.419 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 t -114.81 173.92 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 HD11 ' B' ' 118' ' ' LEU . 26.8 pt -141.74 151.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.971 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.6 161.84 39.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.09 146.63 28.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.658 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' A' ' 97' ' ' LEU . . . -94.61 -168.55 36.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.109 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.55 -164.81 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.884 2.39 . . . . 0.0 112.536 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.0 mp -83.11 -27.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.88 -28.99 70.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.9 ' HB3' HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -153.92 75.81 6.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.721 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.81 128.2 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.481 2.121 . . . . 0.0 112.339 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.63 167.9 39.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.522 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -102.53 106.23 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -100.44 -176.62 3.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.657 HD13 HG22 ' A' ' 27' ' ' ILE . 22.8 mm -107.49 144.08 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 111.914 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -168.9 1.5 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.888 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.603 ' HA ' HD11 ' A' ' 55' ' ' ILE . 3.1 t60 -41.95 149.36 0.14 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 111.178 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' CYS . 18.6 t -132.08 154.87 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 144.5 33.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 158.42 51.43 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.508 2.139 . . . . 0.0 112.422 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.43 69.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.4 m -142.96 -178.5 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.1 mm? -64.9 -50.83 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.656 ' HA ' HD12 ' A' ' 53' ' ' LEU . 78.9 p -59.14 -37.54 77.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.018 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.17 -41.21 67.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.31 -46.94 84.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.746 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.8 m -68.06 -28.81 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.196 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.27 55.09 0.87 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.438 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.656 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.0 mt -102.29 166.95 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HA ' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER 179.19 165.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.684 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 41' ' ' HIS . 4.3 mt -58.21 132.77 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.72 -30.42 6.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.32 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB3' HG13 ' A' ' 89' ' ' ILE . 2.1 m-20 -60.06 171.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.646 0.26 . . . . 0.0 110.736 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.563 ' CB ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -152.12 110.34 3.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.366 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.407 HG21 ' CG2' ' A' ' 62' ' ' VAL . 6.4 mt -69.45 117.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 88' ' ' SER . 35.7 m -101.49 4.14 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.998 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.37 148.44 1.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 87' ' ' ILE . 41.3 t -151.85 104.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 60.33 30.78 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.03 13.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.3 133.04 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.17 116.67 21.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.633 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.7 m-85 -92.14 13.7 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -33.75 76.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.556 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -140.75 32.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.645 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.55 HD21 ' N ' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -81.72 146.77 29.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.6 167.69 21.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -65.32 -57.32 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -39.13 72.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -60.47 -38.38 84.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -66.4 -45.79 78.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.781 HG11 HG21 ' B' ' 116' ' ' THR . 22.1 t -68.55 -43.98 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -55.36 -57.15 13.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.7 m -57.55 -45.53 86.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.267 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.553 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.6 mm? -65.26 -30.2 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -82.56 -31.77 28.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -59.53 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.82 135.16 36.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.33 -39.64 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -108.2 87.27 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.588 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -127.05 145.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 14' ' ' PHE . 43.0 m -90.44 121.36 32.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.117 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.89 HG22 HG22 ' A' ' 62' ' ' VAL . 7.5 pt -116.67 126.36 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.56 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -95.58 109.52 21.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.258 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.54 149.58 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.306 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.7 t -123.66 118.47 54.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.62 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.588 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -58.96 138.42 57.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.674 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.48 -18.26 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.245 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.563 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -61.57 -18.88 61.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.44 -30.97 2.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.48 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -56.64 -34.22 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -48.14 -46.11 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.9 HD21 ' HB3' ' A' ' 34' ' ' LYS . 34.5 mt -71.32 -45.24 63.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.87 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.772 0.32 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.781 HG21 HG11 ' A' ' 76' ' ' VAL . 58.7 m -140.87 132.5 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.85 143.61 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.735 HD11 HG12 ' A' ' 27' ' ' ILE . 1.4 mp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.839 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.854 0.359 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HE3' HG23 ' A' ' 89' ' ' ILE . 14.3 ttpp -101.98 145.9 28.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -110.91 142.06 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.577 HG13 ' HB ' ' A' ' 51' ' ' VAL . 42.0 t -142.62 151.63 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.4 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.562 ' CE1' HG23 ' A' ' 86' ' ' THR . 22.6 m-85 -130.08 131.78 45.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.694 HG23 HD13 ' A' ' 47' ' ' LEU . 17.2 mm -129.44 104.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.845 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 1.1 t . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.8 tp . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 84.67 33.33 19.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.767 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' A' ' 42' ' ' VAL . 1.7 t -152.13 156.5 39.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.792 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -114.55 173.73 6.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.859 HD11 HG22 ' A' ' 76' ' ' VAL . 9.2 pt -136.94 137.37 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.248 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -120.07 161.88 20.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.771 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -105.16 154.33 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.28 179.69 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.723 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HD2' HD13 ' A' ' 97' ' ' LEU . 61.6 Cg_endo -73.17 -168.27 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.645 2.23 . . . . 0.0 112.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -75.07 -26.9 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.134 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.48 -33.48 74.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.8 mtmm -149.86 76.32 8.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.25 141.89 26.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.697 2.264 . . . . 0.0 112.312 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.66 171.54 25.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.616 HG13 ' HB2' ' A' ' 75' ' ' ALA . 12.8 mm -82.91 114.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.419 ' CD1' ' HG3' ' A' ' 58' ' ' GLN . 93.8 m-85 -103.01 174.05 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.495 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.2 mm -107.81 135.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.536 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.2 -169.68 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.243 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.43 141.39 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.661 HG12 ' SG ' ' A' ' 25' ' ' CYS . 1.9 m -123.86 147.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.107 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.89 153.3 39.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.33 179.56 5.38 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.575 2.183 . . . . 0.0 112.328 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.1 34.67 47.36 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.547 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 18.5 p -132.13 -165.72 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 110.848 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.694 HD13 HG23 ' A' ' 15' ' ' ILE . 9.7 mt -88.38 -42.61 12.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.707 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.9 p -53.05 -39.24 63.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.605 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.08 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.54 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.75 -42.43 95.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 13' ' ' VAL . 32.5 m -78.66 -34.72 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.62 60.62 0.41 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.285 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 48' ' ' SER . 21.6 mt -110.91 164.47 12.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 175.94 165.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 4.1 mt -54.93 139.96 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.009 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 110.72 -30.41 8.14 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.183 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' HB3' HG13 ' A' ' 89' ' ' ILE . 85.7 m-20 -70.61 165.56 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.668 0.271 . . . . 0.0 110.491 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 4.0 tt0 -151.35 117.07 5.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.17 117.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 88' ' ' SER . 34.3 m -98.08 5.06 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.828 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.84 156.77 1.12 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.911 0.386 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.678 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 94.2 t -154.19 100.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.45 29.98 17.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.18 -31.21 8.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 70' ' ' LEU . 21.9 t -58.86 120.13 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.16 104.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.678 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.4 m-85 -91.32 9.21 32.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.64 70.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -141.28 30.55 1.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -81.71 147.49 29.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.9 158.37 34.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -57.47 -51.96 67.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.019 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -39.5 84.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' C ' HD21 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.52 -41.86 95.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.731 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -62.89 -47.31 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.016 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.859 HG22 HD11 ' A' ' 27' ' ' ILE . 28.1 t -68.99 -35.7 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.52 -58.74 6.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG23 HD22 ' A' ' 79' ' ' LEU . 34.6 m -57.49 -43.65 83.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.731 0.301 . . . . 0.0 110.952 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 75' ' ' ALA . 2.3 mm? -61.67 -34.09 75.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.84 -27.74 30.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.748 ' O ' HD11 ' A' ' 85' ' ' LEU . 45.6 t -93.23 140.54 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.117 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -79.06 -42.81 25.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.569 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.2 t -104.74 92.08 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.632 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.748 HD11 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -121.21 146.23 47.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.562 HG23 ' CE1' ' A' ' 14' ' ' PHE . 6.7 m -101.57 116.97 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.218 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.602 HG22 HG22 ' A' ' 62' ' ' VAL . 10.7 pt -106.84 125.79 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.599 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.667 ' O ' HG22 ' A' ' 60' ' ' VAL . 15.0 m -96.91 103.5 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.133 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -109.26 147.52 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.588 ' N ' HD13 ' A' ' 89' ' ' ILE . 24.4 t -120.92 114.95 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.4 137.88 47.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.49 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.87 -17.39 0.48 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.102 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.52 -21.97 29.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.798 0.333 . . . . 0.0 111.212 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.69 -31.12 2.02 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.521 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 1.1 mtp-105 -56.96 -34.64 68.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.498 0.19 . . . . 0.0 111.289 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -51.89 -49.96 61.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.498 HD13 ' HD2' ' A' ' 31' ' ' PRO . 13.6 mt -71.35 -40.09 70.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.997 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.428 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 1.9 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.809 0.338 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.835 HG21 HG21 ' A' ' 76' ' ' VAL . 69.2 m -128.81 123.71 33.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -88.28 121.99 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.63 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.3 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.798 ' HA ' HG22 ' A' ' 90' ' ' VAL . 8.5 mp0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 6.1 ttpm? -98.01 148.07 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.977 0.418 . . . . 0.0 110.955 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.98 145.22 30.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.725 HG13 ' HB ' ' A' ' 51' ' ' VAL . 60.4 t -147.99 146.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -137.1 120.67 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.606 HD12 ' CD1' ' A' ' 23' ' ' LEU . 28.1 mm -105.12 117.7 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 179.917 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD1' HD12 ' A' ' 15' ' ' ILE . 11.8 tp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.885 0.374 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 107.61 16.77 12.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.741 ' SG ' HG23 ' A' ' 39' ' ' ILE . 36.8 t -140.68 156.23 46.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -114.83 173.6 6.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.776 HD11 HG22 ' A' ' 76' ' ' VAL . 8.3 pt -138.9 141.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 111.092 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -131.02 161.66 31.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -105.15 145.2 30.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.16 178.47 44.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.659 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.38 -168.15 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.64 2.227 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.2 mp -71.33 -26.84 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -69.76 -30.11 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.748 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.6 ttmm -149.5 68.39 9.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.83 140.15 22.95 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.206 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.72 -179.67 36.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 75' ' ' ALA . 11.3 mm -88.63 114.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.624 ' CE2' HD12 ' A' ' 97' ' ' LEU . 34.1 m-85 -111.07 176.85 4.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.316 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.741 HG23 ' SG ' ' A' ' 25' ' ' CYS . 22.8 mm -107.56 136.66 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.706 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.29 -169.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.396 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -44.41 140.66 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.401 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' SG ' ' A' ' 25' ' ' CYS . 21.2 t -117.6 157.97 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.31 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 42' ' ' VAL . 11.1 mmpt? -99.76 129.81 27.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.98 -50.3 13.69 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.477 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.33 75.52 1.01 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.497 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -160.92 -179.81 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.968 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.86 -41.86 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.8 p -52.91 -43.78 66.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.9 77.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.638 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.39 -36.75 76.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.725 ' HB ' HG13 ' A' ' 13' ' ' VAL . 19.3 m -85.25 -26.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.52 39.9 1.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.399 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 48' ' ' SER . 13.7 mt -89.64 134.13 34.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -149.44 163.27 38.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.578 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 33.9 mt -58.86 148.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -22.7 39.58 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.32 161.9 28.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.665 0.269 . . . . 0.0 110.663 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -141.5 114.57 8.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.26 117.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.544 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 88' ' ' SER . 25.0 m -103.49 3.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.984 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.03 152.0 1.14 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.366 . . . . 0.0 111.236 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.918 HG13 HG22 ' A' ' 87' ' ' ILE . 48.6 t -151.53 105.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.961 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.57 29.87 17.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.98 -28.31 16.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.9 t -59.4 122.86 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.11 111.7 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.663 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.8 m-85 -90.2 -2.39 58.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.346 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -59.76 -41.83 91.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.26 31.41 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.621 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -88.7 147.56 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.79 161.43 23.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -59.05 -50.53 73.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -59.49 -40.07 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -43.17 99.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.621 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -60.21 -44.55 95.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.776 HG22 HD11 ' A' ' 27' ' ' ILE . 43.6 t -70.2 -43.63 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.088 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -54.88 -52.87 61.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.274 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 79' ' ' LEU . 26.9 m -61.96 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.625 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.5 mm? -64.45 -31.52 72.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.626 ' HE3' HD23 ' B' ' 118' ' ' LEU . 1.1 mptm? -82.6 -31.87 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.27 -67.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.561 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.0 OUTLIER -81.75 133.43 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.047 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -76.02 -57.23 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 m -99.74 97.62 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -131.12 141.01 50.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.284 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.8 m -93.5 132.99 37.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.281 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.918 HG22 HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -125.15 140.12 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.704 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.664 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.5 m -101.37 108.83 20.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -112.72 147.43 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.037 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.798 HG22 ' HA ' ' A' ' 10' ' ' GLU . 36.4 t -115.13 123.37 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.648 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -63.59 134.7 55.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.757 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.86 -17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.543 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.75 -20.26 21.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.373 . . . . 0.0 111.139 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 -30.38 2.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.733 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -56.03 -34.71 66.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.58 -50.01 34.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.757 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.748 HD21 ' CB ' ' A' ' 34' ' ' LYS . 11.0 mt -71.55 -47.4 55.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.993 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 7.9 m-85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 31.0 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.599 HG21 HG11 ' A' ' 76' ' ' VAL . 33.5 m -113.74 150.94 32.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.18 135.26 45.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.626 HD23 ' HE3' ' A' ' 80' ' ' LYS . 1.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.598 ' HA ' HG22 ' A' ' 90' ' ' VAL . 1.3 mt-10 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.768 0.318 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 14.3 ttpt -95.69 133.94 39.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -96.0 143.94 26.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.636 HG13 ' HB ' ' A' ' 51' ' ' VAL . 28.6 t -149.51 153.24 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.262 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.27 121.79 22.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mm -112.55 136.6 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.415 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.405 ' O ' HD13 ' A' ' 47' ' ' LEU . 1.7 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.8 tp . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.34 24.24 7.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.377 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.615 ' SG ' HG23 ' A' ' 39' ' ' ILE . 41.8 t -149.44 159.05 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -114.44 173.57 6.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.191 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.733 HD11 HG22 ' A' ' 76' ' ' VAL . 20.6 pt -137.05 149.35 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.432 . . . . 0.0 111.407 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -128.57 162.23 27.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.696 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.7 139.48 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.7 179.67 45.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.047 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.815 ' CD ' HD12 ' A' ' 97' ' ' LEU . 56.8 Cg_endo -70.04 -160.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.959 2.44 . . . . 0.0 112.346 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -86.01 -28.25 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -64.57 -32.81 74.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HB2' HD11 ' A' ' 97' ' ' LEU . 5.7 mttt -142.38 76.55 18.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.809 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 126.32 10.57 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.153 . . . . 0.0 112.423 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.01 173.98 41.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.511 HG13 ' HB2' ' A' ' 75' ' ' ALA . 21.5 mm -87.51 115.97 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 5.3 m-85 -100.61 172.54 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.615 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.5 mm -107.77 134.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.029 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.15 -169.27 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -46.22 141.41 3.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 25' ' ' CYS . 6.5 t -111.15 157.13 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.072 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' N ' HG12 ' A' ' 42' ' ' VAL . 33.1 mttt -108.41 112.53 60.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 155.32 9.47 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.405 2.07 . . . . 0.0 112.28 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.1 29.37 74.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.504 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.433 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 71.3 p -124.6 -170.72 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 16' ' ' SER . 6.9 mt -76.39 -45.42 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.763 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 11.6 p -52.9 -37.21 60.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.974 0.416 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.38 -37.99 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.563 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.43 -31.19 69.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.801 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.0 m -86.59 -30.56 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.74 58.81 0.59 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.374 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.28 167.82 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -179.75 162.24 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -56.8 142.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.24 -23.53 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.133 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.58 163.47 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.6 tt0 -148.59 115.14 5.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.089 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.35 117.32 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.694 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 88' ' ' SER . 35.8 m -97.9 -4.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.892 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.82 150.73 8.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.948 HG22 HG22 ' A' ' 87' ' ' ILE . 61.4 t -149.5 98.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.72 35.39 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.44 -27.93 15.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.545 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.6 124.42 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 109.73 5.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.727 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.9 m-85 -87.5 -10.02 52.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.362 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.7 p -56.42 -31.92 64.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.852 0.358 . . . . 0.0 111.0 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -132.92 32.09 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.3 tp -92.09 147.59 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.24 162.14 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.17 -57.67 9.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -36.17 70.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -39.53 94.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.581 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -63.33 -46.68 85.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.816 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.84 HG11 HG21 ' B' ' 116' ' ' THR . 39.7 t -68.28 -35.43 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.952 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -58.77 6.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 79' ' ' LEU . 34.4 m -57.32 -41.23 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.324 . . . . 0.0 111.097 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.411 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.7 mm? -66.43 -31.97 73.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.642 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.6 mptp? -82.57 -31.17 29.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.227 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -74.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.629 ' OG ' HD23 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -66.56 118.85 10.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.08 -56.97 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.92 105.54 15.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.65 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -131.31 144.51 51.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.966 0.413 . . . . 0.0 111.41 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.21 116.93 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.146 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.948 HG22 HG22 ' A' ' 62' ' ' VAL . 10.2 pt -109.69 127.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.654 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -99.75 103.53 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.659 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -105.08 145.49 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.08 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.6 t -115.24 117.25 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.713 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.579 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.57 135.48 56.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.935 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.95 -17.35 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.432 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.78 -19.99 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.15 -29.99 3.08 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.578 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 2.4 ptp180 -55.4 -34.67 64.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.569 0.223 . . . . 0.0 111.277 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -55.99 -43.62 77.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.042 0.448 . . . . 0.0 110.11 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.815 HD12 ' CD ' ' A' ' 31' ' ' PRO . 2.8 mm? -71.44 -50.11 34.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.794 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.388 -179.745 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.84 HG21 HG11 ' A' ' 76' ' ' VAL . 80.3 m -133.25 136.37 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -88.71 112.33 23.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.642 HD23 ' HE2' ' A' ' 80' ' ' LYS . 4.1 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -115.36 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -91.73 135.27 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.882 HG13 ' HB ' ' A' ' 51' ' ' VAL . 48.6 t -137.47 142.22 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.998 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -125.87 130.0 50.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 HD12 HD12 ' A' ' 23' ' ' LEU . 30.3 mm -122.02 106.48 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 9.4 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.68 0.276 . . . . 0.0 110.446 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.89 33.17 6.17 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.631 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.799 ' HB3' HD21 ' A' ' 23' ' ' LEU . 1.9 t -151.45 168.9 23.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 0.0 110.794 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 14.9 m -114.69 172.28 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.418 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.973 HD11 HG22 ' A' ' 76' ' ' VAL . 3.6 pt -142.34 140.34 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 111.203 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 t -122.49 161.72 23.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.995 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -105.25 138.7 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.13 38.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.514 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' HD13 ' A' ' 97' ' ' LEU . 38.4 Cg_endo -66.64 -172.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.54 2.16 . . . . 0.0 112.28 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -70.12 -25.17 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -70.13 -27.49 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.166 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HB3' HD11 ' A' ' 97' ' ' LEU . 6.5 mtpt -147.7 64.07 8.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.249 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 17.3 Cg_exo -66.75 126.2 14.99 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.195 . . . . 0.0 112.1 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.72 42.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 67' ' ' PHE . 11.2 mm -89.88 115.51 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.056 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.908 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.9 m-85 -103.61 171.72 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mm -107.55 134.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.366 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -106.12 -169.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.439 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -47.74 144.84 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.166 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.78 HG22 ' SG ' ' A' ' 25' ' ' CYS . 1.7 t -110.26 157.92 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 3.0 mptt -115.07 133.62 22.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 51.5 Cg_exo -55.4 161.52 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.438 2.092 . . . . 0.0 112.293 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.46 70.36 0.97 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.446 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -161.75 -167.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 110.976 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.629 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.5 mm? -84.76 -44.67 13.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.3 p -55.71 -39.49 71.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.926 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.96 79.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.5 -44.49 96.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.882 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.1 m -71.75 -24.89 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 63.76 1.06 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 48' ' ' SER . 15.6 mt -105.67 164.94 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.26 162.25 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.65 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.8 mt -56.88 143.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.96 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.5 -34.87 5.23 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.201 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.92 162.37 19.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.6 117.52 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.156 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.22 117.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.467 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 88' ' ' SER . 33.9 m -100.45 -18.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.744 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.03 149.57 27.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.758 HG13 HG22 ' A' ' 87' ' ' ILE . 46.8 t -143.83 95.05 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.086 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 59.9 36.86 21.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -29.8 9.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.542 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.08 116.62 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.14 119.66 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.729 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.4 m-85 -96.78 22.66 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.7 t -79.92 -58.85 2.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -104.49 29.03 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.644 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -89.12 147.75 24.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -82.66 173.73 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -68.65 -54.25 17.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -56.61 -39.15 73.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' A' ' 70' ' ' LEU . 29.9 mt-10 -60.05 -42.81 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.762 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.37 -46.45 90.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.978 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 27' ' ' ILE . 26.0 t -69.35 -38.82 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.9 -53.6 55.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.163 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 79' ' ' LEU . 33.9 m -59.45 -43.59 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.908 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.807 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.0 mm? -64.32 -35.22 80.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.488 . . . . 0.0 110.65 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -82.92 -26.25 31.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.681 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -85.29 -67.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.588 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -52.93 -37.34 60.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.496 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 67.36 -72.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.282 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.7 p -90.19 86.0 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.023 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.807 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -130.73 146.22 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.589 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.2 m -94.51 116.73 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.758 HG22 HG13 ' A' ' 62' ' ' VAL . 7.9 pt -110.86 127.64 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 0.0 111.634 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -98.72 107.84 20.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.97 146.88 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.709 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -109.58 130.01 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -70.08 130.63 42.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.432 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 87.13 -17.23 0.35 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.47 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.709 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -54.55 -21.31 9.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 111.262 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.92 -30.74 2.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.725 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 4.5 ptp180 -56.59 -34.67 67.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.462 0.172 . . . . 0.0 111.385 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.52 -50.13 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.908 HD12 ' CE2' ' A' ' 38' ' ' PHE . 17.1 mt -71.56 -41.8 68.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.774 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 27.2 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.854 0.359 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.622 HG21 HG21 ' A' ' 76' ' ' VAL . 31.6 m -119.31 151.01 39.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 124.63 49.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.495 HD22 HG13 ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.802 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 90' ' ' VAL . 1.8 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.728 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -101.34 120.35 40.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.23 143.47 27.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.782 HG13 ' HB ' ' A' ' 51' ' ' VAL . 26.2 t -151.36 151.92 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.221 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.51 131.08 39.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 mm -120.1 134.95 61.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.276 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' A' ' 48' ' ' SER . 13.9 tp . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.923 0.392 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.33 17.19 14.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.469 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.749 ' SG ' HG22 ' A' ' 42' ' ' VAL . 4.8 t -142.88 166.95 23.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.7 m -114.49 169.44 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.67 HG22 HD13 ' A' ' 39' ' ' ILE . 30.6 pt -142.66 155.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.983 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.508 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 m -146.62 162.1 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.84 150.94 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 97' ' ' LEU . . . -89.89 -172.93 45.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.907 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.09 -164.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.661 2.24 . . . . 0.0 112.418 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.3 -25.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.375 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.6 -29.86 70.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HB3' HD21 ' A' ' 97' ' ' LEU . 2.0 ttpt -156.41 66.06 4.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.77 116.6 3.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.493 2.129 . . . . 0.0 112.176 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.84 141.78 8.31 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.0 mm -82.76 106.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.574 0.226 . . . . 0.0 110.889 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 4.3 p90 -100.55 -176.35 3.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.67 HD13 HG22 ' A' ' 27' ' ' ILE . 18.6 mm -107.06 140.53 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 111.625 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -169.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.109 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -46.34 143.52 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.087 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.749 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -110.3 150.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.982 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -106.33 108.84 62.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.78 145.3 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.332 2.022 . . . . 0.0 112.315 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.7 40.21 9.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.304 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.515 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.5 m -144.42 -173.52 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.563 HD22 ' H ' ' A' ' 47' ' ' LEU . 2.1 mm? -67.93 -48.51 65.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.676 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.556 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.36 97.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 110.599 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.39 -53.1 62.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.782 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.7 m -67.54 -28.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.207 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.54 65.61 0.83 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 48' ' ' SER . 17.3 mt -106.24 156.5 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -167.0 162.59 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.439 HG23 ' CZ ' ' A' ' 98' ' ' PHE . 3.7 mt -56.26 146.71 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.009 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.33 -32.43 7.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.34 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' CB ' HD11 ' A' ' 89' ' ' ILE . 49.5 m-20 -58.9 164.99 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.578 0.228 . . . . 0.0 110.862 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -147.55 113.66 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.7 mt -69.36 117.09 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 88' ' ' SER . 26.8 m -105.61 7.85 9.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.946 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.7 145.67 0.54 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 87' ' ' ILE . 58.0 t -148.43 99.27 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.886 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.47 30.82 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.9 13.21 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.14 129.49 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.75 121.92 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.0 m-85 -99.19 26.68 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.27 -66.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -103.49 30.69 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.618 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 74' ' ' GLU . 1.4 tp -79.51 145.52 33.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.06 162.89 24.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.792 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 28' ' ' SER . 3.3 t-160 -60.51 -54.13 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.11 -38.47 70.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.635 ' HB3' HD11 ' A' ' 70' ' ' LEU . 20.8 mt-10 -61.39 -47.23 86.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.6 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -58.35 -44.72 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.863 HG11 HG21 ' B' ' 116' ' ' THR . 27.4 t -69.71 -45.49 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.3 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -55.03 -53.57 54.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.256 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.3 m -60.22 -43.42 93.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.078 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.541 ' HB3' HD22 ' B' ' 118' ' ' LEU . 3.4 mm? -67.49 -31.17 71.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.711 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.758 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.2 mptp? -82.53 -30.05 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -70.01 -66.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.223 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.634 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.3 m -81.45 118.79 22.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -68.8 -40.31 79.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.5 p -114.23 102.68 10.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -137.47 146.17 43.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -91.5 116.99 29.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.185 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 62' ' ' VAL . 16.1 pt -111.36 130.99 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.642 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -102.99 103.61 13.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.322 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.728 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -104.62 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 10' ' ' GLU . 42.1 t -127.22 115.94 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.06 140.39 49.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.636 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.41 -22.72 0.22 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.014 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -59.69 -20.79 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.906 0.384 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.03 3.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -56.68 -34.61 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -50.26 -49.65 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.712 HD21 ' HB3' ' A' ' 34' ' ' LYS . 20.4 mt -71.09 -39.83 71.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CE2' ' CD2' ' A' ' 38' ' ' PHE . 4.1 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.161 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.863 HG21 HG11 ' A' ' 76' ' ' VAL . 95.9 m -129.37 145.98 51.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.41 116.38 31.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.758 HD23 ' HE2' ' A' ' 80' ' ' LYS . 3.2 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -117.97 141.25 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 138.84 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 HG11 ' A' ' 51' ' ' VAL . 55.7 t -139.98 136.69 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.63 ' HD2' HG23 ' A' ' 86' ' ' THR . 31.6 t80 -119.51 117.67 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' CG1' HD11 ' A' ' 87' ' ' ILE . 29.1 mm -106.81 126.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' A' ' 48' ' ' SER . 16.9 tp . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.68 26.93 11.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.433 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.828 ' SG ' HG22 ' A' ' 42' ' ' VAL . 50.6 t -147.37 159.33 43.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.416 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 3.1 m -114.43 173.65 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.929 HD11 HG22 ' A' ' 76' ' ' VAL . 9.2 pt -139.4 157.47 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.399 . . . . 0.0 111.37 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.29 162.03 28.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.483 ' HG ' ' HB2' ' A' ' 72' ' ' HIS . 1.1 m -104.8 140.82 37.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.523 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 162.1 31.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' HD12 ' A' ' 97' ' ' LEU . 27.6 Cg_endo -62.11 -159.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.955 2.437 . . . . 0.0 112.216 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.67 -27.63 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.95 -29.89 55.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -141.05 60.77 13.11 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.88 135.04 20.75 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.29 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 37' ' ' ILE . . . 176.25 -146.96 8.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.621 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.491 HD11 ' O ' ' A' ' 71' ' ' ASP . 19.7 mm -127.13 111.14 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.999 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 20.0 m-85 -100.58 173.55 6.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.557 HG23 ' SG ' ' A' ' 25' ' ' CYS . 16.5 mm -107.84 133.21 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.88 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 26' ' ' SER . 0.6 OUTLIER -106.12 -169.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.724 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.432 ' ND1' HD11 ' A' ' 55' ' ' ILE . 86.0 m-70 -44.71 133.93 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.645 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.828 HG22 ' SG ' ' A' ' 25' ' ' CYS . 22.2 t -111.01 148.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.55 145.21 30.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.02 172.12 15.33 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.503 2.135 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.14 33.87 61.67 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.506 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -131.73 -172.79 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.9 mm? -77.42 -47.43 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.5 p -59.44 -35.92 74.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.35 72.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.89 -39.99 91.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.785 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 13' ' ' VAL . 28.6 m -75.11 -29.76 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.03 55.14 0.93 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 48' ' ' SER . 14.4 mt -97.0 144.98 26.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.42 162.83 40.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.432 HD11 ' ND1' ' A' ' 41' ' ' HIS . 3.1 mt -56.96 138.54 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.085 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 116.82 -40.14 2.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.446 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -55.54 166.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.737 0.303 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.68 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 20.3 tm0? -146.79 116.72 7.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.47 120.08 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 88' ' ' SER . 29.7 m -100.09 -18.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.597 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -158.67 155.14 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.312 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 87' ' ' ILE . 56.2 t -153.1 109.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.77 30.8 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.6 -31.09 8.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.489 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.54 131.88 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.29 116.4 17.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE1' HD22 ' A' ' 70' ' ' LEU . 2.1 m-85 -89.79 -9.4 49.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.321 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.8 t -55.38 -30.73 60.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -130.41 32.52 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.671 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.5 tp -96.46 147.63 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.491 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -77.99 174.22 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.483 ' HB2' ' HG ' ' A' ' 29' ' ' SER . 2.0 t-160 -68.97 -54.7 13.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.78 -38.32 78.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.567 ' HB3' HD11 ' A' ' 70' ' ' LEU . 24.6 mt-10 -60.62 -44.57 96.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.671 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -63.1 -40.88 98.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.929 HG22 HD11 ' A' ' 27' ' ' ILE . 39.6 t -70.26 -47.0 69.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -52.67 62.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.244 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 79' ' ' LEU . 34.3 m -60.17 -44.78 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.4 mm? -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.7 mptp? -81.84 -30.67 31.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -69.9 -67.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.254 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -83.39 138.82 33.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -89.99 -55.26 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -91.85 81.92 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.592 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -121.03 145.22 48.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.63 HG23 ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -92.49 119.36 31.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.034 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.934 HG22 HG22 ' A' ' 62' ' ' VAL . 7.2 pt -116.55 122.44 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.792 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -95.84 122.7 38.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -129.32 144.74 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -111.69 131.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.623 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -68.58 132.51 47.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.249 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 86.26 -17.89 0.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -55.09 -20.9 10.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.34 -29.99 2.18 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.751 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 44.4 mtp85 -55.56 -34.46 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.531 0.205 . . . . 0.0 111.188 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -49.3 -39.81 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.046 0.451 . . . . 0.0 110.358 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.589 HD12 ' CD ' ' A' ' 31' ' ' PRO . 3.2 mm? -71.29 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.851 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.387 -179.719 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.7 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.916 HG21 HG21 ' A' ' 76' ' ' VAL . 29.9 m -133.03 131.6 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.11 137.17 32.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.173 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.554 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.843 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' CB ' HG22 ' A' ' 90' ' ' VAL . 2.2 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.808 0.337 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 91' ' ' ALA . 7.0 ttpm? -101.28 140.5 35.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.29 134.6 41.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 51' ' ' VAL . 60.9 t -139.56 147.23 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HD1' ' HG1' ' A' ' 86' ' ' THR . 82.7 t80 -135.96 126.16 26.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.458 HD12 ' CD1' ' A' ' 23' ' ' LEU . 32.1 mm -114.49 115.06 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.266 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' CD1' HD12 ' A' ' 15' ' ' ILE . 14.7 tp . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.85 0.357 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.73 25.23 12.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.347 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' HG23 ' A' ' 39' ' ' ILE . 32.5 t -148.98 159.02 44.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -114.32 173.8 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 76' ' ' VAL . 17.5 pt -137.96 141.25 39.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.255 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -119.09 161.72 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.06 147.9 27.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.66 175.37 43.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.69 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.36 -165.6 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.662 2.241 . . . . 0.0 112.262 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.6 -28.93 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.253 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -78.54 -28.91 46.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -138.63 60.08 18.75 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.42 136.49 21.78 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.43 -172.03 44.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.534 HD11 ' O ' ' A' ' 71' ' ' ASP . 19.3 mm -98.08 115.21 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.103 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.619 ' CE2' HD12 ' A' ' 97' ' ' LEU . 6.1 m-85 -110.89 175.9 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.664 HG23 ' SG ' ' A' ' 25' ' ' CYS . 20.1 mm -107.69 137.04 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.375 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.16 -169.41 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.436 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -48.83 141.42 7.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 25' ' ' CYS . 11.0 t -110.93 154.14 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -109.81 146.27 33.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 161.4 45.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.52 2.146 . . . . 0.0 112.291 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.68 57.47 19.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.404 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.484 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -152.59 -173.42 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.98 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.2 mm? -73.22 -48.59 33.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.585 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.644 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -55.07 -42.11 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.97 82.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.62 -41.79 87.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.706 ' HB ' HG13 ' A' ' 13' ' ' VAL . 36.0 m -74.26 -30.04 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.063 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.91 61.84 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.9 mt -109.58 162.99 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.2 162.29 3.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.629 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.449 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 6.3 mt -54.86 145.68 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.44 -30.58 10.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.301 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.23 162.91 8.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.263 . . . . 0.0 110.601 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 3.6 tm0? -144.93 113.73 6.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 39' ' ' ILE . 3.5 mt -69.22 117.14 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.774 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 88' ' ' SER . 35.9 m -92.95 -25.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.648 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -152.86 158.11 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 111.283 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.8 HG13 HG22 ' A' ' 87' ' ' ILE . 59.8 t -149.98 103.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.952 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 63.76 30.2 14.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 -26.82 19.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.623 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.37 130.54 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.72 125.3 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.7 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -99.35 -17.62 17.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.269 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -50.55 65.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.786 0.327 . . . . 0.0 111.092 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.07 30.77 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.572 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -98.53 146.69 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.534 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -75.24 170.93 15.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -70.89 -55.82 7.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -58.12 -34.07 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -40.31 91.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.66 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -62.86 -44.48 96.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.805 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 27' ' ' ILE . 38.9 t -69.55 -35.76 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 -52.35 63.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.7 m -61.13 -43.38 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.535 ' HB3' HD22 ' B' ' 118' ' ' LEU . 3.7 mm? -65.94 -30.8 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.89 ' HE2' HD23 ' B' ' 118' ' ' LEU . 2.4 mptp? -82.61 -34.19 27.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.61 -65.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.81 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -79.1 125.32 29.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -73.71 -43.97 57.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.604 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.2 p -115.08 98.89 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.53 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.81 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -129.3 146.16 51.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.98 0.419 . . . . 0.0 111.277 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.451 ' HG1' ' HD1' ' A' ' 14' ' ' PHE . 12.4 m -92.9 116.98 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.198 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.8 HG22 HG13 ' A' ' 62' ' ' VAL . 14.2 pt -114.02 129.2 70.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 111.673 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.699 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.4 m -101.84 110.32 22.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.354 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -110.5 147.04 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.209 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.484 ' N ' HD13 ' A' ' 89' ' ' ILE . 29.1 t -117.06 113.34 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.24 141.09 47.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.8 -19.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.957 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -58.92 -20.17 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.47 -30.51 2.03 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.502 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -56.08 -34.13 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -48.14 -42.83 30.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.744 0.306 . . . . 0.0 110.616 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.619 HD12 ' CE2' ' A' ' 38' ' ' PHE . 56.6 mt -71.35 -49.31 43.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.717 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 17.1 m-85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.821 0.343 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.591 HG21 HG11 ' A' ' 76' ' ' VAL . 90.1 m -125.49 151.0 46.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.24 108.6 20.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.89 HD23 ' HE2' ' A' ' 80' ' ' LYS . 52.2 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.597 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.3 mt-10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.806 0.336 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 12.8 ttpp -100.28 114.6 28.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -86.53 142.6 28.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.563 HG13 ' HB ' ' A' ' 51' ' ' VAL . 21.8 t -148.56 158.86 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' N ' HG12 ' A' ' 13' ' ' VAL . 51.1 p90 -141.07 116.88 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.706 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG1' HD11 ' A' ' 87' ' ' ILE . 39.4 mm -102.43 135.45 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.196 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.2 tp . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 111.11 23.44 5.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.402 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' HG22 ' A' ' 42' ' ' VAL . 13.8 t -150.7 164.3 36.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.65 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -114.43 173.32 6.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.391 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.945 HD11 HG22 ' A' ' 76' ' ' VAL . 2.2 pt -137.15 146.67 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.389 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.5 p -125.17 161.87 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.734 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.93 144.52 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.83 38.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.882 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 97' ' ' LEU . 34.6 Cg_endo -64.28 -164.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.771 2.314 . . . . 0.0 112.32 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -81.96 -28.93 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.17 -29.56 54.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.673 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.3 tttp -141.83 60.54 11.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.85 147.82 35.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.41 175.88 32.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.4 mm -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.953 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.746 ' CE2' HD12 ' A' ' 97' ' ' LEU . 26.3 m-85 -108.5 174.53 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.9 mm -107.63 134.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.375 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -106.19 -169.42 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.392 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -45.28 153.06 0.23 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.36 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.858 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.8 t -125.48 157.98 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 138.75 27.9 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 155.44 69.45 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.41 2.073 . . . . 0.0 112.329 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.05 7.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.357 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.453 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -157.2 -170.29 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.726 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? -76.94 -45.35 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.852 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.9 p -55.7 -45.3 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.62 88.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -60.56 -40.12 90.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.563 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.5 m -76.83 -27.11 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.49 57.66 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -98.75 156.96 16.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -163.44 159.6 22.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mt -55.23 153.51 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.1 -23.93 31.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.221 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.67 159.46 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.279 . . . . 0.0 110.58 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 89' ' ' ILE . 2.5 tt0 -146.85 120.22 9.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 HG21 ' CG2' ' A' ' 62' ' ' VAL . 2.1 mt -69.31 117.18 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.6 m -97.32 -5.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.843 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.83 148.07 5.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.843 HG22 HG22 ' A' ' 87' ' ' ILE . 49.0 t -146.77 109.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 1.0 OUTLIER 57.95 30.56 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.73 12.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.23 138.08 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.13 111.4 14.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.761 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.5 m-85 -91.09 11.08 24.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.317 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -75.27 -34.87 61.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -127.25 29.53 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.761 HD22 ' CE1' ' A' ' 67' ' ' PHE . 2.4 tp -87.35 148.92 24.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 163.87 21.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -56.62 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -57.81 -40.32 79.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -41.02 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.642 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -63.23 -46.05 88.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.945 HG22 HD11 ' A' ' 27' ' ' ILE . 35.7 t -69.4 -35.56 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.07 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -50.81 69.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.18 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.9 m -62.73 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.457 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.7 mm? -63.26 -31.87 73.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.62 -34.37 27.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 -62.4 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.684 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -83.84 134.56 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.193 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -98.41 25.88 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.855 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -177.93 71.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.1 OUTLIER -115.27 146.17 41.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.7 m -90.5 116.87 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.026 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 62' ' ' VAL . 8.1 pt -110.79 128.27 67.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.919 0.39 . . . . 0.0 111.582 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.23 122.19 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -128.19 147.39 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 10' ' ' GLU . 25.4 t -117.72 117.87 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.736 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.586 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.26 136.42 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.801 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.47 -17.5 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.276 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.73 35.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.11 -30.3 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.484 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -56.05 -34.4 65.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -48.38 -49.99 32.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.746 HD12 ' CE2' ' A' ' 38' ' ' PHE . 10.1 mt -71.76 -45.82 60.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.855 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.283 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.845 0.355 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.688 HG21 HG21 ' A' ' 76' ' ' VAL . 28.7 m -125.45 138.82 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.32 140.27 29.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.707 HD11 HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' CG ' HG22 ' A' ' 90' ' ' VAL . 3.1 mt-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 91' ' ' ALA . 5.9 ttpm? -96.78 136.93 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.093 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -100.6 136.08 41.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.844 HG13 ' HB ' ' A' ' 51' ' ' VAL . 48.4 t -141.92 143.96 26.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -128.34 124.92 37.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.46 HD13 HG11 ' A' ' 51' ' ' VAL . 28.9 mm -116.93 124.16 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.213 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.424 ' O ' HD11 ' A' ' 47' ' ' LEU . 11.1 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.4 tp . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.741 0.305 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 63.36 50.9 58.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.555 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.597 ' SG ' HG23 ' A' ' 39' ' ' ILE . 52.7 t -161.52 156.99 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.78 173.46 6.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.977 HD11 HG22 ' A' ' 76' ' ' VAL . 19.3 pt -142.01 133.65 26.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.341 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.06 162.17 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.734 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.86 145.7 30.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 110.381 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.6 160.33 30.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.028 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.535 ' CD ' HD12 ' A' ' 97' ' ' LEU . 59.0 Cg_endo -71.33 -160.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.827 2.351 . . . . 0.0 112.156 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.33 -29.57 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.67 -31.78 72.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.403 ' CB ' HD21 ' A' ' 97' ' ' LEU . 2.4 mtmt -155.4 74.31 5.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.28 125.99 10.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.589 2.193 . . . . 0.0 112.32 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.23 -178.99 48.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 75' ' ' ALA . 26.9 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.5 m-85 -107.54 170.39 8.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.597 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.7 mm -107.65 129.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 -169.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -46.72 141.2 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.36 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 43' ' ' LYS . 13.6 t -109.27 157.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.433 ' N ' HG12 ' A' ' 42' ' ' VAL . 24.7 mttp -120.91 145.28 41.12 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 17.3 Cg_exo -66.67 173.56 7.76 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.616 2.211 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.32 43.22 43.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.757 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -136.71 -174.16 3.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.369 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 16' ' ' SER . 46.9 mt -84.95 -35.24 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.463 ' HA ' HD12 ' A' ' 53' ' ' LEU . 16.4 p -56.28 -41.07 75.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.22 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.686 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -59.8 -39.66 85.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.6 m -80.45 -30.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.035 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.73 64.12 0.72 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 48' ' ' SER . 18.0 mt -108.25 164.56 12.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 111.005 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.05 162.62 5.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mt -59.83 140.44 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.811 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.08 -38.16 3.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.451 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -55.52 157.33 3.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.673 0.273 . . . . 0.0 110.767 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.407 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.44 114.99 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.161 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 39' ' ' ILE . 6.7 mt -69.06 121.09 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.869 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' SER . 32.0 m -109.47 9.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.885 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.62 146.5 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 111.336 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.675 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 61.9 t -151.0 106.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.68 30.94 20.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.016 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.41 13.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.29 129.67 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -71.45 107.35 4.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.852 ' CE1' HD22 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -82.54 0.02 44.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.376 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -60.53 -54.3 47.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -108.72 33.7 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.852 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -92.94 148.28 22.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' O ' HD11 ' A' ' 37' ' ' ILE . 4.8 t0 -89.52 170.57 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -62.76 -53.03 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -57.6 -38.0 74.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.569 ' O ' HG22 ' A' ' 78' ' ' VAL . 7.3 mt-10 -64.89 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.603 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -67.56 -42.07 83.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 27' ' ' ILE . 33.1 t -70.87 -46.58 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.04 -55.92 25.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 74' ' ' GLU . 33.8 m -58.39 -45.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.494 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.3 mm? -65.02 -30.83 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.715 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -82.58 -30.49 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -66.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -84.9 144.81 28.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -92.65 -57.6 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -89.86 77.67 6.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 139.23 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -92.74 116.9 29.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.12 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.644 HG22 HG22 ' A' ' 62' ' ' VAL . 10.1 pt -111.05 127.44 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.696 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.555 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -97.26 103.48 15.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.469 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -105.34 151.39 7.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.635 ' N ' HD13 ' A' ' 89' ' ' ILE . 31.7 t -124.89 114.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.768 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.38 136.63 49.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.506 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 84.59 -20.56 0.29 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.194 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.18 46.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.87 -30.13 2.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.519 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 63.4 mtp85 -55.43 -34.52 64.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 111.01 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -54.03 -37.13 63.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.128 0.489 . . . . 0.0 110.108 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.535 HD12 ' CD ' ' A' ' 31' ' ' PRO . 4.6 mm? -71.29 -55.27 8.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.419 ' CD2' ' HA2' ' A' ' 56' ' ' GLY . 23.6 m-85 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.847 0.356 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.736 HG21 HG11 ' A' ' 76' ' ' VAL . 25.5 m -115.13 151.04 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.94 125.95 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.54 ' CD1' HG23 ' A' ' 27' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.968 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.817 0.341 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.72 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -120.17 117.37 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.602 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -86.24 143.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.76 HG13 ' HB ' ' A' ' 51' ' ' VAL . 22.0 t -148.16 150.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.298 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -130.3 122.24 27.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.777 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.46 HD12 ' CD1' ' A' ' 23' ' ' LEU . 37.7 mm -110.33 129.4 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.28 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.1 tp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.826 0.345 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 93.88 29.16 10.08 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.383 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.726 ' SG ' HG22 ' A' ' 42' ' ' VAL . 42.7 t -155.93 157.55 36.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.531 ' HA ' HD12 ' B' ' 118' ' ' LEU . 17.8 m -114.7 173.8 6.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.91 HD11 HG22 ' A' ' 76' ' ' VAL . 7.1 pt -138.12 153.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.3 p -137.22 161.71 35.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -105.45 154.96 19.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -108.86 -177.35 21.64 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.764 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HD2' HD13 ' A' ' 97' ' ' LEU . 38.5 Cg_endo -66.49 -166.44 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -85.63 -23.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.236 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -69.75 -30.99 68.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HB3' HD11 ' A' ' 97' ' ' LEU . 8.2 tttt -146.47 69.54 12.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.92 143.12 32.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.93 163.78 20.11 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 67' ' ' PHE . 12.7 mm -81.63 114.56 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.671 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 2.8 m-30 -100.53 171.73 7.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.187 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.679 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.8 mm -107.72 121.03 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.017 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.6 OUTLIER -90.01 -169.41 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.548 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.51 140.08 2.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG22 ' SG ' ' A' ' 25' ' ' CYS . 23.6 t -119.53 140.11 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.711 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -104.44 149.68 37.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.32 168.42 21.02 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.658 2.238 . . . . 0.0 112.321 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.02 60.8 8.17 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.308 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.508 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -158.9 -177.62 6.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.984 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.2 mm? -71.65 -49.67 37.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.819 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.516 ' CB ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -56.72 -38.29 72.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.04 -38.43 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.79 -42.78 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.76 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.7 m -70.09 -27.26 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.273 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.97 52.58 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' A' ' 48' ' ' SER . 16.9 mt -94.96 160.25 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -159.57 158.55 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mt -58.55 136.56 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 111.47 -37.81 3.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -49.21 164.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.291 . . . . 0.0 110.908 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.622 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 19.9 tt0 -146.94 113.7 6.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.115 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.47 122.87 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -110.63 5.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.846 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -168.5 146.16 4.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 111.13 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 87' ' ' ILE . 39.1 t -152.22 107.92 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.51 31.06 19.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.13 14.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.9 127.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.878 0.371 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.09 119.24 16.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.628 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.6 m-85 -96.19 23.11 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 p -77.16 -57.14 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.585 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -108.41 29.37 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.675 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.628 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.8 tp -84.65 148.48 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.944 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.32 164.69 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -59.69 -55.04 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -56.99 -37.6 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HB3' HD11 ' A' ' 70' ' ' LEU . 55.6 mt-10 -61.94 -41.6 98.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.63 -47.32 85.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.91 HG22 HD11 ' A' ' 27' ' ' ILE . 43.0 t -68.59 -42.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.123 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -56.74 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 79' ' ' LEU . 31.8 m -58.49 -45.94 89.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.849 0.357 . . . . 0.0 111.146 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.4 mm? -63.42 -31.78 73.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.521 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -82.65 -29.51 29.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 t -65.97 -63.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.28 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.51 139.6 30.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -59.48 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.61 88.13 6.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.556 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.404 ' CD1' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -122.53 134.91 54.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -84.64 117.0 23.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.852 HG22 HG13 ' A' ' 62' ' ' VAL . 11.9 pt -112.38 133.61 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.636 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.0 114.67 29.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.572 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -114.53 152.31 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.956 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -123.13 115.86 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.498 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.611 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -58.61 134.12 56.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.74 -20.37 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.249 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.772 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -55.68 -24.32 33.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.091 0.472 . . . . 0.0 110.816 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.44 -30.32 1.73 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.134 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 42.3 mtp180 -56.06 -34.25 65.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.293 0.237 . . . . 0.0 111.287 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -48.18 -49.4 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.671 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 19.7 mt -71.33 -43.76 66.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.766 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.875 0.369 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.862 HG21 HG21 ' A' ' 76' ' ' VAL . 23.7 m -127.26 129.48 47.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.99 133.17 34.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.739 HD11 HG12 ' A' ' 27' ' ' ILE . 2.0 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.723 ' HA ' HG22 ' A' ' 90' ' ' VAL . 10.1 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.807 0.337 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 21.2 ttpt -114.67 150.26 35.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.775 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 148.15 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.873 HG13 ' HB ' ' A' ' 51' ' ' VAL . 50.5 t -147.28 141.75 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -126.11 117.77 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.618 HD13 HG11 ' A' ' 51' ' ' VAL . 31.6 mm -107.73 115.9 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.215 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.885 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 48' ' ' SER . 17.9 tp . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 59.96 50.2 70.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.733 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.38 152.82 24.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -114.89 173.57 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.824 HD11 HG22 ' A' ' 76' ' ' VAL . 6.9 pt -135.54 141.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.104 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -117.22 161.53 19.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.798 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -105.45 142.91 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.769 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -91.4 167.8 31.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.624 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.683 ' HD2' HD13 ' A' ' 97' ' ' LEU . 89.6 Cg_endo -78.67 -165.62 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.716 2.277 . . . . 0.0 112.276 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.2 mp -65.79 -28.17 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.164 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.34 -26.76 65.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -156.48 66.9 4.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.243 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.59 111.69 3.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.013 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.45 -170.74 37.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.608 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.557 HG22 HD12 ' A' ' 59' ' ' ILE . 14.0 mm -94.97 118.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 52.0 m-85 -111.24 174.67 5.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.318 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -107.69 136.46 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.194 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.12 -169.45 1.58 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.638 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CG ' HD11 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -47.25 140.19 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.262 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.86 148.75 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -107.94 138.84 20.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.3 173.22 2.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.471 2.114 . . . . 0.0 112.111 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.22 27.77 24.7 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -121.8 166.24 14.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.86 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.32 -35.66 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 53' ' ' LEU . 11.7 p -53.09 -40.95 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.03 -39.85 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.56 -35.06 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.803 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.873 ' HB ' HG13 ' A' ' 13' ' ' VAL . 28.2 m -82.44 -30.83 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.68 41.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.457 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.8 mt -90.18 164.68 14.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.988 0.423 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.93 168.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.533 HD11 ' CG ' ' A' ' 41' ' ' HIS . 20.2 mt -65.07 133.78 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.721 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ARG . . . 112.77 -18.0 22.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.358 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' CB ' HD11 ' A' ' 89' ' ' ILE . 64.5 m-20 -71.97 169.13 16.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -148.52 115.08 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.04 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.557 HD12 HG22 ' A' ' 37' ' ' ILE . 3.8 mt -69.02 116.95 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.652 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 88' ' ' SER . 27.0 m -104.21 3.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.793 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -176.44 152.68 1.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.729 HG13 HG22 ' A' ' 87' ' ' ILE . 47.7 t -151.95 102.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 60.58 37.77 19.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.92 -31.94 7.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 t -70.51 114.65 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 111.029 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.13 124.16 21.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.2 m-85 -96.11 21.9 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.102 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.7 t -73.76 -37.58 64.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -128.9 28.85 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.733 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.601 HD22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.74 148.01 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.03 158.05 25.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -57.34 -53.51 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.47 -38.62 77.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.08 -44.13 97.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -59.54 -45.66 91.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 27' ' ' ILE . 38.1 t -69.31 -42.64 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -55.99 -58.9 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 74' ' ' GLU . 27.1 m -58.58 -40.53 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.181 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -68.55 -29.52 68.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.717 ' HE2' HD23 ' B' ' 118' ' ' LEU . 4.0 mptp? -82.59 -33.18 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -60.94 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -45.84 22.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.7 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -100.42 92.44 5.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -132.22 144.35 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.4 m -89.43 117.01 28.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.272 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.729 HG22 HG13 ' A' ' 62' ' ' VAL . 13.1 pt -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.859 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.0 t -94.66 116.66 29.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.247 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.468 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -123.67 142.66 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.207 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 10' ' ' GLU . 40.5 t -109.76 131.86 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.508 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -69.65 136.56 51.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.713 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.99 -17.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.396 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -54.95 -21.3 11.26 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.881 0.372 . . . . 0.0 111.102 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -30.47 2.52 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD3' ' CB ' ' A' ' 92' ' ' ALA . 1.7 ptt180 -56.04 -34.47 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.672 0.273 . . . . 0.0 111.321 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -49.97 38.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.683 HD13 ' HD2' ' A' ' 31' ' ' PRO . 14.9 mt -71.39 -58.43 3.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.411 -179.579 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.836 0.351 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.641 HG21 HG11 ' A' ' 76' ' ' VAL . 68.5 m -124.4 147.36 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.01 138.05 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.717 HD23 ' HE2' ' A' ' 80' ' ' LYS . 3.1 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 90' ' ' VAL . 54.7 mt-10 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.763 0.316 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.799 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.8 OUTLIER -112.4 141.2 46.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -109.3 143.55 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.729 HG13 ' HB ' ' A' ' 51' ' ' VAL . 18.5 t -149.96 153.15 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.389 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.37 114.54 9.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.636 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.587 HD12 ' CD1' ' A' ' 23' ' ' LEU . 41.3 mm -97.92 118.92 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.587 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.5 tp . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.0 28.24 9.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.364 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -147.28 160.95 41.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.393 . . . . 0.0 111.152 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.94 173.64 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.971 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 1.047 HD11 HG22 ' A' ' 76' ' ' VAL . 26.0 pt -143.45 135.57 23.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.2 t -119.78 161.78 20.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.657 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.11 147.67 27.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 -178.32 46.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.589 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.571 ' HD2' HD13 ' A' ' 97' ' ' LEU . 37.1 Cg_endo -65.68 -165.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.62 2.213 . . . . 0.0 112.236 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.86 -30.06 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -68.05 -30.21 69.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -143.53 74.14 17.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.014 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.82 141.51 27.31 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.6 173.33 40.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.656 HG13 ' HB2' ' A' ' 75' ' ' ALA . 23.9 mm -90.32 115.09 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.054 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.859 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.4 m-85 -105.56 171.35 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 27' ' ' ILE . 23.7 mm -107.73 137.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.1 -169.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.442 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 142.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.184 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.3 t -110.08 157.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.972 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -114.5 145.43 33.79 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 162.51 38.8 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.543 2.162 . . . . 0.0 112.197 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.9 86.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.488 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -135.56 -177.36 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.2 mm? -71.04 -49.52 43.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.628 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.432 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -53.46 -41.84 66.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.43 84.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -64.15 -37.57 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.729 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.7 m -78.89 -36.38 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.46 70.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.406 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.566 ' O ' HG21 ' A' ' 42' ' ' VAL . 29.3 mt -116.38 150.91 36.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -154.58 162.45 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.455 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.9 mt -57.92 137.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.475 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.67 -29.18 9.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.564 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.438 ' HB3' HG13 ' A' ' 89' ' ' ILE . 21.6 m-20 -57.63 164.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.649 0.261 . . . . 0.0 110.593 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -146.39 114.4 6.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.239 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.27 117.15 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.06 0.58 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.808 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -175.62 159.49 2.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.906 ' O ' HG12 ' A' ' 65' ' ' VAL . 62.1 t -155.22 103.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 63.78 17.23 10.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.278 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.12 -27.21 9.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.642 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 62' ' ' VAL . 10.8 p -65.05 134.23 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.728 0.299 . . . . 0.0 111.215 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.57 121.81 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.522 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.4 m-85 -94.84 19.02 10.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.236 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -75.34 -56.74 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.98 26.65 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.522 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -87.19 150.34 24.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.26 167.9 11.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -58.56 -53.57 56.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -54.67 -41.99 70.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -59.77 -42.64 93.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.761 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -63.4 -46.13 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.133 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.047 HG22 HD11 ' A' ' 27' ' ' ILE . 40.4 t -68.67 -36.96 76.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -58.98 6.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.675 HG23 HD22 ' A' ' 79' ' ' LEU . 34.3 m -57.86 -40.47 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.312 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.0 mm? -66.55 -32.14 73.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 110.656 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -35.97 37.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 t -61.0 -57.08 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.458 ' HB3' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.92 142.84 29.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.253 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.11 -49.03 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.509 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 t -98.21 81.99 2.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -120.51 137.83 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.278 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.5 m -85.97 116.92 24.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.833 HG22 HG22 ' A' ' 62' ' ' VAL . 7.2 pt -110.28 132.68 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -101.88 118.95 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.37 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.799 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -123.4 151.84 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.607 ' N ' HD13 ' A' ' 89' ' ' ILE . 41.1 t -125.71 110.45 24.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.442 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.41 138.18 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.462 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.38 -22.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.927 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -57.46 -21.85 39.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.033 0.444 . . . . 0.0 110.854 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.27 -30.34 1.92 Allowed Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.428 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.475 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 31.6 mtt-85 -56.19 -34.73 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.558 0.218 . . . . 0.0 111.352 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -49.32 -50.03 41.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.679 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.859 HD12 ' CE2' ' A' ' 38' ' ' PHE . 11.3 mt -71.74 -43.51 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.455 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.358 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.484 HG22 ' N ' ' B' ' 116' ' ' THR . 21.2 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.791 0.329 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' THR . . . . . 0.484 ' N ' HG22 ' B' ' 115' ' ' ILE . 78.5 m -150.93 148.94 29.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.444 ' O ' HD23 ' B' ' 118' ' ' LEU . 0.9 OUTLIER -94.67 136.57 34.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.793 HD11 HD13 ' A' ' 27' ' ' ILE . 78.1 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 90' ' ' VAL . 5.2 mt-10 -62.72 115.21 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -105.16 147.79 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -109.43 138.17 46.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.784 HG13 ' HB ' ' A' ' 51' ' ' VAL . 40.5 t -143.0 128.86 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.786 ' CD2' HG23 ' A' ' 86' ' ' THR . 3.9 m-85 -114.58 116.64 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 51' ' ' VAL . 42.3 mm -104.3 124.68 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.8 m -138.25 124.99 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 20' ' ' SER . 0.7 OUTLIER -77.61 78.12 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.954 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.02 -30.69 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.47 -120.93 4.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.584 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.448 ' HA ' HD21 ' A' ' 17' ' ' LEU . 1.5 p -143.81 43.15 1.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 151.26 44.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.82 -168.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.43 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.87 HD21 ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -77.66 -40.97 39.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.678 0.275 . . . . 0.0 110.662 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 102.62 20.39 11.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.304 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -132.62 158.57 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.213 0.506 . . . . 0.0 111.581 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 m -114.82 173.73 6.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.649 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.983 HD11 HG22 ' A' ' 76' ' ' VAL . 4.8 pt -143.53 145.54 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.103 0.478 . . . . 0.0 111.71 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -129.03 162.46 27.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.554 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -104.38 143.83 32.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.781 0.324 . . . . 0.0 110.443 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.67 175.14 43.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.073 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.788 ' CD ' HD12 ' A' ' 97' ' ' LEU . 55.8 Cg_endo -69.55 -160.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.843 2.362 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -85.87 -27.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.301 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -66.43 -32.65 74.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' HD11 ' A' ' 97' ' ' LEU . 16.9 mttp -151.08 70.48 8.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.35 137.51 28.44 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.624 2.216 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.05 -175.44 46.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.389 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.442 HG13 ' CD2' ' A' ' 67' ' ' PHE . 22.4 mm -92.93 116.58 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 27' ' ' ILE . 2.6 m-85 -105.12 170.37 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.82 134.06 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.024 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.1 -169.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.438 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.425 ' ND1' HD11 ' A' ' 55' ' ' ILE . 1.8 t60 -51.59 149.24 4.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.014 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' A' ' 25' ' ' CYS . 6.0 m -130.17 155.43 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -95.89 147.11 32.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.46 144.62 22.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.39 -24.23 26.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.524 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -74.06 -179.08 3.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -70.48 -35.9 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.522 ' HA ' HD12 ' A' ' 53' ' ' LEU . 45.1 t -52.83 -51.25 61.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -33.73 75.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -31.13 71.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.14 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.784 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.3 m -88.54 -20.82 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.03 39.0 3.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.074 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 48' ' ' SER . 8.0 mt -90.38 159.31 16.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.088 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 179.49 171.24 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 2.3 mt -60.35 147.71 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 103.66 -41.93 2.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.431 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.9 m-20 -55.15 169.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.657 0.265 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.523 ' CB ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -150.8 113.03 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.094 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -69.22 121.96 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.453 ' CG2' HG23 ' A' ' 90' ' ' VAL . 27.9 m -111.55 8.54 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.775 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.37 147.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.986 0.422 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.874 HG22 HG22 ' A' ' 87' ' ' ILE . 47.5 t -153.68 100.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.856 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 63.47 30.42 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.83 -29.62 12.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.429 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.4 118.48 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.72 123.26 20.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 3.1 m-85 -98.86 19.83 14.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -41.15 96.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -139.13 28.54 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.675 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.556 HD21 ' N ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -71.29 140.99 50.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.74 154.69 36.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -58.29 -54.61 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.001 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -57.2 -40.0 76.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.5 mm-40 -59.49 -40.76 88.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.556 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -63.1 -47.27 83.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.983 HG22 HD11 ' A' ' 27' ' ' ILE . 40.3 t -68.68 -36.13 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.44 -58.96 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 74' ' ' GLU . 29.3 m -57.67 -40.46 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.207 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.467 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.7 mm? -67.03 -31.95 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -34.77 38.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.4 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.068 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.563 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.1 m -97.8 119.29 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -67.17 -39.76 86.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.709 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 p -113.39 107.17 15.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.548 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.599 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -144.31 146.34 32.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.954 0.407 . . . . 0.0 111.303 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.786 HG23 ' CD2' ' A' ' 14' ' ' PHE . 31.3 m -85.22 123.03 30.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.064 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 62' ' ' VAL . 6.3 pt -118.25 126.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.534 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -95.46 112.37 24.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.465 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -112.74 149.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.039 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 10' ' ' GLU . 32.4 t -122.09 115.45 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.71 137.76 53.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.524 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.12 -17.49 0.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.176 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -57.73 -22.19 45.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 110.991 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -117.11 -30.69 1.87 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.551 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 58.0 mtp180 -56.16 -34.54 66.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 0.0 111.027 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -42.05 78.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.788 HD12 ' CD ' ' A' ' 31' ' ' PRO . 3.2 mm? -71.24 -48.59 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 2.1 m-85 -50.26 -34.08 22.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.5 mmt -69.34 72.51 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.728 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 100' ' ' THR . 59.0 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.421 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.31 151.06 30.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.641 2.228 . . . . 0.0 112.281 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 29' ' ' SER . 4.7 mt -83.29 154.35 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.76 149.22 40.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.02 152.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 76' ' ' VAL . 27.0 m -134.89 148.13 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.12 127.83 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 27' ' ' ILE . 14.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.5 mm-40 61.67 116.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 5.8 ttpm? -99.2 145.54 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.222 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 139.07 39.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.778 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.794 HG13 ' HB ' ' A' ' 51' ' ' VAL . 39.4 t -145.99 145.51 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -131.93 121.92 24.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mm -108.27 129.69 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -134.36 144.38 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.57 52.5 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.794 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 16' ' ' SER . 5.4 m -130.03 111.02 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.0 -26.43 20.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.478 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.411 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 73.3 m -122.65 -173.7 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.727 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 112.29 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.61 ' O ' HD23 ' A' ' 47' ' ' LEU . . . 52.4 -104.24 0.16 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.924 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.9 tp -125.06 -66.75 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.608 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 113.11 27.26 3.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.205 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 42' ' ' VAL . 54.0 t -154.18 156.05 36.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.94 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.9 t -114.87 136.09 53.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.026 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.678 HD11 HG22 ' A' ' 76' ' ' VAL . 20.9 pt -101.64 146.95 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 111.443 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 p -129.0 161.84 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.723 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 144.78 31.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.77 173.73 42.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.606 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.21 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.537 2.158 . . . . 0.0 112.365 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 mt -68.22 -28.12 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -66.76 -26.84 67.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.216 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HB3' HD11 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -154.51 76.78 5.47 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.112 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.22 133.28 12.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.514 2.142 . . . . 0.0 112.263 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.15 -179.95 38.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 75' ' ' ALA . 20.0 mm -88.71 114.6 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE2' HD12 ' A' ' 97' ' ' LEU . 20.2 m-85 -109.03 173.55 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.528 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.3 mm -107.83 131.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.269 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.22 -168.98 1.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.528 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.429 ' HA ' HD11 ' A' ' 55' ' ' ILE . 44.8 t-80 -45.87 140.3 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' SG ' ' A' ' 25' ' ' CYS . 25.3 t -108.66 157.44 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.458 ' N ' HG12 ' A' ' 42' ' ' VAL . 12.2 mttt -108.15 121.44 43.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.53 151.17 39.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.4 2.067 . . . . 0.0 112.135 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 53.51 24.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.41 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.456 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -151.61 -169.28 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 22' ' ' GLY . 2.3 mm? -76.08 -46.56 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.394 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 51' ' ' VAL . 23.0 t -56.26 -42.01 76.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -38.77 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.98 -35.61 81.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.794 ' HB ' HG13 ' A' ' 13' ' ' VAL . 31.0 m -77.91 -27.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.47 30.32 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.589 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.444 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 11.7 mt -75.73 166.36 23.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -179.31 155.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.783 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 41' ' ' HIS . 4.6 mt -53.16 131.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.008 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 117.12 -25.72 8.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.284 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' CB ' HD11 ' A' ' 89' ' ' ILE . 52.5 m-20 -69.11 166.52 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -148.05 115.18 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.084 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.27 117.26 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 88' ' ' SER . 35.6 m -98.71 -15.36 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.73 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -158.34 155.05 28.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.931 HG13 HG22 ' A' ' 87' ' ' ILE . 47.8 t -152.12 103.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.01 31.3 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.9 -28.38 13.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.06 126.39 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.126 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.18 112.91 3.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.2 m-85 -98.75 11.68 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -72.3 -44.29 62.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.712 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -123.43 30.5 6.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.604 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.0 146.96 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.914 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.499 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -73.42 167.59 20.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -66.3 -55.16 17.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -39.11 80.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.63 -37.82 82.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.752 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.646 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -66.15 -46.07 78.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.962 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.692 HG11 HG21 ' B' ' 116' ' ' THR . 24.8 t -68.71 -42.46 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.044 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -56.07 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 79' ' ' LEU . 32.7 m -58.84 -43.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.452 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -65.79 -31.42 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -69.67 -67.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.11 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.679 ' CB ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -77.27 136.1 38.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -51.19 7.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.622 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.0 p -106.14 83.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.679 HD23 ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -116.02 139.81 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.0 m -90.49 116.85 28.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.24 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.931 HG22 HG13 ' A' ' 62' ' ' VAL . 17.4 pt -111.91 129.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.71 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.579 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -97.27 108.9 21.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.449 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.466 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -109.82 146.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 10' ' ' GLU . 11.4 t -117.15 112.59 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 110.977 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.6 143.37 36.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.347 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.75 -19.48 0.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.779 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -58.62 -20.68 49.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.88 -30.85 2.05 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.533 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 59.3 mtt180 -56.62 -34.28 67.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.52 0.2 . . . . 0.0 111.398 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.23 -49.8 31.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' A' ' 34' ' ' LYS . 9.3 mt -71.15 -43.28 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -58.74 -66.26 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 142.5 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' B' ' 112' ' ' PRO . 27.2 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.72 0.295 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' B' ' 111' ' ' THR . 18.1 Cg_endo -59.29 159.55 22.44 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.629 2.219 . . . . 0.0 112.292 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.72 166.53 12.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -78.65 138.71 38.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.79 136.21 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.189 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.692 HG21 HG11 ' A' ' 76' ' ' VAL . 33.5 m -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.31 143.43 27.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 27' ' ' ILE . 3.6 mp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 63.45 124.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.042 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -97.91 135.51 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -94.39 140.44 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.875 HG13 ' HB ' ' A' ' 51' ' ' VAL . 44.6 t -145.52 137.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -124.76 115.99 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.493 HD12 HD13 ' A' ' 23' ' ' LEU . 42.8 mm -101.15 127.64 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.232 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 131.21 34.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.616 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD22 ' HG2' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -54.72 -70.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.934 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 m 40.98 89.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.867 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.99 26.37 6.73 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.59 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m 56.19 25.62 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 111.22 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.87 109.46 21.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.11 -96.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.013 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 HD12 ' A' ' 15' ' ' ILE . 13.5 tp -140.79 -56.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 106.75 23.82 6.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.27 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.776 ' SG ' HG22 ' A' ' 42' ' ' VAL . 2.8 t -145.09 164.85 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 111.016 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 m -114.94 173.75 6.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.758 HD13 HD11 ' B' ' 118' ' ' LEU . 16.0 pt -142.81 145.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 111.377 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.24 161.95 28.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.789 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.769 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.5 OUTLIER -104.95 141.9 35.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.745 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.03 172.95 34.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.917 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' HD13 ' A' ' 97' ' ' LEU . 42.2 Cg_endo -67.65 -165.71 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.34 -25.54 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.26 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.15 -5.48 49.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.283 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HB3' HD11 ' A' ' 97' ' ' LEU . 6.9 tttt -171.01 59.31 0.29 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.773 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.27 144.54 56.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.606 2.204 . . . . 0.0 112.315 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.13 174.87 33.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.278 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 75' ' ' ALA . 11.8 mm -89.58 113.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.898 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.937 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.6 m-85 -101.96 172.51 6.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.503 HG23 ' SG ' ' A' ' 25' ' ' CYS . 23.3 mm -109.21 136.26 45.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.234 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.05 -169.35 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.375 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -45.02 145.72 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.776 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.2 t -113.73 151.32 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -105.43 124.02 37.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 159.79 8.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.045 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.01 50.24 67.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 2.5 m -141.05 -173.62 3.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.733 0.301 . . . . 0.0 110.912 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.9 mt -78.15 -42.32 32.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -52.87 -40.11 63.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.939 0.4 . . . . 0.0 110.572 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.33 68.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.611 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -37.15 79.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.817 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.875 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.2 m -83.05 -30.22 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.08 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.72 52.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 48' ' ' SER . 14.0 mt -97.63 164.89 12.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.12 162.42 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 4.1 mt -58.02 140.9 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 -37.16 3.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.257 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.51 156.14 13.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.756 0.312 . . . . 0.0 110.637 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.4 119.09 12.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 62' ' ' VAL . 15.5 mt -69.42 117.13 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.614 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.64 -16.01 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.714 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -155.52 148.36 24.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.402 . . . . 0.0 111.044 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.859 HG13 HG22 ' A' ' 87' ' ' ILE . 41.8 t -147.66 105.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 55.92 32.66 20.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.8 23.41 38.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.659 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 62' ' ' VAL . 23.6 t -112.21 120.16 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.326 . . . . 0.0 111.063 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -65.14 111.92 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.676 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.3 m-85 -95.78 19.84 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.86 -41.07 45.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -123.61 28.04 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.694 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -83.52 148.98 26.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.45 164.33 17.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.2 t-160 -59.37 -48.95 79.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -60.63 -41.85 95.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.0 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -59.04 -45.73 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.608 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -59.07 -47.71 84.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.745 HG22 HD11 ' A' ' 27' ' ' ILE . 28.0 t -66.87 -43.47 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -58.13 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.7 m -57.28 -44.58 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.528 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.4 mm? -64.43 -31.51 72.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.693 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.1 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 t -66.56 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -87.56 131.76 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HG2' HD22 ' A' ' 17' ' ' LEU . 3.2 mpp_? -77.66 -55.69 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.8 m -100.03 83.03 2.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -113.84 141.87 46.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -89.85 116.94 28.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.859 HG22 HG13 ' A' ' 62' ' ' VAL . 12.3 pt -115.02 126.51 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 0.0 111.542 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -96.04 122.9 39.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 145.94 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.409 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.77 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -111.18 126.17 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.298 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -65.91 132.11 47.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.525 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.54 -19.42 0.32 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.627 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.77 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -53.6 -24.18 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.52 -30.77 2.97 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -34.56 66.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.624 0.25 . . . . 0.0 111.282 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.65 -50.01 44.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.937 HD12 ' CE2' ' A' ' 38' ' ' PHE . 18.9 mt -71.52 -41.03 69.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.005 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -55.3 -50.77 68.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.193 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ptm -56.16 153.47 9.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.64 -179.48 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.61 2.207 . . . . 0.0 112.27 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.769 HD13 ' O ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -67.32 160.44 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.2 164.02 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 30.6 mt -144.49 134.29 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.202 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.452 HG21 HG21 ' A' ' 76' ' ' VAL . 32.5 m -111.68 145.09 39.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -98.06 111.78 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.758 HD11 HD13 ' A' ' 27' ' ' ILE . 6.1 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.793 0.33 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.546 ' HA ' HG22 ' A' ' 90' ' ' VAL . 4.9 mt-10 -72.99 131.38 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.741 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -102.01 116.85 33.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -86.23 131.88 34.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.763 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.759 HG13 ' HB ' ' A' ' 51' ' ' VAL . 40.1 t -140.75 149.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.286 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 5.1 m-85 -128.32 131.59 48.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.705 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.8 131.29 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.461 ' HB2' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -137.21 156.68 48.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.655 HD13 ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -94.51 46.78 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 16' ' ' SER . 30.0 t -88.03 80.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.085 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.63 -110.36 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.591 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.1 t -149.53 30.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 145.67 26.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -75.05 -55.36 5.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.435 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 48' ' ' SER . 12.7 tp -148.13 -64.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 108.67 36.38 2.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.063 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.718 ' SG ' HG12 ' A' ' 42' ' ' VAL . 1.3 t -160.23 160.71 33.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.0 110.486 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 4.2 m -114.36 173.45 6.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.53 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.12 HD11 HG22 ' A' ' 76' ' ' VAL . 10.0 pt -135.29 153.5 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.41 . . . . 0.0 111.354 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 29.5 p -131.29 162.68 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.8 p -104.61 140.79 37.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 175.31 43.58 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.716 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.72 ' HD2' HD13 ' A' ' 97' ' ' LEU . 57.5 Cg_endo -71.06 -167.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.646 2.231 . . . . 0.0 112.586 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.9 mt -78.2 -21.42 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.257 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -71.92 -30.31 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.1 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB3' HD11 ' A' ' 97' ' ' LEU . 11.2 mttm -147.53 64.77 8.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 21.8 Cg_exo -64.7 114.45 2.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.629 2.22 . . . . 0.0 112.014 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 -157.38 8.99 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 75' ' ' ALA . 19.7 mm -111.67 118.0 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.053 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.868 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 2.1 m-85 -100.36 172.28 7.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.716 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.4 mm -118.74 121.62 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.33 -169.5 2.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.611 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -54.34 141.99 28.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.718 HG12 ' SG ' ' A' ' 25' ' ' CYS . 1.7 m -119.71 153.48 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 147.07 32.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.38 172.74 15.75 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.29 33.89 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.603 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 73.7 p -119.11 -171.76 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.788 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 4.4 mt -78.0 -44.03 27.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -53.05 -46.13 68.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.533 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -36.28 75.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.564 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.06 -38.5 83.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.759 ' HB ' HG13 ' A' ' 13' ' ' VAL . 21.0 m -80.36 -29.69 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 36.18 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.377 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 48' ' ' SER . 13.1 mt -85.06 161.05 19.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.0 166.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.674 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.86 144.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 105.94 -13.3 45.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.646 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.5 m-20 -86.32 162.32 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.446 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -142.85 114.93 8.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.07 117.19 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.851 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 88' ' ' SER . 30.7 m -106.86 6.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.764 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -177.15 149.89 0.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.843 0.354 . . . . 0.0 111.136 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.85 HG22 HG22 ' A' ' 87' ' ' ILE . 58.1 t -153.84 112.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 56.95 29.47 16.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.73 -26.18 19.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.45 124.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.899 0.38 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.22 114.88 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.9 m-85 -95.75 22.31 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -53.8 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.642 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -111.78 28.49 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.554 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.1 tp -83.17 147.69 27.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.61 163.09 20.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -59.5 -50.34 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -59.56 -37.5 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HB3' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -61.64 -43.15 99.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.554 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.66 -46.2 90.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.16 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.12 HG22 HD11 ' A' ' 27' ' ' ILE . 40.5 t -67.95 -43.85 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.4 -57.21 12.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 79' ' ' LEU . 33.3 m -58.02 -45.34 88.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.4 mm? -63.84 -29.66 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.645 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.814 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.3 mptp? -82.58 -34.65 27.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -69.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.383 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -75.77 131.18 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.288 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.655 ' HG3' HD13 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -82.33 -50.61 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.551 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -102.4 86.92 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.507 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -121.42 143.16 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.289 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 m -92.19 116.92 29.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.051 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 62' ' ' VAL . 5.9 pt -109.37 130.44 62.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.928 0.394 . . . . 0.0 111.546 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -105.18 103.56 13.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.785 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.741 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.85 147.61 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.9 t -114.44 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 0.0 110.964 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.655 ' HB2' ' NZ ' ' A' ' 11' ' ' LYS . . . -55.38 138.41 45.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.268 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.68 -22.45 0.18 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.773 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.68 55.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.922 0.392 . . . . 0.0 111.023 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA2' ' CZ ' ' A' ' 38' ' ' PHE . . . -110.86 -30.21 3.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.67 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 27.4 mtp85 -55.75 -34.49 65.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.549 0.214 . . . . 0.0 111.482 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.22 -50.05 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.868 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 19.3 mt -71.53 -50.03 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.022 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.457 ' HB3' ' HE3' ' A' ' 99' ' ' MET . 0.1 OUTLIER -47.23 -54.14 11.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.371 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.457 ' HE3' ' HB3' ' A' ' 98' ' ' PHE . 17.0 mmt -73.35 119.28 17.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.967 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 52.5 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 -167.97 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.581 2.187 . . . . 0.0 112.302 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mt -77.47 170.28 16.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.62 150.19 44.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.1 mt -139.57 139.2 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.566 HG21 HG21 ' A' ' 76' ' ' VAL . 83.1 m -129.76 149.48 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.37 144.02 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.814 HD23 ' HE2' ' A' ' 80' ' ' LYS . 15.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.707 0.289 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.3 mt-10 -61.51 125.54 24.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -118.59 158.41 25.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -121.08 141.2 51.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.704 HG13 ' HB ' ' A' ' 51' ' ' VAL . 21.7 t -141.37 150.06 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.339 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' HE1' ' HG ' ' A' ' 16' ' ' SER . 1.8 t80 -128.13 120.36 27.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.699 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 23' ' ' LEU . 36.5 mm -110.14 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.435 ' HG ' ' HE1' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -134.61 138.48 44.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.961 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.639 HD11 ' HA2' ' A' ' 22' ' ' GLY . 2.3 mp -73.44 122.07 21.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.82 -44.28 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.31 -72.36 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -145.32 32.03 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.844 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -119.69 122.67 41.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.639 ' HA2' HD11 ' A' ' 17' ' ' LEU . . . -66.62 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.622 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.6 tp -133.2 -56.29 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 100.03 27.92 7.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.455 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.658 ' SG ' HG22 ' A' ' 42' ' ' VAL . 35.9 t -154.28 159.29 41.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.2 m -114.42 173.68 6.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.764 HD11 HG22 ' A' ' 76' ' ' VAL . 19.1 pt -135.93 138.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.1 p -116.28 161.71 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.829 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.606 ' O ' HD13 ' B' ' 113' ' ' LEU . 5.9 t -105.17 144.91 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.46 171.89 35.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.575 ' HD2' HD13 ' A' ' 97' ' ' LEU . 57.6 Cg_endo -71.37 -166.44 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.66 2.24 . . . . 0.0 112.393 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.43 -25.28 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -68.22 -28.14 66.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' HB3' HD11 ' A' ' 97' ' ' LEU . 11.8 tttp -157.25 65.63 3.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.226 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.78 144.68 84.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.62 2.213 . . . . 0.0 112.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 38' ' ' PHE . . . 163.61 168.64 25.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.551 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 75' ' ' ALA . 24.7 mm -82.89 114.58 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.051 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.591 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 70.2 m-85 -108.25 176.15 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.205 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.648 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.8 mm -107.69 137.85 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.623 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -169.45 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.23 150.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.658 HG22 ' SG ' ' A' ' 25' ' ' CYS . 29.9 t -126.97 157.59 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' N ' HG12 ' A' ' 42' ' ' VAL . 14.3 pttt -121.94 141.69 34.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 160.6 43.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.534 2.156 . . . . 0.0 112.399 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.52 82.63 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.933 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.541 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.4 m -103.87 -166.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.5 mm? -80.35 -43.47 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.769 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 53' ' ' LEU . 11.7 t -56.15 -40.58 74.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.53 79.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.22 -35.09 79.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.704 ' HB ' HG13 ' A' ' 13' ' ' VAL . 25.4 m -78.9 -17.44 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.467 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.52 5.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.289 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 9.1 mt -88.97 155.06 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -167.04 161.03 14.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.94 149.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 101.1 -23.39 35.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.291 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' HB3' HG13 ' A' ' 89' ' ' ILE . 46.6 m-20 -71.99 166.73 21.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 2.6 tt0 -152.66 119.03 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 111.348 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.39 117.47 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.92 -19.81 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.869 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -159.95 157.28 28.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.105 0.478 . . . . 0.0 111.416 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.727 HG12 ' ND2' ' A' ' 63' ' ' ASN . 46.3 t -150.21 117.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.499 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.727 ' ND2' HG12 ' A' ' 62' ' ' VAL . 0.1 OUTLIER 45.36 47.78 10.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 111.168 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.73 22.29 73.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.311 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 62' ' ' VAL . 21.8 t -109.31 127.38 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.91 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.94 114.66 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.117 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.69 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -99.33 -21.42 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.072 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 m -53.12 -45.82 68.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -106.85 35.45 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.2 tp -105.54 149.68 26.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.765 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.42 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -84.11 166.07 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -60.17 -53.92 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.17 -39.63 79.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.405 ' C ' HD21 ' A' ' 70' ' ' LEU . 2.9 mt-10 -61.32 -43.57 98.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.756 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -58.8 -45.54 89.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.764 HG22 HD11 ' A' ' 27' ' ' ILE . 39.1 t -68.73 -39.95 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.79 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.356 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 79' ' ' LEU . 29.9 m -59.06 -44.82 92.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 110.939 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -63.45 -31.53 72.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.733 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HE3' HD23 ' B' ' 118' ' ' LEU . 1.1 mptm? -82.66 -31.63 28.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 t -64.66 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.4 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.421 ' CB ' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -88.15 135.3 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.089 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -78.53 -52.07 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.617 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.2 p -102.29 85.17 2.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.427 ' CD2' ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -116.65 146.32 42.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 111.422 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -90.85 117.35 29.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.395 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.645 HG22 HG13 ' A' ' 62' ' ' VAL . 12.3 pt -115.17 121.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.547 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.33 120.76 33.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.534 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -122.38 144.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.25 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 89' ' ' ILE . 41.0 t -115.24 112.45 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.728 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.58 139.38 50.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.479 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.26 -17.32 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.131 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -59.75 -19.27 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 111.23 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 -30.82 2.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.623 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 51.0 mtp180 -56.47 -34.61 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.314 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.56 -49.91 69.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 34' ' ' LYS . 21.8 mt -71.56 -42.92 67.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -50.17 -42.38 50.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.249 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.9 ptm -85.46 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.642 0.258 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.83 152.38 52.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.548 2.165 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.606 HD13 ' O ' ' A' ' 29' ' ' SER . 1.7 mt -60.28 164.76 3.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.48 144.68 41.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 21.6 mt -135.92 138.61 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.157 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.61 HG21 HG21 ' A' ' 76' ' ' VAL . 39.1 m -133.35 143.1 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.23 141.19 28.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' C ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.784 0.326 . . . . 0.0 111.265 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.742 ' HA ' HG22 ' A' ' 90' ' ' VAL . 13.5 tt0 -70.67 121.82 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.789 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -105.96 146.73 29.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 111.047 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -97.95 149.87 21.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.725 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.798 HG13 ' HB ' ' A' ' 51' ' ' VAL . 57.8 t -152.99 141.1 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.04 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -129.23 123.72 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.653 HD12 ' CD1' ' A' ' 23' ' ' LEU . 22.0 mm -110.77 127.64 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -141.49 124.15 15.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.806 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.8 HD11 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -66.62 109.29 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 p -111.3 -32.31 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.94 5.59 46.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.438 ' HA ' HD23 ' A' ' 17' ' ' LEU . 0.3 OUTLIER 58.52 31.27 20.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.997 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -29.52 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.8 ' HA2' HD11 ' A' ' 17' ' ' LEU . . . 125.3 -156.2 19.06 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.653 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.0 tp -88.47 -48.72 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.04 30.89 8.45 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.3 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 39' ' ' ILE . 42.2 t -151.43 158.65 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 111.009 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.31 173.9 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.796 HD13 HD11 ' B' ' 118' ' ' LEU . 11.7 pt -136.01 175.8 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.966 0.412 . . . . 0.0 111.359 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 t -146.76 162.16 39.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.639 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -104.83 148.26 26.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.607 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -88.72 154.49 24.85 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.02 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.484 ' CD ' HD12 ' A' ' 97' ' ' LEU . 57.8 Cg_endo -70.78 -159.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.882 2.388 . . . . 0.0 112.032 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -80.69 -27.05 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.348 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -85.67 0.59 52.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.548 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HD3' HD21 ' A' ' 97' ' ' LEU . 7.4 tttp -175.98 65.43 0.23 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.203 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 13.8 Cg_exo -69.3 119.1 6.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 111.921 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.41 -175.41 38.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.781 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.404 HG13 ' CD2' ' A' ' 67' ' ' PHE . 15.4 mm -106.11 111.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.309 . . . . 0.0 110.937 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 1.8 m-30 -100.99 174.5 5.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.655 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.4 mm -107.85 138.37 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.13 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -169.44 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.402 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -45.25 137.52 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 43' ' ' LYS . 18.7 t -108.58 157.79 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.461 ' N ' HG12 ' A' ' 42' ' ' VAL . 13.4 mttt -107.6 154.52 40.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.79 154.03 15.21 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.743 2.296 . . . . 0.0 112.407 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.1 26.98 64.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.585 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.465 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -111.94 -177.8 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.696 0.284 . . . . 0.0 110.848 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 22' ' ' GLY . 24.8 mt -73.09 -46.19 52.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.756 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -52.93 -38.8 62.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.74 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.437 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.89 -40.19 87.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.704 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.798 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.6 m -78.87 -27.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.056 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.86 48.96 1.12 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 48' ' ' SER . 15.2 mt -96.04 154.27 17.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HA ' HG21 ' A' ' 42' ' ' VAL . 12.5 tt0 -168.01 166.88 13.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.69 138.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.8 17.2 21.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.376 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' CB ' HD11 ' A' ' 89' ' ' ILE . 48.2 m-20 -110.39 159.94 17.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.675 0.274 . . . . 0.0 110.677 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 14.4 tm0? -140.05 112.2 7.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -69.23 118.45 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 88' ' ' SER . 33.2 m -106.42 13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.945 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -176.99 146.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.934 0.397 . . . . 0.0 111.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.803 HG13 HG22 ' A' ' 87' ' ' ILE . 39.0 t -149.53 98.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.04 30.27 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.18 -28.59 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.512 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.35 129.05 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.099 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.82 109.79 6.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.772 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.8 m-85 -96.79 -11.42 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.398 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -50.37 -27.84 7.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.763 0.316 . . . . 0.0 111.21 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -144.57 31.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.772 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -84.68 144.04 28.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.847 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.5 162.93 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -63.64 -54.93 28.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -58.17 -41.02 82.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' HD21 ' A' ' 70' ' ' LEU . 2.0 mp0 -60.38 -34.3 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.688 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -69.13 -45.32 70.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.007 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.82 HG21 HG21 ' B' ' 116' ' ' THR . 42.8 t -68.03 -38.73 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -56.5 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.1 m -59.29 -45.54 93.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.072 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.5 mm? -62.32 -31.17 71.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.606 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.445 ' HE2' HD23 ' B' ' 118' ' ' LEU . 0.1 OUTLIER -82.63 -33.45 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 t -61.72 -61.24 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.442 ' HB2' HD23 ' A' ' 85' ' ' LEU . 3.9 m -97.4 127.22 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.974 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HG2' HD22 ' A' ' 17' ' ' LEU . 14.5 mtp180 -74.22 -48.8 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 t -98.61 94.27 6.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -134.36 140.23 46.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.2 m -91.89 133.11 35.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.272 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.803 HG22 HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -125.19 139.76 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.63 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -102.45 104.39 14.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.213 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.444 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -107.41 143.19 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 10' ' ' GLU . 21.8 t -110.95 129.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -65.48 131.88 47.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.828 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.06 -17.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.521 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.52 -22.43 32.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.782 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.26 -30.27 2.31 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.39 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.442 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -55.83 -34.62 65.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.78 -38.92 64.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.962 0.41 . . . . 0.0 110.322 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.53 HD21 ' HD3' ' A' ' 34' ' ' LYS . 3.9 mm? -71.4 -54.09 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -51.29 -30.5 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.51 -48.89 79.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.656 0.265 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.35 153.99 70.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.495 2.13 . . . . 0.0 112.253 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.35 151.18 45.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -59.07 137.48 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.3 mm -120.54 148.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.82 HG21 HG21 ' A' ' 76' ' ' VAL . 85.3 m -134.19 146.32 50.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.15 128.14 42.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.796 HD11 HD13 ' A' ' 27' ' ' ILE . 40.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tttm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.496 ' HA ' HG13 ' A' ' 90' ' ' VAL . 1.2 mp0 -60.0 124.11 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -109.03 158.84 17.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.423 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -121.6 140.54 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.712 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 51' ' ' VAL . 58.5 t -145.48 145.57 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.246 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.871 ' CD1' HG23 ' A' ' 86' ' ' THR . 1.8 m-85 -123.53 129.07 50.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.657 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 23' ' ' LEU . 36.4 mm -119.72 125.68 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 p -130.54 123.18 29.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -169.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t 64.6 136.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.62 -39.15 2.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -66.41 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.738 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 0.1 OUTLIER -158.73 -172.85 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 47' ' ' LEU . . . -47.98 -76.57 0.14 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.016 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.607 HD13 HD12 ' A' ' 15' ' ' ILE . 12.5 tp -141.06 -43.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.852 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.35 18.71 32.49 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.398 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.683 ' SG ' HG23 ' A' ' 39' ' ' ILE . 49.1 t -139.36 158.66 43.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.524 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 173.53 6.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 76' ' ' VAL . 15.3 pt -143.55 152.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.7 p -136.15 160.28 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.539 ' O ' HD22 ' B' ' 113' ' ' LEU . 2.6 m -105.48 155.09 19.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.71 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.02 -166.04 24.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.88 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.54 -164.17 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.03 -24.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.244 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.42 -29.4 62.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' CB ' HD21 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -147.07 63.31 8.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.34 140.87 31.08 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.517 2.145 . . . . 0.0 112.335 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.98 31.97 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.416 HG13 ' HB2' ' A' ' 75' ' ' ALA . 12.1 mm -85.84 110.32 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -100.69 171.94 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.038 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.683 HG23 ' SG ' ' A' ' 25' ' ' CYS . 20.2 mm -107.78 137.15 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.322 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -169.4 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.189 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 147.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.105 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.616 HG22 ' SG ' ' A' ' 25' ' ' CYS . 35.5 t -121.43 157.92 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 3.1 mtpm? -96.62 156.37 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.804 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -50.57 3.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.509 2.139 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.7 -123.4 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.947 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.459 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 25.0 p 47.63 -159.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 111.313 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 22' ' ' GLY . 1.5 mt -102.48 -29.42 11.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.291 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 51' ' ' VAL . 3.7 p -52.83 -52.4 57.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 43' ' ' LYS . . . -62.01 -35.38 78.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.075 0.464 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.42 -41.65 90.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.993 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.787 ' HB ' HG13 ' A' ' 13' ' ' VAL . 18.2 m -81.43 -29.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.11 61.78 0.82 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.371 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.92 155.38 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.28 159.64 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.42 147.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.65 -28.55 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' CB ' HD11 ' A' ' 89' ' ' ILE . 36.2 m-20 -63.35 146.92 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.689 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 1.5 tm0? -132.05 117.82 18.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.24 119.42 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 88' ' ' SER . 35.3 m -99.47 -20.98 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.0 155.05 34.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.748 HG13 HG22 ' A' ' 87' ' ' ILE . 47.8 t -151.1 96.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 57.42 36.9 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.85 -28.56 13.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.448 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.91 114.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.18 115.41 5.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.651 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.4 m-85 -97.27 25.03 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.024 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -70.94 -53.81 13.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.59 28.67 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.537 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.1 tp -74.2 149.4 40.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 173.02 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.438 ' CE1' ' HG1' ' B' ' 116' ' ' THR . 3.1 t60 -66.6 -58.34 5.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -57.61 -34.86 69.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -44.49 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.24 -44.64 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.768 HG11 HG21 ' B' ' 116' ' ' THR . 39.1 t -69.11 -43.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.032 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -54.81 -55.5 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.202 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 79' ' ' LEU . 28.3 m -59.1 -45.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.475 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -65.08 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.78 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.1 mptp? -82.58 -28.4 30.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -68.04 -64.34 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.716 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -84.75 140.08 31.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.149 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -78.79 -59.61 2.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.65 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 t -102.41 101.36 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -131.7 142.5 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.998 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.871 HG23 ' CD1' ' A' ' 14' ' ' PHE . 17.5 m -87.88 116.96 26.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.283 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.748 HG22 HG13 ' A' ' 62' ' ' VAL . 15.0 pt -111.77 123.99 68.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.984 0.421 . . . . 0.0 111.717 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 60' ' ' VAL . 6.2 t -93.23 113.5 25.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.249 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.51 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -118.34 147.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.29 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 10' ' ' GLU . 11.9 t -116.31 134.05 60.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.539 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -71.19 129.69 39.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.943 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.69 -17.33 0.49 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.678 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -54.88 -21.95 13.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.296 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.59 -30.24 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.606 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 6.2 ptm180 -56.13 -38.27 70.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -51.42 -49.95 60.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.732 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.62 HD21 ' CB ' ' A' ' 34' ' ' LYS . 12.5 mt -71.61 -35.94 70.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -40.73 66.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.4 mmt -57.48 115.19 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.122 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.22 174.7 10.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.698 2.265 . . . . 0.0 112.404 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 29' ' ' SER . 11.5 mt -109.3 130.12 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.755 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -72.1 166.89 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 23.3 mt -149.23 133.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.768 HG21 HG11 ' A' ' 76' ' ' VAL . 95.0 m -121.89 144.15 49.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -88.83 147.87 24.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.78 HD23 ' HE2' ' A' ' 80' ' ' LYS . 1.7 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.825 0.345 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -66.44 115.07 5.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.748 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.0 ttpt -102.67 143.9 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 0.0 111.084 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 131.35 52.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.746 HG13 ' HB ' ' A' ' 51' ' ' VAL . 44.1 t -137.96 144.26 31.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 86' ' ' THR . 2.7 m-85 -130.09 125.77 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.477 HD12 ' CD1' ' A' ' 23' ' ' LEU . 35.3 mm -113.79 119.73 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.7 p -140.22 135.34 32.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 105.59 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.07 -33.08 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.7 -89.28 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -122.67 39.67 3.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -133.57 118.95 18.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.688 ' O ' HD23 ' A' ' 47' ' ' LEU . . . -59.17 -100.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.517 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' B' ' 118' ' ' LEU . 6.7 tp -121.3 -56.08 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.308 . . . . 0.0 110.372 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.89 -2.31 24.36 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.348 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' HD21 ' A' ' 23' ' ' LEU . 20.3 p -139.18 166.41 24.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.038 0.419 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 t -114.81 173.92 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 HD11 ' B' ' 118' ' ' LEU . 26.8 pt -141.74 151.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.971 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.6 161.84 39.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.09 146.63 28.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.658 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' A' ' 97' ' ' LEU . . . -94.61 -168.55 36.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.109 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.55 -164.81 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.884 2.39 . . . . 0.0 112.536 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.0 mp -83.11 -27.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.88 -28.99 70.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.9 ' HB3' HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -153.92 75.81 6.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.721 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.81 128.2 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.481 2.121 . . . . 0.0 112.339 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.63 167.9 39.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.522 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -102.53 106.23 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -100.44 -176.62 3.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.657 HD13 HG22 ' A' ' 27' ' ' ILE . 22.8 mm -107.49 144.08 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 111.914 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -168.9 1.5 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.888 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.603 ' HA ' HD11 ' A' ' 55' ' ' ILE . 3.1 t60 -41.95 149.36 0.14 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 111.178 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' CYS . 18.6 t -132.08 154.87 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 144.5 33.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 158.42 51.43 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.508 2.139 . . . . 0.0 112.422 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.43 69.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.4 m -142.96 -178.5 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 22' ' ' GLY . 3.1 mm? -64.9 -50.83 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.656 ' HA ' HD12 ' A' ' 53' ' ' LEU . 78.9 p -59.14 -37.54 77.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.018 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.17 -41.21 67.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.31 -46.94 84.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.746 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.8 m -68.06 -28.81 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.196 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.27 55.09 0.87 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.438 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.656 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.0 mt -102.29 166.95 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HA ' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER 179.19 165.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.684 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 41' ' ' HIS . 4.3 mt -58.21 132.77 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.72 -30.42 6.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.32 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB3' HG13 ' A' ' 89' ' ' ILE . 2.1 m-20 -60.06 171.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.646 0.26 . . . . 0.0 110.736 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.563 ' CB ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -152.12 110.34 3.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.366 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.407 HG21 ' CG2' ' A' ' 62' ' ' VAL . 6.4 mt -69.45 117.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 88' ' ' SER . 35.7 m -101.49 4.14 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.998 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.37 148.44 1.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 87' ' ' ILE . 41.3 t -151.85 104.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 60.33 30.78 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.03 13.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.3 133.04 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.17 116.67 21.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.633 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.7 m-85 -92.14 13.7 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -33.75 76.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.556 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -140.75 32.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.645 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.55 HD21 ' N ' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -81.72 146.77 29.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.6 167.69 21.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -65.32 -57.32 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -39.13 72.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -60.47 -38.38 84.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -66.4 -45.79 78.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.781 HG11 HG21 ' B' ' 116' ' ' THR . 22.1 t -68.55 -43.98 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -55.36 -57.15 13.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.7 m -57.55 -45.53 86.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.267 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.553 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.6 mm? -65.26 -30.2 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -82.56 -31.77 28.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -59.53 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.82 135.16 36.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.33 -39.64 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -108.2 87.27 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.588 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -127.05 145.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 14' ' ' PHE . 43.0 m -90.44 121.36 32.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.117 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.89 HG22 HG22 ' A' ' 62' ' ' VAL . 7.5 pt -116.67 126.36 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.56 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -95.58 109.52 21.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.258 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.54 149.58 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.306 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.7 t -123.66 118.47 54.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.62 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.588 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -58.96 138.42 57.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.674 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.48 -18.26 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.245 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.563 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -61.57 -18.88 61.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.44 -30.97 2.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.48 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -56.64 -34.22 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -48.14 -46.11 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.9 HD21 ' HB3' ' A' ' 34' ' ' LYS . 34.5 mt -71.32 -45.24 63.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.87 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -58.57 -28.36 65.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.51 118.75 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 111.052 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.632 0.253 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.73 158.0 35.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.585 2.19 . . . . 0.0 112.398 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.05 127.57 54.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.83 149.02 49.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 9.8 mt -136.98 146.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.024 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.781 HG21 HG11 ' A' ' 76' ' ' VAL . 58.7 m -140.87 132.5 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.85 143.61 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.735 HD11 HG12 ' A' ' 27' ' ' ILE . 1.4 mp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.839 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.9 tptp . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.54 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HE3' HG23 ' A' ' 89' ' ' ILE . 14.3 ttpp -101.98 145.9 28.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -110.91 142.06 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.577 HG13 ' HB ' ' A' ' 51' ' ' VAL . 42.0 t -142.62 151.63 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.4 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.562 ' CE1' HG23 ' A' ' 86' ' ' THR . 22.6 m-85 -130.08 131.78 45.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.694 HG23 HD13 ' A' ' 47' ' ' LEU . 17.2 mm -129.44 104.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.845 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 1.1 t -116.45 26.05 10.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.824 ' HA ' HD11 ' A' ' 47' ' ' LEU . 7.5 mp 48.04 63.2 2.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.441 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.667 ' H ' HD21 ' A' ' 47' ' ' LEU . 7.7 p -117.19 111.37 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.15 86.05 1.78 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.294 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.47 2.78 3.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.526 0.203 . . . . 0.0 111.411 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.11 101.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.817 0.342 . . . . 0.0 111.284 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.01 145.16 4.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.568 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.8 tp -77.45 -48.44 17.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.363 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 84.67 33.33 19.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.767 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' A' ' 42' ' ' VAL . 1.7 t -152.13 156.5 39.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.792 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -114.55 173.73 6.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.859 HD11 HG22 ' A' ' 76' ' ' VAL . 9.2 pt -136.94 137.37 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.248 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -120.07 161.88 20.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.771 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.547 ' O ' HD22 ' B' ' 113' ' ' LEU . 12.2 p -105.16 154.33 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.28 179.69 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.723 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HD2' HD13 ' A' ' 97' ' ' LEU . 61.6 Cg_endo -73.17 -168.27 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.645 2.23 . . . . 0.0 112.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -75.07 -26.9 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.134 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.48 -33.48 74.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.8 mtmm -149.86 76.32 8.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.25 141.89 26.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.697 2.264 . . . . 0.0 112.312 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.66 171.54 25.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.616 HG13 ' HB2' ' A' ' 75' ' ' ALA . 12.8 mm -82.91 114.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.419 ' CD1' ' HG3' ' A' ' 58' ' ' GLN . 93.8 m-85 -103.01 174.05 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.495 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.2 mm -107.81 135.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.536 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.2 -169.68 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.243 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.43 141.39 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.661 HG12 ' SG ' ' A' ' 25' ' ' CYS . 1.9 m -123.86 147.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.107 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.89 153.3 39.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.33 179.56 5.38 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.575 2.183 . . . . 0.0 112.328 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.1 34.67 47.36 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.547 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 18.5 p -132.13 -165.72 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 110.848 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.824 HD11 ' HA ' ' A' ' 17' ' ' LEU . 9.7 mt -88.38 -42.61 12.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.707 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.9 p -53.05 -39.24 63.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.605 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.08 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.54 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.75 -42.43 95.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 13' ' ' VAL . 32.5 m -78.66 -34.72 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.62 60.62 0.41 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.285 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 48' ' ' SER . 21.6 mt -110.91 164.47 12.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 175.94 165.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 4.1 mt -54.93 139.96 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.009 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 110.72 -30.41 8.14 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.183 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' HB3' HG13 ' A' ' 89' ' ' ILE . 85.7 m-20 -70.61 165.56 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.668 0.271 . . . . 0.0 110.491 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 4.0 tt0 -151.35 117.07 5.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.17 117.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 88' ' ' SER . 34.3 m -98.08 5.06 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.828 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.84 156.77 1.12 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.911 0.386 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.678 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 94.2 t -154.19 100.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.45 29.98 17.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.18 -31.21 8.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 70' ' ' LEU . 21.9 t -58.86 120.13 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.16 104.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.678 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.4 m-85 -91.32 9.21 32.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.64 70.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -141.28 30.55 1.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -81.71 147.49 29.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.9 158.37 34.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -57.47 -51.96 67.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.019 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -39.5 84.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' C ' HD21 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.52 -41.86 95.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.731 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -62.89 -47.31 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.016 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.859 HG22 HD11 ' A' ' 27' ' ' ILE . 28.1 t -68.99 -35.7 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.52 -58.74 6.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG23 HD22 ' A' ' 79' ' ' LEU . 34.6 m -57.49 -43.65 83.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.731 0.301 . . . . 0.0 110.952 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 75' ' ' ALA . 2.3 mm? -61.67 -34.09 75.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.84 -27.74 30.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.748 ' O ' HD11 ' A' ' 85' ' ' LEU . 45.6 t -93.23 140.54 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.117 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.537 ' HG2' HD13 ' A' ' 17' ' ' LEU . 1.4 ttm105 -79.06 -42.81 25.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.569 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.2 t -104.74 92.08 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.632 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.748 HD11 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -121.21 146.23 47.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.562 HG23 ' CE1' ' A' ' 14' ' ' PHE . 6.7 m -101.57 116.97 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.218 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.602 HG22 HG22 ' A' ' 62' ' ' VAL . 10.7 pt -106.84 125.79 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.599 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.667 ' O ' HG22 ' A' ' 60' ' ' VAL . 15.0 m -96.91 103.5 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.133 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -109.26 147.52 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 9' ' ' LYS . 24.4 t -120.92 114.95 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.4 137.88 47.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.49 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.87 -17.39 0.48 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.102 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.52 -21.97 29.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.798 0.333 . . . . 0.0 111.212 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.69 -31.12 2.02 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.521 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 1.1 mtp-105 -56.96 -34.64 68.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.498 0.19 . . . . 0.0 111.289 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -51.89 -49.96 61.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.498 HD13 ' HD2' ' A' ' 31' ' ' PRO . 13.6 mt -71.35 -40.09 70.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.997 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.428 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 1.9 m-85 -53.88 -37.86 64.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -105.79 86.83 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.924 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.46 HG22 ' HD2' ' B' ' 112' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.715 0.293 . . . . 0.0 110.836 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' B' ' 111' ' ' THR . 56.9 Cg_endo -70.82 -170.72 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.524 2.149 . . . . 0.0 112.286 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 29' ' ' SER . 5.4 mt -129.43 147.84 51.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.25 154.86 30.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.8 mt -144.9 127.7 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.835 HG21 HG21 ' A' ' 76' ' ' VAL . 69.2 m -128.81 123.71 33.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -88.28 121.99 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.63 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.3 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.749 0.309 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.798 ' HA ' HG22 ' A' ' 90' ' ' VAL . 8.5 mp0 60.51 108.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 6.1 ttpm? -98.01 148.07 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.977 0.418 . . . . 0.0 110.955 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.98 145.22 30.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.725 HG13 ' HB ' ' A' ' 51' ' ' VAL . 60.4 t -147.99 146.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -137.1 120.67 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.606 HD12 ' CD1' ' A' ' 23' ' ' LEU . 28.1 mm -105.12 117.7 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.6 t -124.52 126.62 46.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD22 ' HG2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -76.03 146.03 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 18' ' ' VAL . 13.5 t -133.76 31.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.009 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.48 -114.04 0.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 31.86 5.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 107.51 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.731 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' HA2' HD11 ' A' ' 17' ' ' LEU . . . -57.36 -83.93 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.482 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD1' HD12 ' A' ' 15' ' ' ILE . 11.8 tp -148.52 -54.3 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.453 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 107.61 16.77 12.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.741 ' SG ' HG23 ' A' ' 39' ' ' ILE . 36.8 t -140.68 156.23 46.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -114.83 173.6 6.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.776 HD11 HG22 ' A' ' 76' ' ' VAL . 8.3 pt -138.9 141.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 111.092 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -131.02 161.66 31.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.429 ' O ' HD13 ' B' ' 113' ' ' LEU . 29.0 t -105.15 145.2 30.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.16 178.47 44.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.659 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.38 -168.15 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.64 2.227 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.2 mp -71.33 -26.84 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -69.76 -30.11 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.748 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.6 ttmm -149.5 68.39 9.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.83 140.15 22.95 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.206 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.72 -179.67 36.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 75' ' ' ALA . 11.3 mm -88.63 114.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.624 ' CE2' HD12 ' A' ' 97' ' ' LEU . 34.1 m-85 -111.07 176.85 4.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.316 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.741 HG23 ' SG ' ' A' ' 25' ' ' CYS . 22.8 mm -107.56 136.66 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.706 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.29 -169.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.396 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -44.41 140.66 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.401 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' SG ' ' A' ' 25' ' ' CYS . 21.2 t -117.6 157.97 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.31 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 42' ' ' VAL . 11.1 mmpt? -99.76 129.81 27.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.98 -50.3 13.69 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.477 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.33 75.52 1.01 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.497 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -160.92 -179.81 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.968 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.86 -41.86 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.8 p -52.91 -43.78 66.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.9 77.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.638 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.39 -36.75 76.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.725 ' HB ' HG13 ' A' ' 13' ' ' VAL . 19.3 m -85.25 -26.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.52 39.9 1.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.399 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 48' ' ' SER . 13.7 mt -89.64 134.13 34.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -149.44 163.27 38.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.578 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 33.9 mt -58.86 148.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -22.7 39.58 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.32 161.9 28.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.665 0.269 . . . . 0.0 110.663 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -141.5 114.57 8.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.26 117.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.544 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 88' ' ' SER . 25.0 m -103.49 3.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.984 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.03 152.0 1.14 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.366 . . . . 0.0 111.236 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.918 HG13 HG22 ' A' ' 87' ' ' ILE . 48.6 t -151.53 105.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.961 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.57 29.87 17.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.98 -28.31 16.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.9 t -59.4 122.86 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.11 111.7 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.663 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.8 m-85 -90.2 -2.39 58.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.346 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -59.76 -41.83 91.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.26 31.41 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.621 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -88.7 147.56 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.79 161.43 23.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -59.05 -50.53 73.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -59.49 -40.07 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -43.17 99.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.621 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -60.21 -44.55 95.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.776 HG22 HD11 ' A' ' 27' ' ' ILE . 43.6 t -70.2 -43.63 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.088 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -54.88 -52.87 61.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.274 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 79' ' ' LEU . 26.9 m -61.96 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.625 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.5 mm? -64.45 -31.52 72.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.626 ' HE3' HD23 ' B' ' 118' ' ' LEU . 1.1 mptm? -82.6 -31.87 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.27 -67.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.561 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.0 OUTLIER -81.75 133.43 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.047 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.53 ' HG2' HD22 ' A' ' 17' ' ' LEU . 2.6 mtt85 -76.02 -57.23 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 m -99.74 97.62 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -131.12 141.01 50.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.284 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.8 m -93.5 132.99 37.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.281 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.918 HG22 HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -125.15 140.12 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.704 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.664 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.5 m -101.37 108.83 20.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -112.72 147.43 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.037 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.798 HG22 ' HA ' ' A' ' 10' ' ' GLU . 36.4 t -115.13 123.37 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.648 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -63.59 134.7 55.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.757 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.86 -17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.543 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.75 -20.26 21.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.373 . . . . 0.0 111.139 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 -30.38 2.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.733 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -56.03 -34.71 66.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.58 -50.01 34.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.757 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.748 HD21 ' CB ' ' A' ' 34' ' ' LYS . 11.0 mt -71.55 -47.4 55.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.993 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 7.9 m-85 -49.65 -27.58 4.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 85.5 mmm -57.79 145.49 34.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.951 -179.899 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.669 0.271 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.06 144.75 53.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.595 2.196 . . . . 0.0 112.389 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 29' ' ' SER . 12.0 mt -96.38 158.98 15.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -102.94 163.9 11.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 31.0 mt -144.65 125.09 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.599 HG21 HG11 ' A' ' 76' ' ' VAL . 33.5 m -113.74 150.94 32.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.18 135.26 45.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.626 HD23 ' HE3' ' A' ' 80' ' ' LYS . 1.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.598 ' HA ' HG22 ' A' ' 90' ' ' VAL . 1.3 mt-10 -58.77 131.84 52.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.849 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 14.3 ttpt -95.69 133.94 39.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -96.0 143.94 26.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.636 HG13 ' HB ' ' A' ' 51' ' ' VAL . 28.6 t -149.51 153.24 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.262 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.27 121.79 22.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mm -112.55 136.6 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.415 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.405 ' O ' HD13 ' A' ' 47' ' ' LEU . 1.7 p -141.5 173.35 11.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.546 HD23 ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -77.65 -57.22 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 18' ' ' VAL . 14.6 p 43.69 40.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.584 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 17' ' ' LEU . . . 142.98 -115.11 0.9 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -122.1 -41.38 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -57.42 138.78 54.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.78 -62.5 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.464 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.8 tp -146.05 -57.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.847 0.356 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.34 24.24 7.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.377 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.615 ' SG ' HG23 ' A' ' 39' ' ' ILE . 41.8 t -149.44 159.05 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -114.44 173.57 6.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.191 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.733 HD11 HG22 ' A' ' 76' ' ' VAL . 20.6 pt -137.05 149.35 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.432 . . . . 0.0 111.407 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -128.57 162.23 27.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.696 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.723 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.5 OUTLIER -104.7 139.48 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.7 179.67 45.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.047 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.815 ' CD ' HD12 ' A' ' 97' ' ' LEU . 56.8 Cg_endo -70.04 -160.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.959 2.44 . . . . 0.0 112.346 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -86.01 -28.25 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -64.57 -32.81 74.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HB2' HD11 ' A' ' 97' ' ' LEU . 5.7 mttt -142.38 76.55 18.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.809 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 126.32 10.57 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.153 . . . . 0.0 112.423 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.01 173.98 41.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.511 HG13 ' HB2' ' A' ' 75' ' ' ALA . 21.5 mm -87.51 115.97 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 5.3 m-85 -100.61 172.54 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.615 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.5 mm -107.77 134.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.029 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.15 -169.27 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -46.22 141.41 3.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 25' ' ' CYS . 6.5 t -111.15 157.13 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.072 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' N ' HG12 ' A' ' 42' ' ' VAL . 33.1 mttt -108.41 112.53 60.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 155.32 9.47 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.405 2.07 . . . . 0.0 112.28 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.1 29.37 74.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.504 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.433 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 71.3 p -124.6 -170.72 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 16' ' ' SER . 6.9 mt -76.39 -45.42 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.763 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 11.6 p -52.9 -37.21 60.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.974 0.416 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.38 -37.99 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.563 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.43 -31.19 69.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.801 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.0 m -86.59 -30.56 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.74 58.81 0.59 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.374 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.28 167.82 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -179.75 162.24 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -56.8 142.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.24 -23.53 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.133 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.58 163.47 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.6 tt0 -148.59 115.14 5.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.089 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.35 117.32 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.694 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 88' ' ' SER . 35.8 m -97.9 -4.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.892 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.82 150.73 8.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.948 HG22 HG22 ' A' ' 87' ' ' ILE . 61.4 t -149.5 98.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.72 35.39 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.44 -27.93 15.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.545 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.6 124.42 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 109.73 5.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.727 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.9 m-85 -87.5 -10.02 52.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.362 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.7 p -56.42 -31.92 64.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.852 0.358 . . . . 0.0 111.0 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -132.92 32.09 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.3 tp -92.09 147.59 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.24 162.14 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.17 -57.67 9.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -36.17 70.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -39.53 94.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.581 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -63.33 -46.68 85.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.816 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.84 HG11 HG21 ' B' ' 116' ' ' THR . 39.7 t -68.28 -35.43 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.952 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -58.77 6.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 79' ' ' LEU . 34.4 m -57.32 -41.23 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.324 . . . . 0.0 111.097 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.411 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.7 mm? -66.43 -31.97 73.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.642 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.6 mptp? -82.57 -31.17 29.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.227 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -74.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.629 ' OG ' HD23 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -66.56 118.85 10.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG3' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.08 -56.97 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.92 105.54 15.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -131.31 144.51 51.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.966 0.413 . . . . 0.0 111.41 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.21 116.93 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.146 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.948 HG22 HG22 ' A' ' 62' ' ' VAL . 10.2 pt -109.69 127.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.654 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -99.75 103.53 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.659 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -105.08 145.49 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.08 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.6 t -115.24 117.25 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.713 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.579 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.57 135.48 56.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.935 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.95 -17.35 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.432 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.78 -19.99 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.15 -29.99 3.08 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.578 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 2.4 ptp180 -55.4 -34.67 64.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.569 0.223 . . . . 0.0 111.277 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -55.99 -43.62 77.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.042 0.448 . . . . 0.0 110.11 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.815 HD12 ' CD ' ' A' ' 31' ' ' PRO . 2.8 mm? -71.44 -50.11 34.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.794 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -49.79 -32.37 13.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.388 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.6 mmt -77.37 -53.88 7.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.984 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.672 0.272 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 -176.1 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.492 2.128 . . . . 0.0 112.324 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 29' ' ' SER . 4.4 mt -124.85 158.95 32.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -88.87 149.19 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.98 143.54 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.84 HG21 HG11 ' A' ' 76' ' ' VAL . 80.3 m -133.25 136.37 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -88.71 112.33 23.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.642 HD23 ' HE2' ' A' ' 80' ' ' LYS . 4.1 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 61.24 153.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.983 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -115.36 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -91.73 135.27 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.882 HG13 ' HB ' ' A' ' 51' ' ' VAL . 48.6 t -137.47 142.22 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.998 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -125.87 130.0 50.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 HD12 HD12 ' A' ' 23' ' ' LEU . 30.3 mm -122.02 106.48 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 9.4 t -106.32 -22.56 12.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' HA2' ' A' ' 22' ' ' GLY . 0.6 OUTLIER 68.0 160.45 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.862 0.363 . . . . 0.0 110.906 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -99.4 -65.33 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.18 -76.77 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.581 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.0 p -157.98 30.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.42 -29.51 21.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.001 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 17' ' ' LEU . . . 102.96 174.96 26.65 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.36 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -59.3 -40.75 87.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.446 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.89 33.17 6.17 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.631 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.799 ' HB3' HD21 ' A' ' 23' ' ' LEU . 1.9 t -151.45 168.9 23.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 0.0 110.794 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 14.9 m -114.69 172.28 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.418 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.973 HD11 HG22 ' A' ' 76' ' ' VAL . 3.6 pt -142.34 140.34 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 111.203 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 t -122.49 161.72 23.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.995 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.613 ' O ' HD22 ' B' ' 113' ' ' LEU . 70.6 p -105.25 138.7 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.13 38.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.514 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' HD13 ' A' ' 97' ' ' LEU . 38.4 Cg_endo -66.64 -172.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.54 2.16 . . . . 0.0 112.28 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -70.12 -25.17 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -70.13 -27.49 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.166 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HB3' HD11 ' A' ' 97' ' ' LEU . 6.5 mtpt -147.7 64.07 8.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.249 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 17.3 Cg_exo -66.75 126.2 14.99 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.195 . . . . 0.0 112.1 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.72 42.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 67' ' ' PHE . 11.2 mm -89.88 115.51 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.056 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.908 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.9 m-85 -103.61 171.72 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mm -107.55 134.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.366 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -106.12 -169.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.439 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -47.74 144.84 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.166 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.78 HG22 ' SG ' ' A' ' 25' ' ' CYS . 1.7 t -110.26 157.92 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 3.0 mptt -115.07 133.62 22.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 51.5 Cg_exo -55.4 161.52 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.438 2.092 . . . . 0.0 112.293 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.46 70.36 0.97 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.446 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -161.75 -167.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 110.976 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.629 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.5 mm? -84.76 -44.67 13.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.3 p -55.71 -39.49 71.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.926 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.96 79.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.5 -44.49 96.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.882 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.1 m -71.75 -24.89 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 63.76 1.06 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 48' ' ' SER . 15.6 mt -105.67 164.94 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.26 162.25 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.65 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.8 mt -56.88 143.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.96 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.5 -34.87 5.23 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.201 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.92 162.37 19.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.6 117.52 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.156 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.22 117.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.467 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 88' ' ' SER . 33.9 m -100.45 -18.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.744 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.03 149.57 27.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.758 HG13 HG22 ' A' ' 87' ' ' ILE . 46.8 t -143.83 95.05 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.086 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 59.9 36.86 21.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -29.8 9.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.542 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.08 116.62 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.14 119.66 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.729 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.4 m-85 -96.78 22.66 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.7 t -79.92 -58.85 2.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -104.49 29.03 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.644 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -89.12 147.75 24.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -82.66 173.73 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -68.65 -54.25 17.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -56.61 -39.15 73.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' A' ' 70' ' ' LEU . 29.9 mt-10 -60.05 -42.81 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.762 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.37 -46.45 90.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.978 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 27' ' ' ILE . 26.0 t -69.35 -38.82 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.9 -53.6 55.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.163 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 79' ' ' LEU . 33.9 m -59.45 -43.59 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.908 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.807 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.0 mm? -64.32 -35.22 80.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.488 . . . . 0.0 110.65 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -82.92 -26.25 31.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.681 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -85.29 -67.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.588 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -52.93 -37.34 60.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.496 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 67.36 -72.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.282 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.7 p -90.19 86.0 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.023 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.807 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -130.73 146.22 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.589 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.2 m -94.51 116.73 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.758 HG22 HG13 ' A' ' 62' ' ' VAL . 7.9 pt -110.86 127.64 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 0.0 111.634 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -98.72 107.84 20.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.97 146.88 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.709 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -109.58 130.01 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -70.08 130.63 42.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.432 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 87.13 -17.23 0.35 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.47 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.709 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -54.55 -21.31 9.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 111.262 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.92 -30.74 2.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.725 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 4.5 ptp180 -56.59 -34.67 67.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.462 0.172 . . . . 0.0 111.385 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.52 -50.13 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.908 HD12 ' CE2' ' A' ' 38' ' ' PHE . 17.1 mt -71.56 -41.8 68.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.774 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -56.25 -22.74 31.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 33.7 mtt -59.11 86.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.713 0.292 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 -169.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.528 2.152 . . . . 0.0 112.39 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 29' ' ' SER . 18.5 mt -112.89 140.8 47.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -77.22 142.15 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.22 141.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.622 HG21 HG21 ' A' ' 76' ' ' VAL . 31.6 m -119.31 151.01 39.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 124.63 49.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.495 HD22 HG13 ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.802 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 90' ' ' VAL . 2.9 tptt . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 90' ' ' VAL . 1.8 mp0 -104.92 144.95 31.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.963 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.728 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -101.34 120.35 40.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.23 143.47 27.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.782 HG13 ' HB ' ' A' ' 51' ' ' VAL . 26.2 t -151.36 151.92 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.221 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.51 131.08 39.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 mm -120.1 134.95 61.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.276 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -141.5 128.6 20.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 19' ' ' GLY . 5.7 tt -75.21 104.3 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.897 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 18' ' ' VAL . 9.8 p -88.43 60.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.034 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' N ' HD23 ' A' ' 17' ' ' LEU . . . 83.81 -62.46 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.496 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -113.68 146.92 39.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.768 0.318 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 62.29 128.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.99 -50.24 4.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' A' ' 48' ' ' SER . 13.9 tp -136.01 -56.23 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.688 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.33 17.19 14.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.469 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.749 ' SG ' HG22 ' A' ' 42' ' ' VAL . 4.8 t -142.88 166.95 23.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.7 m -114.49 169.44 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.67 HG22 HD13 ' A' ' 39' ' ' ILE . 30.6 pt -142.66 155.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.983 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.508 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 m -146.62 162.1 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.84 150.94 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 97' ' ' LEU . . . -89.89 -172.93 45.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.907 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.09 -164.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.661 2.24 . . . . 0.0 112.418 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.3 -25.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.375 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.6 -29.86 70.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HB3' HD21 ' A' ' 97' ' ' LEU . 2.0 ttpt -156.41 66.06 4.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.77 116.6 3.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.493 2.129 . . . . 0.0 112.176 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.84 141.78 8.31 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.0 mm -82.76 106.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.574 0.226 . . . . 0.0 110.889 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 4.3 p90 -100.55 -176.35 3.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.67 HD13 HG22 ' A' ' 27' ' ' ILE . 18.6 mm -107.06 140.53 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 111.625 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -169.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.109 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -46.34 143.52 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.087 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.749 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -110.3 150.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.982 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -106.33 108.84 62.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.78 145.3 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.332 2.022 . . . . 0.0 112.315 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.7 40.21 9.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.304 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.515 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.5 m -144.42 -173.52 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.563 HD22 ' H ' ' A' ' 47' ' ' LEU . 2.1 mm? -67.93 -48.51 65.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.676 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.556 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.36 97.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 110.599 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.39 -53.1 62.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.782 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.7 m -67.54 -28.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.207 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.54 65.61 0.83 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 48' ' ' SER . 17.3 mt -106.24 156.5 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -167.0 162.59 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.439 HG23 ' CZ ' ' A' ' 98' ' ' PHE . 3.7 mt -56.26 146.71 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.009 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.33 -32.43 7.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.34 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' CB ' HD11 ' A' ' 89' ' ' ILE . 49.5 m-20 -58.9 164.99 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.578 0.228 . . . . 0.0 110.862 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -147.55 113.66 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.7 mt -69.36 117.09 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 88' ' ' SER . 26.8 m -105.61 7.85 9.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.946 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.7 145.67 0.54 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 87' ' ' ILE . 58.0 t -148.43 99.27 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.886 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.47 30.82 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.9 13.21 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.14 129.49 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.75 121.92 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.0 m-85 -99.19 26.68 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.27 -66.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -103.49 30.69 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.618 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 74' ' ' GLU . 1.4 tp -79.51 145.52 33.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.06 162.89 24.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.792 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 28' ' ' SER . 3.3 t-160 -60.51 -54.13 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.11 -38.47 70.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.635 ' HB3' HD11 ' A' ' 70' ' ' LEU . 20.8 mt-10 -61.39 -47.23 86.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.6 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -58.35 -44.72 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.863 HG11 HG21 ' B' ' 116' ' ' THR . 27.4 t -69.71 -45.49 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.3 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -55.03 -53.57 54.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.256 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.3 m -60.22 -43.42 93.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.078 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.541 ' HB3' HD22 ' B' ' 118' ' ' LEU . 3.4 mm? -67.49 -31.17 71.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.711 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.758 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.2 mptp? -82.53 -30.05 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -70.01 -66.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.223 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.634 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.3 m -81.45 118.79 22.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -68.8 -40.31 79.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.5 p -114.23 102.68 10.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -137.47 146.17 43.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -91.5 116.99 29.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.185 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 62' ' ' VAL . 16.1 pt -111.36 130.99 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.642 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -102.99 103.61 13.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.322 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.728 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -104.62 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 10' ' ' GLU . 42.1 t -127.22 115.94 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.06 140.39 49.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.636 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.41 -22.72 0.22 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.014 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -59.69 -20.79 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.906 0.384 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.03 3.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -56.68 -34.61 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -50.26 -49.65 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.712 HD21 ' HB3' ' A' ' 34' ' ' LYS . 20.4 mt -71.09 -39.83 71.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CE2' ' CD2' ' A' ' 38' ' ' PHE . 4.1 m-85 -54.66 -47.96 72.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.161 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.78 130.88 34.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.931 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.771 0.319 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.88 157.39 62.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.168 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.65 140.45 49.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.43 159.36 34.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.676 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -141.17 141.98 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.863 HG21 HG11 ' A' ' 76' ' ' VAL . 95.9 m -129.37 145.98 51.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.41 116.38 31.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.758 HD23 ' HE2' ' A' ' 80' ' ' LYS . 3.2 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttm . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.733 0.301 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 145.6 40.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -117.97 141.25 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 138.84 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 HG11 ' A' ' 51' ' ' VAL . 55.7 t -139.98 136.69 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.63 ' HD2' HG23 ' A' ' 86' ' ' THR . 31.6 t80 -119.51 117.67 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' CG1' HD11 ' A' ' 87' ' ' ILE . 29.1 mm -106.81 126.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 p -139.79 112.87 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.22 112.06 1.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 18' ' ' VAL . 5.9 m -136.11 94.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.25 70.67 1.31 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.564 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m 60.18 173.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 60.7 110.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.632 ' O ' HD23 ' A' ' 47' ' ' LEU . . . -68.15 -69.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.435 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' A' ' 48' ' ' SER . 16.9 tp -126.73 -53.51 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.863 0.364 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.68 26.93 11.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.433 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.828 ' SG ' HG22 ' A' ' 42' ' ' VAL . 50.6 t -147.37 159.33 43.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.416 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 3.1 m -114.43 173.65 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.929 HD11 HG22 ' A' ' 76' ' ' VAL . 9.2 pt -139.4 157.47 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.399 . . . . 0.0 111.37 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.29 162.03 28.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.548 ' O ' HD13 ' B' ' 113' ' ' LEU . 1.1 m -104.8 140.82 37.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.523 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 162.1 31.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' HD12 ' A' ' 97' ' ' LEU . 27.6 Cg_endo -62.11 -159.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.955 2.437 . . . . 0.0 112.216 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.67 -27.63 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.95 -29.89 55.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -141.05 60.77 13.11 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.88 135.04 20.75 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.29 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 37' ' ' ILE . . . 176.25 -146.96 8.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.621 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.491 HD11 ' O ' ' A' ' 71' ' ' ASP . 19.7 mm -127.13 111.14 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.999 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 20.0 m-85 -100.58 173.55 6.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.557 HG23 ' SG ' ' A' ' 25' ' ' CYS . 16.5 mm -107.84 133.21 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.88 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 26' ' ' SER . 0.6 OUTLIER -106.12 -169.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.724 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.432 ' ND1' HD11 ' A' ' 55' ' ' ILE . 86.0 m-70 -44.71 133.93 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.645 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.828 HG22 ' SG ' ' A' ' 25' ' ' CYS . 22.2 t -111.01 148.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.55 145.21 30.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.02 172.12 15.33 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.503 2.135 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.14 33.87 61.67 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.506 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -131.73 -172.79 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 22' ' ' GLY . 2.9 mm? -77.42 -47.43 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.5 p -59.44 -35.92 74.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.35 72.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.89 -39.99 91.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.785 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 13' ' ' VAL . 28.6 m -75.11 -29.76 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.03 55.14 0.93 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 48' ' ' SER . 14.4 mt -97.0 144.98 26.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.42 162.83 40.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.432 HD11 ' ND1' ' A' ' 41' ' ' HIS . 3.1 mt -56.96 138.54 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.085 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 116.82 -40.14 2.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.446 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -55.54 166.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.737 0.303 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.68 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 20.3 tm0? -146.79 116.72 7.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.47 120.08 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 88' ' ' SER . 29.7 m -100.09 -18.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.597 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -158.67 155.14 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.312 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 87' ' ' ILE . 56.2 t -153.1 109.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.77 30.8 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.6 -31.09 8.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.489 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.54 131.88 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.29 116.4 17.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE1' HD22 ' A' ' 70' ' ' LEU . 2.1 m-85 -89.79 -9.4 49.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.321 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.8 t -55.38 -30.73 60.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -130.41 32.52 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.671 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.5 tp -96.46 147.63 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.491 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -77.99 174.22 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.483 ' HB2' ' HG ' ' A' ' 29' ' ' SER . 2.0 t-160 -68.97 -54.7 13.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.78 -38.32 78.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.567 ' HB3' HD11 ' A' ' 70' ' ' LEU . 24.6 mt-10 -60.62 -44.57 96.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.671 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -63.1 -40.88 98.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.929 HG22 HD11 ' A' ' 27' ' ' ILE . 39.6 t -70.26 -47.0 69.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -52.67 62.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.244 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 79' ' ' LEU . 34.3 m -60.17 -44.78 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.4 mm? -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.7 mptp? -81.84 -30.67 31.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -69.9 -67.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.254 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -83.39 138.82 33.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -89.99 -55.26 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -91.85 81.92 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.592 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -121.03 145.22 48.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.63 HG23 ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -92.49 119.36 31.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.034 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.934 HG22 HG22 ' A' ' 62' ' ' VAL . 7.2 pt -116.55 122.44 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.792 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -95.84 122.7 38.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -129.32 144.74 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -111.69 131.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.623 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -68.58 132.51 47.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.249 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 86.26 -17.89 0.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -55.09 -20.9 10.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.34 -29.99 2.18 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.751 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 44.4 mtp85 -55.56 -34.46 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.531 0.205 . . . . 0.0 111.188 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -49.3 -39.81 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.046 0.451 . . . . 0.0 110.358 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.589 HD12 ' CD ' ' A' ' 31' ' ' PRO . 3.2 mm? -71.29 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.851 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -48.73 -28.54 3.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.387 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.5 mmm -58.84 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.945 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.814 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.81 153.68 77.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.62 2.213 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 29' ' ' SER . 4.4 mt -72.75 174.07 8.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -81.79 168.64 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.7 mt -148.32 139.88 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.916 HG21 HG21 ' A' ' 76' ' ' VAL . 29.9 m -133.03 131.6 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.11 137.17 32.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.173 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.554 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.843 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.007 0.432 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' CB ' HG22 ' A' ' 90' ' ' VAL . 2.2 mt-10 -58.38 140.62 53.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 91' ' ' ALA . 7.0 ttpm? -101.28 140.5 35.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.29 134.6 41.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 51' ' ' VAL . 60.9 t -139.56 147.23 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HD1' ' HG1' ' A' ' 86' ' ' THR . 82.7 t80 -135.96 126.16 26.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.458 HD12 ' CD1' ' A' ' 23' ' ' LEU . 32.1 mm -114.49 115.06 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -106.53 -22.85 12.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.266 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 16' ' ' SER . 3.0 tt 86.86 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.723 HG23 HD11 ' A' ' 47' ' ' LEU . 16.9 t 69.61 -67.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 111.201 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.66 -55.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.55 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 m -83.97 157.41 21.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.445 ' O ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER 43.58 -165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.467 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 47' ' ' LEU . . . -114.75 -77.46 0.73 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.566 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' CD1' HD12 ' A' ' 15' ' ' ILE . 14.7 tp -122.19 -48.34 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.688 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.73 25.23 12.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.347 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' HG23 ' A' ' 39' ' ' ILE . 32.5 t -148.98 159.02 44.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -114.32 173.8 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 76' ' ' VAL . 17.5 pt -137.96 141.25 39.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.255 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -119.09 161.72 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.536 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -105.06 147.9 27.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.66 175.37 43.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.69 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.36 -165.6 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.662 2.241 . . . . 0.0 112.262 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.6 -28.93 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.253 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -78.54 -28.91 46.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -138.63 60.08 18.75 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.42 136.49 21.78 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.43 -172.03 44.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.534 HD11 ' O ' ' A' ' 71' ' ' ASP . 19.3 mm -98.08 115.21 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.103 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.619 ' CE2' HD12 ' A' ' 97' ' ' LEU . 6.1 m-85 -110.89 175.9 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.664 HG23 ' SG ' ' A' ' 25' ' ' CYS . 20.1 mm -107.69 137.04 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.375 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.16 -169.41 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.436 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -48.83 141.42 7.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 25' ' ' CYS . 11.0 t -110.93 154.14 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -109.81 146.27 33.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 161.4 45.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.52 2.146 . . . . 0.0 112.291 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.68 57.47 19.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.404 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.484 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -152.59 -173.42 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.98 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.723 HD11 HG23 ' A' ' 18' ' ' VAL . 3.2 mm? -73.22 -48.59 33.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.585 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.644 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -55.07 -42.11 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.97 82.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.62 -41.79 87.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.706 ' HB ' HG13 ' A' ' 13' ' ' VAL . 36.0 m -74.26 -30.04 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.063 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.91 61.84 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.9 mt -109.58 162.99 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.2 162.29 3.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.629 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.449 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 6.3 mt -54.86 145.68 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.44 -30.58 10.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.301 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.23 162.91 8.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.263 . . . . 0.0 110.601 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 3.6 tm0? -144.93 113.73 6.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 39' ' ' ILE . 3.5 mt -69.22 117.14 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.774 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 88' ' ' SER . 35.9 m -92.95 -25.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.648 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -152.86 158.11 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 111.283 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.8 HG13 HG22 ' A' ' 87' ' ' ILE . 59.8 t -149.98 103.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.952 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 63.76 30.2 14.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 -26.82 19.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.623 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.37 130.54 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.72 125.3 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.7 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -99.35 -17.62 17.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.269 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -50.55 65.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.786 0.327 . . . . 0.0 111.092 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.07 30.77 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.572 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -98.53 146.69 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.534 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -75.24 170.93 15.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -70.89 -55.82 7.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -58.12 -34.07 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -40.31 91.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.66 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -62.86 -44.48 96.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.805 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 27' ' ' ILE . 38.9 t -69.55 -35.76 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 -52.35 63.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.7 m -61.13 -43.38 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.535 ' HB3' HD22 ' B' ' 118' ' ' LEU . 3.7 mm? -65.94 -30.8 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.89 ' HE2' HD23 ' B' ' 118' ' ' LEU . 2.4 mptp? -82.61 -34.19 27.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.61 -65.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.81 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -79.1 125.32 29.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -73.71 -43.97 57.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.604 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.2 p -115.08 98.89 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.53 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.81 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -129.3 146.16 51.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.98 0.419 . . . . 0.0 111.277 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.451 ' HG1' ' HD1' ' A' ' 14' ' ' PHE . 12.4 m -92.9 116.98 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.198 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.8 HG22 HG13 ' A' ' 62' ' ' VAL . 14.2 pt -114.02 129.2 70.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 111.673 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.699 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.4 m -101.84 110.32 22.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.354 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -110.5 147.04 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.209 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.484 ' N ' HD13 ' A' ' 89' ' ' ILE . 29.1 t -117.06 113.34 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.24 141.09 47.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.8 -19.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.957 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -58.92 -20.17 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.47 -30.51 2.03 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.502 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -56.08 -34.13 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -48.14 -42.83 30.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.744 0.306 . . . . 0.0 110.616 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.619 HD12 ' CE2' ' A' ' 38' ' ' PHE . 56.6 mt -71.35 -49.31 43.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.717 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 17.1 m-85 -54.3 -28.85 44.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.37 124.86 19.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.074 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.4 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 154.45 65.91 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.577 2.184 . . . . 0.0 112.276 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 29' ' ' SER . 10.0 mt -138.33 149.06 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -88.32 158.68 18.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.2 mt -137.19 147.24 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.591 HG21 HG11 ' A' ' 76' ' ' VAL . 90.1 m -125.49 151.0 46.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.24 108.6 20.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.89 HD23 ' HE2' ' A' ' 80' ' ' LYS . 52.2 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.597 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.3 mt-10 -161.19 118.79 2.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 12.8 ttpp -100.28 114.6 28.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -86.53 142.6 28.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.563 HG13 ' HB ' ' A' ' 51' ' ' VAL . 21.8 t -148.56 158.86 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' N ' HG12 ' A' ' 13' ' ' VAL . 51.1 p90 -141.07 116.88 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.706 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG1' HD11 ' A' ' 87' ' ' ILE . 39.4 mm -102.43 135.45 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.196 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.16 131.18 27.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.95 134.08 41.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 21' ' ' ARG . 7.5 m -106.99 -156.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -45.58 -45.14 12.24 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.059 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -164.49 64.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.381 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.633 ' HB2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -156.11 109.9 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -76.75 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.602 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.2 tp -138.57 -63.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 111.11 23.44 5.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.402 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' HG22 ' A' ' 42' ' ' VAL . 13.8 t -150.7 164.3 36.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.65 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -114.43 173.32 6.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.391 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.945 HD11 HG22 ' A' ' 76' ' ' VAL . 2.2 pt -137.15 146.67 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.389 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.5 p -125.17 161.87 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.734 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.545 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -104.93 144.52 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.83 38.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.882 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 97' ' ' LEU . 34.6 Cg_endo -64.28 -164.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.771 2.314 . . . . 0.0 112.32 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -81.96 -28.93 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.17 -29.56 54.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.673 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.3 tttp -141.83 60.54 11.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.85 147.82 35.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.41 175.88 32.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.4 mm -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.953 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.746 ' CE2' HD12 ' A' ' 97' ' ' LEU . 26.3 m-85 -108.5 174.53 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.9 mm -107.63 134.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.375 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -106.19 -169.42 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.392 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -45.28 153.06 0.23 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.36 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.858 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.8 t -125.48 157.98 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 138.75 27.9 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 155.44 69.45 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.41 2.073 . . . . 0.0 112.329 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.05 7.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.357 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.453 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -157.2 -170.29 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.726 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? -76.94 -45.35 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.852 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.9 p -55.7 -45.3 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.62 88.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -60.56 -40.12 90.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.563 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.5 m -76.83 -27.11 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.49 57.66 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -98.75 156.96 16.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -163.44 159.6 22.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mt -55.23 153.51 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.1 -23.93 31.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.221 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.67 159.46 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.279 . . . . 0.0 110.58 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 89' ' ' ILE . 2.5 tt0 -146.85 120.22 9.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.427 HG21 ' CG2' ' A' ' 62' ' ' VAL . 2.1 mt -69.31 117.18 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.6 m -97.32 -5.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.843 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.83 148.07 5.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.843 HG22 HG22 ' A' ' 87' ' ' ILE . 49.0 t -146.77 109.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 1.0 OUTLIER 57.95 30.56 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.73 12.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.23 138.08 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.13 111.4 14.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.761 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.5 m-85 -91.09 11.08 24.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.317 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -75.27 -34.87 61.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -127.25 29.53 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.761 HD22 ' CE1' ' A' ' 67' ' ' PHE . 2.4 tp -87.35 148.92 24.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 163.87 21.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -56.62 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -57.81 -40.32 79.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -41.02 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.642 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -63.23 -46.05 88.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.945 HG22 HD11 ' A' ' 27' ' ' ILE . 35.7 t -69.4 -35.56 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.07 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -50.81 69.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.18 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.9 m -62.73 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.457 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.7 mm? -63.26 -31.87 73.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.62 -34.37 27.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 -62.4 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.684 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -83.84 134.56 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.193 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -98.41 25.88 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.855 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -177.93 71.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.1 OUTLIER -115.27 146.17 41.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.7 m -90.5 116.87 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.026 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 62' ' ' VAL . 8.1 pt -110.79 128.27 67.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.919 0.39 . . . . 0.0 111.582 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.23 122.19 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -128.19 147.39 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 10' ' ' GLU . 25.4 t -117.72 117.87 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.736 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.586 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.26 136.42 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.801 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.47 -17.5 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.276 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.73 35.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.11 -30.3 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.484 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -56.05 -34.4 65.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -48.38 -49.99 32.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.746 HD12 ' CE2' ' A' ' 38' ' ' PHE . 10.1 mt -71.76 -45.82 60.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.855 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -28.64 53.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.283 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.41 126.09 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.766 0.317 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.81 143.61 56.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.602 2.201 . . . . 0.0 112.407 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 29' ' ' SER . 2.8 mt -65.64 160.65 22.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.75 153.82 19.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.12 134.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.688 HG21 HG21 ' A' ' 76' ' ' VAL . 28.7 m -125.45 138.82 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.32 140.27 29.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.707 HD11 HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' CG ' HG22 ' A' ' 90' ' ' VAL . 3.1 mt-10 -157.86 129.39 6.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.761 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 91' ' ' ALA . 5.9 ttpm? -96.78 136.93 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.093 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -100.6 136.08 41.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.844 HG13 ' HB ' ' A' ' 51' ' ' VAL . 48.4 t -141.92 143.96 26.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -128.34 124.92 37.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.46 HD13 HG11 ' A' ' 51' ' ' VAL . 28.9 mm -116.93 124.16 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.213 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.424 ' O ' HD11 ' A' ' 47' ' ' LEU . 11.1 t -120.57 109.39 15.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.573 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -81.41 58.52 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 17' ' ' LEU . 3.4 m -160.4 37.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.251 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.52 -59.25 0.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -158.86 -46.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.806 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.48 166.41 23.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.441 ' HA2' HD21 ' A' ' 17' ' ' LEU . . . -58.45 -164.18 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.439 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.4 tp -72.69 -29.71 63.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.741 0.305 . . . . 0.0 110.433 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 63.36 50.9 58.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.555 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.597 ' SG ' HG23 ' A' ' 39' ' ' ILE . 52.7 t -161.52 156.99 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.78 173.46 6.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.977 HD11 HG22 ' A' ' 76' ' ' VAL . 19.3 pt -142.01 133.65 26.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.341 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.06 162.17 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.734 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.86 145.7 30.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 110.381 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.6 160.33 30.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.028 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.535 ' CD ' HD12 ' A' ' 97' ' ' LEU . 59.0 Cg_endo -71.33 -160.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.827 2.351 . . . . 0.0 112.156 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.33 -29.57 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.67 -31.78 72.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' CB ' HD21 ' A' ' 97' ' ' LEU . 2.4 mtmt -155.4 74.31 5.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.28 125.99 10.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.589 2.193 . . . . 0.0 112.32 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.23 -178.99 48.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 75' ' ' ALA . 26.9 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 2.5 m-85 -107.54 170.39 8.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.597 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.7 mm -107.65 129.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 -169.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -46.72 141.2 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.36 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 43' ' ' LYS . 13.6 t -109.27 157.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.433 ' N ' HG12 ' A' ' 42' ' ' VAL . 24.7 mttp -120.91 145.28 41.12 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 17.3 Cg_exo -66.67 173.56 7.76 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.616 2.211 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.32 43.22 43.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.757 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -136.71 -174.16 3.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.369 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 16' ' ' SER . 46.9 mt -84.95 -35.24 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.463 ' HA ' HD12 ' A' ' 53' ' ' LEU . 16.4 p -56.28 -41.07 75.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.22 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.686 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -59.8 -39.66 85.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.6 m -80.45 -30.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.035 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.73 64.12 0.72 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 48' ' ' SER . 18.0 mt -108.25 164.56 12.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 111.005 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.05 162.62 5.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mt -59.83 140.44 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.811 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.08 -38.16 3.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.451 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -55.52 157.33 3.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.673 0.273 . . . . 0.0 110.767 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.407 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.44 114.99 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.161 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 39' ' ' ILE . 6.7 mt -69.06 121.09 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.869 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' SER . 32.0 m -109.47 9.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.885 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.62 146.5 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 111.336 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.675 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 61.9 t -151.0 106.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.68 30.94 20.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.016 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.41 13.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.29 129.67 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -71.45 107.35 4.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.852 ' CE1' HD22 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -82.54 0.02 44.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.376 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -60.53 -54.3 47.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -108.72 33.7 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.852 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -92.94 148.28 22.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' O ' HD11 ' A' ' 37' ' ' ILE . 4.8 t0 -89.52 170.57 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -62.76 -53.03 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -57.6 -38.0 74.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.569 ' O ' HG22 ' A' ' 78' ' ' VAL . 7.3 mt-10 -64.89 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.603 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -67.56 -42.07 83.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 27' ' ' ILE . 33.1 t -70.87 -46.58 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.04 -55.92 25.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 74' ' ' GLU . 33.8 m -58.39 -45.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.494 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.3 mm? -65.02 -30.83 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.715 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -82.58 -30.49 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -66.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -84.9 144.81 28.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.5 ' HD2' HG13 ' A' ' 18' ' ' VAL . 4.8 mtt180 -92.65 -57.6 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -89.86 77.67 6.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 139.23 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -92.74 116.9 29.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.12 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.644 HG22 HG22 ' A' ' 62' ' ' VAL . 10.1 pt -111.05 127.44 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.696 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.555 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -97.26 103.48 15.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.469 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -105.34 151.39 7.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.635 ' N ' HD13 ' A' ' 89' ' ' ILE . 31.7 t -124.89 114.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.768 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.38 136.63 49.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.506 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 84.59 -20.56 0.29 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.194 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.18 46.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.87 -30.13 2.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.519 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 63.4 mtp85 -55.43 -34.52 64.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 111.01 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -54.03 -37.13 63.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.128 0.489 . . . . 0.0 110.108 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.535 HD12 ' CD ' ' A' ' 31' ' ' PRO . 4.6 mm? -71.29 -55.27 8.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.419 ' CD2' ' HA2' ' A' ' 56' ' ' GLY . 23.6 m-85 -50.83 -30.92 15.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 21.0 mmt -70.2 121.84 18.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.942 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.701 0.286 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.3 170.35 2.39 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.534 2.156 . . . . 0.0 112.255 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 28.2 mt -119.36 149.0 42.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.792 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -93.15 158.01 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.1 mt -147.51 130.02 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.736 HG21 HG11 ' A' ' 76' ' ' VAL . 25.5 m -115.13 151.04 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.94 125.95 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.54 ' CD1' HG23 ' A' ' 27' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.968 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.643 0.259 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.08 140.62 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.72 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -120.17 117.37 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.602 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -86.24 143.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.76 HG13 ' HB ' ' A' ' 51' ' ' VAL . 22.0 t -148.16 150.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.298 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -130.3 122.24 27.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.777 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.46 HD12 ' CD1' ' A' ' 23' ' ' LEU . 37.7 mm -110.33 129.4 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.28 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.4 144.98 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD12 ' HA2' ' A' ' 22' ' ' GLY . 0.6 OUTLIER -63.49 -44.54 94.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.5 t 68.57 -67.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.286 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.43 -84.73 0.62 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.541 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -140.03 31.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 116.88 23.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -57.7 -87.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.614 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.1 tp -132.94 -48.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.345 . . . . 0.0 110.651 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 93.88 29.16 10.08 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.383 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.726 ' SG ' HG22 ' A' ' 42' ' ' VAL . 42.7 t -155.93 157.55 36.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.531 ' HA ' HD12 ' B' ' 118' ' ' LEU . 17.8 m -114.7 173.8 6.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.91 HD11 HG22 ' A' ' 76' ' ' VAL . 7.1 pt -138.12 153.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.3 p -137.22 161.71 35.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.594 ' O ' HD22 ' B' ' 113' ' ' LEU . 2.4 p -105.45 154.96 19.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -108.86 -177.35 21.64 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.764 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HD2' HD13 ' A' ' 97' ' ' LEU . 38.5 Cg_endo -66.49 -166.44 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -85.63 -23.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.236 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -69.75 -30.99 68.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HB3' HD11 ' A' ' 97' ' ' LEU . 8.2 tttt -146.47 69.54 12.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.92 143.12 32.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.93 163.78 20.11 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 67' ' ' PHE . 12.7 mm -81.63 114.56 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.671 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 2.8 m-30 -100.53 171.73 7.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.187 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.679 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.8 mm -107.72 121.03 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.017 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.6 OUTLIER -90.01 -169.41 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.548 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.51 140.08 2.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG22 ' SG ' ' A' ' 25' ' ' CYS . 23.6 t -119.53 140.11 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.711 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -104.44 149.68 37.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.32 168.42 21.02 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.658 2.238 . . . . 0.0 112.321 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.02 60.8 8.17 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.308 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.508 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -158.9 -177.62 6.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.984 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.2 mm? -71.65 -49.67 37.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.819 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.516 ' CB ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -56.72 -38.29 72.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.04 -38.43 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.79 -42.78 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.76 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.7 m -70.09 -27.26 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.273 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.97 52.58 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' A' ' 48' ' ' SER . 16.9 mt -94.96 160.25 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -159.57 158.55 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mt -58.55 136.56 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 111.47 -37.81 3.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -49.21 164.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.291 . . . . 0.0 110.908 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.622 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 19.9 tt0 -146.94 113.7 6.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.115 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.47 122.87 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -110.63 5.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.846 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -168.5 146.16 4.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 111.13 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 87' ' ' ILE . 39.1 t -152.22 107.92 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.51 31.06 19.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.13 14.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.9 127.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.878 0.371 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.09 119.24 16.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.628 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.6 m-85 -96.19 23.11 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 p -77.16 -57.14 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.585 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -108.41 29.37 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.675 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.628 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.8 tp -84.65 148.48 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.944 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.32 164.69 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -59.69 -55.04 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -56.99 -37.6 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HB3' HD11 ' A' ' 70' ' ' LEU . 55.6 mt-10 -61.94 -41.6 98.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.63 -47.32 85.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.91 HG22 HD11 ' A' ' 27' ' ' ILE . 43.0 t -68.59 -42.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.123 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -56.74 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 79' ' ' LEU . 31.8 m -58.49 -45.94 89.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.849 0.357 . . . . 0.0 111.146 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.4 mm? -63.42 -31.78 73.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.521 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -82.65 -29.51 29.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 t -65.97 -63.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.28 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.51 139.6 30.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' CG ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -81.11 -59.48 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.61 88.13 6.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.556 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.404 ' CD1' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -122.53 134.91 54.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -84.64 117.0 23.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.852 HG22 HG13 ' A' ' 62' ' ' VAL . 11.9 pt -112.38 133.61 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.636 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.0 114.67 29.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.572 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -114.53 152.31 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.956 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -123.13 115.86 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.498 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.611 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -58.61 134.12 56.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.74 -20.37 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.249 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.772 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -55.68 -24.32 33.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.091 0.472 . . . . 0.0 110.816 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.44 -30.32 1.73 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.134 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 42.3 mtp180 -56.06 -34.25 65.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.293 0.237 . . . . 0.0 111.287 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -48.18 -49.4 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.671 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 19.7 mt -71.33 -43.76 66.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.766 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -30.45 59.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -59.48 -34.28 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.589 0.233 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.25 103.25 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.652 2.235 . . . . 0.0 112.457 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 29' ' ' SER . 2.0 mt -138.63 179.77 6.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.851 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -96.09 150.51 20.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt -138.67 127.2 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.219 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.862 HG21 HG21 ' A' ' 76' ' ' VAL . 23.7 m -127.26 129.48 47.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.99 133.17 34.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.739 HD11 HG12 ' A' ' 27' ' ' ILE . 2.0 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.863 0.363 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.723 ' HA ' HG22 ' A' ' 90' ' ' VAL . 10.1 mt-10 -61.63 127.16 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 21.2 ttpt -114.67 150.26 35.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.775 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 148.15 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.873 HG13 ' HB ' ' A' ' 51' ' ' VAL . 50.5 t -147.28 141.75 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -126.11 117.77 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.618 HD13 HG11 ' A' ' 51' ' ' VAL . 31.6 mm -107.73 115.9 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.215 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.9 p -134.69 131.49 37.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.879 HD13 ' HG2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -66.04 153.79 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.27 54.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 -91.0 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.562 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -117.89 67.88 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -153.64 -177.46 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.783 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 47' ' ' LEU . . . -144.75 -157.14 7.09 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.465 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 48' ' ' SER . 17.9 tp -93.34 -29.44 15.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.555 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 59.96 50.2 70.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.733 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.38 152.82 24.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -114.89 173.57 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.824 HD11 HG22 ' A' ' 76' ' ' VAL . 6.9 pt -135.54 141.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.104 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -117.22 161.53 19.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.798 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -105.45 142.91 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.769 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -91.4 167.8 31.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.624 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.683 ' HD2' HD13 ' A' ' 97' ' ' LEU . 89.6 Cg_endo -78.67 -165.62 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.716 2.277 . . . . 0.0 112.276 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.2 mp -65.79 -28.17 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.164 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.34 -26.76 65.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -156.48 66.9 4.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.243 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.59 111.69 3.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.013 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.45 -170.74 37.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.608 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.557 HG22 HD12 ' A' ' 59' ' ' ILE . 14.0 mm -94.97 118.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 52.0 m-85 -111.24 174.67 5.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.318 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -107.69 136.46 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.194 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.12 -169.45 1.58 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.638 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CG ' HD11 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -47.25 140.19 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.262 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.86 148.75 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -107.94 138.84 20.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.3 173.22 2.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.471 2.114 . . . . 0.0 112.111 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.22 27.77 24.7 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -121.8 166.24 14.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.86 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 22' ' ' GLY . 12.8 mt -66.32 -35.66 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.705 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 53' ' ' LEU . 11.7 p -53.09 -40.95 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.03 -39.85 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.56 -35.06 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.803 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.873 ' HB ' HG13 ' A' ' 13' ' ' VAL . 28.2 m -82.44 -30.83 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.68 41.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.457 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.8 mt -90.18 164.68 14.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.988 0.423 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.93 168.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.533 HD11 ' CG ' ' A' ' 41' ' ' HIS . 20.2 mt -65.07 133.78 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.721 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ARG . . . 112.77 -18.0 22.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.358 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' CB ' HD11 ' A' ' 89' ' ' ILE . 64.5 m-20 -71.97 169.13 16.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -148.52 115.08 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.04 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.557 HD12 HG22 ' A' ' 37' ' ' ILE . 3.8 mt -69.02 116.95 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.652 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 88' ' ' SER . 27.0 m -104.21 3.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.793 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -176.44 152.68 1.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.729 HG13 HG22 ' A' ' 87' ' ' ILE . 47.7 t -151.95 102.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 60.58 37.77 19.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.92 -31.94 7.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 t -70.51 114.65 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 111.029 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.13 124.16 21.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.2 m-85 -96.11 21.9 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.102 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.7 t -73.76 -37.58 64.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -128.9 28.85 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.733 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.601 HD22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.74 148.01 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.03 158.05 25.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -57.34 -53.51 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.47 -38.62 77.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.08 -44.13 97.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -59.54 -45.66 91.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 27' ' ' ILE . 38.1 t -69.31 -42.64 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -55.99 -58.9 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 74' ' ' GLU . 27.1 m -58.58 -40.53 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.181 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -68.55 -29.52 68.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.717 ' HE2' HD23 ' B' ' 118' ' ' LEU . 4.0 mptp? -82.59 -33.18 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -60.94 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.879 ' HG2' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -78.15 -45.84 22.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.7 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -100.42 92.44 5.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -132.22 144.35 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.4 m -89.43 117.01 28.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.272 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.729 HG22 HG13 ' A' ' 62' ' ' VAL . 13.1 pt -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.859 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.0 t -94.66 116.66 29.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.247 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.468 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -123.67 142.66 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.207 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 10' ' ' GLU . 40.5 t -109.76 131.86 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.508 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -69.65 136.56 51.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.713 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.99 -17.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.396 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -54.95 -21.3 11.26 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.881 0.372 . . . . 0.0 111.102 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -30.47 2.52 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD3' ' CB ' ' A' ' 92' ' ' ALA . 1.7 ptt180 -56.04 -34.47 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.672 0.273 . . . . 0.0 111.321 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -49.97 38.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.683 HD13 ' HD2' ' A' ' 31' ' ' PRO . 14.9 mt -71.39 -58.43 3.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -46.05 -40.5 10.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.411 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 38.0 mmt -73.17 64.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.901 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.729 0.299 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.13 160.93 2.81 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.624 2.216 . . . . 0.0 112.303 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.57 128.56 52.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.73 145.24 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt -141.71 138.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.641 HG21 HG11 ' A' ' 76' ' ' VAL . 68.5 m -124.4 147.36 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.01 138.05 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.717 HD23 ' HE2' ' A' ' 80' ' ' LYS . 3.1 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 90' ' ' VAL . 54.7 mt-10 -59.88 131.93 52.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.799 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.8 OUTLIER -112.4 141.2 46.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -109.3 143.55 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.729 HG13 ' HB ' ' A' ' 51' ' ' VAL . 18.5 t -149.96 153.15 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.389 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.37 114.54 9.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.636 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.587 HD12 ' CD1' ' A' ' 23' ' ' LEU . 41.3 mm -97.92 118.92 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 p -129.25 109.97 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.636 HD22 ' NH1' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -59.16 121.84 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 t -71.03 -47.26 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.07 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.84 -58.58 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.546 ' HA ' HD21 ' A' ' 17' ' ' LEU . 4.2 t -164.34 49.11 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.935 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -110.75 -30.78 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.023 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' HD23 ' A' ' 47' ' ' LEU . . . 92.5 -122.53 6.92 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.587 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.5 tp -124.41 -50.24 1.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.0 28.24 9.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.364 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -147.28 160.95 41.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.393 . . . . 0.0 111.152 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.94 173.64 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.971 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.047 HD11 HG22 ' A' ' 76' ' ' VAL . 26.0 pt -143.45 135.57 23.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.2 t -119.78 161.78 20.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.657 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.704 ' O ' HD22 ' B' ' 113' ' ' LEU . 1.0 OUTLIER -105.11 147.67 27.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 -178.32 46.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.589 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.571 ' HD2' HD13 ' A' ' 97' ' ' LEU . 37.1 Cg_endo -65.68 -165.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.62 2.213 . . . . 0.0 112.236 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.86 -30.06 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -68.05 -30.21 69.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -143.53 74.14 17.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.014 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.82 141.51 27.31 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.6 173.33 40.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.656 HG13 ' HB2' ' A' ' 75' ' ' ALA . 23.9 mm -90.32 115.09 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.054 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.859 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.4 m-85 -105.56 171.35 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 27' ' ' ILE . 23.7 mm -107.73 137.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.1 -169.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.442 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 142.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.184 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.3 t -110.08 157.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.972 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -114.5 145.43 33.79 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 162.51 38.8 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.543 2.162 . . . . 0.0 112.197 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.9 86.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.488 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -135.56 -177.36 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 22' ' ' GLY . 3.2 mm? -71.04 -49.52 43.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.628 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.432 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -53.46 -41.84 66.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.43 84.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -64.15 -37.57 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.729 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.7 m -78.89 -36.38 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.46 70.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.406 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.566 ' O ' HG21 ' A' ' 42' ' ' VAL . 29.3 mt -116.38 150.91 36.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -154.58 162.45 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.455 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.9 mt -57.92 137.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.475 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.67 -29.18 9.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.564 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.438 ' HB3' HG13 ' A' ' 89' ' ' ILE . 21.6 m-20 -57.63 164.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.649 0.261 . . . . 0.0 110.593 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -146.39 114.4 6.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.239 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.27 117.15 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.06 0.58 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.808 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -175.62 159.49 2.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.906 ' O ' HG12 ' A' ' 65' ' ' VAL . 62.1 t -155.22 103.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 63.78 17.23 10.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.278 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.12 -27.21 9.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.642 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 62' ' ' VAL . 10.8 p -65.05 134.23 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.728 0.299 . . . . 0.0 111.215 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.57 121.81 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.522 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.4 m-85 -94.84 19.02 10.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.236 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -75.34 -56.74 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.98 26.65 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.522 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -87.19 150.34 24.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.26 167.9 11.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -58.56 -53.57 56.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -54.67 -41.99 70.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -59.77 -42.64 93.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.761 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -63.4 -46.13 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.133 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.047 HG22 HD11 ' A' ' 27' ' ' ILE . 40.4 t -68.67 -36.96 76.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -58.98 6.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.675 HG23 HD22 ' A' ' 79' ' ' LEU . 34.3 m -57.86 -40.47 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.312 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.0 mm? -66.55 -32.14 73.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 110.656 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -35.97 37.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 t -61.0 -57.08 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.458 ' HB3' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.92 142.84 29.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.253 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.636 ' NH1' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -91.11 -49.03 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.509 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 t -98.21 81.99 2.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -120.51 137.83 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.278 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.5 m -85.97 116.92 24.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.833 HG22 HG22 ' A' ' 62' ' ' VAL . 7.2 pt -110.28 132.68 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -101.88 118.95 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.37 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.799 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -123.4 151.84 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.607 ' N ' HD13 ' A' ' 89' ' ' ILE . 41.1 t -125.71 110.45 24.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.442 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.41 138.18 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.462 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.38 -22.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.927 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -57.46 -21.85 39.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.033 0.444 . . . . 0.0 110.854 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.27 -30.34 1.92 Allowed Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.428 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.475 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 31.6 mtt-85 -56.19 -34.73 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.558 0.218 . . . . 0.0 111.352 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -49.32 -50.03 41.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.679 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.859 HD12 ' CE2' ' A' ' 38' ' ' PHE . 11.3 mt -71.74 -43.51 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.455 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -53.01 -24.76 10.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.358 -179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.6 mmm -53.13 122.49 9.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.43 179.22 6.73 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.607 2.205 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 29' ' ' SER . 16.8 mt -123.25 149.8 44.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.78 107.21 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.484 HG22 ' N ' ' B' ' 116' ' ' THR . 21.2 mt -100.62 158.44 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' THR . . . . . 0.484 ' N ' HG22 ' B' ' 115' ' ' ILE . 78.5 m -150.93 148.94 29.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.444 ' O ' HD23 ' B' ' 118' ' ' LEU . 0.9 OUTLIER -94.67 136.57 34.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.793 HD11 HD13 ' A' ' 27' ' ' ILE . 78.1 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 90' ' ' VAL . 5.2 mt-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.81 0.338 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -105.16 147.79 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -109.43 138.17 46.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.784 HG13 ' HB ' ' A' ' 51' ' ' VAL . 40.5 t -143.0 128.86 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.786 ' CD2' HG23 ' A' ' 86' ' ' THR . 3.9 m-85 -114.58 116.64 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 51' ' ' VAL . 42.3 mm -104.3 124.68 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.87 HD21 ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.678 0.275 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 102.62 20.39 11.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.304 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -132.62 158.57 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.213 0.506 . . . . 0.0 111.581 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 m -114.82 173.73 6.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.649 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.983 HD11 HG22 ' A' ' 76' ' ' VAL . 4.8 pt -143.53 145.54 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.103 0.478 . . . . 0.0 111.71 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -129.03 162.46 27.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.38 143.83 32.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.781 0.324 . . . . 0.0 110.443 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.67 175.14 43.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.073 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.788 ' CD ' HD12 ' A' ' 97' ' ' LEU . 55.8 Cg_endo -69.55 -160.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.843 2.362 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -85.87 -27.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.301 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -66.43 -32.65 74.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' HD11 ' A' ' 97' ' ' LEU . 16.9 mttp -151.08 70.48 8.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.35 137.51 28.44 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.624 2.216 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.05 -175.44 46.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.389 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.442 HG13 ' CD2' ' A' ' 67' ' ' PHE . 22.4 mm -92.93 116.58 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 27' ' ' ILE . 2.6 m-85 -105.12 170.37 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.82 134.06 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.024 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.1 -169.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.438 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.425 ' ND1' HD11 ' A' ' 55' ' ' ILE . 1.8 t60 -51.59 149.24 4.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.014 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' A' ' 25' ' ' CYS . 6.0 m -130.17 155.43 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -95.89 147.11 32.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.46 144.62 22.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.39 -24.23 26.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.524 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -74.06 -179.08 3.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -70.48 -35.9 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.522 ' HA ' HD12 ' A' ' 53' ' ' LEU . 45.1 t -52.83 -51.25 61.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -33.73 75.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -31.13 71.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.14 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.784 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.3 m -88.54 -20.82 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.03 39.0 3.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.074 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 48' ' ' SER . 8.0 mt -90.38 159.31 16.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.088 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 179.49 171.24 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 2.3 mt -60.35 147.71 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 103.66 -41.93 2.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.431 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.9 m-20 -55.15 169.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.657 0.265 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.523 ' CB ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -150.8 113.03 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.094 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -69.22 121.96 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.453 ' CG2' HG23 ' A' ' 90' ' ' VAL . 27.9 m -111.55 8.54 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.775 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.37 147.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.986 0.422 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.874 HG22 HG22 ' A' ' 87' ' ' ILE . 47.5 t -153.68 100.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.856 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 63.47 30.42 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.83 -29.62 12.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.429 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.4 118.48 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.72 123.26 20.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 3.1 m-85 -98.86 19.83 14.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -41.15 96.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -139.13 28.54 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.675 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.556 HD21 ' N ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -71.29 140.99 50.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.74 154.69 36.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -58.29 -54.61 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.001 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -57.2 -40.0 76.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.5 mm-40 -59.49 -40.76 88.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.556 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -63.1 -47.27 83.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.983 HG22 HD11 ' A' ' 27' ' ' ILE . 40.3 t -68.68 -36.13 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.44 -58.96 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 74' ' ' GLU . 29.3 m -57.67 -40.46 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.207 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.467 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.7 mm? -67.03 -31.95 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -34.77 38.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.4 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.068 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.563 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.1 m -97.8 119.29 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -67.17 -39.76 86.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.709 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 p -113.39 107.17 15.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.548 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.599 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -144.31 146.34 32.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.954 0.407 . . . . 0.0 111.303 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.786 HG23 ' CD2' ' A' ' 14' ' ' PHE . 31.3 m -85.22 123.03 30.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.064 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 62' ' ' VAL . 6.3 pt -118.25 126.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.534 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -95.46 112.37 24.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.465 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -112.74 149.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.039 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 10' ' ' GLU . 32.4 t -122.09 115.45 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.71 137.76 53.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.524 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.12 -17.49 0.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.176 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -57.73 -22.19 45.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 110.991 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -117.11 -30.69 1.87 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.551 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 58.0 mtp180 -56.16 -34.54 66.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 0.0 111.027 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -42.05 78.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.788 HD12 ' CD ' ' A' ' 31' ' ' PRO . 3.2 mm? -71.24 -48.59 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 2.1 m-85 . . . . . 0 C--N 1.333 -0.144 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 34.5 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.778 0.323 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 76' ' ' VAL . 27.0 m -134.89 148.13 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.12 127.83 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 27' ' ' ILE . 14.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.5 mm-40 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.835 0.35 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 5.8 ttpm? -99.2 145.54 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.222 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 139.07 39.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.778 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.794 HG13 ' HB ' ' A' ' 51' ' ' VAL . 39.4 t -145.99 145.51 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -131.93 121.92 24.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mm -108.27 129.69 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.9 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.934 0.397 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 113.11 27.26 3.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.205 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 42' ' ' VAL . 54.0 t -154.18 156.05 36.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.94 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.9 t -114.87 136.09 53.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.026 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.678 HD11 HG22 ' A' ' 76' ' ' VAL . 20.9 pt -101.64 146.95 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 111.443 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 p -129.0 161.84 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.723 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 144.78 31.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.77 173.73 42.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.606 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.21 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.537 2.158 . . . . 0.0 112.365 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 mt -68.22 -28.12 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -66.76 -26.84 67.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.216 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HB3' HD11 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -154.51 76.78 5.47 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.112 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.22 133.28 12.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.514 2.142 . . . . 0.0 112.263 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.15 -179.95 38.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 75' ' ' ALA . 20.0 mm -88.71 114.6 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE2' HD12 ' A' ' 97' ' ' LEU . 20.2 m-85 -109.03 173.55 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.528 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.3 mm -107.83 131.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.269 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.22 -168.98 1.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.528 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.429 ' HA ' HD11 ' A' ' 55' ' ' ILE . 44.8 t-80 -45.87 140.3 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' SG ' ' A' ' 25' ' ' CYS . 25.3 t -108.66 157.44 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.458 ' N ' HG12 ' A' ' 42' ' ' VAL . 12.2 mttt -108.15 121.44 43.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.53 151.17 39.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.4 2.067 . . . . 0.0 112.135 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 53.51 24.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.41 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.456 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -151.61 -169.28 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 47' ' ' LEU . 2.3 mm? -76.08 -46.56 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.394 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 51' ' ' VAL . 23.0 t -56.26 -42.01 76.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -38.77 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.98 -35.61 81.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.794 ' HB ' HG13 ' A' ' 13' ' ' VAL . 31.0 m -77.91 -27.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.47 30.32 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.589 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.444 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 11.7 mt -75.73 166.36 23.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -179.31 155.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.783 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 41' ' ' HIS . 4.6 mt -53.16 131.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.008 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 117.12 -25.72 8.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.284 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.466 ' CB ' HD11 ' A' ' 89' ' ' ILE . 52.5 m-20 -69.11 166.52 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -148.05 115.18 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.084 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.27 117.26 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 88' ' ' SER . 35.6 m -98.71 -15.36 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.73 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -158.34 155.05 28.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.931 HG13 HG22 ' A' ' 87' ' ' ILE . 47.8 t -152.12 103.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 60.01 31.3 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.9 -28.38 13.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.06 126.39 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.126 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.18 112.91 3.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.2 m-85 -98.75 11.68 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -72.3 -44.29 62.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.712 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -123.43 30.5 6.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.604 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.0 146.96 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.914 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.499 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -73.42 167.59 20.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -66.3 -55.16 17.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -39.11 80.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.63 -37.82 82.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.752 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.646 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -66.15 -46.07 78.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.962 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.692 HG11 HG21 ' B' ' 116' ' ' THR . 24.8 t -68.71 -42.46 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.044 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -56.07 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 79' ' ' LEU . 32.7 m -58.84 -43.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.452 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -65.79 -31.42 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -69.67 -67.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.11 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.679 ' CB ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -77.27 136.1 38.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -51.19 7.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.622 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.0 p -106.14 83.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.679 HD23 ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -116.02 139.81 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.0 m -90.49 116.85 28.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.24 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.931 HG22 HG13 ' A' ' 62' ' ' VAL . 17.4 pt -111.91 129.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.71 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.579 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -97.27 108.9 21.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.449 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.466 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -109.82 146.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 10' ' ' GLU . 11.4 t -117.15 112.59 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 110.977 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.6 143.37 36.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.347 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.75 -19.48 0.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.779 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -58.62 -20.68 49.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.88 -30.85 2.05 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.533 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 59.3 mtt180 -56.62 -34.28 67.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.52 0.2 . . . . 0.0 111.398 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.23 -49.8 31.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' A' ' 34' ' ' LYS . 9.3 mt -71.15 -43.28 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.831 0.348 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.692 HG21 HG11 ' A' ' 76' ' ' VAL . 33.5 m -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.31 143.43 27.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 27' ' ' ILE . 3.6 mp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -97.91 135.51 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -94.39 140.44 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.875 HG13 ' HB ' ' A' ' 51' ' ' VAL . 44.6 t -145.52 137.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -124.76 115.99 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.493 HD12 HD13 ' A' ' 23' ' ' LEU . 42.8 mm -101.15 127.64 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.232 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.616 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 HD12 ' A' ' 15' ' ' ILE . 13.5 tp . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 106.75 23.82 6.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.27 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.776 ' SG ' HG22 ' A' ' 42' ' ' VAL . 2.8 t -145.09 164.85 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 111.016 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 m -114.94 173.75 6.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.758 HD13 HD11 ' B' ' 118' ' ' LEU . 16.0 pt -142.81 145.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 111.377 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.24 161.95 28.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.789 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.95 141.9 35.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.745 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.03 172.95 34.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.917 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' HD13 ' A' ' 97' ' ' LEU . 42.2 Cg_endo -67.65 -165.71 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.34 -25.54 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.26 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.15 -5.48 49.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.283 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HB3' HD11 ' A' ' 97' ' ' LEU . 6.9 tttt -171.01 59.31 0.29 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.773 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.27 144.54 56.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.606 2.204 . . . . 0.0 112.315 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.13 174.87 33.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.278 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 75' ' ' ALA . 11.8 mm -89.58 113.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.898 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.937 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.6 m-85 -101.96 172.51 6.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.503 HG23 ' SG ' ' A' ' 25' ' ' CYS . 23.3 mm -109.21 136.26 45.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.234 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.05 -169.35 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.375 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.509 ' CD2' HD11 ' A' ' 55' ' ' ILE . 38.1 m80 -45.02 145.72 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.776 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.2 t -113.73 151.32 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -105.43 124.02 37.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 159.79 8.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.045 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.01 50.24 67.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 2.5 m -141.05 -173.62 3.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.733 0.301 . . . . 0.0 110.912 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.9 mt -78.15 -42.32 32.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -52.87 -40.11 63.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.939 0.4 . . . . 0.0 110.572 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.33 68.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.611 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -37.15 79.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.817 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.875 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.2 m -83.05 -30.22 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.08 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.72 52.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 48' ' ' SER . 14.0 mt -97.63 164.89 12.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.12 162.42 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.509 HD11 ' CD2' ' A' ' 41' ' ' HIS . 4.1 mt -58.02 140.9 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 -37.16 3.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.257 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.51 156.14 13.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.756 0.312 . . . . 0.0 110.637 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -140.4 119.09 12.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 62' ' ' VAL . 15.5 mt -69.42 117.13 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.614 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.64 -16.01 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.714 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -155.52 148.36 24.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.402 . . . . 0.0 111.044 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.859 HG13 HG22 ' A' ' 87' ' ' ILE . 41.8 t -147.66 105.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 55.92 32.66 20.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.8 23.41 38.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.659 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 62' ' ' VAL . 23.6 t -112.21 120.16 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.326 . . . . 0.0 111.063 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -65.14 111.92 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.676 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.3 m-85 -95.78 19.84 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.86 -41.07 45.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -123.61 28.04 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.694 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -83.52 148.98 26.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.45 164.33 17.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.2 t-160 -59.37 -48.95 79.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -60.63 -41.85 95.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.0 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -59.04 -45.73 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.608 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -59.07 -47.71 84.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.745 HG22 HD11 ' A' ' 27' ' ' ILE . 28.0 t -66.87 -43.47 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -58.13 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.7 m -57.28 -44.58 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.528 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.4 mm? -64.43 -31.51 72.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.693 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.1 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 t -66.56 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -87.56 131.76 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -77.66 -55.69 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.8 m -100.03 83.03 2.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -113.84 141.87 46.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -89.85 116.94 28.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.859 HG22 HG13 ' A' ' 62' ' ' VAL . 12.3 pt -115.02 126.51 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 0.0 111.542 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -96.04 122.9 39.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 145.94 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.409 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.77 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -111.18 126.17 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.298 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -65.91 132.11 47.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.525 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.54 -19.42 0.32 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.627 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.77 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -53.6 -24.18 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.52 -30.77 2.97 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -34.56 66.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.624 0.25 . . . . 0.0 111.282 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.65 -50.01 44.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.937 HD12 ' CE2' ' A' ' 38' ' ' PHE . 18.9 mt -71.52 -41.03 69.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.005 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.193 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 30.6 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.913 0.387 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.452 HG21 HG21 ' A' ' 76' ' ' VAL . 32.5 m -111.68 145.09 39.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -98.06 111.78 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.758 HD11 HD13 ' A' ' 27' ' ' ILE . 6.1 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.546 ' HA ' HG22 ' A' ' 90' ' ' VAL . 4.9 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.99 0.424 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.741 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -102.01 116.85 33.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -86.23 131.88 34.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.763 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.759 HG13 ' HB ' ' A' ' 51' ' ' VAL . 40.1 t -140.75 149.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.286 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 5.1 m-85 -128.32 131.59 48.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.705 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.8 131.29 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 48' ' ' SER . 12.7 tp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 108.67 36.38 2.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.063 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.718 ' SG ' HG12 ' A' ' 42' ' ' VAL . 1.3 t -160.23 160.71 33.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.0 110.486 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 4.2 m -114.36 173.45 6.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.53 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.12 HD11 HG22 ' A' ' 76' ' ' VAL . 10.0 pt -135.29 153.5 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.41 . . . . 0.0 111.354 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 29.5 p -131.29 162.68 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.8 p -104.61 140.79 37.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 175.31 43.58 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.716 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.72 ' HD2' HD13 ' A' ' 97' ' ' LEU . 57.5 Cg_endo -71.06 -167.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.646 2.231 . . . . 0.0 112.586 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.9 mt -78.2 -21.42 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.257 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -71.92 -30.31 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.1 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB3' HD11 ' A' ' 97' ' ' LEU . 11.2 mttm -147.53 64.77 8.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 21.8 Cg_exo -64.7 114.45 2.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.629 2.22 . . . . 0.0 112.014 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 -157.38 8.99 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 75' ' ' ALA . 19.7 mm -111.67 118.0 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.053 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.868 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 2.1 m-85 -100.36 172.28 7.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.716 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.4 mm -118.74 121.62 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.33 -169.5 2.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.611 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -54.34 141.99 28.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.718 HG12 ' SG ' ' A' ' 25' ' ' CYS . 1.7 m -119.71 153.48 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 147.07 32.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.38 172.74 15.75 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.29 33.89 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.603 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 73.7 p -119.11 -171.76 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.788 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 4.4 mt -78.0 -44.03 27.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -53.05 -46.13 68.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.533 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -36.28 75.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.564 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.06 -38.5 83.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.759 ' HB ' HG13 ' A' ' 13' ' ' VAL . 21.0 m -80.36 -29.69 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 36.18 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.377 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 48' ' ' SER . 13.1 mt -85.06 161.05 19.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.0 166.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.674 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.86 144.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 105.94 -13.3 45.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.646 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.457 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.5 m-20 -86.32 162.32 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.446 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -142.85 114.93 8.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.07 117.19 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.851 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 88' ' ' SER . 30.7 m -106.86 6.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.764 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -177.15 149.89 0.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.843 0.354 . . . . 0.0 111.136 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.85 HG22 HG22 ' A' ' 87' ' ' ILE . 58.1 t -153.84 112.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 56.95 29.47 16.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.73 -26.18 19.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.45 124.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.899 0.38 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.22 114.88 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.9 m-85 -95.75 22.31 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -53.8 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.642 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -111.78 28.49 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.554 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.1 tp -83.17 147.69 27.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.61 163.09 20.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -59.5 -50.34 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -59.56 -37.5 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HB3' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -61.64 -43.15 99.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.554 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.66 -46.2 90.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.16 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.12 HG22 HD11 ' A' ' 27' ' ' ILE . 40.5 t -67.95 -43.85 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.4 -57.21 12.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 79' ' ' LEU . 33.3 m -58.02 -45.34 88.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.512 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.4 mm? -63.84 -29.66 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.645 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.814 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.3 mptp? -82.58 -34.65 27.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -69.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.383 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -75.77 131.18 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.288 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.33 -50.61 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.551 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -102.4 86.92 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.507 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -121.42 143.16 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.289 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 m -92.19 116.92 29.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.051 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 62' ' ' VAL . 5.9 pt -109.37 130.44 62.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.928 0.394 . . . . 0.0 111.546 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -105.18 103.56 13.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.785 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.741 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.85 147.61 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.9 t -114.44 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 0.0 110.964 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.655 ' HB2' ' NZ ' ' A' ' 11' ' ' LYS . . . -55.38 138.41 45.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.268 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.68 -22.45 0.18 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.773 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.68 55.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.922 0.392 . . . . 0.0 111.023 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA2' ' CZ ' ' A' ' 38' ' ' PHE . . . -110.86 -30.21 3.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.67 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 27.4 mtp85 -55.75 -34.49 65.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.549 0.214 . . . . 0.0 111.482 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.22 -50.05 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.868 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 19.3 mt -71.53 -50.03 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.022 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.371 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.1 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.948 0.404 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.566 HG21 HG21 ' A' ' 76' ' ' VAL . 83.1 m -129.76 149.48 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.37 144.02 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.814 HD23 ' HE2' ' A' ' 80' ' ' LYS . 15.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.3 mt-10 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.756 0.312 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -118.59 158.41 25.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -121.08 141.2 51.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.704 HG13 ' HB ' ' A' ' 51' ' ' VAL . 21.7 t -141.37 150.06 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.339 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' HE1' ' HG ' ' A' ' 16' ' ' SER . 1.8 t80 -128.13 120.36 27.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.699 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 23' ' ' LEU . 36.5 mm -110.14 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.435 ' HG ' ' HE1' ' A' ' 14' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.961 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.622 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.6 tp . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 100.03 27.92 7.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.455 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.658 ' SG ' HG22 ' A' ' 42' ' ' VAL . 35.9 t -154.28 159.29 41.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.2 m -114.42 173.68 6.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.764 HD11 HG22 ' A' ' 76' ' ' VAL . 19.1 pt -135.93 138.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.1 p -116.28 161.71 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.829 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 t -105.17 144.91 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.46 171.89 35.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.575 ' HD2' HD13 ' A' ' 97' ' ' LEU . 57.6 Cg_endo -71.37 -166.44 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.66 2.24 . . . . 0.0 112.393 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.43 -25.28 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -68.22 -28.14 66.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' HB3' HD11 ' A' ' 97' ' ' LEU . 11.8 tttp -157.25 65.63 3.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.226 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.78 144.68 84.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.62 2.213 . . . . 0.0 112.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 38' ' ' PHE . . . 163.61 168.64 25.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.551 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 75' ' ' ALA . 24.7 mm -82.89 114.58 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.051 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.591 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 70.2 m-85 -108.25 176.15 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.205 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.648 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.8 mm -107.69 137.85 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.623 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -169.45 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.23 150.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.658 HG22 ' SG ' ' A' ' 25' ' ' CYS . 29.9 t -126.97 157.59 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' N ' HG12 ' A' ' 42' ' ' VAL . 14.3 pttt -121.94 141.69 34.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 160.6 43.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.534 2.156 . . . . 0.0 112.399 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.52 82.63 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.933 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.541 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.4 m -103.87 -166.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.5 mm? -80.35 -43.47 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.769 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.421 ' OG ' ' CD1' ' A' ' 53' ' ' LEU . 11.7 t -56.15 -40.58 74.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.53 79.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.22 -35.09 79.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.704 ' HB ' HG13 ' A' ' 13' ' ' VAL . 25.4 m -78.9 -17.44 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.467 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.52 5.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.289 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CD1' ' OG ' ' A' ' 48' ' ' SER . 9.1 mt -88.97 155.06 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -167.04 161.03 14.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.94 149.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 101.1 -23.39 35.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.291 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.418 ' HB3' HG13 ' A' ' 89' ' ' ILE . 46.6 m-20 -71.99 166.73 21.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 2.6 tt0 -152.66 119.03 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 111.348 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.39 117.47 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.92 -19.81 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.869 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -159.95 157.28 28.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.105 0.478 . . . . 0.0 111.416 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.727 HG12 ' ND2' ' A' ' 63' ' ' ASN . 46.3 t -150.21 117.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.499 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.727 ' ND2' HG12 ' A' ' 62' ' ' VAL . 0.1 OUTLIER 45.36 47.78 10.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 111.168 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.73 22.29 73.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.311 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 62' ' ' VAL . 21.8 t -109.31 127.38 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.91 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.94 114.66 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.117 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.69 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -99.33 -21.42 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.072 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 m -53.12 -45.82 68.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -106.85 35.45 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.2 tp -105.54 149.68 26.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.765 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.42 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -84.11 166.07 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -60.17 -53.92 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.17 -39.63 79.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.405 ' C ' HD21 ' A' ' 70' ' ' LEU . 2.9 mt-10 -61.32 -43.57 98.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.756 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -58.8 -45.54 89.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.764 HG22 HD11 ' A' ' 27' ' ' ILE . 39.1 t -68.73 -39.95 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.79 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.356 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 79' ' ' LEU . 29.9 m -59.06 -44.82 92.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 110.939 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -63.45 -31.53 72.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.733 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HE3' HD23 ' B' ' 118' ' ' LEU . 1.1 mptm? -82.66 -31.63 28.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 t -64.66 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.4 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.421 ' CB ' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -88.15 135.3 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.089 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -78.53 -52.07 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.617 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.2 p -102.29 85.17 2.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.427 ' CD2' ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -116.65 146.32 42.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 111.422 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -90.85 117.35 29.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.395 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.645 HG22 HG13 ' A' ' 62' ' ' VAL . 12.3 pt -115.17 121.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.547 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.33 120.76 33.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.534 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -122.38 144.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.25 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 89' ' ' ILE . 41.0 t -115.24 112.45 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.728 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.58 139.38 50.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.479 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.26 -17.32 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.131 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -59.75 -19.27 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 111.23 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 -30.82 2.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.623 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 51.0 mtp180 -56.47 -34.61 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.314 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.56 -49.91 69.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 34' ' ' LYS . 21.8 mt -71.56 -42.92 67.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.249 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 21.6 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.804 0.335 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.61 HG21 HG21 ' A' ' 76' ' ' VAL . 39.1 m -133.35 143.1 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.23 141.19 28.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.742 ' HA ' HG22 ' A' ' 90' ' ' VAL . 13.5 tt0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -105.96 146.73 29.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 111.047 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -97.95 149.87 21.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.725 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.798 HG13 ' HB ' ' A' ' 51' ' ' VAL . 57.8 t -152.99 141.1 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.04 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -129.23 123.72 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.653 HD12 ' CD1' ' A' ' 23' ' ' LEU . 22.0 mm -110.77 127.64 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.806 179.905 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.653 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.0 tp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.04 30.89 8.45 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.3 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 39' ' ' ILE . 42.2 t -151.43 158.65 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 111.009 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.31 173.9 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.796 HD13 HD11 ' B' ' 118' ' ' LEU . 11.7 pt -136.01 175.8 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.966 0.412 . . . . 0.0 111.359 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 t -146.76 162.16 39.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.639 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -104.83 148.26 26.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.607 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -88.72 154.49 24.85 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.02 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.484 ' CD ' HD12 ' A' ' 97' ' ' LEU . 57.8 Cg_endo -70.78 -159.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.882 2.388 . . . . 0.0 112.032 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -80.69 -27.05 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.348 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -85.67 0.59 52.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.548 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HD3' HD21 ' A' ' 97' ' ' LEU . 7.4 tttp -175.98 65.43 0.23 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.203 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 13.8 Cg_exo -69.3 119.1 6.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 111.921 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.41 -175.41 38.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.781 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.404 HG13 ' CD2' ' A' ' 67' ' ' PHE . 15.4 mm -106.11 111.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.309 . . . . 0.0 110.937 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 1.8 m-30 -100.99 174.5 5.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.655 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.4 mm -107.85 138.37 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.13 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -169.44 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.402 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -45.25 137.52 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 43' ' ' LYS . 18.7 t -108.58 157.79 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.461 ' N ' HG12 ' A' ' 42' ' ' VAL . 13.4 mttt -107.6 154.52 40.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.79 154.03 15.21 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.743 2.296 . . . . 0.0 112.407 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.1 26.98 64.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.585 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.465 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -111.94 -177.8 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.696 0.284 . . . . 0.0 110.848 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 24.8 mt -73.09 -46.19 52.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.756 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -52.93 -38.8 62.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.74 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.437 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.89 -40.19 87.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.704 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.798 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.6 m -78.87 -27.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.056 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.86 48.96 1.12 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 48' ' ' SER . 15.2 mt -96.04 154.27 17.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HA ' HG21 ' A' ' 42' ' ' VAL . 12.5 tt0 -168.01 166.88 13.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.69 138.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.8 17.2 21.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.376 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' CB ' HD11 ' A' ' 89' ' ' ILE . 48.2 m-20 -110.39 159.94 17.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.675 0.274 . . . . 0.0 110.677 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 14.4 tm0? -140.05 112.2 7.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -69.23 118.45 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 88' ' ' SER . 33.2 m -106.42 13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.945 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -176.99 146.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.934 0.397 . . . . 0.0 111.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.803 HG13 HG22 ' A' ' 87' ' ' ILE . 39.0 t -149.53 98.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 58.04 30.27 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.18 -28.59 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.512 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.35 129.05 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.099 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.82 109.79 6.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.772 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.8 m-85 -96.79 -11.42 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.398 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -50.37 -27.84 7.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.763 0.316 . . . . 0.0 111.21 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -144.57 31.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.772 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -84.68 144.04 28.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.847 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.5 162.93 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -63.64 -54.93 28.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -58.17 -41.02 82.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' HD21 ' A' ' 70' ' ' LEU . 2.0 mp0 -60.38 -34.3 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.688 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -69.13 -45.32 70.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.007 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.82 HG21 HG21 ' B' ' 116' ' ' THR . 42.8 t -68.03 -38.73 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -56.5 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.1 m -59.29 -45.54 93.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.072 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.512 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.5 mm? -62.32 -31.17 71.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.606 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.445 ' HE2' HD23 ' B' ' 118' ' ' LEU . 0.1 OUTLIER -82.63 -33.45 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 t -61.72 -61.24 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.442 ' HB2' HD23 ' A' ' 85' ' ' LEU . 3.9 m -97.4 127.22 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.974 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -74.22 -48.8 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 t -98.61 94.27 6.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -134.36 140.23 46.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.2 m -91.89 133.11 35.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.272 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.803 HG22 HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -125.19 139.76 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.63 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -102.45 104.39 14.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.213 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.444 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -107.41 143.19 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 10' ' ' GLU . 21.8 t -110.95 129.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -65.48 131.88 47.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.828 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.06 -17.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.521 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.52 -22.43 32.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.782 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.26 -30.27 2.31 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.39 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.442 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -55.83 -34.62 65.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.78 -38.92 64.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.962 0.41 . . . . 0.0 110.322 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.53 HD21 ' HD3' ' A' ' 34' ' ' LYS . 3.9 mm? -71.4 -54.09 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.3 mm . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.806 0.336 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.82 HG21 HG21 ' A' ' 76' ' ' VAL . 85.3 m -134.19 146.32 50.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.15 128.14 42.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.796 HD11 HD13 ' A' ' 27' ' ' ILE . 40.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.496 ' HA ' HG13 ' A' ' 90' ' ' VAL . 1.2 mp0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.765 0.317 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -109.03 158.84 17.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.423 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -121.6 140.54 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.712 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 51' ' ' VAL . 58.5 t -145.48 145.57 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.246 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.871 ' CD1' HG23 ' A' ' 86' ' ' THR . 1.8 m-85 -123.53 129.07 50.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.657 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 23' ' ' LEU . 36.4 mm -119.72 125.68 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.607 HD13 HD12 ' A' ' 15' ' ' ILE . 12.5 tp . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.794 0.33 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.35 18.71 32.49 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.398 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.683 ' SG ' HG23 ' A' ' 39' ' ' ILE . 49.1 t -139.36 158.66 43.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.524 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 173.53 6.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 76' ' ' VAL . 15.3 pt -143.55 152.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.7 p -136.15 160.28 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -105.48 155.09 19.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.71 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.02 -166.04 24.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.88 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.54 -164.17 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.03 -24.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.244 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.42 -29.4 62.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' CB ' HD21 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -147.07 63.31 8.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.34 140.87 31.08 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.517 2.145 . . . . 0.0 112.335 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.98 31.97 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.416 HG13 ' HB2' ' A' ' 75' ' ' ALA . 12.1 mm -85.84 110.32 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -100.69 171.94 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.038 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.683 HG23 ' SG ' ' A' ' 25' ' ' CYS . 20.2 mm -107.78 137.15 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.322 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -169.4 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.189 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 147.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.105 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.616 HG22 ' SG ' ' A' ' 25' ' ' CYS . 35.5 t -121.43 157.92 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 3.1 mtpm? -96.62 156.37 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.804 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -50.57 3.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.509 2.139 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.7 -123.4 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.947 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.459 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 25.0 p 47.63 -159.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 111.313 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mt -102.48 -29.42 11.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 51' ' ' VAL . 3.7 p -52.83 -52.4 57.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 43' ' ' LYS . . . -62.01 -35.38 78.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.075 0.464 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.42 -41.65 90.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.993 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.787 ' HB ' HG13 ' A' ' 13' ' ' VAL . 18.2 m -81.43 -29.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.11 61.78 0.82 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.371 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.92 155.38 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.28 159.64 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.42 147.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.65 -28.55 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' CB ' HD11 ' A' ' 89' ' ' ILE . 36.2 m-20 -63.35 146.92 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.689 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 1.5 tm0? -132.05 117.82 18.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.24 119.42 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 88' ' ' SER . 35.3 m -99.47 -20.98 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.0 155.05 34.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.748 HG13 HG22 ' A' ' 87' ' ' ILE . 47.8 t -151.1 96.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 57.42 36.9 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.85 -28.56 13.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.448 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.91 114.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.18 115.41 5.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.651 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.4 m-85 -97.27 25.03 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.024 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -70.94 -53.81 13.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.59 28.67 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.537 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.1 tp -74.2 149.4 40.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 173.02 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.438 ' CE1' ' HG1' ' B' ' 116' ' ' THR . 3.1 t60 -66.6 -58.34 5.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -57.61 -34.86 69.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -44.49 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.537 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.24 -44.64 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.768 HG11 HG21 ' B' ' 116' ' ' THR . 39.1 t -69.11 -43.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.032 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -54.81 -55.5 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.202 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 79' ' ' LEU . 28.3 m -59.1 -45.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.475 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -65.08 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.78 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.1 mptp? -82.58 -28.4 30.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -68.04 -64.34 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.716 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -84.75 140.08 31.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.149 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -78.79 -59.61 2.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.65 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 t -102.41 101.36 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -131.7 142.5 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.998 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.871 HG23 ' CD1' ' A' ' 14' ' ' PHE . 17.5 m -87.88 116.96 26.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.283 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.748 HG22 HG13 ' A' ' 62' ' ' VAL . 15.0 pt -111.77 123.99 68.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.984 0.421 . . . . 0.0 111.717 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 60' ' ' VAL . 6.2 t -93.23 113.5 25.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.249 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.51 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -118.34 147.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.29 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 10' ' ' GLU . 11.9 t -116.31 134.05 60.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.539 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -71.19 129.69 39.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.943 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.69 -17.33 0.49 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.678 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -54.88 -21.95 13.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.296 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.59 -30.24 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.606 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.407 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 6.2 ptm180 -56.13 -38.27 70.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -51.42 -49.95 60.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.732 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.62 HD21 ' CB ' ' A' ' 34' ' ' LYS . 12.5 mt -71.61 -35.94 70.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.351 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 23.3 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.789 0.328 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.768 HG21 HG11 ' A' ' 76' ' ' VAL . 95.0 m -121.89 144.15 49.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -88.83 147.87 24.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.78 HD23 ' HE2' ' A' ' 80' ' ' LYS . 1.7 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.0 ttpt -102.67 143.9 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 0.0 111.084 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 131.35 52.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.746 HG13 ' HB ' ' A' ' 51' ' ' VAL . 44.1 t -137.96 144.26 31.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 86' ' ' THR . 2.7 m-85 -130.09 125.77 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.477 HD12 ' CD1' ' A' ' 23' ' ' LEU . 35.3 mm -113.79 119.73 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' B' ' 118' ' ' LEU . 6.7 tp . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.748 0.308 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.89 -2.31 24.36 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.348 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' HD21 ' A' ' 23' ' ' LEU . 20.3 p -139.18 166.41 24.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.038 0.419 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 t -114.81 173.92 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 HD11 ' B' ' 118' ' ' LEU . 26.8 pt -141.74 151.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.971 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.6 161.84 39.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.09 146.63 28.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.658 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' A' ' 97' ' ' LEU . . . -94.61 -168.55 36.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.109 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.55 -164.81 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.884 2.39 . . . . 0.0 112.536 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.0 mp -83.11 -27.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.88 -28.99 70.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.9 ' HB3' HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -153.92 75.81 6.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.721 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.81 128.2 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.481 2.121 . . . . 0.0 112.339 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.63 167.9 39.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.522 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -102.53 106.23 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -100.44 -176.62 3.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.657 HD13 HG22 ' A' ' 27' ' ' ILE . 22.8 mm -107.49 144.08 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 111.914 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -168.9 1.5 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.888 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.603 ' HA ' HD11 ' A' ' 55' ' ' ILE . 3.1 t60 -41.95 149.36 0.14 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 111.178 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' CYS . 18.6 t -132.08 154.87 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 144.5 33.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 158.42 51.43 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.508 2.139 . . . . 0.0 112.422 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.43 69.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.4 m -142.96 -178.5 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.1 mm? -64.9 -50.83 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.656 ' HA ' HD12 ' A' ' 53' ' ' LEU . 78.9 p -59.14 -37.54 77.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.018 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.17 -41.21 67.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.31 -46.94 84.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.746 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.8 m -68.06 -28.81 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.196 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.27 55.09 0.87 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.438 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.656 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.0 mt -102.29 166.95 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HA ' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER 179.19 165.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.684 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 41' ' ' HIS . 4.3 mt -58.21 132.77 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.72 -30.42 6.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.32 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB3' HG13 ' A' ' 89' ' ' ILE . 2.1 m-20 -60.06 171.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.646 0.26 . . . . 0.0 110.736 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.563 ' CB ' ' HB3' ' A' ' 93' ' ' ALA . 4.9 tm0? -152.12 110.34 3.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.407 HG21 ' CG2' ' A' ' 62' ' ' VAL . 6.4 mt -69.45 117.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 88' ' ' SER . 35.7 m -101.49 4.14 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.998 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.37 148.44 1.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 87' ' ' ILE . 41.3 t -151.85 104.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 60.33 30.78 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.03 13.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.3 133.04 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.17 116.67 21.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.633 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.7 m-85 -92.14 13.7 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -33.75 76.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.556 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -140.75 32.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.645 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.55 HD21 ' N ' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -81.72 146.77 29.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.6 167.69 21.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -65.32 -57.32 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -39.13 72.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -60.47 -38.38 84.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -66.4 -45.79 78.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.781 HG11 HG21 ' B' ' 116' ' ' THR . 22.1 t -68.55 -43.98 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -55.36 -57.15 13.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.7 m -57.55 -45.53 86.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.267 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.553 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.6 mm? -65.26 -30.2 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -82.56 -31.77 28.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -59.53 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.82 135.16 36.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.33 -39.64 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -108.2 87.27 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.588 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -127.05 145.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 14' ' ' PHE . 43.0 m -90.44 121.36 32.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.117 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.89 HG22 HG22 ' A' ' 62' ' ' VAL . 7.5 pt -116.67 126.36 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.56 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -95.58 109.52 21.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.258 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.54 149.58 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.306 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.7 t -123.66 118.47 54.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.62 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.588 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -58.96 138.42 57.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.674 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.48 -18.26 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.245 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.563 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -61.57 -18.88 61.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.44 -30.97 2.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.48 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -56.64 -34.22 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -48.14 -46.11 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.9 HD21 ' HB3' ' A' ' 34' ' ' LYS . 34.5 mt -71.32 -45.24 63.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.87 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 9.8 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.772 0.32 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.781 HG21 HG11 ' A' ' 76' ' ' VAL . 58.7 m -140.87 132.5 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.85 143.61 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.735 HD11 HG12 ' A' ' 27' ' ' ILE . 1.4 mp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.839 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.854 0.359 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HE3' HG23 ' A' ' 89' ' ' ILE . 14.3 ttpp -101.98 145.9 28.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -110.91 142.06 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.577 HG13 ' HB ' ' A' ' 51' ' ' VAL . 42.0 t -142.62 151.63 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.4 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.562 ' CE1' HG23 ' A' ' 86' ' ' THR . 22.6 m-85 -130.08 131.78 45.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.694 HG23 HD13 ' A' ' 47' ' ' LEU . 17.2 mm -129.44 104.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.845 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 1.1 t . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.163 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.8 tp . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 84.67 33.33 19.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.767 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' A' ' 42' ' ' VAL . 1.7 t -152.13 156.5 39.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.792 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -114.55 173.73 6.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.859 HD11 HG22 ' A' ' 76' ' ' VAL . 9.2 pt -136.94 137.37 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.248 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -120.07 161.88 20.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.771 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 p -105.16 154.33 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.28 179.69 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.723 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HD2' HD13 ' A' ' 97' ' ' LEU . 61.6 Cg_endo -73.17 -168.27 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.645 2.23 . . . . 0.0 112.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -75.07 -26.9 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.134 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.48 -33.48 74.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.8 mtmm -149.86 76.32 8.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.25 141.89 26.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.697 2.264 . . . . 0.0 112.312 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.66 171.54 25.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.616 HG13 ' HB2' ' A' ' 75' ' ' ALA . 12.8 mm -82.91 114.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.419 ' CD1' ' HG3' ' A' ' 58' ' ' GLN . 93.8 m-85 -103.01 174.05 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.495 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.2 mm -107.81 135.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.536 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.2 -169.68 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.243 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.43 141.39 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.661 HG12 ' SG ' ' A' ' 25' ' ' CYS . 1.9 m -123.86 147.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.107 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.89 153.3 39.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.33 179.56 5.38 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.575 2.183 . . . . 0.0 112.328 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.1 34.67 47.36 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.547 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 18.5 p -132.13 -165.72 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 110.848 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.694 HD13 HG23 ' A' ' 15' ' ' ILE . 9.7 mt -88.38 -42.61 12.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.707 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.9 p -53.05 -39.24 63.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.605 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.08 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.54 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.75 -42.43 95.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 13' ' ' VAL . 32.5 m -78.66 -34.72 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.62 60.62 0.41 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.285 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 48' ' ' SER . 21.6 mt -110.91 164.47 12.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 175.94 165.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 4.1 mt -54.93 139.96 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.009 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 110.72 -30.41 8.14 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.183 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' HB3' HG13 ' A' ' 89' ' ' ILE . 85.7 m-20 -70.61 165.56 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.668 0.271 . . . . 0.0 110.491 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 4.0 tt0 -151.35 117.07 5.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.17 117.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 88' ' ' SER . 34.3 m -98.08 5.06 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.828 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.84 156.77 1.12 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.911 0.386 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.678 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 94.2 t -154.19 100.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.45 29.98 17.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.18 -31.21 8.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 70' ' ' LEU . 21.9 t -58.86 120.13 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.16 104.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.678 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.4 m-85 -91.32 9.21 32.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.64 70.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -141.28 30.55 1.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -81.71 147.49 29.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.9 158.37 34.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -57.47 -51.96 67.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.019 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -39.5 84.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' C ' HD21 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.52 -41.86 95.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.731 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -62.89 -47.31 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.016 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.859 HG22 HD11 ' A' ' 27' ' ' ILE . 28.1 t -68.99 -35.7 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.52 -58.74 6.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG23 HD22 ' A' ' 79' ' ' LEU . 34.6 m -57.49 -43.65 83.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.731 0.301 . . . . 0.0 110.952 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 75' ' ' ALA . 2.3 mm? -61.67 -34.09 75.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.84 -27.74 30.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.748 ' O ' HD11 ' A' ' 85' ' ' LEU . 45.6 t -93.23 140.54 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.117 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -79.06 -42.81 25.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.569 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.2 t -104.74 92.08 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.632 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.748 HD11 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -121.21 146.23 47.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.562 HG23 ' CE1' ' A' ' 14' ' ' PHE . 6.7 m -101.57 116.97 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.218 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.602 HG22 HG22 ' A' ' 62' ' ' VAL . 10.7 pt -106.84 125.79 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.599 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.667 ' O ' HG22 ' A' ' 60' ' ' VAL . 15.0 m -96.91 103.5 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.133 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -109.26 147.52 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.588 ' N ' HD13 ' A' ' 89' ' ' ILE . 24.4 t -120.92 114.95 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.4 137.88 47.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.49 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.87 -17.39 0.48 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.102 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.52 -21.97 29.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.798 0.333 . . . . 0.0 111.212 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.69 -31.12 2.02 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.521 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 1.1 mtp-105 -56.96 -34.64 68.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.498 0.19 . . . . 0.0 111.289 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -51.89 -49.96 61.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.498 HD13 ' HD2' ' A' ' 31' ' ' PRO . 13.6 mt -71.35 -40.09 70.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.997 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.428 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 1.9 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.809 0.338 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.835 HG21 HG21 ' A' ' 76' ' ' VAL . 69.2 m -128.81 123.71 33.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -88.28 121.99 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.63 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.3 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.798 ' HA ' HG22 ' A' ' 90' ' ' VAL . 8.5 mp0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.762 0.315 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 6.1 ttpm? -98.01 148.07 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.977 0.418 . . . . 0.0 110.955 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.98 145.22 30.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.725 HG13 ' HB ' ' A' ' 51' ' ' VAL . 60.4 t -147.99 146.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -137.1 120.67 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.606 HD12 ' CD1' ' A' ' 23' ' ' LEU . 28.1 mm -105.12 117.7 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 179.917 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD1' HD12 ' A' ' 15' ' ' ILE . 11.8 tp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.885 0.374 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 107.61 16.77 12.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.741 ' SG ' HG23 ' A' ' 39' ' ' ILE . 36.8 t -140.68 156.23 46.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -114.83 173.6 6.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.776 HD11 HG22 ' A' ' 76' ' ' VAL . 8.3 pt -138.9 141.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 111.092 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -131.02 161.66 31.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -105.15 145.2 30.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.16 178.47 44.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.659 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.38 -168.15 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.64 2.227 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.2 mp -71.33 -26.84 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -69.76 -30.11 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.748 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.6 ttmm -149.5 68.39 9.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.83 140.15 22.95 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.206 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.72 -179.67 36.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 75' ' ' ALA . 11.3 mm -88.63 114.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.624 ' CE2' HD12 ' A' ' 97' ' ' LEU . 34.1 m-85 -111.07 176.85 4.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.316 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.741 HG23 ' SG ' ' A' ' 25' ' ' CYS . 22.8 mm -107.56 136.66 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.706 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.29 -169.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.396 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -44.41 140.66 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.401 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' SG ' ' A' ' 25' ' ' CYS . 21.2 t -117.6 157.97 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.31 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 42' ' ' VAL . 11.1 mmpt? -99.76 129.81 27.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.98 -50.3 13.69 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.477 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.33 75.52 1.01 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.497 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -160.92 -179.81 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.968 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.86 -41.86 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.8 p -52.91 -43.78 66.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.9 77.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.638 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.39 -36.75 76.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.725 ' HB ' HG13 ' A' ' 13' ' ' VAL . 19.3 m -85.25 -26.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.52 39.9 1.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.399 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 48' ' ' SER . 13.7 mt -89.64 134.13 34.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -149.44 163.27 38.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.578 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 33.9 mt -58.86 148.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -22.7 39.58 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.32 161.9 28.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.665 0.269 . . . . 0.0 110.663 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -141.5 114.57 8.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.26 117.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.544 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 88' ' ' SER . 25.0 m -103.49 3.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.984 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.03 152.0 1.14 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.366 . . . . 0.0 111.236 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.918 HG13 HG22 ' A' ' 87' ' ' ILE . 48.6 t -151.53 105.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.961 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.57 29.87 17.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.98 -28.31 16.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.9 t -59.4 122.86 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.11 111.7 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.663 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.8 m-85 -90.2 -2.39 58.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.346 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -59.76 -41.83 91.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.26 31.41 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.621 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -88.7 147.56 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.79 161.43 23.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -59.05 -50.53 73.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -59.49 -40.07 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -43.17 99.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.621 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -60.21 -44.55 95.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.776 HG22 HD11 ' A' ' 27' ' ' ILE . 43.6 t -70.2 -43.63 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.088 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -54.88 -52.87 61.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.274 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 79' ' ' LEU . 26.9 m -61.96 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.625 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.5 mm? -64.45 -31.52 72.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.626 ' HE3' HD23 ' B' ' 118' ' ' LEU . 1.1 mptm? -82.6 -31.87 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.27 -67.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.561 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.0 OUTLIER -81.75 133.43 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.047 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -76.02 -57.23 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 m -99.74 97.62 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -131.12 141.01 50.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.284 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.8 m -93.5 132.99 37.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.281 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.918 HG22 HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -125.15 140.12 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.704 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.664 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.5 m -101.37 108.83 20.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -112.72 147.43 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.037 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.798 HG22 ' HA ' ' A' ' 10' ' ' GLU . 36.4 t -115.13 123.37 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.648 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -63.59 134.7 55.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.757 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.86 -17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.543 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.75 -20.26 21.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.373 . . . . 0.0 111.139 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 -30.38 2.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.733 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -56.03 -34.71 66.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.58 -50.01 34.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.757 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.748 HD21 ' CB ' ' A' ' 34' ' ' LYS . 11.0 mt -71.55 -47.4 55.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.993 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 7.9 m-85 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 31.0 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.791 0.329 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.599 HG21 HG11 ' A' ' 76' ' ' VAL . 33.5 m -113.74 150.94 32.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.18 135.26 45.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.626 HD23 ' HE3' ' A' ' 80' ' ' LYS . 1.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.598 ' HA ' HG22 ' A' ' 90' ' ' VAL . 1.3 mt-10 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.768 0.318 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 14.3 ttpt -95.69 133.94 39.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -96.0 143.94 26.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.636 HG13 ' HB ' ' A' ' 51' ' ' VAL . 28.6 t -149.51 153.24 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.262 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.27 121.79 22.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mm -112.55 136.6 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.415 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.405 ' O ' HD13 ' A' ' 47' ' ' LEU . 1.7 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.8 tp . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.34 24.24 7.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.377 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.615 ' SG ' HG23 ' A' ' 39' ' ' ILE . 41.8 t -149.44 159.05 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -114.44 173.57 6.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.191 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.733 HD11 HG22 ' A' ' 76' ' ' VAL . 20.6 pt -137.05 149.35 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.432 . . . . 0.0 111.407 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -128.57 162.23 27.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.696 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.7 139.48 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.7 179.67 45.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.047 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.815 ' CD ' HD12 ' A' ' 97' ' ' LEU . 56.8 Cg_endo -70.04 -160.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.959 2.44 . . . . 0.0 112.346 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -86.01 -28.25 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -64.57 -32.81 74.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HB2' HD11 ' A' ' 97' ' ' LEU . 5.7 mttt -142.38 76.55 18.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.809 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 126.32 10.57 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.153 . . . . 0.0 112.423 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.01 173.98 41.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.511 HG13 ' HB2' ' A' ' 75' ' ' ALA . 21.5 mm -87.51 115.97 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 5.3 m-85 -100.61 172.54 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.615 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.5 mm -107.77 134.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.029 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.15 -169.27 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -46.22 141.41 3.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 25' ' ' CYS . 6.5 t -111.15 157.13 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.072 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' N ' HG12 ' A' ' 42' ' ' VAL . 33.1 mttt -108.41 112.53 60.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 155.32 9.47 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.405 2.07 . . . . 0.0 112.28 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.1 29.37 74.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.504 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.433 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 71.3 p -124.6 -170.72 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 16' ' ' SER . 6.9 mt -76.39 -45.42 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.763 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 11.6 p -52.9 -37.21 60.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.974 0.416 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.38 -37.99 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.563 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.43 -31.19 69.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.801 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.0 m -86.59 -30.56 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.74 58.81 0.59 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.374 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.28 167.82 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -179.75 162.24 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -56.8 142.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.24 -23.53 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.133 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.58 163.47 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.6 tt0 -148.59 115.14 5.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.089 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.35 117.32 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.694 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 88' ' ' SER . 35.8 m -97.9 -4.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.892 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.82 150.73 8.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.948 HG22 HG22 ' A' ' 87' ' ' ILE . 61.4 t -149.5 98.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.72 35.39 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.44 -27.93 15.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.545 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.6 124.42 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 109.73 5.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.727 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.9 m-85 -87.5 -10.02 52.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.362 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.7 p -56.42 -31.92 64.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.852 0.358 . . . . 0.0 111.0 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -132.92 32.09 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.3 tp -92.09 147.59 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.24 162.14 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.17 -57.67 9.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -36.17 70.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -39.53 94.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.581 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -63.33 -46.68 85.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.816 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.84 HG11 HG21 ' B' ' 116' ' ' THR . 39.7 t -68.28 -35.43 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.952 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -58.77 6.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 79' ' ' LEU . 34.4 m -57.32 -41.23 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.324 . . . . 0.0 111.097 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.411 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.7 mm? -66.43 -31.97 73.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.642 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.6 mptp? -82.57 -31.17 29.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.227 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -74.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.629 ' OG ' HD23 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -66.56 118.85 10.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.08 -56.97 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.92 105.54 15.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.65 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -131.31 144.51 51.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.966 0.413 . . . . 0.0 111.41 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.21 116.93 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.146 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.948 HG22 HG22 ' A' ' 62' ' ' VAL . 10.2 pt -109.69 127.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.654 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -99.75 103.53 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.659 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -105.08 145.49 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.08 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.6 t -115.24 117.25 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.713 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.579 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.57 135.48 56.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.935 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.95 -17.35 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.432 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.78 -19.99 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.15 -29.99 3.08 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.578 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 2.4 ptp180 -55.4 -34.67 64.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.569 0.223 . . . . 0.0 111.277 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -55.99 -43.62 77.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.042 0.448 . . . . 0.0 110.11 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.815 HD12 ' CD ' ' A' ' 31' ' ' PRO . 2.8 mm? -71.44 -50.11 34.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.794 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.388 -179.745 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.84 HG21 HG11 ' A' ' 76' ' ' VAL . 80.3 m -133.25 136.37 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -88.71 112.33 23.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.642 HD23 ' HE2' ' A' ' 80' ' ' LYS . 4.1 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -115.36 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -91.73 135.27 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.882 HG13 ' HB ' ' A' ' 51' ' ' VAL . 48.6 t -137.47 142.22 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.998 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -125.87 130.0 50.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 HD12 HD12 ' A' ' 23' ' ' LEU . 30.3 mm -122.02 106.48 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 9.4 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 25' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.68 0.276 . . . . 0.0 110.446 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.89 33.17 6.17 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.631 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.799 ' HB3' HD21 ' A' ' 23' ' ' LEU . 1.9 t -151.45 168.9 23.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 0.0 110.794 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 14.9 m -114.69 172.28 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.418 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.973 HD11 HG22 ' A' ' 76' ' ' VAL . 3.6 pt -142.34 140.34 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 111.203 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 t -122.49 161.72 23.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.995 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -105.25 138.7 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.13 38.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.514 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' HD13 ' A' ' 97' ' ' LEU . 38.4 Cg_endo -66.64 -172.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.54 2.16 . . . . 0.0 112.28 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -70.12 -25.17 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -70.13 -27.49 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.166 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HB3' HD11 ' A' ' 97' ' ' LEU . 6.5 mtpt -147.7 64.07 8.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.249 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 17.3 Cg_exo -66.75 126.2 14.99 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.195 . . . . 0.0 112.1 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.72 42.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 67' ' ' PHE . 11.2 mm -89.88 115.51 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.056 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.908 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.9 m-85 -103.61 171.72 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mm -107.55 134.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.366 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -106.12 -169.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.439 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -47.74 144.84 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.166 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.78 HG22 ' SG ' ' A' ' 25' ' ' CYS . 1.7 t -110.26 157.92 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 3.0 mptt -115.07 133.62 22.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 51.5 Cg_exo -55.4 161.52 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.438 2.092 . . . . 0.0 112.293 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.46 70.36 0.97 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.446 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -161.75 -167.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 110.976 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.629 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.5 mm? -84.76 -44.67 13.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.3 p -55.71 -39.49 71.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.926 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.96 79.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.5 -44.49 96.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.882 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.1 m -71.75 -24.89 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 63.76 1.06 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 48' ' ' SER . 15.6 mt -105.67 164.94 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.26 162.25 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.65 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.8 mt -56.88 143.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.96 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.5 -34.87 5.23 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.201 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.92 162.37 19.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.6 117.52 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.156 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.22 117.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.467 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 88' ' ' SER . 33.9 m -100.45 -18.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.744 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.03 149.57 27.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.758 HG13 HG22 ' A' ' 87' ' ' ILE . 46.8 t -143.83 95.05 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.086 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 59.9 36.86 21.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -29.8 9.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.542 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.08 116.62 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.14 119.66 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.729 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.4 m-85 -96.78 22.66 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.7 t -79.92 -58.85 2.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -104.49 29.03 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.644 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -89.12 147.75 24.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -82.66 173.73 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -68.65 -54.25 17.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -56.61 -39.15 73.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' A' ' 70' ' ' LEU . 29.9 mt-10 -60.05 -42.81 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.762 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.37 -46.45 90.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.978 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 27' ' ' ILE . 26.0 t -69.35 -38.82 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.9 -53.6 55.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.163 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 79' ' ' LEU . 33.9 m -59.45 -43.59 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.908 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.807 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.0 mm? -64.32 -35.22 80.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.488 . . . . 0.0 110.65 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -82.92 -26.25 31.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.681 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -85.29 -67.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.588 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -52.93 -37.34 60.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.496 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 67.36 -72.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.282 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.7 p -90.19 86.0 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.023 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.807 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -130.73 146.22 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.589 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.2 m -94.51 116.73 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.758 HG22 HG13 ' A' ' 62' ' ' VAL . 7.9 pt -110.86 127.64 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 0.0 111.634 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -98.72 107.84 20.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.97 146.88 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.709 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -109.58 130.01 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -70.08 130.63 42.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.432 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 87.13 -17.23 0.35 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.47 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.709 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -54.55 -21.31 9.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 111.262 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.92 -30.74 2.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.725 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 4.5 ptp180 -56.59 -34.67 67.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.462 0.172 . . . . 0.0 111.385 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.52 -50.13 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.908 HD12 ' CE2' ' A' ' 38' ' ' PHE . 17.1 mt -71.56 -41.8 68.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.774 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 27.2 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.854 0.359 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.622 HG21 HG21 ' A' ' 76' ' ' VAL . 31.6 m -119.31 151.01 39.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 124.63 49.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.495 HD22 HG13 ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.802 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 90' ' ' VAL . 1.8 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.728 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -101.34 120.35 40.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.23 143.47 27.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.782 HG13 ' HB ' ' A' ' 51' ' ' VAL . 26.2 t -151.36 151.92 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.221 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.51 131.08 39.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 mm -120.1 134.95 61.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.276 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' A' ' 48' ' ' SER . 13.9 tp . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.923 0.392 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.33 17.19 14.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.469 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.749 ' SG ' HG22 ' A' ' 42' ' ' VAL . 4.8 t -142.88 166.95 23.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.7 m -114.49 169.44 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.67 HG22 HD13 ' A' ' 39' ' ' ILE . 30.6 pt -142.66 155.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.983 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.508 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 m -146.62 162.1 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.84 150.94 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 97' ' ' LEU . . . -89.89 -172.93 45.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.907 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.09 -164.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.661 2.24 . . . . 0.0 112.418 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.3 -25.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.375 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.6 -29.86 70.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HB3' HD21 ' A' ' 97' ' ' LEU . 2.0 ttpt -156.41 66.06 4.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.77 116.6 3.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.493 2.129 . . . . 0.0 112.176 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.84 141.78 8.31 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.0 mm -82.76 106.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.574 0.226 . . . . 0.0 110.889 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 4.3 p90 -100.55 -176.35 3.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.67 HD13 HG22 ' A' ' 27' ' ' ILE . 18.6 mm -107.06 140.53 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 111.625 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -169.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.109 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -46.34 143.52 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.087 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.749 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -110.3 150.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.982 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -106.33 108.84 62.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.78 145.3 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.332 2.022 . . . . 0.0 112.315 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.7 40.21 9.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.304 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.515 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.5 m -144.42 -173.52 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.563 HD22 ' H ' ' A' ' 47' ' ' LEU . 2.1 mm? -67.93 -48.51 65.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.676 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.556 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.36 97.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 110.599 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.39 -53.1 62.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.782 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.7 m -67.54 -28.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.207 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.54 65.61 0.83 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 48' ' ' SER . 17.3 mt -106.24 156.5 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -167.0 162.59 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.439 HG23 ' CZ ' ' A' ' 98' ' ' PHE . 3.7 mt -56.26 146.71 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.009 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.33 -32.43 7.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.34 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' CB ' HD11 ' A' ' 89' ' ' ILE . 49.5 m-20 -58.9 164.99 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.578 0.228 . . . . 0.0 110.862 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -147.55 113.66 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.7 mt -69.36 117.09 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 88' ' ' SER . 26.8 m -105.61 7.85 9.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.946 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.7 145.67 0.54 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 87' ' ' ILE . 58.0 t -148.43 99.27 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.886 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.47 30.82 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.9 13.21 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.14 129.49 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.75 121.92 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.0 m-85 -99.19 26.68 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.27 -66.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.49 30.69 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.618 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 74' ' ' GLU . 1.4 tp -79.51 145.52 33.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.06 162.89 24.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.792 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 28' ' ' SER . 3.3 t-160 -60.51 -54.13 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.11 -38.47 70.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.635 ' HB3' HD11 ' A' ' 70' ' ' LEU . 20.8 mt-10 -61.39 -47.23 86.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.6 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -58.35 -44.72 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.863 HG11 HG21 ' B' ' 116' ' ' THR . 27.4 t -69.71 -45.49 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.3 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -55.03 -53.57 54.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.256 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.3 m -60.22 -43.42 93.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.078 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.541 ' HB3' HD22 ' B' ' 118' ' ' LEU . 3.4 mm? -67.49 -31.17 71.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.711 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.758 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.2 mptp? -82.53 -30.05 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -70.01 -66.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.223 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.634 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.3 m -81.45 118.79 22.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -68.8 -40.31 79.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.5 p -114.23 102.68 10.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -137.47 146.17 43.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -91.5 116.99 29.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.185 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 62' ' ' VAL . 16.1 pt -111.36 130.99 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.642 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -102.99 103.61 13.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.322 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.728 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -104.62 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 10' ' ' GLU . 42.1 t -127.22 115.94 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.06 140.39 49.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.636 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.41 -22.72 0.22 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.014 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -59.69 -20.79 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.906 0.384 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.03 3.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -56.68 -34.61 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -50.26 -49.65 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.712 HD21 ' HB3' ' A' ' 34' ' ' LYS . 20.4 mt -71.09 -39.83 71.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CE2' ' CD2' ' A' ' 38' ' ' PHE . 4.1 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.161 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.863 HG21 HG11 ' A' ' 76' ' ' VAL . 95.9 m -129.37 145.98 51.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.41 116.38 31.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.758 HD23 ' HE2' ' A' ' 80' ' ' LYS . 3.2 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -117.97 141.25 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 138.84 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 HG11 ' A' ' 51' ' ' VAL . 55.7 t -139.98 136.69 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.63 ' HD2' HG23 ' A' ' 86' ' ' THR . 31.6 t80 -119.51 117.67 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' CG1' HD11 ' A' ' 87' ' ' ILE . 29.1 mm -106.81 126.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' A' ' 48' ' ' SER . 16.9 tp . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.68 26.93 11.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.433 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.828 ' SG ' HG22 ' A' ' 42' ' ' VAL . 50.6 t -147.37 159.33 43.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.416 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 3.1 m -114.43 173.65 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.929 HD11 HG22 ' A' ' 76' ' ' VAL . 9.2 pt -139.4 157.47 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.399 . . . . 0.0 111.37 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.29 162.03 28.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.483 ' HG ' ' HB2' ' A' ' 72' ' ' HIS . 1.1 m -104.8 140.82 37.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.523 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 162.1 31.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' HD12 ' A' ' 97' ' ' LEU . 27.6 Cg_endo -62.11 -159.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.955 2.437 . . . . 0.0 112.216 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.67 -27.63 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.95 -29.89 55.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -141.05 60.77 13.11 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.88 135.04 20.75 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.29 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 37' ' ' ILE . . . 176.25 -146.96 8.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.621 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.491 HD11 ' O ' ' A' ' 71' ' ' ASP . 19.7 mm -127.13 111.14 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.999 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 20.0 m-85 -100.58 173.55 6.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.557 HG23 ' SG ' ' A' ' 25' ' ' CYS . 16.5 mm -107.84 133.21 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.88 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 26' ' ' SER . 0.6 OUTLIER -106.12 -169.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.724 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.432 ' ND1' HD11 ' A' ' 55' ' ' ILE . 86.0 m-70 -44.71 133.93 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.645 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.828 HG22 ' SG ' ' A' ' 25' ' ' CYS . 22.2 t -111.01 148.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.55 145.21 30.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.02 172.12 15.33 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.503 2.135 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.14 33.87 61.67 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.506 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -131.73 -172.79 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.9 mm? -77.42 -47.43 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.5 p -59.44 -35.92 74.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.35 72.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.89 -39.99 91.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.785 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 13' ' ' VAL . 28.6 m -75.11 -29.76 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.03 55.14 0.93 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 48' ' ' SER . 14.4 mt -97.0 144.98 26.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.42 162.83 40.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.432 HD11 ' ND1' ' A' ' 41' ' ' HIS . 3.1 mt -56.96 138.54 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.085 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 116.82 -40.14 2.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.446 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -55.54 166.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.737 0.303 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.68 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 20.3 tm0? -146.79 116.72 7.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.47 120.08 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 88' ' ' SER . 29.7 m -100.09 -18.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.597 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -158.67 155.14 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.312 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 87' ' ' ILE . 56.2 t -153.1 109.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 58.77 30.8 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.6 -31.09 8.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.489 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.54 131.88 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.29 116.4 17.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE1' HD22 ' A' ' 70' ' ' LEU . 2.1 m-85 -89.79 -9.4 49.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.321 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.8 t -55.38 -30.73 60.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -130.41 32.52 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.671 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.5 tp -96.46 147.63 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.491 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -77.99 174.22 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.483 ' HB2' ' HG ' ' A' ' 29' ' ' SER . 2.0 t-160 -68.97 -54.7 13.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.78 -38.32 78.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.567 ' HB3' HD11 ' A' ' 70' ' ' LEU . 24.6 mt-10 -60.62 -44.57 96.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.671 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -63.1 -40.88 98.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.929 HG22 HD11 ' A' ' 27' ' ' ILE . 39.6 t -70.26 -47.0 69.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -52.67 62.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.244 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 79' ' ' LEU . 34.3 m -60.17 -44.78 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.4 mm? -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.7 mptp? -81.84 -30.67 31.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -69.9 -67.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.254 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -83.39 138.82 33.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -89.99 -55.26 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -91.85 81.92 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.592 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -121.03 145.22 48.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.63 HG23 ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -92.49 119.36 31.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.034 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.934 HG22 HG22 ' A' ' 62' ' ' VAL . 7.2 pt -116.55 122.44 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.792 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -95.84 122.7 38.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -129.32 144.74 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -111.69 131.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.623 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -68.58 132.51 47.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.249 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 86.26 -17.89 0.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -55.09 -20.9 10.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.34 -29.99 2.18 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.751 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 44.4 mtp85 -55.56 -34.46 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.531 0.205 . . . . 0.0 111.188 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -49.3 -39.81 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.046 0.451 . . . . 0.0 110.358 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.589 HD12 ' CD ' ' A' ' 31' ' ' PRO . 3.2 mm? -71.29 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.851 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.387 -179.719 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.7 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.843 0.354 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.916 HG21 HG21 ' A' ' 76' ' ' VAL . 29.9 m -133.03 131.6 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.11 137.17 32.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.173 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.554 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.843 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' CB ' HG22 ' A' ' 90' ' ' VAL . 2.2 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.808 0.337 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 91' ' ' ALA . 7.0 ttpm? -101.28 140.5 35.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.29 134.6 41.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 51' ' ' VAL . 60.9 t -139.56 147.23 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HD1' ' HG1' ' A' ' 86' ' ' THR . 82.7 t80 -135.96 126.16 26.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.458 HD12 ' CD1' ' A' ' 23' ' ' LEU . 32.1 mm -114.49 115.06 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.266 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' CD1' HD12 ' A' ' 15' ' ' ILE . 14.7 tp . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.85 0.357 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.73 25.23 12.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.347 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' HG23 ' A' ' 39' ' ' ILE . 32.5 t -148.98 159.02 44.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -114.32 173.8 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 76' ' ' VAL . 17.5 pt -137.96 141.25 39.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.255 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -119.09 161.72 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.06 147.9 27.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.66 175.37 43.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.69 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.36 -165.6 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.662 2.241 . . . . 0.0 112.262 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.6 -28.93 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.253 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -78.54 -28.91 46.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -138.63 60.08 18.75 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.42 136.49 21.78 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.43 -172.03 44.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.534 HD11 ' O ' ' A' ' 71' ' ' ASP . 19.3 mm -98.08 115.21 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.103 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.619 ' CE2' HD12 ' A' ' 97' ' ' LEU . 6.1 m-85 -110.89 175.9 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.664 HG23 ' SG ' ' A' ' 25' ' ' CYS . 20.1 mm -107.69 137.04 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.375 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.16 -169.41 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.436 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -48.83 141.42 7.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 25' ' ' CYS . 11.0 t -110.93 154.14 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -109.81 146.27 33.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 161.4 45.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.52 2.146 . . . . 0.0 112.291 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.68 57.47 19.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.404 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.484 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -152.59 -173.42 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.98 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.2 mm? -73.22 -48.59 33.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.585 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.644 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -55.07 -42.11 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.97 82.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.62 -41.79 87.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.706 ' HB ' HG13 ' A' ' 13' ' ' VAL . 36.0 m -74.26 -30.04 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.063 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.91 61.84 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.9 mt -109.58 162.99 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.2 162.29 3.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.629 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.449 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 6.3 mt -54.86 145.68 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.44 -30.58 10.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.301 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.23 162.91 8.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.263 . . . . 0.0 110.601 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 3.6 tm0? -144.93 113.73 6.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 39' ' ' ILE . 3.5 mt -69.22 117.14 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.774 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 88' ' ' SER . 35.9 m -92.95 -25.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.648 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -152.86 158.11 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 111.283 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.8 HG13 HG22 ' A' ' 87' ' ' ILE . 59.8 t -149.98 103.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.952 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 63.76 30.2 14.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 -26.82 19.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.623 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.37 130.54 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.72 125.3 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.7 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -99.35 -17.62 17.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.269 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -50.55 65.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.786 0.327 . . . . 0.0 111.092 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.07 30.77 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.572 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -98.53 146.69 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.534 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -75.24 170.93 15.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -70.89 -55.82 7.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -58.12 -34.07 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -40.31 91.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.66 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -62.86 -44.48 96.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.805 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 27' ' ' ILE . 38.9 t -69.55 -35.76 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 -52.35 63.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.7 m -61.13 -43.38 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.535 ' HB3' HD22 ' B' ' 118' ' ' LEU . 3.7 mm? -65.94 -30.8 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.89 ' HE2' HD23 ' B' ' 118' ' ' LEU . 2.4 mptp? -82.61 -34.19 27.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.61 -65.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.81 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -79.1 125.32 29.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -73.71 -43.97 57.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.604 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.2 p -115.08 98.89 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.53 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.81 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -129.3 146.16 51.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.98 0.419 . . . . 0.0 111.277 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.451 ' HG1' ' HD1' ' A' ' 14' ' ' PHE . 12.4 m -92.9 116.98 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.198 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.8 HG22 HG13 ' A' ' 62' ' ' VAL . 14.2 pt -114.02 129.2 70.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 111.673 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.699 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.4 m -101.84 110.32 22.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.354 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -110.5 147.04 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.209 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.484 ' N ' HD13 ' A' ' 89' ' ' ILE . 29.1 t -117.06 113.34 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.24 141.09 47.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.8 -19.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.957 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -58.92 -20.17 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.47 -30.51 2.03 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.502 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -56.08 -34.13 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -48.14 -42.83 30.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.744 0.306 . . . . 0.0 110.616 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.619 HD12 ' CE2' ' A' ' 38' ' ' PHE . 56.6 mt -71.35 -49.31 43.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.717 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 17.1 m-85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.13 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.821 0.343 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.591 HG21 HG11 ' A' ' 76' ' ' VAL . 90.1 m -125.49 151.0 46.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.24 108.6 20.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.89 HD23 ' HE2' ' A' ' 80' ' ' LYS . 52.2 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.597 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.3 mt-10 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.806 0.336 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 12.8 ttpp -100.28 114.6 28.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -86.53 142.6 28.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.563 HG13 ' HB ' ' A' ' 51' ' ' VAL . 21.8 t -148.56 158.86 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.487 ' N ' HG12 ' A' ' 13' ' ' VAL . 51.1 p90 -141.07 116.88 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.706 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG1' HD11 ' A' ' 87' ' ' ILE . 39.4 mm -102.43 135.45 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.196 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.2 tp . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 111.11 23.44 5.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.402 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' HG22 ' A' ' 42' ' ' VAL . 13.8 t -150.7 164.3 36.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.65 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -114.43 173.32 6.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.391 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.945 HD11 HG22 ' A' ' 76' ' ' VAL . 2.2 pt -137.15 146.67 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.389 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.5 p -125.17 161.87 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.734 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.93 144.52 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.83 38.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.882 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 97' ' ' LEU . 34.6 Cg_endo -64.28 -164.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.771 2.314 . . . . 0.0 112.32 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -81.96 -28.93 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.17 -29.56 54.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.673 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.3 tttp -141.83 60.54 11.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.85 147.82 35.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.41 175.88 32.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.4 mm -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.953 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.746 ' CE2' HD12 ' A' ' 97' ' ' LEU . 26.3 m-85 -108.5 174.53 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.9 mm -107.63 134.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.375 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -106.19 -169.42 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.392 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -45.28 153.06 0.23 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.36 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.858 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.8 t -125.48 157.98 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 138.75 27.9 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 155.44 69.45 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.41 2.073 . . . . 0.0 112.329 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.05 7.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.357 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.453 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -157.2 -170.29 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.726 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? -76.94 -45.35 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.852 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.9 p -55.7 -45.3 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.62 88.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -60.56 -40.12 90.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.563 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.5 m -76.83 -27.11 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.49 57.66 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -98.75 156.96 16.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -163.44 159.6 22.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mt -55.23 153.51 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.1 -23.93 31.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.221 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.67 159.46 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.279 . . . . 0.0 110.58 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 89' ' ' ILE . 2.5 tt0 -146.85 120.22 9.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 HG21 ' CG2' ' A' ' 62' ' ' VAL . 2.1 mt -69.31 117.18 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.6 m -97.32 -5.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.843 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.83 148.07 5.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.843 HG22 HG22 ' A' ' 87' ' ' ILE . 49.0 t -146.77 109.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 57.95 30.56 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.73 12.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.23 138.08 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.13 111.4 14.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.761 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.5 m-85 -91.09 11.08 24.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.317 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -75.27 -34.87 61.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -127.25 29.53 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.761 HD22 ' CE1' ' A' ' 67' ' ' PHE . 2.4 tp -87.35 148.92 24.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 163.87 21.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -56.62 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -57.81 -40.32 79.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -41.02 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.642 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -63.23 -46.05 88.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.945 HG22 HD11 ' A' ' 27' ' ' ILE . 35.7 t -69.4 -35.56 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.07 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -50.81 69.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.18 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.9 m -62.73 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.457 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.7 mm? -63.26 -31.87 73.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.62 -34.37 27.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 -62.4 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.684 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -83.84 134.56 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.193 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -98.41 25.88 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.855 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -177.93 71.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.1 OUTLIER -115.27 146.17 41.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.7 m -90.5 116.87 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.026 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 62' ' ' VAL . 8.1 pt -110.79 128.27 67.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.919 0.39 . . . . 0.0 111.582 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.23 122.19 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -128.19 147.39 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 10' ' ' GLU . 25.4 t -117.72 117.87 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.736 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.586 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.26 136.42 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.801 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.47 -17.5 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.276 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.73 35.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.11 -30.3 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.484 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -56.05 -34.4 65.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -48.38 -49.99 32.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.746 HD12 ' CE2' ' A' ' 38' ' ' PHE . 10.1 mt -71.76 -45.82 60.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.855 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.283 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.845 0.355 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.688 HG21 HG21 ' A' ' 76' ' ' VAL . 28.7 m -125.45 138.82 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.32 140.27 29.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.707 HD11 HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' CG ' HG22 ' A' ' 90' ' ' VAL . 3.1 mt-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 91' ' ' ALA . 5.9 ttpm? -96.78 136.93 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.093 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -100.6 136.08 41.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.844 HG13 ' HB ' ' A' ' 51' ' ' VAL . 48.4 t -141.92 143.96 26.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -128.34 124.92 37.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.46 HD13 HG11 ' A' ' 51' ' ' VAL . 28.9 mm -116.93 124.16 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.213 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.424 ' O ' HD11 ' A' ' 47' ' ' LEU . 11.1 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.4 tp . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.741 0.305 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 63.36 50.9 58.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.555 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.597 ' SG ' HG23 ' A' ' 39' ' ' ILE . 52.7 t -161.52 156.99 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.78 173.46 6.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.977 HD11 HG22 ' A' ' 76' ' ' VAL . 19.3 pt -142.01 133.65 26.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.341 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.06 162.17 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.734 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.86 145.7 30.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 110.381 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.6 160.33 30.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.028 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.535 ' CD ' HD12 ' A' ' 97' ' ' LEU . 59.0 Cg_endo -71.33 -160.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.827 2.351 . . . . 0.0 112.156 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.33 -29.57 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.67 -31.78 72.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.403 ' CB ' HD21 ' A' ' 97' ' ' LEU . 2.4 mtmt -155.4 74.31 5.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.28 125.99 10.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.589 2.193 . . . . 0.0 112.32 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.23 -178.99 48.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 75' ' ' ALA . 26.9 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 2.5 m-85 -107.54 170.39 8.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.597 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.7 mm -107.65 129.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 -169.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -46.72 141.2 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.36 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 43' ' ' LYS . 13.6 t -109.27 157.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.433 ' N ' HG12 ' A' ' 42' ' ' VAL . 24.7 mttp -120.91 145.28 41.12 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 17.3 Cg_exo -66.67 173.56 7.76 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.616 2.211 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.32 43.22 43.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.757 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -136.71 -174.16 3.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.369 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 16' ' ' SER . 46.9 mt -84.95 -35.24 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.463 ' HA ' HD12 ' A' ' 53' ' ' LEU . 16.4 p -56.28 -41.07 75.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.22 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.686 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -59.8 -39.66 85.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.6 m -80.45 -30.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.035 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.73 64.12 0.72 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 48' ' ' SER . 18.0 mt -108.25 164.56 12.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 111.005 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.05 162.62 5.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mt -59.83 140.44 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.811 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.08 -38.16 3.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.451 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -55.52 157.33 3.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.673 0.273 . . . . 0.0 110.767 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.407 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.44 114.99 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.161 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 39' ' ' ILE . 6.7 mt -69.06 121.09 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.869 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' SER . 32.0 m -109.47 9.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.885 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.62 146.5 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 111.336 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.675 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 61.9 t -151.0 106.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.68 30.94 20.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.016 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.41 13.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.29 129.67 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -71.45 107.35 4.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.852 ' CE1' HD22 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -82.54 0.02 44.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.376 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -60.53 -54.3 47.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -108.72 33.7 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.852 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -92.94 148.28 22.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' O ' HD11 ' A' ' 37' ' ' ILE . 4.8 t0 -89.52 170.57 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -62.76 -53.03 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -57.6 -38.0 74.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.569 ' O ' HG22 ' A' ' 78' ' ' VAL . 7.3 mt-10 -64.89 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.603 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -67.56 -42.07 83.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 27' ' ' ILE . 33.1 t -70.87 -46.58 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.04 -55.92 25.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 74' ' ' GLU . 33.8 m -58.39 -45.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.494 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.3 mm? -65.02 -30.83 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.715 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -82.58 -30.49 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -66.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -84.9 144.81 28.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -92.65 -57.6 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -89.86 77.67 6.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 139.23 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -92.74 116.9 29.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.12 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.644 HG22 HG22 ' A' ' 62' ' ' VAL . 10.1 pt -111.05 127.44 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.696 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.555 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -97.26 103.48 15.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.469 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -105.34 151.39 7.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.635 ' N ' HD13 ' A' ' 89' ' ' ILE . 31.7 t -124.89 114.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.768 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.38 136.63 49.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.506 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 84.59 -20.56 0.29 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.194 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.18 46.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.87 -30.13 2.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.519 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 63.4 mtp85 -55.43 -34.52 64.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 111.01 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -54.03 -37.13 63.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.128 0.489 . . . . 0.0 110.108 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.535 HD12 ' CD ' ' A' ' 31' ' ' PRO . 4.6 mm? -71.29 -55.27 8.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.419 ' CD2' ' HA2' ' A' ' 56' ' ' GLY . 23.6 m-85 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.847 0.356 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.736 HG21 HG11 ' A' ' 76' ' ' VAL . 25.5 m -115.13 151.04 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.94 125.95 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.54 ' CD1' HG23 ' A' ' 27' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.968 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.817 0.341 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.72 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -120.17 117.37 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.602 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -86.24 143.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.76 HG13 ' HB ' ' A' ' 51' ' ' VAL . 22.0 t -148.16 150.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.298 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -130.3 122.24 27.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.777 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.46 HD12 ' CD1' ' A' ' 23' ' ' LEU . 37.7 mm -110.33 129.4 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.28 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.1 tp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.826 0.345 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 93.88 29.16 10.08 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.383 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.726 ' SG ' HG22 ' A' ' 42' ' ' VAL . 42.7 t -155.93 157.55 36.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.531 ' HA ' HD12 ' B' ' 118' ' ' LEU . 17.8 m -114.7 173.8 6.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.91 HD11 HG22 ' A' ' 76' ' ' VAL . 7.1 pt -138.12 153.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.3 p -137.22 161.71 35.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -105.45 154.96 19.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -108.86 -177.35 21.64 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.764 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HD2' HD13 ' A' ' 97' ' ' LEU . 38.5 Cg_endo -66.49 -166.44 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -85.63 -23.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.236 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -69.75 -30.99 68.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HB3' HD11 ' A' ' 97' ' ' LEU . 8.2 tttt -146.47 69.54 12.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.92 143.12 32.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.93 163.78 20.11 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 67' ' ' PHE . 12.7 mm -81.63 114.56 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.671 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 2.8 m-30 -100.53 171.73 7.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.187 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.679 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.8 mm -107.72 121.03 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.017 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.6 OUTLIER -90.01 -169.41 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.548 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.51 140.08 2.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG22 ' SG ' ' A' ' 25' ' ' CYS . 23.6 t -119.53 140.11 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.711 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -104.44 149.68 37.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.32 168.42 21.02 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.658 2.238 . . . . 0.0 112.321 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.02 60.8 8.17 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.308 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.508 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -158.9 -177.62 6.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.984 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.2 mm? -71.65 -49.67 37.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.819 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.516 ' CB ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -56.72 -38.29 72.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.04 -38.43 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.79 -42.78 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.76 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.7 m -70.09 -27.26 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.273 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.97 52.58 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' A' ' 48' ' ' SER . 16.9 mt -94.96 160.25 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -159.57 158.55 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mt -58.55 136.56 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 111.47 -37.81 3.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -49.21 164.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.291 . . . . 0.0 110.908 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.622 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 19.9 tt0 -146.94 113.7 6.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.115 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.47 122.87 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -110.63 5.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.846 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -168.5 146.16 4.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 111.13 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 87' ' ' ILE . 39.1 t -152.22 107.92 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 57.51 31.06 19.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.13 14.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.9 127.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.878 0.371 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.09 119.24 16.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.628 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.6 m-85 -96.19 23.11 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 p -77.16 -57.14 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.585 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -108.41 29.37 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.675 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.628 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.8 tp -84.65 148.48 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.944 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.32 164.69 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -59.69 -55.04 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -56.99 -37.6 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HB3' HD11 ' A' ' 70' ' ' LEU . 55.6 mt-10 -61.94 -41.6 98.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.466 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.63 -47.32 85.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.91 HG22 HD11 ' A' ' 27' ' ' ILE . 43.0 t -68.59 -42.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.123 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -56.74 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 79' ' ' LEU . 31.8 m -58.49 -45.94 89.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.849 0.357 . . . . 0.0 111.146 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.4 mm? -63.42 -31.78 73.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.521 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -82.65 -29.51 29.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 t -65.97 -63.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.28 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.51 139.6 30.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -59.48 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.61 88.13 6.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.556 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.404 ' CD1' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -122.53 134.91 54.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -84.64 117.0 23.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.852 HG22 HG13 ' A' ' 62' ' ' VAL . 11.9 pt -112.38 133.61 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.636 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.0 114.67 29.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.572 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -114.53 152.31 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.956 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -123.13 115.86 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.498 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.611 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -58.61 134.12 56.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.74 -20.37 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.249 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.772 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -55.68 -24.32 33.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.091 0.472 . . . . 0.0 110.816 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.44 -30.32 1.73 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.134 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 42.3 mtp180 -56.06 -34.25 65.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.293 0.237 . . . . 0.0 111.287 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -48.18 -49.4 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.671 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 19.7 mt -71.33 -43.76 66.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.766 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.875 0.369 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.862 HG21 HG21 ' A' ' 76' ' ' VAL . 23.7 m -127.26 129.48 47.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.99 133.17 34.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.739 HD11 HG12 ' A' ' 27' ' ' ILE . 2.0 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.723 ' HA ' HG22 ' A' ' 90' ' ' VAL . 10.1 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.807 0.337 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 21.2 ttpt -114.67 150.26 35.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.775 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 148.15 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.873 HG13 ' HB ' ' A' ' 51' ' ' VAL . 50.5 t -147.28 141.75 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -126.11 117.77 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.618 HD13 HG11 ' A' ' 51' ' ' VAL . 31.6 mm -107.73 115.9 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.215 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.885 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 48' ' ' SER . 17.9 tp . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.851 0.358 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 59.96 50.2 70.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.733 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.38 152.82 24.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -114.89 173.57 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.824 HD11 HG22 ' A' ' 76' ' ' VAL . 6.9 pt -135.54 141.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.104 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -117.22 161.53 19.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.798 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -105.45 142.91 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.769 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -91.4 167.8 31.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.624 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.683 ' HD2' HD13 ' A' ' 97' ' ' LEU . 89.6 Cg_endo -78.67 -165.62 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.716 2.277 . . . . 0.0 112.276 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.2 mp -65.79 -28.17 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.164 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.34 -26.76 65.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -156.48 66.9 4.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.243 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.59 111.69 3.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.013 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.45 -170.74 37.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.608 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.557 HG22 HD12 ' A' ' 59' ' ' ILE . 14.0 mm -94.97 118.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 52.0 m-85 -111.24 174.67 5.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.318 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -107.69 136.46 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.194 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.12 -169.45 1.58 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.638 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CG ' HD11 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -47.25 140.19 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.262 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.86 148.75 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -107.94 138.84 20.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.3 173.22 2.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.471 2.114 . . . . 0.0 112.111 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.22 27.77 24.7 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -121.8 166.24 14.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.86 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.32 -35.66 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.705 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 53' ' ' LEU . 11.7 p -53.09 -40.95 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.03 -39.85 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.56 -35.06 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.803 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.873 ' HB ' HG13 ' A' ' 13' ' ' VAL . 28.2 m -82.44 -30.83 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.68 41.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.457 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.8 mt -90.18 164.68 14.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.988 0.423 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.93 168.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.533 HD11 ' CG ' ' A' ' 41' ' ' HIS . 20.2 mt -65.07 133.78 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.721 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ARG . . . 112.77 -18.0 22.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.358 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' CB ' HD11 ' A' ' 89' ' ' ILE . 64.5 m-20 -71.97 169.13 16.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -148.52 115.08 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.04 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.557 HD12 HG22 ' A' ' 37' ' ' ILE . 3.8 mt -69.02 116.95 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.652 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 88' ' ' SER . 27.0 m -104.21 3.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.793 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -176.44 152.68 1.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.729 HG13 HG22 ' A' ' 87' ' ' ILE . 47.7 t -151.95 102.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 60.58 37.77 19.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.92 -31.94 7.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 t -70.51 114.65 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 111.029 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.13 124.16 21.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.2 m-85 -96.11 21.9 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.102 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.7 t -73.76 -37.58 64.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -128.9 28.85 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.733 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.601 HD22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.74 148.01 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.03 158.05 25.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -57.34 -53.51 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.47 -38.62 77.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.08 -44.13 97.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -59.54 -45.66 91.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 27' ' ' ILE . 38.1 t -69.31 -42.64 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -55.99 -58.9 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 74' ' ' GLU . 27.1 m -58.58 -40.53 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.181 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -68.55 -29.52 68.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.717 ' HE2' HD23 ' B' ' 118' ' ' LEU . 4.0 mptp? -82.59 -33.18 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -60.94 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -45.84 22.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.7 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -100.42 92.44 5.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -132.22 144.35 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.4 m -89.43 117.01 28.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.272 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.729 HG22 HG13 ' A' ' 62' ' ' VAL . 13.1 pt -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.859 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.0 t -94.66 116.66 29.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.247 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.468 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -123.67 142.66 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.207 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 10' ' ' GLU . 40.5 t -109.76 131.86 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.508 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -69.65 136.56 51.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.713 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.99 -17.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.396 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -54.95 -21.3 11.26 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.881 0.372 . . . . 0.0 111.102 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -30.47 2.52 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD3' ' CB ' ' A' ' 92' ' ' ALA . 1.7 ptt180 -56.04 -34.47 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.672 0.273 . . . . 0.0 111.321 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -49.97 38.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.683 HD13 ' HD2' ' A' ' 31' ' ' PRO . 14.9 mt -71.39 -58.43 3.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.463 0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.411 -179.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.836 0.351 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.641 HG21 HG11 ' A' ' 76' ' ' VAL . 68.5 m -124.4 147.36 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.01 138.05 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.717 HD23 ' HE2' ' A' ' 80' ' ' LYS . 3.1 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 90' ' ' VAL . 54.7 mt-10 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.763 0.316 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.799 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.8 OUTLIER -112.4 141.2 46.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -109.3 143.55 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.729 HG13 ' HB ' ' A' ' 51' ' ' VAL . 18.5 t -149.96 153.15 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.389 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.37 114.54 9.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.636 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.587 HD12 ' CD1' ' A' ' 23' ' ' LEU . 41.3 mm -97.92 118.92 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.587 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.5 tp . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.0 28.24 9.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.364 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -147.28 160.95 41.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.393 . . . . 0.0 111.152 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.94 173.64 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.971 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 1.047 HD11 HG22 ' A' ' 76' ' ' VAL . 26.0 pt -143.45 135.57 23.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.2 t -119.78 161.78 20.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.657 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.11 147.67 27.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 -178.32 46.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.589 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.571 ' HD2' HD13 ' A' ' 97' ' ' LEU . 37.1 Cg_endo -65.68 -165.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.62 2.213 . . . . 0.0 112.236 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.86 -30.06 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -68.05 -30.21 69.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -143.53 74.14 17.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.014 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.82 141.51 27.31 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.6 173.33 40.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.656 HG13 ' HB2' ' A' ' 75' ' ' ALA . 23.9 mm -90.32 115.09 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.054 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.859 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.4 m-85 -105.56 171.35 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 27' ' ' ILE . 23.7 mm -107.73 137.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.1 -169.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.442 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 142.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.184 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.3 t -110.08 157.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.972 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -114.5 145.43 33.79 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 162.51 38.8 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.543 2.162 . . . . 0.0 112.197 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.9 86.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.488 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -135.56 -177.36 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.2 mm? -71.04 -49.52 43.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.628 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.432 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -53.46 -41.84 66.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.43 84.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -64.15 -37.57 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.729 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.7 m -78.89 -36.38 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.46 70.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.406 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.566 ' O ' HG21 ' A' ' 42' ' ' VAL . 29.3 mt -116.38 150.91 36.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -154.58 162.45 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.455 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.9 mt -57.92 137.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.475 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.67 -29.18 9.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.564 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.438 ' HB3' HG13 ' A' ' 89' ' ' ILE . 21.6 m-20 -57.63 164.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.649 0.261 . . . . 0.0 110.593 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -146.39 114.4 6.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.239 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.27 117.15 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.06 0.58 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.808 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -175.62 159.49 2.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.906 ' O ' HG12 ' A' ' 65' ' ' VAL . 62.1 t -155.22 103.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 63.78 17.23 10.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.278 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.12 -27.21 9.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.642 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 62' ' ' VAL . 10.8 p -65.05 134.23 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.728 0.299 . . . . 0.0 111.215 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.57 121.81 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.522 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.4 m-85 -94.84 19.02 10.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.236 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -75.34 -56.74 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.98 26.65 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.522 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -87.19 150.34 24.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.26 167.9 11.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.56 -53.57 56.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -54.67 -41.99 70.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -59.77 -42.64 93.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.761 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -63.4 -46.13 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.133 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.047 HG22 HD11 ' A' ' 27' ' ' ILE . 40.4 t -68.67 -36.96 76.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -58.98 6.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.675 HG23 HD22 ' A' ' 79' ' ' LEU . 34.3 m -57.86 -40.47 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.312 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.0 mm? -66.55 -32.14 73.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 110.656 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -35.97 37.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 t -61.0 -57.08 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.458 ' HB3' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.92 142.84 29.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.253 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.11 -49.03 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.509 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 t -98.21 81.99 2.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -120.51 137.83 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.278 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.5 m -85.97 116.92 24.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.833 HG22 HG22 ' A' ' 62' ' ' VAL . 7.2 pt -110.28 132.68 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -101.88 118.95 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.37 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.799 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -123.4 151.84 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.607 ' N ' HD13 ' A' ' 89' ' ' ILE . 41.1 t -125.71 110.45 24.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.442 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.41 138.18 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.462 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.38 -22.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.927 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -57.46 -21.85 39.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.033 0.444 . . . . 0.0 110.854 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.27 -30.34 1.92 Allowed Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.428 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.475 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 31.6 mtt-85 -56.19 -34.73 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.558 0.218 . . . . 0.0 111.352 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -49.32 -50.03 41.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.679 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.859 HD12 ' CE2' ' A' ' 38' ' ' PHE . 11.3 mt -71.74 -43.51 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.455 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.358 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.484 HG22 ' N ' ' B' ' 116' ' ' THR . 21.2 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.791 0.329 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' THR . . . . . 0.484 ' N ' HG22 ' B' ' 115' ' ' ILE . 78.5 m -150.93 148.94 29.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.444 ' O ' HD23 ' B' ' 118' ' ' LEU . 0.9 OUTLIER -94.67 136.57 34.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.793 HD11 HD13 ' A' ' 27' ' ' ILE . 78.1 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.852 0.358 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 90' ' ' VAL . 5.2 mt-10 -62.72 115.21 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -105.16 147.79 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.025 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -109.43 138.17 46.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.784 HG13 ' HB ' ' A' ' 51' ' ' VAL . 40.5 t -143.0 128.86 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.786 ' CD2' HG23 ' A' ' 86' ' ' THR . 3.9 m-85 -114.58 116.64 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 51' ' ' VAL . 42.3 mm -104.3 124.68 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.936 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.8 m -138.25 124.99 20.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 20' ' ' SER . 0.7 OUTLIER -77.61 78.12 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.954 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.02 -30.69 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.47 -120.93 4.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.584 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.448 ' HA ' HD21 ' A' ' 17' ' ' LEU . 1.5 p -143.81 43.15 1.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.825 0.345 . . . . 0.0 110.944 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 151.26 44.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.82 -168.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.43 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.87 HD21 ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -77.66 -40.97 39.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.678 0.275 . . . . 0.0 110.662 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.524 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 102.62 20.39 11.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.304 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -132.62 158.57 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.213 0.506 . . . . 0.0 111.581 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 m -114.82 173.73 6.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.649 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.983 HD11 HG22 ' A' ' 76' ' ' VAL . 4.8 pt -143.53 145.54 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.103 0.478 . . . . 0.0 111.71 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -129.03 162.46 27.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.554 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -104.38 143.83 32.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.781 0.324 . . . . 0.0 110.443 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.67 175.14 43.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.073 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.788 ' CD ' HD12 ' A' ' 97' ' ' LEU . 55.8 Cg_endo -69.55 -160.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.843 2.362 . . . . 0.0 112.286 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -85.87 -27.03 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.301 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -66.43 -32.65 74.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.868 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' HD11 ' A' ' 97' ' ' LEU . 16.9 mttp -151.08 70.48 8.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.35 137.51 28.44 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.624 2.216 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.05 -175.44 46.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.389 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.442 HG13 ' CD2' ' A' ' 67' ' ' PHE . 22.4 mm -92.93 116.58 34.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 111.053 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 27' ' ' ILE . 2.6 m-85 -105.12 170.37 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.82 134.06 50.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.024 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.1 -169.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.438 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.425 ' ND1' HD11 ' A' ' 55' ' ' ILE . 1.8 t60 -51.59 149.24 4.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.014 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.701 HG12 ' HB2' ' A' ' 25' ' ' CYS . 6.0 m -130.17 155.43 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -95.89 147.11 32.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.178 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.46 144.62 22.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.66 2.24 . . . . 0.0 112.359 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.39 -24.23 26.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.524 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -74.06 -179.08 3.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -70.48 -35.9 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.753 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.522 ' HA ' HD12 ' A' ' 53' ' ' LEU . 45.1 t -52.83 -51.25 61.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.65 -33.73 75.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -31.13 71.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.14 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.784 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.3 m -88.54 -20.82 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.03 39.0 3.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.074 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 48' ' ' SER . 8.0 mt -90.38 159.31 16.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.088 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 179.49 171.24 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 2.3 mt -60.35 147.71 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.405 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 103.66 -41.93 2.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.431 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.9 m-20 -55.15 169.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.657 0.265 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.523 ' CB ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -150.8 113.03 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.094 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.6 mt -69.22 121.96 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.948 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.453 ' CG2' HG23 ' A' ' 90' ' ' VAL . 27.9 m -111.55 8.54 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.775 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.37 147.78 1.98 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.986 0.422 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.874 HG22 HG22 ' A' ' 87' ' ' ILE . 47.5 t -153.68 100.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.856 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 63.47 30.42 15.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.83 -29.62 12.11 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.429 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.4 118.48 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.72 123.26 20.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 3.1 m-85 -98.86 19.83 14.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -41.15 96.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -139.13 28.54 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.675 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.556 HD21 ' N ' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -71.29 140.99 50.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.74 154.69 36.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -58.29 -54.61 45.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.001 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -57.2 -40.0 76.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.5 mm-40 -59.49 -40.76 88.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.556 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -63.1 -47.27 83.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.983 HG22 HD11 ' A' ' 27' ' ' ILE . 40.3 t -68.68 -36.13 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.44 -58.96 5.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.236 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 74' ' ' GLU . 29.3 m -57.67 -40.46 75.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.207 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.467 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.7 mm? -67.03 -31.95 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -34.77 38.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -58.4 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.068 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.563 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.1 m -97.8 119.29 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -67.17 -39.76 86.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.709 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 p -113.39 107.17 15.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.548 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.599 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -144.31 146.34 32.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.954 0.407 . . . . 0.0 111.303 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.786 HG23 ' CD2' ' A' ' 14' ' ' PHE . 31.3 m -85.22 123.03 30.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.064 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 62' ' ' VAL . 6.3 pt -118.25 126.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.534 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -95.46 112.37 24.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.465 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -112.74 149.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.039 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 10' ' ' GLU . 32.4 t -122.09 115.45 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.71 137.76 53.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.524 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.12 -17.49 0.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.176 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -57.73 -22.19 45.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 110.991 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -117.11 -30.69 1.87 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.551 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 58.0 mtp180 -56.16 -34.54 66.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 0.0 111.027 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -42.05 78.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.788 HD12 ' CD ' ' A' ' 31' ' ' PRO . 3.2 mm? -71.24 -48.59 50.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.873 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 2.1 m-85 -50.26 -34.08 22.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.5 mmt -69.34 72.51 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.728 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 100' ' ' THR . 59.0 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.421 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.787 0.327 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.31 151.06 30.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.641 2.228 . . . . 0.0 112.281 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 29' ' ' SER . 4.7 mt -83.29 154.35 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.76 149.22 40.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.02 152.05 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.465 HG21 HG21 ' A' ' 76' ' ' VAL . 27.0 m -134.89 148.13 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.12 127.83 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 27' ' ' ILE . 14.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.733 0.301 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.5 mm-40 61.67 116.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 5.8 ttpm? -99.2 145.54 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.222 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 139.07 39.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.778 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.794 HG13 ' HB ' ' A' ' 51' ' ' VAL . 39.4 t -145.99 145.51 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -131.93 121.92 24.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.3 mm -108.27 129.69 62.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -134.36 144.38 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.57 52.5 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.794 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 16' ' ' SER . 5.4 m -130.03 111.02 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.205 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.0 -26.43 20.81 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.478 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.411 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 73.3 m -122.65 -173.7 2.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.727 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 112.29 24.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.61 ' O ' HD23 ' A' ' 47' ' ' LEU . . . 52.4 -104.24 0.16 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.924 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.9 tp -125.06 -66.75 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.608 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 113.11 27.26 3.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.205 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 42' ' ' VAL . 54.0 t -154.18 156.05 36.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.94 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.9 t -114.87 136.09 53.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.026 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.678 HD11 HG22 ' A' ' 76' ' ' VAL . 20.9 pt -101.64 146.95 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.045 0.45 . . . . 0.0 111.443 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.7 p -129.0 161.84 29.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.723 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.19 144.78 31.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.77 173.73 42.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.606 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.21 -168.14 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.537 2.158 . . . . 0.0 112.365 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.1 mt -68.22 -28.12 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.143 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -66.76 -26.84 67.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.216 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HB3' HD11 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -154.51 76.78 5.47 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.112 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.22 133.28 12.0 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.514 2.142 . . . . 0.0 112.263 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.15 -179.95 38.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.646 HG13 ' HB2' ' A' ' 75' ' ' ALA . 20.0 mm -88.71 114.6 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.351 . . . . 0.0 111.086 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE2' HD12 ' A' ' 97' ' ' LEU . 20.2 m-85 -109.03 173.55 6.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.528 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.3 mm -107.83 131.85 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.269 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.22 -168.98 1.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.528 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.429 ' HA ' HD11 ' A' ' 55' ' ' ILE . 44.8 t-80 -45.87 140.3 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.301 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' SG ' ' A' ' 25' ' ' CYS . 25.3 t -108.66 157.44 8.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.157 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.458 ' N ' HG12 ' A' ' 42' ' ' VAL . 12.2 mttt -108.15 121.44 43.73 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.53 151.17 39.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.4 2.067 . . . . 0.0 112.135 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.4 53.51 24.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.41 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.456 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -151.61 -169.28 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.757 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 22' ' ' GLY . 2.3 mm? -76.08 -46.56 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.394 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 51' ' ' VAL . 23.0 t -56.26 -42.01 76.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.857 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.0 -38.77 72.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.98 -35.61 81.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.136 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.794 ' HB ' HG13 ' A' ' 13' ' ' VAL . 31.0 m -77.91 -27.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.273 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.47 30.32 4.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.589 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.444 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 11.7 mt -75.73 166.36 23.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -179.31 155.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.783 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 41' ' ' HIS . 4.6 mt -53.16 131.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.849 0.357 . . . . 0.0 111.008 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 117.12 -25.72 8.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.284 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' CB ' HD11 ' A' ' 89' ' ' ILE . 52.5 m-20 -69.11 166.52 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.492 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -148.05 115.18 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.084 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.27 117.26 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 88' ' ' SER . 35.6 m -98.71 -15.36 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.73 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -158.34 155.05 28.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.931 HG13 HG22 ' A' ' 87' ' ' ILE . 47.8 t -152.12 103.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 60.01 31.3 20.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.9 -28.38 13.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.06 126.39 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.126 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.18 112.91 3.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.604 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.2 m-85 -98.75 11.68 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.292 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -72.3 -44.29 62.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.712 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -123.43 30.5 6.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.604 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.0 146.96 29.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.914 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.499 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -73.42 167.59 20.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -66.3 -55.16 17.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -39.11 80.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.794 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -60.63 -37.82 82.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.752 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.646 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -66.15 -46.07 78.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.962 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.692 HG11 HG21 ' B' ' 116' ' ' THR . 24.8 t -68.71 -42.46 83.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.044 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -56.07 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG23 ' N ' ' A' ' 79' ' ' LEU . 32.7 m -58.84 -43.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.452 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -65.79 -31.42 72.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.744 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -69.67 -67.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.11 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.679 ' CB ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -77.27 136.1 38.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.022 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -51.19 7.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.622 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.0 p -106.14 83.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.708 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.679 HD23 ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -116.02 139.81 49.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.0 m -90.49 116.85 28.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.24 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.931 HG22 HG13 ' A' ' 62' ' ' VAL . 17.4 pt -111.91 129.07 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.71 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.579 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -97.27 108.9 21.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.449 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.466 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -109.82 146.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 10' ' ' GLU . 11.4 t -117.15 112.59 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.408 . . . . 0.0 110.977 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.6 143.37 36.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.347 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.75 -19.48 0.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.779 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -58.62 -20.68 49.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.043 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.88 -30.85 2.05 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.533 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 59.3 mtt180 -56.62 -34.28 67.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.52 0.2 . . . . 0.0 111.398 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.23 -49.8 31.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' A' ' 34' ' ' LYS . 9.3 mt -71.15 -43.28 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.77 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -58.74 -66.26 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.37 142.5 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.845 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' B' ' 112' ' ' PRO . 27.2 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.72 0.295 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' B' ' 111' ' ' THR . 18.1 Cg_endo -59.29 159.55 22.44 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.629 2.219 . . . . 0.0 112.292 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.72 166.53 12.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -78.65 138.71 38.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.804 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 18.4 mt -137.79 136.21 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.189 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.692 HG21 HG11 ' A' ' 76' ' ' VAL . 33.5 m -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -88.31 143.43 27.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 27' ' ' ILE . 3.6 mp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.914 0.388 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 63.45 124.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.042 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -97.91 135.51 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -94.39 140.44 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.875 HG13 ' HB ' ' A' ' 51' ' ' VAL . 44.6 t -145.52 137.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.131 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -124.76 115.99 21.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.493 HD12 HD13 ' A' ' 23' ' ' LEU . 42.8 mm -101.15 127.64 54.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.232 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.04 131.21 34.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.616 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD22 ' HG2' ' A' ' 83' ' ' ARG . 0.8 OUTLIER -54.72 -70.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.934 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 m 40.98 89.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.867 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.99 26.37 6.73 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.59 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m 56.19 25.62 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 111.22 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -102.87 109.46 21.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.776 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.11 -96.1 0.01 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.013 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 HD12 ' A' ' 15' ' ' ILE . 13.5 tp -140.79 -56.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 106.75 23.82 6.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.27 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.776 ' SG ' HG22 ' A' ' 42' ' ' VAL . 2.8 t -145.09 164.85 29.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 111.016 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 m -114.94 173.75 6.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.421 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.758 HD13 HD11 ' B' ' 118' ' ' LEU . 16.0 pt -142.81 145.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 111.377 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.24 161.95 28.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.789 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.769 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.5 OUTLIER -104.95 141.9 35.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.745 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.03 172.95 34.18 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.917 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' HD13 ' A' ' 97' ' ' LEU . 42.2 Cg_endo -67.65 -165.71 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.689 2.259 . . . . 0.0 112.527 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -81.34 -25.54 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.26 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.15 -5.48 49.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.283 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HB3' HD11 ' A' ' 97' ' ' LEU . 6.9 tttt -171.01 59.31 0.29 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.851 0.358 . . . . 0.0 110.773 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.27 144.54 56.99 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.606 2.204 . . . . 0.0 112.315 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.13 174.87 33.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.278 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 75' ' ' ALA . 11.8 mm -89.58 113.94 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 110.898 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.937 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.6 m-85 -101.96 172.51 6.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.037 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.503 HG23 ' SG ' ' A' ' 25' ' ' CYS . 23.3 mm -109.21 136.26 45.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.234 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.05 -169.35 1.56 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.375 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.509 ' CD2' HD11 ' A' ' 55' ' ' ILE . 38.1 m80 -45.02 145.72 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.776 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.2 t -113.73 151.32 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -105.43 124.02 37.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 159.79 8.2 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.368 2.045 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.01 50.24 67.81 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 2.5 m -141.05 -173.62 3.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.733 0.301 . . . . 0.0 110.912 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.9 mt -78.15 -42.32 32.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -52.87 -40.11 63.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.939 0.4 . . . . 0.0 110.572 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.33 68.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.611 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.11 -37.15 79.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.817 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.875 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.2 m -83.05 -30.22 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.08 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.72 52.28 0.81 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 48' ' ' SER . 14.0 mt -97.63 164.89 12.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.934 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.12 162.42 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.509 HD11 ' CD2' ' A' ' 41' ' ' HIS . 4.1 mt -58.02 140.9 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.28 -37.16 3.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.257 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -59.51 156.14 13.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.756 0.312 . . . . 0.0 110.637 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -140.4 119.09 12.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 62' ' ' VAL . 15.5 mt -69.42 117.13 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.614 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.64 -16.01 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.714 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -155.52 148.36 24.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.402 . . . . 0.0 111.044 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.859 HG13 HG22 ' A' ' 87' ' ' ILE . 41.8 t -147.66 105.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.069 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 55.92 32.66 20.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.8 23.41 38.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.659 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 62' ' ' VAL . 23.6 t -112.21 120.16 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.326 . . . . 0.0 111.063 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -65.14 111.92 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.797 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.676 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.3 m-85 -95.78 19.84 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.86 -41.07 45.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -123.61 28.04 7.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.694 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.608 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -83.52 148.98 26.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.45 164.33 17.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.431 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.2 t-160 -59.37 -48.95 79.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -60.63 -41.85 95.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.0 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -59.04 -45.73 90.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.608 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -59.07 -47.71 84.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.223 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.745 HG22 HD11 ' A' ' 27' ' ' ILE . 28.0 t -66.87 -43.47 89.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.026 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.96 -58.13 9.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.7 m -57.28 -44.58 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.528 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.4 mm? -64.43 -31.51 72.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.693 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.1 mptp? -82.64 -30.19 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 t -66.56 -64.17 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.425 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -87.56 131.76 34.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.946 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HG2' HD22 ' A' ' 17' ' ' LEU . 3.2 mpp_? -77.66 -55.69 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.8 m -100.03 83.03 2.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.654 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -113.84 141.87 46.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -89.85 116.94 28.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.859 HG22 HG13 ' A' ' 62' ' ' VAL . 12.3 pt -115.02 126.51 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 0.0 111.542 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -96.04 122.9 39.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.331 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 145.94 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.011 0.434 . . . . 0.0 111.409 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.77 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -111.18 126.17 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.298 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -65.91 132.11 47.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.525 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.54 -19.42 0.32 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.627 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.77 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -53.6 -24.18 13.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.52 -30.77 2.97 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.477 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -34.56 66.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.624 0.25 . . . . 0.0 111.282 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -49.65 -50.01 44.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 110.772 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.937 HD12 ' CE2' ' A' ' 38' ' ' PHE . 18.9 mt -71.52 -41.03 69.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.005 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -55.3 -50.77 68.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.193 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ptm -56.16 153.47 9.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.735 0.302 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.64 -179.48 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.61 2.207 . . . . 0.0 112.27 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.769 HD13 ' O ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -67.32 160.44 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.2 164.02 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 30.6 mt -144.49 134.29 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.202 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.452 HG21 HG21 ' A' ' 76' ' ' VAL . 32.5 m -111.68 145.09 39.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.812 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -98.06 111.78 23.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.758 HD11 HD13 ' A' ' 27' ' ' ILE . 6.1 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.842 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.793 0.33 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.546 ' HA ' HG22 ' A' ' 90' ' ' VAL . 4.9 mt-10 -72.99 131.38 42.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.741 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -102.01 116.85 33.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.673 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HE3' ' CZ ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -86.23 131.88 34.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.763 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.759 HG13 ' HB ' ' A' ' 51' ' ' VAL . 40.1 t -140.75 149.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.286 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 5.1 m-85 -128.32 131.59 48.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.705 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.8 131.29 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.461 ' HB2' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -137.21 156.68 48.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.655 HD13 ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -94.51 46.78 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 16' ' ' SER . 30.0 t -88.03 80.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.085 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.63 -110.36 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.591 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.1 t -149.53 30.99 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 145.67 26.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -75.05 -55.36 5.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.435 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 48' ' ' SER . 12.7 tp -148.13 -64.49 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 108.67 36.38 2.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.063 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.718 ' SG ' HG12 ' A' ' 42' ' ' VAL . 1.3 t -160.23 160.71 33.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.704 0.288 . . . . 0.0 110.486 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 4.2 m -114.36 173.45 6.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.53 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.12 HD11 HG22 ' A' ' 76' ' ' VAL . 10.0 pt -135.29 153.5 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.41 . . . . 0.0 111.354 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 29.5 p -131.29 162.68 29.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.603 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.8 p -104.61 140.79 37.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 175.31 43.58 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.716 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.72 ' HD2' HD13 ' A' ' 97' ' ' LEU . 57.5 Cg_endo -71.06 -167.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.646 2.231 . . . . 0.0 112.586 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.9 mt -78.2 -21.42 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.257 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -71.92 -30.31 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.1 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB3' HD11 ' A' ' 97' ' ' LEU . 11.2 mttm -147.53 64.77 8.84 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 21.8 Cg_exo -64.7 114.45 2.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.629 2.22 . . . . 0.0 112.014 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 -157.38 8.99 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.502 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 75' ' ' ALA . 19.7 mm -111.67 118.0 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.053 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.868 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 2.1 m-85 -100.36 172.28 7.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.716 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.4 mm -118.74 121.62 67.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.553 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.33 -169.5 2.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.611 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -54.34 141.99 28.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.718 HG12 ' SG ' ' A' ' 25' ' ' CYS . 1.7 m -119.71 153.48 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 147.07 32.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.171 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.38 172.74 15.75 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.693 2.262 . . . . 0.0 112.337 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.94 24.29 33.89 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.603 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 73.7 p -119.11 -171.76 2.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.788 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 4.4 mt -78.0 -44.03 27.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.5 t -53.05 -46.13 68.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.533 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -36.28 75.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.564 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.06 -38.5 83.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.759 ' HB ' HG13 ' A' ' 13' ' ' VAL . 21.0 m -80.36 -29.69 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 109.55 36.18 2.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.377 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 48' ' ' SER . 13.1 mt -85.06 161.05 19.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 111.024 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 178.0 166.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.674 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.86 144.79 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 105.94 -13.3 45.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.646 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' HB3' HG13 ' A' ' 89' ' ' ILE . 59.5 m-20 -86.32 162.32 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.446 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -142.85 114.93 8.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.07 117.19 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.851 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 88' ' ' SER . 30.7 m -106.86 6.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.764 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -177.15 149.89 0.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.843 0.354 . . . . 0.0 111.136 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.85 HG22 HG22 ' A' ' 87' ' ' ILE . 58.1 t -153.84 112.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 56.95 29.47 16.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.73 -26.18 19.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.496 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.45 124.88 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.899 0.38 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -65.22 114.88 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.9 m-85 -95.75 22.31 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.091 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.51 -53.8 7.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.642 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -111.78 28.49 8.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.7 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.554 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.1 tp -83.17 147.69 27.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.61 163.09 20.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -59.5 -50.34 74.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -59.56 -37.5 78.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HB3' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -61.64 -43.15 99.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.554 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.66 -46.2 90.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.16 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.12 HG22 HD11 ' A' ' 27' ' ' ILE . 40.5 t -67.95 -43.85 85.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -55.4 -57.21 12.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.239 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 79' ' ' LEU . 33.3 m -58.02 -45.34 88.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.262 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.4 mm? -63.84 -29.66 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.645 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.814 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.3 mptp? -82.58 -34.65 27.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -69.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.383 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.662 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -75.77 131.18 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.288 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.655 ' HG3' HD13 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -82.33 -50.61 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.551 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -102.4 86.92 2.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.507 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.662 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -121.42 143.16 49.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.289 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.9 m -92.19 116.92 29.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.051 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.85 HG22 HG22 ' A' ' 62' ' ' VAL . 5.9 pt -109.37 130.44 62.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.928 0.394 . . . . 0.0 111.546 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -105.18 103.56 13.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.785 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.741 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.85 147.61 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.9 t -114.44 110.0 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 0.0 110.964 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.655 ' HB2' ' NZ ' ' A' ' 11' ' ' LYS . . . -55.38 138.41 45.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.268 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.68 -22.45 0.18 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.773 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.2 -19.68 55.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.922 0.392 . . . . 0.0 111.023 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA2' ' CZ ' ' A' ' 38' ' ' PHE . . . -110.86 -30.21 3.3 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.67 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 27.4 mtp85 -55.75 -34.49 65.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.549 0.214 . . . . 0.0 111.482 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.22 -50.05 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.868 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 19.3 mt -71.53 -50.03 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.022 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.457 ' HB3' ' HE3' ' A' ' 99' ' ' MET . 0.1 OUTLIER -47.23 -54.14 11.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.371 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.457 ' HE3' ' HB3' ' A' ' 98' ' ' PHE . 17.0 mmt -73.35 119.28 17.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.967 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 52.5 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.658 0.266 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 -167.97 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.581 2.187 . . . . 0.0 112.302 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mt -77.47 170.28 16.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.62 150.19 44.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.1 mt -139.57 139.2 38.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.184 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.566 HG21 HG21 ' A' ' 76' ' ' VAL . 83.1 m -129.76 149.48 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.37 144.02 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.015 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.814 HD23 ' HE2' ' A' ' 80' ' ' LYS . 15.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.707 0.289 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.3 mt-10 -61.51 125.54 24.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -118.59 158.41 25.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -121.08 141.2 51.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.704 HG13 ' HB ' ' A' ' 51' ' ' VAL . 21.7 t -141.37 150.06 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.995 0.426 . . . . 0.0 111.339 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' HE1' ' HG ' ' A' ' 16' ' ' SER . 1.8 t80 -128.13 120.36 27.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.699 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 23' ' ' LEU . 36.5 mm -110.14 112.71 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.435 ' HG ' ' HE1' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -134.61 138.48 44.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.961 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.639 HD11 ' HA2' ' A' ' 22' ' ' GLY . 2.3 mp -73.44 122.07 21.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.82 -44.28 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.31 -72.36 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -145.32 32.03 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.844 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -119.69 122.67 41.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.639 ' HA2' HD11 ' A' ' 17' ' ' LEU . . . -66.62 -87.17 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.622 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.6 tp -133.2 -56.29 0.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 110.755 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 100.03 27.92 7.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.455 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.658 ' SG ' HG22 ' A' ' 42' ' ' VAL . 35.9 t -154.28 159.29 41.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.2 m -114.42 173.68 6.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.764 HD11 HG22 ' A' ' 76' ' ' VAL . 19.1 pt -135.93 138.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.878 0.371 . . . . 0.0 111.221 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.1 p -116.28 161.71 18.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.829 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.606 ' O ' HD13 ' B' ' 113' ' ' LEU . 5.9 t -105.17 144.91 31.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.46 171.89 35.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.575 ' HD2' HD13 ' A' ' 97' ' ' LEU . 57.6 Cg_endo -71.37 -166.44 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.66 2.24 . . . . 0.0 112.393 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 mt -77.43 -25.28 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.194 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -68.22 -28.14 66.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' HB3' HD11 ' A' ' 97' ' ' LEU . 11.8 tttp -157.25 65.63 3.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.226 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.78 144.68 84.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.62 2.213 . . . . 0.0 112.069 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 38' ' ' PHE . . . 163.61 168.64 25.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.551 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 75' ' ' ALA . 24.7 mm -82.89 114.58 23.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.051 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.591 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 70.2 m-85 -108.25 176.15 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.205 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.648 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.8 mm -107.69 137.85 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.623 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -169.45 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.35 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.23 150.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.658 HG22 ' SG ' ' A' ' 25' ' ' CYS . 29.9 t -126.97 157.59 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.083 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' N ' HG12 ' A' ' 42' ' ' VAL . 14.3 pttt -121.94 141.69 34.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 160.6 43.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.534 2.156 . . . . 0.0 112.399 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.52 82.63 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.933 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.541 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.4 m -103.87 -166.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.795 0.331 . . . . 0.0 111.007 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.5 mm? -80.35 -43.47 21.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.769 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.421 ' OG ' ' CD1' ' A' ' 53' ' ' LEU . 11.7 t -56.15 -40.58 74.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.53 79.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.209 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.22 -35.09 79.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.704 ' HB ' HG13 ' A' ' 13' ' ' VAL . 25.4 m -78.9 -17.44 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.467 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.52 5.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.289 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CD1' ' OG ' ' A' ' 48' ' ' SER . 9.1 mt -88.97 155.06 19.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -167.04 161.03 14.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.757 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.94 149.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.851 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 101.1 -23.39 35.67 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.291 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' HB3' HG13 ' A' ' 89' ' ' ILE . 46.6 m-20 -71.99 166.73 21.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.684 0.278 . . . . 0.0 110.591 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 2.6 tt0 -152.66 119.03 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 111.348 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.39 117.47 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.681 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.9 m -93.92 -19.81 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.869 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -159.95 157.28 28.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.105 0.478 . . . . 0.0 111.416 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.727 HG12 ' ND2' ' A' ' 63' ' ' ASN . 46.3 t -150.21 117.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.499 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.727 ' ND2' HG12 ' A' ' 62' ' ' VAL . 0.1 OUTLIER 45.36 47.78 10.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.959 0.409 . . . . 0.0 111.168 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.73 22.29 73.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.311 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 62' ' ' VAL . 21.8 t -109.31 127.38 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 110.91 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.94 114.66 4.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.117 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.69 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -99.33 -21.42 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.072 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.1 m -53.12 -45.82 68.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -106.85 35.45 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.751 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.2 tp -105.54 149.68 26.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.765 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.42 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -84.11 166.07 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -60.17 -53.92 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.17 -39.63 79.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.405 ' C ' HD21 ' A' ' 70' ' ' LEU . 2.9 mt-10 -61.32 -43.57 98.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.7 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.756 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -58.8 -45.54 89.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.891 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.764 HG22 HD11 ' A' ' 27' ' ' ILE . 39.1 t -68.73 -39.95 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.79 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.356 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 79' ' ' LEU . 29.9 m -59.06 -44.82 92.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 0.0 110.939 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -63.45 -31.53 72.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.733 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HE3' HD23 ' B' ' 118' ' ' LEU . 1.1 mptm? -82.66 -31.63 28.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 t -64.66 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.4 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.421 ' CB ' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -88.15 135.3 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.089 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -78.53 -52.07 9.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.617 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.2 p -102.29 85.17 2.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.427 ' CD2' ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -116.65 146.32 42.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.032 0.444 . . . . 0.0 111.422 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -90.85 117.35 29.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.395 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.645 HG22 HG13 ' A' ' 62' ' ' VAL . 12.3 pt -115.17 121.63 67.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 111.547 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.33 120.76 33.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.428 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.534 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -122.38 144.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.25 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 89' ' ' ILE . 41.0 t -115.24 112.45 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.728 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.58 139.38 50.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.479 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.26 -17.32 0.51 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.131 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -59.75 -19.27 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 111.23 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.66 -30.82 2.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.623 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 51.0 mtp180 -56.47 -34.61 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.314 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.56 -49.91 69.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 34' ' ' LYS . 21.8 mt -71.56 -42.92 67.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.957 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -50.17 -42.38 50.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.249 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.9 ptm -85.46 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.642 0.258 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.83 152.38 52.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.548 2.165 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.606 HD13 ' O ' ' A' ' 29' ' ' SER . 1.7 mt -60.28 164.76 3.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.48 144.68 41.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 21.6 mt -135.92 138.61 47.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.157 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.61 HG21 HG21 ' A' ' 76' ' ' VAL . 39.1 m -133.35 143.1 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.23 141.19 28.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' C ' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.784 0.326 . . . . 0.0 111.265 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.742 ' HA ' HG22 ' A' ' 90' ' ' VAL . 13.5 tt0 -70.67 121.82 18.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.789 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -105.96 146.73 29.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.029 0.442 . . . . 0.0 111.047 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -97.95 149.87 21.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.725 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.798 HG13 ' HB ' ' A' ' 51' ' ' VAL . 57.8 t -152.99 141.1 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.04 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -129.23 123.72 32.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.653 HD12 ' CD1' ' A' ' 23' ' ' LEU . 22.0 mm -110.77 127.64 67.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.232 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -141.49 124.15 15.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.806 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.8 HD11 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -66.62 109.29 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 p -111.3 -32.31 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.94 5.59 46.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.438 ' HA ' HD23 ' A' ' 17' ' ' LEU . 0.3 OUTLIER 58.52 31.27 20.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.997 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -29.52 7.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.99 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.8 ' HA2' HD11 ' A' ' 17' ' ' LEU . . . 125.3 -156.2 19.06 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.489 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.653 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.0 tp -88.47 -48.72 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 94.04 30.89 8.45 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.3 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 39' ' ' ILE . 42.2 t -151.43 158.65 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.852 0.358 . . . . 0.0 111.009 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.31 173.9 6.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.18 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.796 HD13 HD11 ' B' ' 118' ' ' LEU . 11.7 pt -136.01 175.8 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.966 0.412 . . . . 0.0 111.359 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 t -146.76 162.16 39.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.639 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 p -104.83 148.26 26.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.607 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' ' CE2' ' A' ' 38' ' ' PHE . . . -88.72 154.49 24.85 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.02 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.484 ' CD ' HD12 ' A' ' 97' ' ' LEU . 57.8 Cg_endo -70.78 -159.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.882 2.388 . . . . 0.0 112.032 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -80.69 -27.05 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.348 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -85.67 0.59 52.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.548 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HD3' HD21 ' A' ' 97' ' ' LEU . 7.4 tttp -175.98 65.43 0.23 Allowed Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.719 0.295 . . . . 0.0 111.203 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 13.8 Cg_exo -69.3 119.1 6.11 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.734 2.289 . . . . 0.0 111.921 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.41 -175.41 38.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.781 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.404 HG13 ' CD2' ' A' ' 67' ' ' PHE . 15.4 mm -106.11 111.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.309 . . . . 0.0 110.937 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 1.8 m-30 -100.99 174.5 5.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.193 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.655 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.4 mm -107.85 138.37 34.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.13 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.06 -169.44 1.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.402 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -45.25 137.52 4.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 43' ' ' LYS . 18.7 t -108.58 157.79 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.149 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.461 ' N ' HG12 ' A' ' 42' ' ' VAL . 13.4 mttt -107.6 154.52 40.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.79 154.03 15.21 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.743 2.296 . . . . 0.0 112.407 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.1 26.98 64.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.585 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.465 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -111.94 -177.8 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.696 0.284 . . . . 0.0 110.848 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 22' ' ' GLY . 24.8 mt -73.09 -46.19 52.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.756 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -52.93 -38.8 62.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.74 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.437 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.89 -40.19 87.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.704 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.798 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.6 m -78.87 -27.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.056 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.86 48.96 1.12 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.48 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 48' ' ' SER . 15.2 mt -96.04 154.27 17.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HA ' HG21 ' A' ' 42' ' ' VAL . 12.5 tt0 -168.01 166.88 13.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.69 138.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.8 17.2 21.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.376 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' CB ' HD11 ' A' ' 89' ' ' ILE . 48.2 m-20 -110.39 159.94 17.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.675 0.274 . . . . 0.0 110.677 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.655 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 14.4 tm0? -140.05 112.2 7.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 111.153 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -69.23 118.45 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.516 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 88' ' ' SER . 33.2 m -106.42 13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.945 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -176.99 146.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.934 0.397 . . . . 0.0 111.251 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.803 HG13 HG22 ' A' ' 87' ' ' ILE . 39.0 t -149.53 98.71 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.087 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 58.04 30.27 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.18 -28.59 15.09 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.512 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.35 129.05 25.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.739 0.304 . . . . 0.0 111.099 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.82 109.79 6.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.89 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.772 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.8 m-85 -96.79 -11.42 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.398 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 m -50.37 -27.84 7.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.763 0.316 . . . . 0.0 111.21 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -144.57 31.44 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.99 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.772 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -84.68 144.04 28.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.847 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.5 162.93 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -63.64 -54.93 28.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -58.17 -41.02 82.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.813 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' HD21 ' A' ' 70' ' ' LEU . 2.0 mp0 -60.38 -34.3 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.688 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -69.13 -45.32 70.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.007 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.82 HG21 HG21 ' B' ' 116' ' ' THR . 42.8 t -68.03 -38.73 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -56.5 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.073 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.1 m -59.29 -45.54 93.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.072 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.5 mm? -62.32 -31.17 71.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.606 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.445 ' HE2' HD23 ' B' ' 118' ' ' LEU . 0.1 OUTLIER -82.63 -33.45 27.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.9 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 t -61.72 -61.24 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.442 ' HB2' HD23 ' A' ' 85' ' ' LEU . 3.9 m -97.4 127.22 43.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.974 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' HG2' HD22 ' A' ' 17' ' ' LEU . 14.5 mtp180 -74.22 -48.8 26.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 t -98.61 94.27 6.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -134.36 140.23 46.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.2 m -91.89 133.11 35.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.272 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.803 HG22 HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -125.19 139.76 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.63 -179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -102.45 104.39 14.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.213 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.444 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -107.41 143.19 18.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 10' ' ' GLU . 21.8 t -110.95 129.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -65.48 131.88 47.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.828 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.06 -17.52 0.53 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.521 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.52 -22.43 32.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.782 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.26 -30.27 2.31 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.39 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.442 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -55.83 -34.62 65.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.78 -38.92 64.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.962 0.41 . . . . 0.0 110.322 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.53 HD21 ' HD3' ' A' ' 34' ' ' LYS . 3.9 mm? -71.4 -54.09 11.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.708 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -51.29 -30.5 18.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.2 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.51 -48.89 79.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.656 0.265 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.35 153.99 70.0 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.495 2.13 . . . . 0.0 112.253 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.35 151.18 45.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -59.07 137.48 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 27' ' ' ILE . 12.3 mm -120.54 148.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.82 HG21 HG21 ' A' ' 76' ' ' VAL . 85.3 m -134.19 146.32 50.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -96.15 128.14 42.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.796 HD11 HD13 ' A' ' 27' ' ' ILE . 40.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tttm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.909 0.385 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.496 ' HA ' HG13 ' A' ' 90' ' ' VAL . 1.2 mp0 -60.0 124.11 19.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -109.03 158.84 17.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.987 0.423 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -121.6 140.54 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.712 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.787 HG13 ' HB ' ' A' ' 51' ' ' VAL . 58.5 t -145.48 145.57 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.246 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.871 ' CD1' HG23 ' A' ' 86' ' ' THR . 1.8 m-85 -123.53 129.07 50.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.657 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 23' ' ' LEU . 36.4 mm -119.72 125.68 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 p -130.54 123.18 29.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.82 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -169.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t 64.6 136.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.62 -39.15 2.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -66.41 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.738 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HD2' ' HB2' ' A' ' 46' ' ' SER . 0.1 OUTLIER -158.73 -172.85 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 47' ' ' LEU . . . -47.98 -76.57 0.14 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.016 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.607 HD13 HD12 ' A' ' 15' ' ' ILE . 12.5 tp -141.06 -43.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.852 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.35 18.71 32.49 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.398 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.683 ' SG ' HG23 ' A' ' 39' ' ' ILE . 49.1 t -139.36 158.66 43.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.721 0.296 . . . . 0.0 110.524 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 173.53 6.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.858 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 76' ' ' VAL . 15.3 pt -143.55 152.78 16.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.7 p -136.15 160.28 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 111.243 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.539 ' O ' HD22 ' B' ' 113' ' ' LEU . 2.6 m -105.48 155.09 19.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.71 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.02 -166.04 24.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.88 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.54 -164.17 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.03 -24.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.244 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.42 -29.4 62.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' CB ' HD21 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -147.07 63.31 8.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.34 140.87 31.08 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.517 2.145 . . . . 0.0 112.335 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.63 164.98 31.97 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.416 HG13 ' HB2' ' A' ' 75' ' ' ALA . 12.1 mm -85.84 110.32 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.849 0.357 . . . . 0.0 111.023 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -100.69 171.94 7.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.038 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.683 HG23 ' SG ' ' A' ' 25' ' ' CYS . 20.2 mm -107.78 137.15 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.322 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -169.4 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.189 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 147.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 111.105 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.616 HG22 ' SG ' ' A' ' 25' ' ' CYS . 35.5 t -121.43 157.92 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.15 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 3.1 mtpm? -96.62 156.37 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.804 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -50.57 3.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.509 2.139 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.7 -123.4 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.947 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.459 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 25.0 p 47.63 -159.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 111.313 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 22' ' ' GLY . 1.5 mt -102.48 -29.42 11.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.291 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 51' ' ' VAL . 3.7 p -52.83 -52.4 57.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.013 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 43' ' ' LYS . . . -62.01 -35.38 78.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.075 0.464 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.42 -41.65 90.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.993 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.787 ' HB ' HG13 ' A' ' 13' ' ' VAL . 18.2 m -81.43 -29.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.11 61.78 0.82 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.371 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.92 155.38 17.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -163.28 159.64 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.758 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -56.42 147.23 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.65 -28.55 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' CB ' HD11 ' A' ' 89' ' ' ILE . 36.2 m-20 -63.35 146.92 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.689 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 1.5 tm0? -132.05 117.82 18.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.237 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.24 119.42 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 88' ' ' SER . 35.3 m -99.47 -20.98 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.0 155.05 34.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.748 HG13 HG22 ' A' ' 87' ' ' ILE . 47.8 t -151.1 96.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 57.42 36.9 27.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.85 -28.56 13.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.448 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.91 114.59 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.18 115.41 5.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.651 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.4 m-85 -97.27 25.03 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.024 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 t -70.94 -53.81 13.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.69 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -119.59 28.67 8.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.782 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.537 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.1 tp -74.2 149.4 40.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.36 173.02 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.979 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.438 ' CE1' ' HG1' ' B' ' 116' ' ' THR . 3.1 t60 -66.6 -58.34 5.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -57.61 -34.86 69.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.31 -44.49 96.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.736 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.24 -44.64 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.768 HG11 HG21 ' B' ' 116' ' ' THR . 39.1 t -69.11 -43.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.032 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -54.81 -55.5 29.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.202 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 79' ' ' LEU . 28.3 m -59.1 -45.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.475 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.5 mm? -65.08 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.577 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.78 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.1 mptp? -82.58 -28.4 30.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -68.04 -64.34 0.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.716 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -84.75 140.08 31.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.149 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mtm105 -78.79 -59.61 2.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.65 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.4 t -102.41 101.36 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.716 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -131.7 142.5 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.998 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.871 HG23 ' CD1' ' A' ' 14' ' ' PHE . 17.5 m -87.88 116.96 26.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.283 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.748 HG22 HG13 ' A' ' 62' ' ' VAL . 15.0 pt -111.77 123.99 68.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.984 0.421 . . . . 0.0 111.717 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 60' ' ' VAL . 6.2 t -93.23 113.5 25.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.249 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.51 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -118.34 147.29 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.29 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 10' ' ' GLU . 11.9 t -116.31 134.05 60.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.539 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -71.19 129.69 39.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.943 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.69 -17.33 0.49 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.678 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -54.88 -21.95 13.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.86 0.362 . . . . 0.0 111.296 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.59 -30.24 2.46 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.606 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 6.2 ptm180 -56.13 -38.27 70.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -51.42 -49.95 60.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.732 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.62 HD21 ' CB ' ' A' ' 34' ' ' LYS . 12.5 mt -71.61 -35.94 70.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.65 -40.73 66.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.351 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.4 mmt -57.48 115.19 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.122 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.672 0.272 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.22 174.7 10.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.698 2.265 . . . . 0.0 112.404 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 29' ' ' SER . 11.5 mt -109.3 130.12 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.755 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -72.1 166.89 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 23.3 mt -149.23 133.88 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.768 HG21 HG11 ' A' ' 76' ' ' VAL . 95.0 m -121.89 144.15 49.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.881 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -88.83 147.87 24.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.78 HD23 ' HE2' ' A' ' 80' ' ' LYS . 1.7 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.825 0.345 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -66.44 115.07 5.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.748 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.0 ttpt -102.67 143.9 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 0.0 111.084 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.16 131.35 52.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.746 HG13 ' HB ' ' A' ' 51' ' ' VAL . 44.1 t -137.96 144.26 31.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.63 ' CD2' HG23 ' A' ' 86' ' ' THR . 2.7 m-85 -130.09 125.77 35.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.477 HD12 ' CD1' ' A' ' 23' ' ' LEU . 35.3 mm -113.79 119.73 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.7 p -140.22 135.34 32.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.803 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 105.59 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.07 -33.08 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.7 -89.28 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -122.67 39.67 3.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -133.57 118.95 18.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.956 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.688 ' O ' HD23 ' A' ' 47' ' ' LEU . . . -59.17 -100.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.517 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.634 HD23 ' HB2' ' B' ' 118' ' ' LEU . 6.7 tp -121.3 -56.08 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.308 . . . . 0.0 110.372 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.89 -2.31 24.36 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.348 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' HD21 ' A' ' 23' ' ' LEU . 20.3 p -139.18 166.41 24.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.038 0.419 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 t -114.81 173.92 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 HD11 ' B' ' 118' ' ' LEU . 26.8 pt -141.74 151.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.971 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.6 161.84 39.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.321 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.09 146.63 28.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.658 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA3' HD13 ' A' ' 97' ' ' LEU . . . -94.61 -168.55 36.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.109 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.55 -164.81 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.884 2.39 . . . . 0.0 112.536 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.0 mp -83.11 -27.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.88 -28.99 70.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.9 ' HB3' HD21 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -153.92 75.81 6.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.721 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.81 128.2 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.481 2.121 . . . . 0.0 112.339 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.63 167.9 39.14 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.522 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -102.53 106.23 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.674 0.273 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -100.44 -176.62 3.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.871 0.367 . . . . 0.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.657 HD13 HG22 ' A' ' 27' ' ' ILE . 22.8 mm -107.49 144.08 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 111.914 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -168.9 1.5 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.888 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.603 ' HA ' HD11 ' A' ' 55' ' ' ILE . 3.1 t60 -41.95 149.36 0.14 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 111.178 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' CYS . 18.6 t -132.08 154.87 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 144.5 33.79 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.739 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.39 158.42 51.43 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.508 2.139 . . . . 0.0 112.422 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.2 41.43 69.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.4 m -142.96 -178.5 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 22' ' ' GLY . 3.1 mm? -64.9 -50.83 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.656 ' HA ' HD12 ' A' ' 53' ' ' LEU . 78.9 p -59.14 -37.54 77.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.018 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.17 -41.21 67.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -63.31 -46.94 84.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.746 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.8 m -68.06 -28.81 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.196 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.27 55.09 0.87 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.438 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.656 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.0 mt -102.29 166.95 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HA ' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER 179.19 165.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.684 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.603 HD11 ' HA ' ' A' ' 41' ' ' HIS . 4.3 mt -58.21 132.77 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.72 -30.42 6.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.32 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HB3' HG13 ' A' ' 89' ' ' ILE . 2.1 m-20 -60.06 171.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.646 0.26 . . . . 0.0 110.736 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.563 ' CB ' ' HB3' ' A' ' 93' ' ' ALA . 4.9 tm0? -152.12 110.34 3.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.366 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.407 HG21 ' CG2' ' A' ' 62' ' ' VAL . 6.4 mt -69.45 117.24 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 88' ' ' SER . 35.7 m -101.49 4.14 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.998 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.37 148.44 1.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.89 HG22 HG22 ' A' ' 87' ' ' ILE . 41.3 t -151.85 104.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.053 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 60.33 30.78 20.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.74 -29.03 13.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.3 133.04 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 111.109 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.17 116.67 21.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.633 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.7 m-85 -92.14 13.7 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.17 -33.75 76.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.556 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -140.75 32.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.645 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.55 HD21 ' N ' ' A' ' 75' ' ' ALA . 0.9 OUTLIER -81.72 146.77 29.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.953 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.6 167.69 21.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -65.32 -57.32 8.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.53 -39.13 72.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -60.47 -38.38 84.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -66.4 -45.79 78.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.781 HG11 HG21 ' B' ' 116' ' ' THR . 22.1 t -68.55 -43.98 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.062 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -55.36 -57.15 13.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.7 m -57.55 -45.53 86.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.267 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.553 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.6 mm? -65.26 -30.2 71.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -82.56 -31.77 28.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -59.53 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.134 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.82 135.16 36.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.33 -39.64 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -108.2 87.27 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.588 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -127.05 145.22 50.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.63 HG23 ' CD2' ' A' ' 14' ' ' PHE . 43.0 m -90.44 121.36 32.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.117 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.89 HG22 HG22 ' A' ' 62' ' ' VAL . 7.5 pt -116.67 126.36 74.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.725 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.56 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -95.58 109.52 21.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.258 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.54 149.58 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.306 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.7 t -123.66 118.47 54.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.62 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.588 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -58.96 138.42 57.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.674 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.48 -18.26 0.45 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.245 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.563 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -61.57 -18.88 61.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.44 -30.97 2.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.48 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -56.64 -34.22 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.355 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -48.14 -46.11 33.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.9 HD21 ' HB3' ' A' ' 34' ' ' LYS . 34.5 mt -71.32 -45.24 63.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.87 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -58.57 -28.36 65.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.51 118.75 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 111.052 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.0 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.632 0.253 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.73 158.0 35.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.585 2.19 . . . . 0.0 112.398 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.05 127.57 54.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -68.83 149.02 49.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 9.8 mt -136.98 146.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.024 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.781 HG21 HG11 ' A' ' 76' ' ' VAL . 58.7 m -140.87 132.5 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.994 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.85 143.61 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.735 HD11 HG12 ' A' ' 27' ' ' ILE . 1.4 mp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.839 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' O ' HG13 ' A' ' 90' ' ' VAL . 7.9 tptp . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -102.54 140.17 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.572 ' HE3' HG23 ' A' ' 89' ' ' ILE . 14.3 ttpp -101.98 145.9 28.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -110.91 142.06 43.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.764 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.577 HG13 ' HB ' ' A' ' 51' ' ' VAL . 42.0 t -142.62 151.63 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.4 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.562 ' CE1' HG23 ' A' ' 86' ' ' THR . 22.6 m-85 -130.08 131.78 45.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.694 HG23 HD13 ' A' ' 47' ' ' LEU . 17.2 mm -129.44 104.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.845 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 1.1 t -116.45 26.05 10.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.824 ' HA ' HD11 ' A' ' 47' ' ' LEU . 7.5 mp 48.04 63.2 2.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.441 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.667 ' H ' HD21 ' A' ' 47' ' ' LEU . 7.7 p -117.19 111.37 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.15 86.05 1.78 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.294 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.47 2.78 3.5 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.526 0.203 . . . . 0.0 111.411 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.11 101.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.817 0.342 . . . . 0.0 111.284 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.01 145.16 4.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.568 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.8 tp -77.45 -48.44 17.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.363 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 84.67 33.33 19.35 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.767 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' A' ' 42' ' ' VAL . 1.7 t -152.13 156.5 39.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.792 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -114.55 173.73 6.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.859 HD11 HG22 ' A' ' 76' ' ' VAL . 9.2 pt -136.94 137.37 47.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.013 0.435 . . . . 0.0 111.248 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 p -120.07 161.88 20.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.771 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.547 ' O ' HD22 ' B' ' 113' ' ' LEU . 12.2 p -105.16 154.33 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.28 179.69 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.723 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HD2' HD13 ' A' ' 97' ' ' LEU . 61.6 Cg_endo -73.17 -168.27 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.645 2.23 . . . . 0.0 112.34 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mt -75.07 -26.9 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.134 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.48 -33.48 74.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.8 mtmm -149.86 76.32 8.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.884 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.25 141.89 26.46 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.697 2.264 . . . . 0.0 112.312 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.66 171.54 25.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.616 HG13 ' HB2' ' A' ' 75' ' ' ALA . 12.8 mm -82.91 114.43 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.419 ' CD1' ' HG3' ' A' ' 58' ' ' GLN . 93.8 m-85 -103.01 174.05 6.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.495 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.2 mm -107.81 135.2 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.536 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.2 -169.68 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.243 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.43 141.39 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.831 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.661 HG12 ' SG ' ' A' ' 25' ' ' CYS . 1.9 m -123.86 147.24 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.107 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.89 153.3 39.3 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.077 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.33 179.56 5.38 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.575 2.183 . . . . 0.0 112.328 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.1 34.67 47.36 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.547 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 18.5 p -132.13 -165.72 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.898 0.38 . . . . 0.0 110.848 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.824 HD11 ' HA ' ' A' ' 17' ' ' LEU . 9.7 mt -88.38 -42.61 12.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.755 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.707 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.9 p -53.05 -39.24 63.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.605 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.08 56.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.54 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.75 -42.43 95.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 13' ' ' VAL . 32.5 m -78.66 -34.72 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.62 60.62 0.41 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.285 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 48' ' ' SER . 21.6 mt -110.91 164.47 12.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 175.94 165.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 4.1 mt -54.93 139.96 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.009 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 110.72 -30.41 8.14 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.183 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' HB3' HG13 ' A' ' 89' ' ' ILE . 85.7 m-20 -70.61 165.56 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.668 0.271 . . . . 0.0 110.491 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 4.0 tt0 -151.35 117.07 5.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.258 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -69.17 117.08 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.748 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 88' ' ' SER . 34.3 m -98.08 5.06 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.828 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.84 156.77 1.12 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.911 0.386 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.678 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 94.2 t -154.19 100.46 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.45 29.98 17.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.18 -31.21 8.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 70' ' ' LEU . 21.9 t -58.86 120.13 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.16 104.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.678 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.4 m-85 -91.32 9.21 32.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.64 70.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -141.28 30.55 1.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.607 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -81.71 147.49 29.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.9 158.37 34.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -57.47 -51.96 67.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.019 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -39.5 84.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' C ' HD21 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.52 -41.86 95.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.731 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -62.89 -47.31 83.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.016 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.859 HG22 HD11 ' A' ' 27' ' ' ILE . 28.1 t -68.99 -35.7 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -61.52 -58.74 6.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.136 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG23 HD22 ' A' ' 79' ' ' LEU . 34.6 m -57.49 -43.65 83.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.731 0.301 . . . . 0.0 110.952 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 75' ' ' ALA . 2.3 mm? -61.67 -34.09 75.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.203 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.84 -27.74 30.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.212 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.748 ' O ' HD11 ' A' ' 85' ' ' LEU . 45.6 t -93.23 140.54 29.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.117 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.537 ' HG2' HD13 ' A' ' 17' ' ' LEU . 1.4 ttm105 -79.06 -42.81 25.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.569 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.2 t -104.74 92.08 4.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.632 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.748 HD11 ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -121.21 146.23 47.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.562 HG23 ' CE1' ' A' ' 14' ' ' PHE . 6.7 m -101.57 116.97 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.218 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.602 HG22 HG22 ' A' ' 62' ' ' VAL . 10.7 pt -106.84 125.79 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.599 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.667 ' O ' HG22 ' A' ' 60' ' ' VAL . 15.0 m -96.91 103.5 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.133 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -109.26 147.52 13.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.319 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 9' ' ' LYS . 24.4 t -120.92 114.95 45.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.4 137.88 47.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.49 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.87 -17.39 0.48 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.102 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.52 -21.97 29.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.798 0.333 . . . . 0.0 111.212 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.69 -31.12 2.02 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.521 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 1.1 mtp-105 -56.96 -34.64 68.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.498 0.19 . . . . 0.0 111.289 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -51.89 -49.96 61.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.368 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.498 HD13 ' HD2' ' A' ' 31' ' ' PRO . 13.6 mt -71.35 -40.09 70.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.997 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.428 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 1.9 m-85 -53.88 -37.86 64.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -105.79 86.83 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.924 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.46 HG22 ' HD2' ' B' ' 112' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.715 0.293 . . . . 0.0 110.836 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' B' ' 111' ' ' THR . 56.9 Cg_endo -70.82 -170.72 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.524 2.149 . . . . 0.0 112.286 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 29' ' ' SER . 5.4 mt -129.43 147.84 51.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.25 154.86 30.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.8 mt -144.9 127.7 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.835 HG21 HG21 ' A' ' 76' ' ' VAL . 69.2 m -128.81 123.71 33.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -88.28 121.99 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.63 ' HB2' HD23 ' A' ' 23' ' ' LEU . 21.3 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.853 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.749 0.309 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.798 ' HA ' HG22 ' A' ' 90' ' ' VAL . 8.5 mp0 60.51 108.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 6.1 ttpm? -98.01 148.07 23.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.977 0.418 . . . . 0.0 110.955 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.98 145.22 30.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.823 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.725 HG13 ' HB ' ' A' ' 51' ' ' VAL . 60.4 t -147.99 146.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -137.1 120.67 17.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.606 HD12 ' CD1' ' A' ' 23' ' ' LEU . 28.1 mm -105.12 117.7 51.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.094 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.6 t -124.52 126.62 46.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD22 ' HG2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -76.03 146.03 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.96 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 18' ' ' VAL . 13.5 t -133.76 31.15 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.009 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.48 -114.04 0.74 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.0 31.86 5.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.809 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.29 107.51 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.731 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' HA2' HD11 ' A' ' 17' ' ' LEU . . . -57.36 -83.93 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.482 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD1' HD12 ' A' ' 15' ' ' ILE . 11.8 tp -148.52 -54.3 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.453 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.497 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 107.61 16.77 12.24 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.737 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.741 ' SG ' HG23 ' A' ' 39' ' ' ILE . 36.8 t -140.68 156.23 46.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -114.83 173.6 6.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.776 HD11 HG22 ' A' ' 76' ' ' VAL . 8.3 pt -138.9 141.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 0.0 111.092 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 p -131.02 161.66 31.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.777 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.429 ' O ' HD13 ' B' ' 113' ' ' LEU . 29.0 t -105.15 145.2 30.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.16 178.47 44.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.659 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.38 -168.15 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.64 2.227 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.2 mp -71.33 -26.84 27.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -69.76 -30.11 67.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.009 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.748 ' CB ' HD21 ' A' ' 97' ' ' LEU . 1.6 ttmm -149.5 68.39 9.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.909 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.83 140.15 22.95 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.607 2.205 . . . . 0.0 112.206 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.72 -179.67 36.96 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 75' ' ' ALA . 11.3 mm -88.63 114.89 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.624 ' CE2' HD12 ' A' ' 97' ' ' LEU . 34.1 m-85 -111.07 176.85 4.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.316 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.741 HG23 ' SG ' ' A' ' 25' ' ' CYS . 22.8 mm -107.56 136.66 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.706 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.29 -169.32 1.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.396 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -44.41 140.66 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.401 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' SG ' ' A' ' 25' ' ' CYS . 21.2 t -117.6 157.97 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.31 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 42' ' ' VAL . 11.1 mmpt? -99.76 129.81 27.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.98 -50.3 13.69 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.477 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.33 75.52 1.01 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.497 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -160.92 -179.81 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 0.0 110.968 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.86 -41.86 77.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.489 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.8 p -52.91 -43.78 66.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.638 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.9 77.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.638 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.39 -36.75 76.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.725 ' HB ' HG13 ' A' ' 13' ' ' VAL . 19.3 m -85.25 -26.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.196 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.52 39.9 1.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.399 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 48' ' ' SER . 13.7 mt -89.64 134.13 34.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -149.44 163.27 38.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.578 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 33.9 mt -58.86 148.48 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -22.7 39.58 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.32 161.9 28.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.665 0.269 . . . . 0.0 110.663 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -141.5 114.57 8.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.26 117.06 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.544 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 88' ' ' SER . 25.0 m -103.49 3.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.984 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.03 152.0 1.14 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.366 . . . . 0.0 111.236 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.918 HG13 HG22 ' A' ' 87' ' ' ILE . 48.6 t -151.53 105.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.961 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.57 29.87 17.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.02 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.98 -28.31 16.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.517 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.9 t -59.4 122.86 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.11 111.7 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.663 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.8 m-85 -90.2 -2.39 58.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.346 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -59.76 -41.83 91.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.26 31.41 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.621 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -88.7 147.56 24.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.79 161.43 23.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -59.05 -50.53 73.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -59.49 -40.07 85.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -43.17 99.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.621 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -60.21 -44.55 95.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.776 HG22 HD11 ' A' ' 27' ' ' ILE . 43.6 t -70.2 -43.63 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.088 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -54.88 -52.87 61.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.274 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 79' ' ' LEU . 26.9 m -61.96 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 111.109 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.625 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.5 mm? -64.45 -31.52 72.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.65 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.626 ' HE3' HD23 ' B' ' 118' ' ' LEU . 1.1 mptm? -82.6 -31.87 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.27 -67.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.561 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.0 OUTLIER -81.75 133.43 35.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.047 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.53 ' HG2' HD22 ' A' ' 17' ' ' LEU . 2.6 mtt85 -76.02 -57.23 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.593 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 m -99.74 97.62 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.686 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.561 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -131.12 141.01 50.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.284 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 42.8 m -93.5 132.99 37.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.281 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.918 HG22 HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -125.15 140.12 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 111.704 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.664 ' O ' HG22 ' A' ' 60' ' ' VAL . 1.5 m -101.37 108.83 20.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -112.72 147.43 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.037 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.798 HG22 ' HA ' ' A' ' 10' ' ' GLU . 36.4 t -115.13 123.37 70.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.648 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -63.59 134.7 55.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.757 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.86 -17.41 0.48 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.543 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.75 -20.26 21.17 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.373 . . . . 0.0 111.139 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.49 -30.38 2.88 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.733 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -56.03 -34.71 66.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.58 -50.01 34.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.757 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.748 HD21 ' CB ' ' A' ' 34' ' ' LYS . 11.0 mt -71.55 -47.4 55.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.993 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 7.9 m-85 -49.65 -27.58 4.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 85.5 mmm -57.79 145.49 34.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.2 m . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.951 -179.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.669 0.271 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.06 144.75 53.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.595 2.196 . . . . 0.0 112.389 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 29' ' ' SER . 12.0 mt -96.38 158.98 15.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -102.94 163.9 11.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 31.0 mt -144.65 125.09 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.599 HG21 HG11 ' A' ' 76' ' ' VAL . 33.5 m -113.74 150.94 32.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -103.18 135.26 45.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.626 HD23 ' HE3' ' A' ' 80' ' ' LYS . 1.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.815 0.341 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.598 ' HA ' HG22 ' A' ' 90' ' ' VAL . 1.3 mt-10 -58.77 131.84 52.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.849 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 14.3 ttpt -95.69 133.94 39.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.988 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -96.0 143.94 26.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.636 HG13 ' HB ' ' A' ' 51' ' ' VAL . 28.6 t -149.51 153.24 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.262 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.27 121.79 22.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 35.6 mm -112.55 136.6 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.415 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.405 ' O ' HD13 ' A' ' 47' ' ' LEU . 1.7 p -141.5 173.35 11.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.546 HD23 ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -77.65 -57.22 3.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.892 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 18' ' ' VAL . 14.6 p 43.69 40.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.584 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 17' ' ' LEU . . . 142.98 -115.11 0.9 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.593 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -122.1 -41.38 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.011 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -57.42 138.78 54.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.78 -62.5 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.464 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.8 tp -146.05 -57.6 0.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.847 0.356 . . . . 0.0 110.469 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.34 24.24 7.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.377 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.615 ' SG ' HG23 ' A' ' 39' ' ' ILE . 41.8 t -149.44 159.05 44.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -114.44 173.57 6.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.191 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.733 HD11 HG22 ' A' ' 76' ' ' VAL . 20.6 pt -137.05 149.35 26.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.008 0.432 . . . . 0.0 111.407 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -128.57 162.23 27.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.696 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.723 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.5 OUTLIER -104.7 139.48 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.7 179.67 45.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.047 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.815 ' CD ' HD12 ' A' ' 97' ' ' LEU . 56.8 Cg_endo -70.04 -160.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.959 2.44 . . . . 0.0 112.346 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.5 mt -86.01 -28.25 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -64.57 -32.81 74.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HB2' HD11 ' A' ' 97' ' ' LEU . 5.7 mttt -142.38 76.55 18.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.809 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 126.32 10.57 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.53 2.153 . . . . 0.0 112.423 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.01 173.98 41.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.537 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.511 HG13 ' HB2' ' A' ' 75' ' ' ALA . 21.5 mm -87.51 115.97 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 0.0 111.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 5.3 m-85 -100.61 172.54 7.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.615 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.5 mm -107.77 134.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.029 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.15 -169.27 1.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -46.22 141.41 3.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 25' ' ' CYS . 6.5 t -111.15 157.13 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.072 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' N ' HG12 ' A' ' 42' ' ' VAL . 33.1 mttt -108.41 112.53 60.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 155.32 9.47 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.405 2.07 . . . . 0.0 112.28 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.1 29.37 74.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.504 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.433 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 71.3 p -124.6 -170.72 2.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 16' ' ' SER . 6.9 mt -76.39 -45.42 31.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.763 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 11.6 p -52.9 -37.21 60.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.974 0.416 . . . . 0.0 110.549 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.38 -37.99 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.563 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -59.43 -31.19 69.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.801 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.0 m -86.59 -30.56 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.74 58.81 0.59 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.374 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 mt -107.28 167.82 9.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 0.0 111.139 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -179.75 162.24 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -56.8 142.87 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.24 -23.53 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.133 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -71.58 163.47 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 7.6 tt0 -148.59 115.14 5.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.089 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.35 117.32 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.694 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 88' ' ' SER . 35.8 m -97.9 -4.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.892 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.82 150.73 8.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.948 HG22 HG22 ' A' ' 87' ' ' ILE . 61.4 t -149.5 98.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 62.72 35.39 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.44 -27.93 15.28 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.545 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.6 124.42 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 111.12 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 109.73 5.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.727 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.9 m-85 -87.5 -10.02 52.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.362 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 59.7 p -56.42 -31.92 64.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.852 0.358 . . . . 0.0 111.0 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -132.92 32.09 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.3 tp -92.09 147.59 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.24 162.14 29.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -63.17 -57.67 9.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.11 -36.17 70.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -39.53 94.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.581 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -63.33 -46.68 85.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.816 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.84 HG11 HG21 ' B' ' 116' ' ' THR . 39.7 t -68.28 -35.43 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.952 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -58.77 6.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.225 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 79' ' ' LEU . 34.4 m -57.32 -41.23 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.324 . . . . 0.0 111.097 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.411 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.7 mm? -66.43 -31.97 73.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.642 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.6 mptp? -82.57 -31.17 29.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.227 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -74.88 -69.08 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.255 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.629 ' OG ' HD23 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -66.56 118.85 10.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.081 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HG3' HD23 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -65.08 -56.97 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.509 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.92 105.54 15.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -131.31 144.51 51.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.966 0.413 . . . . 0.0 111.41 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.21 116.93 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.146 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.948 HG22 HG22 ' A' ' 62' ' ' VAL . 10.2 pt -109.69 127.3 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.654 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -99.75 103.53 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.659 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -105.08 145.49 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.08 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 10' ' ' GLU . 39.6 t -115.24 117.25 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.713 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.579 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.57 135.48 56.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.935 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 82.95 -17.35 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.432 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -56.78 -19.99 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.15 -29.99 3.08 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.578 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 2.4 ptp180 -55.4 -34.67 64.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.569 0.223 . . . . 0.0 111.277 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -55.99 -43.62 77.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.042 0.448 . . . . 0.0 110.11 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.815 HD12 ' CD ' ' A' ' 31' ' ' PRO . 2.8 mm? -71.44 -50.11 34.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.794 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -49.79 -32.37 13.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.388 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.6 mmt -77.37 -53.88 7.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.984 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.672 0.272 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 -176.1 1.52 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.492 2.128 . . . . 0.0 112.324 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 29' ' ' SER . 4.4 mt -124.85 158.95 32.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -88.87 149.19 23.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 25.4 mt -134.98 143.54 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.84 HG21 HG11 ' A' ' 76' ' ' VAL . 80.3 m -133.25 136.37 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -88.71 112.33 23.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.642 HD23 ' HE2' ' A' ' 80' ' ' LYS . 4.1 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.933 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.799 0.333 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 61.24 153.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.983 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -115.36 131.02 57.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -91.73 135.27 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.882 HG13 ' HB ' ' A' ' 51' ' ' VAL . 48.6 t -137.47 142.22 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.998 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -125.87 130.0 50.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 HD12 HD12 ' A' ' 23' ' ' LEU . 30.3 mm -122.02 106.48 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 9.4 t -106.32 -22.56 12.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.237 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD11 ' HA2' ' A' ' 22' ' ' GLY . 0.6 OUTLIER 68.0 160.45 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.862 0.363 . . . . 0.0 110.906 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.7 t -99.4 -65.33 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.18 -76.77 0.28 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.581 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.0 p -157.98 30.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.42 -29.51 21.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.001 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.566 ' HA2' HD11 ' A' ' 17' ' ' LEU . . . 102.96 174.96 26.65 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.36 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -59.3 -40.75 87.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.68 0.276 . . . . 0.0 110.446 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.89 33.17 6.17 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.631 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.799 ' HB3' HD21 ' A' ' 23' ' ' LEU . 1.9 t -151.45 168.9 23.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 0.0 110.794 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 14.9 m -114.69 172.28 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.418 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.973 HD11 HG22 ' A' ' 76' ' ' VAL . 3.6 pt -142.34 140.34 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 111.203 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.0 t -122.49 161.72 23.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.995 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.613 ' O ' HD22 ' B' ' 113' ' ' LEU . 70.6 p -105.25 138.7 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.13 38.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.514 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.65 ' HD2' HD13 ' A' ' 97' ' ' LEU . 38.4 Cg_endo -66.64 -172.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.54 2.16 . . . . 0.0 112.28 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -70.12 -25.17 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -70.13 -27.49 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.166 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HB3' HD11 ' A' ' 97' ' ' LEU . 6.5 mtpt -147.7 64.07 8.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.249 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 17.3 Cg_exo -66.75 126.2 14.99 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.592 2.195 . . . . 0.0 112.1 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.72 42.93 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 67' ' ' PHE . 11.2 mm -89.88 115.51 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.775 0.321 . . . . 0.0 111.056 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.908 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.9 m-85 -103.61 171.72 7.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mm -107.55 134.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.366 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -106.12 -169.61 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.439 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -47.74 144.84 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.166 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.78 HG22 ' SG ' ' A' ' 25' ' ' CYS . 1.7 t -110.26 157.92 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 3.0 mptt -115.07 133.62 22.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 51.5 Cg_exo -55.4 161.52 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.438 2.092 . . . . 0.0 112.293 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.46 70.36 0.97 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.446 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -161.75 -167.33 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.85 0.357 . . . . 0.0 110.976 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.629 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.5 mm? -84.76 -44.67 13.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.615 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.3 p -55.71 -39.49 71.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.926 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.96 79.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.5 -44.49 96.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.882 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.1 m -71.75 -24.89 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 63.76 1.06 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 48' ' ' SER . 15.6 mt -105.67 164.94 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -178.26 162.25 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.65 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.8 mt -56.88 143.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.96 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.5 -34.87 5.23 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.201 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.92 162.37 19.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.298 . . . . 0.0 110.604 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.6 117.52 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.156 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.22 117.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.467 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 88' ' ' SER . 33.9 m -100.45 -18.64 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.744 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.03 149.57 27.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 111.207 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.758 HG13 HG22 ' A' ' 87' ' ' ILE . 46.8 t -143.83 95.05 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.086 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 59.9 36.86 21.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.94 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.51 -29.8 9.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.542 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.08 116.62 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.173 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.14 119.66 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.729 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.4 m-85 -96.78 22.66 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.7 t -79.92 -58.85 2.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.877 0.37 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -104.49 29.03 6.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.644 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -89.12 147.75 24.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -82.66 173.73 11.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -68.65 -54.25 17.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -56.61 -39.15 73.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HB3' HD11 ' A' ' 70' ' ' LEU . 29.9 mt-10 -60.05 -42.81 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.762 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.37 -46.45 90.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.978 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 27' ' ' ILE . 26.0 t -69.35 -38.82 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.9 -53.6 55.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.163 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 79' ' ' LEU . 33.9 m -59.45 -43.59 90.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.908 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.807 ' HA ' HD21 ' A' ' 85' ' ' LEU . 3.0 mm? -64.32 -35.22 80.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.126 0.488 . . . . 0.0 110.65 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -82.92 -26.25 31.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.681 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 t -85.29 -67.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.588 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -52.93 -37.34 60.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.496 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 67.36 -72.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.282 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 11.7 p -90.19 86.0 6.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.023 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.807 HD21 ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -130.73 146.22 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.589 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.2 m -94.51 116.73 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.758 HG22 HG13 ' A' ' 62' ' ' VAL . 7.9 pt -110.86 127.64 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 0.0 111.634 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -98.72 107.84 20.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.97 146.88 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.709 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -109.58 130.01 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.616 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -70.08 130.63 42.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.432 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 87.13 -17.23 0.35 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.47 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.709 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -54.55 -21.31 9.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 111.262 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.92 -30.74 2.68 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.725 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 92' ' ' ALA . 4.5 ptp180 -56.59 -34.67 67.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.462 0.172 . . . . 0.0 111.385 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.52 -50.13 43.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.908 HD12 ' CE2' ' A' ' 38' ' ' PHE . 17.1 mt -71.56 -41.8 68.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.774 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -56.25 -22.74 31.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.395 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 33.7 mtt -59.11 86.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.842 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.713 0.292 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 -169.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.528 2.152 . . . . 0.0 112.39 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 29' ' ' SER . 18.5 mt -112.89 140.8 47.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -77.22 142.15 39.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.057 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.22 141.47 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.622 HG21 HG21 ' A' ' 76' ' ' VAL . 31.6 m -119.31 151.01 39.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.49 124.63 49.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.495 HD22 HG13 ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.802 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' O ' HG13 ' A' ' 90' ' ' VAL . 2.9 tptt . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 90' ' ' VAL . 1.8 mp0 -104.92 144.95 31.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.963 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.728 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -101.34 120.35 40.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.856 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.23 143.47 27.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.782 HG13 ' HB ' ' A' ' 51' ' ' VAL . 26.2 t -151.36 151.92 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.221 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.51 131.08 39.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 mm -120.1 134.95 61.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.276 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 t -141.5 128.6 20.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 19' ' ' GLY . 5.7 tt -75.21 104.3 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.897 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 18' ' ' VAL . 9.8 p -88.43 60.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.034 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' N ' HD23 ' A' ' 17' ' ' LEU . . . 83.81 -62.46 4.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.496 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -113.68 146.92 39.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.768 0.318 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 62.29 128.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -82.99 -50.24 4.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.627 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' A' ' 48' ' ' SER . 13.9 tp -136.01 -56.23 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.688 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 105.33 17.19 14.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.469 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.749 ' SG ' HG22 ' A' ' 42' ' ' VAL . 4.8 t -142.88 166.95 23.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.712 0.291 . . . . 0.0 110.637 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.7 m -114.49 169.44 9.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.397 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.67 HG22 HD13 ' A' ' 39' ' ' ILE . 30.6 pt -142.66 155.87 18.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.983 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.508 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 3.2 m -146.62 162.1 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.128 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.84 150.94 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 97' ' ' LEU . . . -89.89 -172.93 45.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.907 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.09 -164.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.661 2.24 . . . . 0.0 112.418 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.3 -25.83 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.375 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.6 -29.86 70.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HB3' HD21 ' A' ' 97' ' ' LEU . 2.0 ttpt -156.41 66.06 4.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.77 116.6 3.41 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.493 2.129 . . . . 0.0 112.176 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -155.84 141.78 8.31 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.0 mm -82.76 106.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.574 0.226 . . . . 0.0 110.889 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 4.3 p90 -100.55 -176.35 3.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.67 HD13 HG22 ' A' ' 27' ' ' ILE . 18.6 mm -107.06 140.53 24.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 111.625 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.07 -169.18 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.109 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -46.34 143.52 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.087 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.749 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -110.3 150.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.982 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -106.33 108.84 62.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.78 145.3 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.332 2.022 . . . . 0.0 112.315 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.7 40.21 9.88 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.304 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.515 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.5 m -144.42 -173.52 4.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.563 HD22 ' H ' ' A' ' 47' ' ' LEU . 2.1 mm? -67.93 -48.51 65.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.676 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.556 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.13 -46.0 68.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.36 97.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 110.599 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.39 -53.1 62.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.698 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.782 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.7 m -67.54 -28.69 42.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.207 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.54 65.61 0.83 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 48' ' ' SER . 17.3 mt -106.24 156.5 18.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 0.0 110.884 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -167.0 162.59 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.439 HG23 ' CZ ' ' A' ' 98' ' ' PHE . 3.7 mt -56.26 146.71 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.009 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.33 -32.43 7.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.34 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' CB ' HD11 ' A' ' 89' ' ' ILE . 49.5 m-20 -58.9 164.99 2.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.578 0.228 . . . . 0.0 110.862 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -147.55 113.66 5.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.838 0.351 . . . . 0.0 111.38 -179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.7 mt -69.36 117.09 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.674 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 88' ' ' SER . 26.8 m -105.61 7.85 9.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.946 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.7 145.67 0.54 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.877 0.37 . . . . 0.0 111.15 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 87' ' ' ILE . 58.0 t -148.43 99.27 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.886 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.47 30.82 15.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.27 -28.9 13.21 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.14 129.49 29.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.75 121.92 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.831 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.0 m-85 -99.19 26.68 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.27 -66.98 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.6 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.49 30.69 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.618 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 74' ' ' GLU . 1.4 tp -79.51 145.52 33.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.977 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.06 162.89 24.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.792 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 28' ' ' SER . 3.3 t-160 -60.51 -54.13 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.992 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.11 -38.47 70.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.635 ' HB3' HD11 ' A' ' 70' ' ' LEU . 20.8 mt-10 -61.39 -47.23 86.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.6 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -58.35 -44.72 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.863 HG11 HG21 ' B' ' 116' ' ' THR . 27.4 t -69.71 -45.49 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.3 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -55.03 -53.57 54.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.256 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 79' ' ' LEU . 35.3 m -60.22 -43.42 93.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.078 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.541 ' HB3' HD22 ' B' ' 118' ' ' LEU . 3.4 mm? -67.49 -31.17 71.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.711 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.758 ' HE2' HD23 ' B' ' 118' ' ' LEU . 5.2 mptp? -82.53 -30.05 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -70.01 -66.26 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.223 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.634 ' HB2' HD23 ' A' ' 85' ' ' LEU . 1.3 m -81.45 118.79 22.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -68.8 -40.31 79.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.586 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 87.5 p -114.23 102.68 10.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.662 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -137.47 146.17 43.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 -179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -91.5 116.99 29.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.185 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.752 HG22 HG22 ' A' ' 62' ' ' VAL . 16.1 pt -111.36 130.99 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 0.0 111.642 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -102.99 103.61 13.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.322 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.728 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -104.62 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 10' ' ' GLU . 42.1 t -127.22 115.94 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.958 0.409 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.06 140.39 49.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.636 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.41 -22.72 0.22 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.014 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' HB3' ' CB ' ' A' ' 58' ' ' GLN . . . -59.69 -20.79 58.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.906 0.384 . . . . 0.0 111.191 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.06 -31.03 3.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -56.68 -34.61 67.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.722 0.296 . . . . 0.0 111.318 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -50.26 -49.65 52.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.712 HD21 ' HB3' ' A' ' 34' ' ' LYS . 20.4 mt -71.09 -39.83 71.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CE2' ' CD2' ' A' ' 38' ' ' PHE . 4.1 m-85 -54.66 -47.96 72.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.161 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -84.78 130.88 34.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.931 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.771 0.319 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.88 157.39 62.05 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.559 2.173 . . . . 0.0 112.168 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.65 140.45 49.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.43 159.36 34.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.676 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -141.17 141.98 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.863 HG21 HG11 ' A' ' 76' ' ' VAL . 95.9 m -129.37 145.98 51.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.41 116.38 31.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.758 HD23 ' HE2' ' A' ' 80' ' ' LYS . 3.2 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 tttm . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.733 0.301 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.7 145.6 40.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -117.97 141.25 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.55 138.84 42.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 HG11 ' A' ' 51' ' ' VAL . 55.7 t -139.98 136.69 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.63 ' HD2' HG23 ' A' ' 86' ' ' THR . 31.6 t80 -119.51 117.67 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.79 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' CG1' HD11 ' A' ' 87' ' ' ILE . 29.1 mm -106.81 126.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.053 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.6 p -139.79 112.87 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.22 112.06 1.98 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 18' ' ' VAL . 5.9 m -136.11 94.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.075 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.25 70.67 1.31 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.564 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m 60.18 173.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.776 0.322 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.0 mtt-85 60.7 110.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.632 ' O ' HD23 ' A' ' 47' ' ' LEU . . . -68.15 -69.15 1.44 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.435 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.583 HD11 ' HB3' ' A' ' 48' ' ' SER . 16.9 tp -126.73 -53.51 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.863 0.364 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.506 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 95.68 26.93 11.01 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.433 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.828 ' SG ' HG22 ' A' ' 42' ' ' VAL . 50.6 t -147.37 159.33 43.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.416 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 3.1 m -114.43 173.65 6.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.22 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.929 HD11 HG22 ' A' ' 76' ' ' VAL . 9.2 pt -139.4 157.47 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.399 . . . . 0.0 111.37 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.29 162.03 28.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.548 ' O ' HD13 ' B' ' 113' ' ' LEU . 1.1 m -104.8 140.82 37.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.523 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.75 162.1 31.28 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.589 ' CD ' HD12 ' A' ' 97' ' ' LEU . 27.6 Cg_endo -62.11 -159.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.955 2.437 . . . . 0.0 112.216 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.67 -27.63 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.95 -29.89 55.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -141.05 60.77 13.11 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.88 135.04 20.75 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.29 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 37' ' ' ILE . . . 176.25 -146.96 8.31 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.621 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.491 HD11 ' O ' ' A' ' 71' ' ' ASP . 19.7 mm -127.13 111.14 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 110.999 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 97' ' ' LEU . 20.0 m-85 -100.58 173.55 6.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.557 HG23 ' SG ' ' A' ' 25' ' ' CYS . 16.5 mm -107.84 133.21 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.88 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 26' ' ' SER . 0.6 OUTLIER -106.12 -169.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.724 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.432 ' ND1' HD11 ' A' ' 55' ' ' ILE . 86.0 m-70 -44.71 133.93 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.645 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.828 HG22 ' SG ' ' A' ' 25' ' ' CYS . 22.2 t -111.01 148.24 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.55 145.21 30.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.972 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.02 172.12 15.33 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.503 2.135 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.14 33.87 61.67 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.506 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.3 m -131.73 -172.79 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 22' ' ' GLY . 2.9 mm? -77.42 -47.43 19.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.556 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.5 p -59.44 -35.92 74.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.35 72.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.89 -39.99 91.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.785 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 13' ' ' VAL . 28.6 m -75.11 -29.76 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.03 55.14 0.93 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD12 ' CB ' ' A' ' 48' ' ' SER . 14.4 mt -97.0 144.98 26.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -153.42 162.83 40.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.658 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.432 HD11 ' ND1' ' A' ' 41' ' ' HIS . 3.1 mt -56.96 138.54 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.085 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 116.82 -40.14 2.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.446 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -55.54 166.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.737 0.303 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.68 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 20.3 tm0? -146.79 116.72 7.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.126 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.47 120.08 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 88' ' ' SER . 29.7 m -100.09 -18.55 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.597 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -158.67 155.14 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 111.312 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 87' ' ' ILE . 56.2 t -153.1 109.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 58.77 30.8 20.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.6 -31.09 8.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.489 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.54 131.88 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 111.16 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -77.29 116.4 17.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE1' HD22 ' A' ' 70' ' ' LEU . 2.1 m-85 -89.79 -9.4 49.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.321 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.8 t -55.38 -30.73 60.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -130.41 32.52 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.671 HD21 ' N ' ' A' ' 75' ' ' ALA . 1.5 tp -96.46 147.63 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.997 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.491 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -77.99 174.22 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.483 ' HB2' ' HG ' ' A' ' 29' ' ' SER . 2.0 t-160 -68.97 -54.7 13.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.78 -38.32 78.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.992 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.567 ' HB3' HD11 ' A' ' 70' ' ' LEU . 24.6 mt-10 -60.62 -44.57 96.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.671 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -63.1 -40.88 98.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.26 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.929 HG22 HD11 ' A' ' 27' ' ' ILE . 39.6 t -70.26 -47.0 69.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -52.67 62.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.244 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 79' ' ' LEU . 34.3 m -60.17 -44.78 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.4 mm? -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.74 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE2' HD23 ' B' ' 118' ' ' LEU . 3.7 mptp? -81.84 -30.67 31.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -69.9 -67.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.254 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -83.39 138.82 33.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -89.99 -55.26 3.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.614 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -91.85 81.92 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.592 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -121.03 145.22 48.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.423 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.63 HG23 ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -92.49 119.36 31.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.034 179.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.934 HG22 HG22 ' A' ' 62' ' ' VAL . 7.2 pt -116.55 122.44 69.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.924 0.392 . . . . 0.0 111.792 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -95.84 122.7 38.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -129.32 144.74 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 111.71 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.739 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -111.69 131.67 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.142 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.623 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -68.58 132.51 47.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.249 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 86.26 -17.89 0.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.739 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -55.09 -20.9 10.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.798 0.332 . . . . 0.0 111.287 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.34 -29.99 2.18 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.751 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 44.4 mtp85 -55.56 -34.46 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.531 0.205 . . . . 0.0 111.188 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -49.3 -39.81 32.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.046 0.451 . . . . 0.0 110.358 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.589 HD12 ' CD ' ' A' ' 31' ' ' PRO . 3.2 mm? -71.29 -59.22 2.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.851 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -48.73 -28.54 3.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.387 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.5 mmm -58.84 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.945 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.814 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.81 153.68 77.12 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.62 2.213 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 29' ' ' SER . 4.4 mt -72.75 174.07 8.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -81.79 168.64 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 28.7 mt -148.32 139.88 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.194 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.916 HG21 HG21 ' A' ' 76' ' ' VAL . 29.9 m -133.03 131.6 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.11 137.17 32.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.173 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.554 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.843 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 121.007 0.432 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' CB ' HG22 ' A' ' 90' ' ' VAL . 2.2 mt-10 -58.38 140.62 53.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 91' ' ' ALA . 7.0 ttpm? -101.28 140.5 35.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.29 134.6 41.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.958 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 51' ' ' VAL . 60.9 t -139.56 147.23 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HD1' ' HG1' ' A' ' 86' ' ' THR . 82.7 t80 -135.96 126.16 26.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.458 HD12 ' CD1' ' A' ' 23' ' ' LEU . 32.1 mm -114.49 115.06 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -106.53 -22.85 12.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.266 -179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 16' ' ' SER . 3.0 tt 86.86 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.472 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.723 HG23 HD11 ' A' ' 47' ' ' LEU . 16.9 t 69.61 -67.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.833 0.349 . . . . 0.0 111.201 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.66 -55.23 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.55 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 m -83.97 157.41 21.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.445 ' O ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER 43.58 -165.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.467 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 47' ' ' LEU . . . -114.75 -77.46 0.73 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.566 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' CD1' HD12 ' A' ' 15' ' ' ILE . 14.7 tp -122.19 -48.34 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.688 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.73 25.23 12.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.347 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' HG23 ' A' ' 39' ' ' ILE . 32.5 t -148.98 159.02 44.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.2 m -114.32 173.8 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 76' ' ' VAL . 17.5 pt -137.96 141.25 39.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 111.255 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -119.09 161.72 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.577 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.536 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -105.06 147.9 27.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.66 175.37 43.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.69 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.36 -165.6 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.662 2.241 . . . . 0.0 112.262 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.3 mm -78.6 -28.93 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.253 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -78.54 -28.91 46.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -138.63 60.08 18.75 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.42 136.49 21.78 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.59 2.193 . . . . 0.0 112.291 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.43 -172.03 44.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.534 HD11 ' O ' ' A' ' 71' ' ' ASP . 19.3 mm -98.08 115.21 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.103 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.619 ' CE2' HD12 ' A' ' 97' ' ' LEU . 6.1 m-85 -110.89 175.9 5.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.664 HG23 ' SG ' ' A' ' 25' ' ' CYS . 20.1 mm -107.69 137.04 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.375 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.16 -169.41 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.436 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -48.83 141.42 7.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 25' ' ' CYS . 11.0 t -110.93 154.14 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -109.81 146.27 33.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.987 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 161.4 45.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.52 2.146 . . . . 0.0 112.291 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.68 57.47 19.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.404 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.484 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -152.59 -173.42 4.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.98 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.723 HD11 HG23 ' A' ' 18' ' ' VAL . 3.2 mm? -73.22 -48.59 33.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.585 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.644 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -55.07 -42.11 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.97 82.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.62 -41.79 87.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.706 ' HB ' HG13 ' A' ' 13' ' ' VAL . 36.0 m -74.26 -30.04 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.063 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.91 61.84 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.9 mt -109.58 162.99 13.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 111.035 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.2 162.29 3.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.629 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.449 ' CG2' ' CE2' ' A' ' 98' ' ' PHE . 6.3 mt -54.86 145.68 4.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.44 -30.58 10.05 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.301 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.23 162.91 8.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.263 . . . . 0.0 110.601 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 3.6 tm0? -144.93 113.73 6.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 39' ' ' ILE . 3.5 mt -69.22 117.14 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.774 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 88' ' ' SER . 35.9 m -92.95 -25.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.648 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -152.86 158.11 41.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.861 0.363 . . . . 0.0 111.283 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.8 HG13 HG22 ' A' ' 87' ' ' ILE . 59.8 t -149.98 103.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.952 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 63.76 30.2 14.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 -26.82 19.18 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.623 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -69.37 130.54 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.128 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.72 125.3 26.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.7 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -99.35 -17.62 17.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.269 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -50.55 65.85 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.786 0.327 . . . . 0.0 111.092 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.07 30.77 5.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.572 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -98.53 146.69 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.534 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -75.24 170.93 15.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -70.89 -55.82 7.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -58.12 -34.07 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -40.31 91.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.66 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -62.86 -44.48 96.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.805 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 27' ' ' ILE . 38.9 t -69.55 -35.76 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.015 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 -52.35 63.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.7 m -61.13 -43.38 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.19 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.535 ' HB3' HD22 ' B' ' 118' ' ' LEU . 3.7 mm? -65.94 -30.8 71.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.799 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.89 ' HE2' HD23 ' B' ' 118' ' ' LEU . 2.4 mptp? -82.61 -34.19 27.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.61 -65.42 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.209 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.81 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -79.1 125.32 29.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -73.71 -43.97 57.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.604 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.2 p -115.08 98.89 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.53 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.81 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.2 OUTLIER -129.3 146.16 51.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.98 0.419 . . . . 0.0 111.277 -179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.451 ' HG1' ' HD1' ' A' ' 14' ' ' PHE . 12.4 m -92.9 116.98 29.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.198 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.8 HG22 HG13 ' A' ' 62' ' ' VAL . 14.2 pt -114.02 129.2 70.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.979 0.419 . . . . 0.0 111.673 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.699 ' O ' HG22 ' A' ' 60' ' ' VAL . 4.4 m -101.84 110.32 22.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.354 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.488 HD13 ' C ' ' A' ' 89' ' ' ILE . 0.0 OUTLIER -110.5 147.04 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.209 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.484 ' N ' HD13 ' A' ' 89' ' ' ILE . 29.1 t -117.06 113.34 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -57.24 141.09 47.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.449 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.8 -19.86 0.35 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.957 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -58.92 -20.17 49.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.47 -30.51 2.03 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.502 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -56.08 -34.13 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -48.14 -42.83 30.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.744 0.306 . . . . 0.0 110.616 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.619 HD12 ' CE2' ' A' ' 38' ' ' PHE . 56.6 mt -71.35 -49.31 43.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.0 110.717 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 55' ' ' ILE . 17.1 m-85 -54.3 -28.85 44.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.13 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.37 124.86 19.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.074 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.4 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.992 -179.958 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.648 0.261 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.22 154.45 65.91 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.577 2.184 . . . . 0.0 112.276 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 29' ' ' SER . 10.0 mt -138.33 149.06 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -88.32 158.68 18.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.2 mt -137.19 147.24 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.591 HG21 HG11 ' A' ' 76' ' ' VAL . 90.1 m -125.49 151.0 46.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.24 108.6 20.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.89 HD23 ' HE2' ' A' ' 80' ' ' LYS . 52.2 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.92 0.39 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.597 ' HA ' HG22 ' A' ' 90' ' ' VAL . 3.3 mt-10 -161.19 118.79 2.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 12.8 ttpp -100.28 114.6 28.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -86.53 142.6 28.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.563 HG13 ' HB ' ' A' ' 51' ' ' VAL . 21.8 t -148.56 158.86 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.176 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.487 ' N ' HG12 ' A' ' 13' ' ' VAL . 51.1 p90 -141.07 116.88 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.706 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG1' HD11 ' A' ' 87' ' ' ILE . 39.4 mm -102.43 135.45 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.196 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.16 131.18 27.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.95 134.08 41.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' A' ' 21' ' ' ARG . 7.5 m -106.99 -156.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -45.58 -45.14 12.24 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.059 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 m -164.49 64.09 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.381 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.633 ' HB2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -156.11 109.9 2.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.787 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -76.75 0.38 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.602 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' B' ' 118' ' ' LEU . 13.2 tp -138.57 -63.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 111.11 23.44 5.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.402 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' HG22 ' A' ' 42' ' ' VAL . 13.8 t -150.7 164.3 36.48 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.65 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -114.43 173.32 6.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.391 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.945 HD11 HG22 ' A' ' 76' ' ' VAL . 2.2 pt -137.15 146.67 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 111.389 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.5 p -125.17 161.87 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.734 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.545 ' O ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -104.93 144.52 31.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.594 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.68 170.83 38.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.882 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 97' ' ' LEU . 34.6 Cg_endo -64.28 -164.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.771 2.314 . . . . 0.0 112.32 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -81.96 -28.93 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.17 -29.56 54.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.673 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.3 tttp -141.83 60.54 11.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.882 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.85 147.82 35.18 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.41 175.88 32.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.4 mm -86.69 114.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.953 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.746 ' CE2' HD12 ' A' ' 97' ' ' LEU . 26.3 m-85 -108.5 174.53 5.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.246 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG23 ' SG ' ' A' ' 25' ' ' CYS . 14.9 mm -107.63 134.64 48.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.375 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.0 t -106.19 -169.42 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.392 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -45.28 153.06 0.23 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.36 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.858 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.8 t -125.48 157.98 34.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.64 138.75 27.9 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 155.44 69.45 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.41 2.073 . . . . 0.0 112.329 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.05 7.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.357 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.453 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -157.2 -170.29 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.732 0.301 . . . . 0.0 110.726 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? -76.94 -45.35 28.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.852 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 23' ' ' LEU . 2.9 p -55.7 -45.3 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.095 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.62 88.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.073 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -60.56 -40.12 90.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.563 ' HB ' HG13 ' A' ' 13' ' ' VAL . 27.5 m -76.83 -27.11 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.168 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.49 57.66 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 mt -98.75 156.96 16.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -163.44 159.6 22.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.76 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mt -55.23 153.51 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.855 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.1 -23.93 31.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.221 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.67 159.46 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.685 0.279 . . . . 0.0 110.58 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 89' ' ' ILE . 2.5 tt0 -146.85 120.22 9.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.858 0.361 . . . . 0.0 111.102 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.427 HG21 ' CG2' ' A' ' 62' ' ' VAL . 2.1 mt -69.31 117.18 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.622 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.6 m -97.32 -5.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.843 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.83 148.07 5.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.843 HG22 HG22 ' A' ' 87' ' ' ILE . 49.0 t -146.77 109.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 57.95 30.56 19.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.73 12.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -61.23 138.08 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.13 111.4 14.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.761 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.5 m-85 -91.09 11.08 24.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.317 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -75.27 -34.87 61.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -127.25 29.53 5.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.682 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.761 HD22 ' CE1' ' A' ' 67' ' ' PHE . 2.4 tp -87.35 148.92 24.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 163.87 21.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -56.62 19.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -57.81 -40.32 79.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -41.02 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.642 ' HB2' HD23 ' A' ' 70' ' ' LEU . . . -63.23 -46.05 88.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.089 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.945 HG22 HD11 ' A' ' 27' ' ' ILE . 35.7 t -69.4 -35.56 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.07 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -50.81 69.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.18 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 79' ' ' LEU . 27.9 m -62.73 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.457 ' N ' HG23 ' A' ' 78' ' ' VAL . 3.7 mm? -63.26 -31.87 73.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.62 -34.37 27.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 -62.4 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.684 ' HB2' HD23 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -83.84 134.56 34.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.193 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -98.41 25.88 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.855 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -177.93 71.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 82' ' ' SER . 0.1 OUTLIER -115.27 146.17 41.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.366 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.7 m -90.5 116.87 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.026 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 62' ' ' VAL . 8.1 pt -110.79 128.27 67.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.919 0.39 . . . . 0.0 111.582 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.23 122.19 42.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.733 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -128.19 147.39 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.746 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 10' ' ' GLU . 25.4 t -117.72 117.87 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.736 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.586 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -56.26 136.42 53.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.801 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.47 -17.5 0.49 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.276 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.73 35.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.11 -30.3 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.484 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -56.05 -34.4 65.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -48.38 -49.99 32.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.746 HD12 ' CE2' ' A' ' 38' ' ' PHE . 10.1 mt -71.76 -45.82 60.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.855 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -28.64 53.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.283 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.41 126.09 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.766 0.317 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.81 143.61 56.19 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.602 2.201 . . . . 0.0 112.407 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 29' ' ' SER . 2.8 mt -65.64 160.65 22.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.75 153.82 19.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 33.2 mt -139.12 134.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.688 HG21 HG21 ' A' ' 76' ' ' VAL . 28.7 m -125.45 138.82 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.32 140.27 29.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.707 HD11 HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.906 0.384 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' CG ' HG22 ' A' ' 90' ' ' VAL . 3.1 mt-10 -157.86 129.39 6.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.761 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 91' ' ' ALA . 5.9 ttpm? -96.78 136.93 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.02 0.438 . . . . 0.0 111.093 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -100.6 136.08 41.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.844 HG13 ' HB ' ' A' ' 51' ' ' VAL . 48.4 t -141.92 143.96 26.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -128.34 124.92 37.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.727 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.46 HD13 HG11 ' A' ' 51' ' ' VAL . 28.9 mm -116.93 124.16 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.213 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.424 ' O ' HD11 ' A' ' 47' ' ' LEU . 11.1 t -120.57 109.39 15.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.573 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -81.41 58.52 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 17' ' ' LEU . 3.4 m -160.4 37.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.251 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.52 -59.25 0.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -158.86 -46.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.806 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.48 166.41 23.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.441 ' HA2' HD21 ' A' ' 17' ' ' LEU . . . -58.45 -164.18 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.439 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.4 tp -72.69 -29.71 63.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.741 0.305 . . . . 0.0 110.433 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 63.36 50.9 58.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.555 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.597 ' SG ' HG23 ' A' ' 39' ' ' ILE . 52.7 t -161.52 156.99 24.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.78 173.46 6.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.451 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.977 HD11 HG22 ' A' ' 76' ' ' VAL . 19.3 pt -142.01 133.65 26.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.98 0.419 . . . . 0.0 111.341 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.06 162.17 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.734 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.86 145.7 30.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 110.381 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -88.6 160.33 30.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.028 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.535 ' CD ' HD12 ' A' ' 97' ' ' LEU . 59.0 Cg_endo -71.33 -160.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.827 2.351 . . . . 0.0 112.156 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.33 -29.57 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.67 -31.78 72.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' CB ' HD21 ' A' ' 97' ' ' LEU . 2.4 mtmt -155.4 74.31 5.38 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.28 125.99 10.69 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.589 2.193 . . . . 0.0 112.32 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.23 -178.99 48.07 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 75' ' ' ALA . 26.9 mm -92.47 116.99 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 2.5 m-85 -107.54 170.39 8.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.597 HG23 ' SG ' ' A' ' 25' ' ' CYS . 19.7 mm -107.65 129.64 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 -169.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -46.72 141.2 4.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.36 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 43' ' ' LYS . 13.6 t -109.27 157.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.854 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.433 ' N ' HG12 ' A' ' 42' ' ' VAL . 24.7 mttp -120.91 145.28 41.12 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.127 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 17.3 Cg_exo -66.67 173.56 7.76 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.616 2.211 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.32 43.22 43.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.757 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.8 OUTLIER -136.71 -174.16 3.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.369 . . . . 0.0 110.896 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 16' ' ' SER . 46.9 mt -84.95 -35.24 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.449 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.463 ' HA ' HD12 ' A' ' 53' ' ' LEU . 16.4 p -56.28 -41.07 75.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.59 -40.22 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.686 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -59.8 -39.66 85.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.851 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.844 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.6 m -80.45 -30.25 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.035 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.73 64.12 0.72 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.472 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 48' ' ' SER . 18.0 mt -108.25 164.56 12.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 0.0 111.005 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.05 162.62 5.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.8 mt -59.83 140.44 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.811 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.08 -38.16 3.46 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.451 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -55.52 157.33 3.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.673 0.273 . . . . 0.0 110.767 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.407 ' O ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.44 114.99 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.161 -179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 39' ' ' ILE . 6.7 mt -69.06 121.09 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.869 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 88' ' ' SER . 32.0 m -109.47 9.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.885 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.62 146.5 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.834 0.35 . . . . 0.0 111.336 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.675 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 61.9 t -151.0 106.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.94 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 58.68 30.94 20.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.016 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.23 -28.41 13.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.522 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.29 129.67 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -71.45 107.35 4.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.852 ' CE1' HD22 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -82.54 0.02 44.57 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.376 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 t -60.53 -54.3 47.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.796 0.331 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -108.72 33.7 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.852 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.2 tp -92.94 148.28 22.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' O ' HD11 ' A' ' 37' ' ' ILE . 4.8 t0 -89.52 170.57 10.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.004 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -62.76 -53.03 60.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -57.6 -38.0 74.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.945 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.569 ' O ' HG22 ' A' ' 78' ' ' VAL . 7.3 mt-10 -64.89 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.603 ' HB2' HG13 ' A' ' 37' ' ' ILE . . . -67.56 -42.07 83.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 27' ' ' ILE . 33.1 t -70.87 -46.58 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.04 -55.92 25.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 74' ' ' GLU . 33.8 m -58.39 -45.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.217 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.494 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.3 mm? -65.02 -30.83 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.715 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -82.58 -30.49 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 -66.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -84.9 144.81 28.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.5 ' HD2' HG13 ' A' ' 18' ' ' VAL . 4.8 mtt180 -92.65 -57.6 2.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.738 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.7 p -89.86 77.67 6.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.56 139.23 48.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 m -92.74 116.9 29.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.12 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.644 HG22 HG22 ' A' ' 62' ' ' VAL . 10.1 pt -111.05 127.44 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.696 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.555 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -97.26 103.48 15.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.469 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -105.34 151.39 7.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.635 ' N ' HD13 ' A' ' 89' ' ' ILE . 31.7 t -124.89 114.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.768 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.38 136.63 49.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.506 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 84.59 -20.56 0.29 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.194 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.2 -21.18 46.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.87 -30.13 2.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.519 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 63.4 mtp85 -55.43 -34.52 64.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.563 0.22 . . . . 0.0 111.01 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -54.03 -37.13 63.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.128 0.489 . . . . 0.0 110.108 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.535 HD12 ' CD ' ' A' ' 31' ' ' PRO . 4.6 mm? -71.29 -55.27 8.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.8 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.419 ' CD2' ' HA2' ' A' ' 56' ' ' GLY . 23.6 m-85 -50.83 -30.92 15.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 21.0 mmt -70.2 121.84 18.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.942 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.701 0.286 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.3 170.35 2.39 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.534 2.156 . . . . 0.0 112.255 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 28.2 mt -119.36 149.0 42.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.792 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -93.15 158.01 15.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 32.1 mt -147.51 130.02 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.736 HG21 HG11 ' A' ' 76' ' ' VAL . 25.5 m -115.13 151.04 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.94 125.95 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.54 ' CD1' HG23 ' A' ' 27' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.968 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.643 0.259 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.08 140.62 30.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.341 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.72 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -120.17 117.37 27.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.602 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -86.24 143.06 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.83 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.76 HG13 ' HB ' ' A' ' 51' ' ' VAL . 22.0 t -148.16 150.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.298 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -130.3 122.24 27.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.777 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.46 HD12 ' CD1' ' A' ' 23' ' ' LEU . 37.7 mm -110.33 129.4 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.28 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.4 144.98 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD12 ' HA2' ' A' ' 22' ' ' GLY . 0.6 OUTLIER -63.49 -44.54 94.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.977 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.5 t 68.57 -67.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.286 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.43 -84.73 0.62 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.541 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 t -140.03 31.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 116.88 23.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -57.7 -87.11 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.614 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD23 ' HB2' ' B' ' 118' ' ' LEU . 14.1 tp -132.94 -48.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.826 0.345 . . . . 0.0 110.651 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.508 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 93.88 29.16 10.08 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.383 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.726 ' SG ' HG22 ' A' ' 42' ' ' VAL . 42.7 t -155.93 157.55 36.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.531 ' HA ' HD12 ' B' ' 118' ' ' LEU . 17.8 m -114.7 173.8 6.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.425 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.91 HD11 HG22 ' A' ' 76' ' ' VAL . 7.1 pt -138.12 153.99 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.041 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.3 p -137.22 161.71 35.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.594 ' O ' HD22 ' B' ' 113' ' ' LEU . 2.4 p -105.45 154.96 19.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -108.86 -177.35 21.64 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.764 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HD2' HD13 ' A' ' 97' ' ' LEU . 38.5 Cg_endo -66.49 -166.44 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.681 2.254 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.9 mt -85.63 -23.82 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.236 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -69.75 -30.99 68.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HB3' HD11 ' A' ' 97' ' ' LEU . 8.2 tttt -146.47 69.54 12.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -73.92 143.12 32.51 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.93 163.78 20.11 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.543 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 67' ' ' PHE . 12.7 mm -81.63 114.56 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.671 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 2.8 m-30 -100.53 171.73 7.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.187 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.679 HG23 ' SG ' ' A' ' 25' ' ' CYS . 17.8 mm -107.72 121.03 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.017 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.6 OUTLIER -90.01 -169.41 2.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.548 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -44.51 140.08 2.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG22 ' SG ' ' A' ' 25' ' ' CYS . 23.6 t -119.53 140.11 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.711 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -104.44 149.68 37.64 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.042 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.32 168.42 21.02 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.658 2.238 . . . . 0.0 112.321 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.02 60.8 8.17 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.308 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.508 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -158.9 -177.62 6.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.984 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.2 mm? -71.65 -49.67 37.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.819 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.516 ' CB ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -56.72 -38.29 72.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.04 -38.43 66.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -66.79 -42.78 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.76 ' HB ' HG13 ' A' ' 13' ' ' VAL . 35.7 m -70.09 -27.26 31.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.273 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.97 52.58 1.17 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.489 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' A' ' 48' ' ' SER . 16.9 mt -94.96 160.25 14.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.932 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -159.57 158.55 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mt -58.55 136.56 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 111.47 -37.81 3.55 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -49.21 164.69 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.291 . . . . 0.0 110.908 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.622 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 19.9 tt0 -146.94 113.7 6.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.115 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 mt -69.47 122.87 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.894 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -110.63 5.64 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.846 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -168.5 146.16 4.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.84 0.352 . . . . 0.0 111.13 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 87' ' ' ILE . 39.1 t -152.22 107.92 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 57.51 31.06 19.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.26 -28.13 14.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 t -62.9 127.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.878 0.371 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.09 119.24 16.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.628 ' CE1' HD22 ' A' ' 70' ' ' LEU . 1.6 m-85 -96.19 23.11 6.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.042 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.5 p -77.16 -57.14 4.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.585 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -108.41 29.37 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.675 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.628 HD22 ' CE1' ' A' ' 67' ' ' PHE . 1.8 tp -84.65 148.48 26.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.944 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.32 164.69 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 -59.69 -55.04 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -56.99 -37.6 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HB3' HD11 ' A' ' 70' ' ' LEU . 55.6 mt-10 -61.94 -41.6 98.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.466 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -61.63 -47.32 85.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.91 HG22 HD11 ' A' ' 27' ' ' ILE . 43.0 t -68.59 -42.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.123 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -56.74 16.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 79' ' ' LEU . 31.8 m -58.49 -45.94 89.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.849 0.357 . . . . 0.0 111.146 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD2' HG11 ' A' ' 62' ' ' VAL . 3.4 mm? -63.42 -31.78 73.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.521 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -82.65 -29.51 29.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 t -65.97 -63.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.28 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.51 139.6 30.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.144 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.411 ' CG ' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -81.11 -59.48 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.61 88.13 6.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.556 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.404 ' CD1' HD13 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -122.53 134.91 54.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.0 m -84.64 117.0 23.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.243 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.852 HG22 HG13 ' A' ' 62' ' ' VAL . 11.9 pt -112.38 133.61 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.636 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.0 114.67 29.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.572 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -114.53 152.31 16.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.956 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.772 HG13 ' CB ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -123.13 115.86 46.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.498 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.611 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -58.61 134.12 56.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.244 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.74 -20.37 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.249 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.772 ' CB ' HG13 ' A' ' 90' ' ' VAL . . . -55.68 -24.32 33.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.091 0.472 . . . . 0.0 110.816 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -118.44 -30.32 1.73 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.134 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 42.3 mtp180 -56.06 -34.25 65.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.293 0.237 . . . . 0.0 111.287 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -48.18 -49.4 32.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.882 0.372 . . . . 0.0 110.701 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.671 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 19.7 mt -71.33 -43.76 66.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.766 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.96 -30.45 59.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -59.48 -34.28 72.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.589 0.233 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.25 103.25 0.3 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.652 2.235 . . . . 0.0 112.457 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 29' ' ' SER . 2.0 mt -138.63 179.77 6.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.851 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -96.09 150.51 20.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt -138.67 127.2 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.219 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.862 HG21 HG21 ' A' ' 76' ' ' VAL . 23.7 m -127.26 129.48 47.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.99 133.17 34.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.739 HD11 HG12 ' A' ' 27' ' ' ILE . 2.0 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.94 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.863 0.363 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.723 ' HA ' HG22 ' A' ' 90' ' ' VAL . 10.1 mt-10 -61.63 127.16 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 21.2 ttpt -114.67 150.26 35.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.775 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 148.15 29.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.832 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.873 HG13 ' HB ' ' A' ' 51' ' ' VAL . 50.5 t -147.28 141.75 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -126.11 117.77 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.618 HD13 HG11 ' A' ' 51' ' ' VAL . 31.6 mm -107.73 115.9 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.215 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.9 p -134.69 131.49 37.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.879 HD13 ' HG2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -66.04 153.79 41.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.27 54.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.32 -91.0 1.46 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.562 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -117.89 67.88 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -153.64 -177.46 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.783 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.563 ' O ' HD12 ' A' ' 47' ' ' LEU . . . -144.75 -157.14 7.09 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.465 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 48' ' ' SER . 17.9 tp -93.34 -29.44 15.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 0.0 110.555 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 59.96 50.2 70.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.733 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.38 152.82 24.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.3 m -114.89 173.57 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.681 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.824 HD11 HG22 ' A' ' 76' ' ' VAL . 6.9 pt -135.54 141.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.104 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 p -117.22 161.53 19.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.798 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 p -105.45 142.91 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.769 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -91.4 167.8 31.61 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.624 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.683 ' HD2' HD13 ' A' ' 97' ' ' LEU . 89.6 Cg_endo -78.67 -165.62 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.716 2.277 . . . . 0.0 112.276 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 32' ' ' ILE . 4.2 mp -65.79 -28.17 43.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.164 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.34 -26.76 65.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -156.48 66.9 4.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 111.243 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.59 111.69 3.04 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.645 2.23 . . . . 0.0 112.013 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.45 -170.74 37.32 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.608 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.557 HG22 HD12 ' A' ' 59' ' ' ILE . 14.0 mm -94.97 118.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.79 0.329 . . . . 0.0 111.025 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 52.0 m-85 -111.24 174.67 5.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.318 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm -107.69 136.46 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.194 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.12 -169.45 1.58 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.638 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CG ' HD11 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -47.25 140.19 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.262 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.86 148.75 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -107.94 138.84 20.19 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.3 173.22 2.7 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.471 2.114 . . . . 0.0 112.111 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.22 27.77 24.7 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.543 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.447 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -121.8 166.24 14.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.86 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.563 HD12 ' O ' ' A' ' 22' ' ' GLY . 12.8 mt -66.32 -35.66 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.705 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.55 ' HA ' HD12 ' A' ' 53' ' ' LEU . 11.7 p -53.09 -40.95 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.03 -39.85 65.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -60.56 -35.06 75.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.803 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.873 ' HB ' HG13 ' A' ' 13' ' ' VAL . 28.2 m -82.44 -30.83 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.68 41.27 1.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.457 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 48' ' ' SER . 19.8 mt -90.18 164.68 14.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.988 0.423 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.93 168.2 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.613 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.533 HD11 ' CG ' ' A' ' 41' ' ' HIS . 20.2 mt -65.07 133.78 30.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.721 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' ARG . . . 112.77 -18.0 22.48 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.358 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' CB ' HD11 ' A' ' 89' ' ' ILE . 64.5 m-20 -71.97 169.13 16.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -148.52 115.08 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.04 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.557 HD12 HG22 ' A' ' 37' ' ' ILE . 3.8 mt -69.02 116.95 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.652 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 88' ' ' SER . 27.0 m -104.21 3.88 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.793 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -176.44 152.68 1.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.729 HG13 HG22 ' A' ' 87' ' ' ILE . 47.7 t -151.95 102.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 60.58 37.77 19.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.92 -31.94 7.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 t -70.51 114.65 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 0.0 111.029 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.13 124.16 21.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 2.2 m-85 -96.11 21.9 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.102 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.7 t -73.76 -37.58 64.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.969 0.414 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -128.9 28.85 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.733 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.601 HD22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -82.74 148.01 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.03 158.05 25.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -57.34 -53.51 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.009 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -58.47 -38.62 77.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.856 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.08 -44.13 97.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' N ' HD21 ' A' ' 70' ' ' LEU . . . -59.54 -45.66 91.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.824 HG22 HD11 ' A' ' 27' ' ' ILE . 38.1 t -69.31 -42.64 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -55.99 -58.9 5.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 74' ' ' GLU . 27.1 m -58.58 -40.53 79.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.181 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -68.55 -29.52 68.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.672 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.717 ' HE2' HD23 ' B' ' 118' ' ' LEU . 4.0 mptp? -82.59 -33.18 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -60.94 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.59 127.22 41.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.879 ' HG2' HD13 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -78.15 -45.84 22.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.7 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -100.42 92.44 5.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.66 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.629 ' H ' HD12 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -132.22 144.35 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.4 m -89.43 117.01 28.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.272 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.729 HG22 HG13 ' A' ' 62' ' ' VAL . 13.1 pt -112.71 127.44 69.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.859 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 60' ' ' VAL . 2.0 t -94.66 116.66 29.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.247 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.468 HD11 ' CB ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -123.67 142.66 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.207 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 10' ' ' GLU . 40.5 t -109.76 131.86 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.508 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -69.65 136.56 51.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.713 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 83.99 -17.34 0.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.396 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -54.95 -21.3 11.26 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.881 0.372 . . . . 0.0 111.102 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -30.47 2.52 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.68 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD3' ' CB ' ' A' ' 92' ' ' ALA . 1.7 ptt180 -56.04 -34.47 65.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.672 0.273 . . . . 0.0 111.321 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -49.97 38.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.683 HD13 ' HD2' ' A' ' 31' ' ' PRO . 14.9 mt -71.39 -58.43 3.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -46.05 -40.5 10.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.411 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 38.0 mmt -73.17 64.83 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.8 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.901 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.729 0.299 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.13 160.93 2.81 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.624 2.216 . . . . 0.0 112.303 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.57 128.56 52.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -62.73 145.24 55.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 29.9 mt -141.71 138.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.641 HG21 HG11 ' A' ' 76' ' ' VAL . 68.5 m -124.4 147.36 48.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -99.01 138.05 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.717 HD23 ' HE2' ' A' ' 80' ' ' LYS . 3.1 mt . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.78 0.324 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 90' ' ' VAL . 54.7 mt-10 -59.88 131.93 52.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.799 ' HD2' HG23 ' A' ' 89' ' ' ILE . 0.8 OUTLIER -112.4 141.2 46.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.847 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -109.3 143.55 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.729 HG13 ' HB ' ' A' ' 51' ' ' VAL . 18.5 t -149.96 153.15 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.389 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.37 114.54 9.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.636 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.587 HD12 ' CD1' ' A' ' 23' ' ' LEU . 41.3 mm -97.92 118.92 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 p -129.25 109.97 11.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.636 HD22 ' NH1' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -59.16 121.84 12.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.8 t -71.03 -47.26 62.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.07 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.84 -58.58 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.546 ' HA ' HD21 ' A' ' 17' ' ' LEU . 4.2 t -164.34 49.11 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.924 0.392 . . . . 0.0 110.935 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -110.75 -30.78 7.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.023 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' HD23 ' A' ' 47' ' ' LEU . . . 92.5 -122.53 6.92 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.587 ' CD1' HD12 ' A' ' 15' ' ' ILE . 15.5 tp -124.41 -50.24 1.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.887 0.375 . . . . 0.0 110.586 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 46' ' ' SER . . . 96.0 28.24 9.52 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.364 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.75 ' SG ' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -147.28 160.95 41.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.393 . . . . 0.0 111.152 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 40' ' ' SER . 0.6 OUTLIER -114.94 173.64 6.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.971 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.047 HD11 HG22 ' A' ' 76' ' ' VAL . 26.0 pt -143.45 135.57 23.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.2 t -119.78 161.78 20.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.657 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.704 ' O ' HD22 ' B' ' 113' ' ' LEU . 1.0 OUTLIER -105.11 147.67 27.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 -178.32 46.31 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.589 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.571 ' HD2' HD13 ' A' ' 97' ' ' LEU . 37.1 Cg_endo -65.68 -165.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.62 2.213 . . . . 0.0 112.236 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.86 -30.06 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.067 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -68.05 -30.21 69.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.086 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -143.53 74.14 17.09 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.014 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.82 141.51 27.31 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.594 2.196 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.6 173.33 40.44 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.656 HG13 ' HB2' ' A' ' 75' ' ' ALA . 23.9 mm -90.32 115.09 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.054 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.859 ' CE2' HD12 ' A' ' 97' ' ' LEU . 3.4 m-85 -105.56 171.35 7.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 27' ' ' ILE . 23.7 mm -107.73 137.49 38.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.15 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -106.1 -169.34 1.56 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.442 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 142.48 1.78 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.184 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.75 HG22 ' SG ' ' A' ' 25' ' ' CYS . 2.3 t -110.08 157.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.972 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -114.5 145.43 33.79 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.05 162.51 38.8 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.543 2.162 . . . . 0.0 112.197 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.9 86.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.45 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.488 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -135.56 -177.36 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 22' ' ' GLY . 3.2 mm? -71.04 -49.52 43.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.628 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.432 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -53.46 -41.84 66.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.43 84.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -64.15 -37.57 87.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.731 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.729 ' HB ' HG13 ' A' ' 13' ' ' VAL . 29.7 m -78.89 -36.38 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.46 70.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.406 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.566 ' O ' HG21 ' A' ' 42' ' ' VAL . 29.3 mt -116.38 150.91 36.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 110.987 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -154.58 162.45 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.455 ' CG2' ' CZ ' ' A' ' 98' ' ' PHE . 3.9 mt -57.92 137.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.475 ' HA3' ' HG2' ' A' ' 95' ' ' ARG . . . 109.67 -29.18 9.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.564 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.438 ' HB3' HG13 ' A' ' 89' ' ' ILE . 21.6 m-20 -57.63 164.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.649 0.261 . . . . 0.0 110.593 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -146.39 114.4 6.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 111.239 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.27 117.15 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.895 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.06 0.58 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.808 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -175.62 159.49 2.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.906 ' O ' HG12 ' A' ' 65' ' ' VAL . 62.1 t -155.22 103.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 63.78 17.23 10.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.278 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.12 -27.21 9.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.642 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 62' ' ' VAL . 10.8 p -65.05 134.23 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.728 0.299 . . . . 0.0 111.215 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.57 121.81 24.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.522 ' CZ ' HG21 ' A' ' 62' ' ' VAL . 1.4 m-85 -94.84 19.02 10.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.236 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.1 p -75.34 -56.74 4.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -106.98 26.65 9.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.522 HD22 ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -87.19 150.34 24.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.26 167.9 11.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.56 -53.57 56.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.968 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -54.67 -41.99 70.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -59.77 -42.64 93.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.761 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -63.4 -46.13 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.133 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.047 HG22 HD11 ' A' ' 27' ' ' ILE . 40.4 t -68.67 -36.96 76.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -58.98 6.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.675 HG23 HD22 ' A' ' 79' ' ' LEU . 34.3 m -57.86 -40.47 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.312 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.0 mm? -66.55 -32.14 73.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.969 0.414 . . . . 0.0 110.656 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -35.97 37.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.869 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 t -61.0 -57.08 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.177 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.458 ' HB3' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -98.92 142.84 29.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.253 -179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.636 ' NH1' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -91.11 -49.03 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.509 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 t -98.21 81.99 2.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 82' ' ' SER . 0.2 OUTLIER -120.51 137.83 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.278 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.5 m -85.97 116.92 24.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.833 HG22 HG22 ' A' ' 62' ' ' VAL . 7.2 pt -110.28 132.68 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.95 0.405 . . . . 0.0 111.782 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -101.88 118.95 37.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.37 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.799 HG23 ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -123.4 151.84 28.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.607 ' N ' HD13 ' A' ' 89' ' ' ILE . 41.1 t -125.71 110.45 24.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.442 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . -55.41 138.18 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.462 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . 85.38 -22.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.927 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . . . -57.46 -21.85 39.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.033 0.444 . . . . 0.0 110.854 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -117.27 -30.34 1.92 Allowed Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.428 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.475 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 31.6 mtt-85 -56.19 -34.73 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.558 0.218 . . . . 0.0 111.352 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -49.32 -50.03 41.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.679 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.859 HD12 ' CE2' ' A' ' 38' ' ' PHE . 11.3 mt -71.74 -43.51 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.455 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -53.01 -24.76 10.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.358 -179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.6 mmm -53.13 122.49 9.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.685 0.279 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.43 179.22 6.73 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.607 2.205 . . . . 0.0 112.349 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 29' ' ' SER . 16.8 mt -123.25 149.8 44.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.78 107.21 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.048 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.484 HG22 ' N ' ' B' ' 116' ' ' THR . 21.2 mt -100.62 158.44 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' THR . . . . . 0.484 ' N ' HG22 ' B' ' 115' ' ' ILE . 78.5 m -150.93 148.94 29.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.444 ' O ' HD23 ' B' ' 118' ' ' LEU . 0.9 OUTLIER -94.67 136.57 34.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.793 HD11 HD13 ' A' ' 27' ' ' ILE . 78.1 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 stop_ save_